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ap  ampicillin 
APS  ammonium  persulphate 
ATP  Adenosine  5-triphosphate 
bp  base  pairs 
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EtOH  ethanol 
g  centrifugal  force  equivalent  to  gravitional 
acceleration 
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knt  kilonucleotides 
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V mins  minutes 
Mr  molecular  weight 
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ORF  open  reading  frame 
OTC  oxytetracycline 
0C  degrees  celsius 
nt  nucleotide 
PCR  polymerase  chain  reaction 
PEG  polyethylene  glycol 
Pi  orthophosphate 
PIPES  piperazine-NN'-bis-2-ethane  sulphonic  acid 
PPCR  potential  protein  coding  region 
RBS  ribosome  binding  site 
RNA  ribonucleic  acid 
mRNA  messenger  ribonucleic  acid 
rRNA  ribosomal  ribonucleic  acid 
tRNA  transfer  ribonucleic  acid 
rpm  revolutions  per  minute 
RT  room  temperature 
a  sigma 
S.  Streptomyces 
SDS  sodium  dodecylsulphate 
ssi  second  strand  initiation 
TEMED  NNN-N'-tetramethylethylenediamine 
TES  N-  tris  (hydroxymethyl)  methy-2- 
aminoethanesulphonic  acid 
transf.  µg  transformants  per  microgram 
TRIS  tris  (hydroxymethyl)  methylamine 
TSB  tryptone  soya  broth 
tsr  thiostrepton 
U  units 
UV  ultraviolet 
V  volts 
v/v  volume  by  volume 
w/v  weight  by  volume 
W  watts 
Xgal  5-bromo4-chloro-3-indoyl-  3-galactoside 
YEME  yeast  extract-malt  extract 
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vii Summary 
Prior  to  the  work  described  in  this  thesis,  a  great  deal  of  the  oxytetracycline 
cluster  (otc)  had  been  sequenced  and  the  putative  functions  of  deduced  gene 
products  assigned,  based  on  similarity  to  known  gene  products  in  the  databases. 
The  3.0  kb  KpnI23-M1uI26bfragment  located  between  the  otcD  and  otcX  loci  was 
sequenced.  Three  open  reading  frames  with  the  same  direction  of  transcription 
were  found,  otcD-ORF3,  -ORF4  and  -ORF5.  OtcD-ORF3  has  good  similarity  to 
oxidoreductases  reported  previously  in  other  polyketide  gene  clusters.  The 
biosynthesis  of  OTC  requires  three  oxidoreductase  steps,  one  at  position  C9 
which  removes  the  keto  function,  one  at  position  C6  in  the  conversion  of  4-keto- 
ATC  to  ATC  and  another  at  the  last  step  [OTC  dehydrogenase].  A  ketoreductase 
has  been  reported  previously  within  the  otcY  locus  that  shows  stronger  similarity 
to  actlII  of  S.  coelicolor.  OtcD-ORF3  has  been  tentatively  assigned  as  catalysing 
the  last  step  of  the  pathway.  OtcD-ORF4  shows  good  end-to-end  similarity  to  a 
coding  region  of  unknown  function  within  the  gene  cluster  for  daunorubicin 
biosynthesis  in  S.  griseus.  OtcD-ORF5  is  clearly  defined  as  a  potential  protein 
coding  region  that  shows  good  similarity  to  a  small  region  of  an  open  reading 
frame  within  the  B.  subtilis  genome  which  again  has  unknown  function.  The  B. 
subtilis  coding  region  is  very  hydrophobic  and  carries  a  series  of  repeat 
sequences,  the  significance  of  which  is  not  yet  understood. 
Preliminary  transcriptional  analysis  of  this  3.0  kb  KpnI23-M1UI26b  fragment  using 
low-resolution  S1  mapping  has  revealed  a  single  transcript  which  encompasses 
OtcD-ORF3  and  OtcD-ORF4.  A  stable  stem-loop  immediately  after  the 
translational  stop  codon  of  OtcD-ORF4  was  located  with  high-resolution 
mapping.  A  potential  promoter  sequence  was  located  immediately  preceding 
OtcD-ORF5,  however  no  transcript  was  detected  with  low-resolution  mapping  at 
the  time  point  when  the  RNA  was  isolated. 
Previous  attempts  to  disrupt  gene  products  in  the  otc  duster  using  suicide-type 
vectors  were  unsuccessful  possibly  due  to  poor  recombination  efficiencies. 
Various  aspects  of  the  biology  the  S.  rimosus  bacterium  were  investigated.  DNA 
isolated  from  a  dcm-  E.  coli  strain  transformed  at  a  much  higher  rate  than  DNA 
viii isolated  from  E.  coli  strains  which  were  capable  of  full  methylation  or  dam-.  The 
technique  to  transform  protoplasts  was  improved  by  electrotransformation. 
'Electrotransformants'  regenerate  much  faster  and  at  a  higher  frequency  than 
those  prepared  by  more  conventional  methods.  Another  method  of  DNA 
transfer,  conjugation  between  E.  coli  and  some  Streptomyces  strains  has  been  very 
successful.  However,  attempts  at  conjugal  transfer  between  E.  coli  and  S.  rimosus 
were  unsuccessful. 
A  strategy  to  further  analyse  the  OtcD-ORF3  gene  product  was  undertaken  by 
attempting  gene  disruption  and  replacement.  The  gentamicin-resistance  gene 
(gmr)  was  initially  inserted  into  the  Kpn126  site  of  the  reductase  gene  which  was 
carried  on  a  plasmid.  When  the  construct  was  introduced  into  S.  rimosus,  a 
homologous  recombination  event  between  the  otc  DNA  carried  on  the  plamid 
and  homologous  regions  on  the  chromosome  allowed  integration  of  this  DNA 
and  produced  gentamicin-resistant  colonies.  The  delivery  vector  has  an  unstable 
Streptomyces  replicon  and  was  lost  through  a  non-selective  round  of  growth. 
Hybridisation  analysis  confirmed  the  integration  event  but  a  high  degree  of 
amplification  was  also  observed.  Further  study  showed  the  disrupted  genome 
also  contained  deletions  of  the  otc  cluster  including  the  otrB  gene.  A  second 
integration  attempt  resulted  in  complete  loss  of  the  otc  duster.  The  otc  duster  is 
situated  towards  one  end  of  the  linear  chromosome  of  S.  rimosus  between  large 
direct  repeats.  Amplifications  and  sequential  chromosomal  deletions  have  been 
reported  in  other  Streptomyces  strains.  Typically,  the  nonessential  genes  are  lost 
in  favour  of  the  primary  metabolite  genes.  Due  to  the  location  of  the  cluster 
within  the  chromosome  the  integration  strategy  developed  was  not  successful. 
However  relocating  the  duster  could  make  this  strategy  feasible. 
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Introduction Chapter  1 
1.1  General  Introduction 
Streptomyces  are  producers  of  more  than  60%  of  the  known  antibiotics. 
The  commerical  importance  of  this  has  lead  to  intense  investigations  into  how 
these  antibiotics  are  produced.  The  work  described  in  this  thesis  investigates 
various  aspects  of  the  oxytetracycline  gene  cluster  from  Streptomyces  rimosus.  A 
general  introduction  of  the  Gram-positive  genus  Streptomyces,  it's  complex  life 
cycle  and  it's  regulation  and  differentiation,  will  be  discussed.  Particular 
emphasis  will  be  given  to  the  co-ordination  of  production  of  antibiotics  within 
this  life  cycle. 
1.2  Medical  and  Commerical  Interests  in  Streptomyces 
Secondary  metabolites,  produced  primarily  by  streptomycetes  and  fungi, 
are  not  essential  for  the  growth  of  the  organism  but  may  give  a  competitive 
advantage,  although  in  some  cases  it  is  not  clearly  evident.  Secondary 
metabolites  show  great  diversity  in  chemical  structures  and  biological  activities. 
The  majority  of  secondary  metabolites  are  biologically-active  and  based  on  their 
function,  have  been  categorised  into  two  major  groups;  the  first  group  is  seen  to 
serve  a  purpose  within  the  producing  species  and  the  second,  to  act  on  targets 
external  to  the  producer.  Broadly  speaking,  the  intrinsic  functions  of  the  first 
group  involve  mediation  of  growth,  reproduction  or  differentiation.  Numerous 
examples  fit  this  pattern  and  are  reviewed  in  Vanek  et  al.,  (1981).  The  secondary 
metabolites  which  act  on  targets  external  to  the  producing  species  include 
antibiotics,  mycotoxins,  insecticides  and  herbicides,  all  of  which  have  found  uses 
in  human  society. 
Streptomyces  have  produced  a  great  deal  of  industrial  and  medical  interest 
because  they  produce  a  multitude  of  chemically-distinct  secondary  metabolites 
such  as  aminoglycosides,  macrolides,  tetracyclines,  polyethers,  ansamycins,  (3- 
lactams  and  oligopeptides.  The  major  role  of  antibiotics,  in  both  human  and 
animal  health,  is  against  bacterial  infection.  The  mechanisms  of  action  of  the 
secreted  antibiotics  on  the  infective  bacteria  include;  inhibition  of  protein  (e.  g. 
tetracyclines  and  macrolides),  and  interference  of  RNA  (e.  g.  rifamycins)  and 
DNA  (e.  g.  anthracylines)  synthesis  (Lewin;  1994).  Anthracylines,  (such  as 
tetracenomycin  and  daunorubicin)  have  also  been  used  as  cytostatic  agents  in  the 
treatment  of  certain  kinds  of  tumours  (Ye  et  al.,  1993).  As  well  as  being  anti- 
infective  agents,  antibiotics  have  also  been  used  as  food  preservatives  to  maintain 
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freshness  in  fish,  meat  and  poultry  by  incorporation  into  ice  during  shipping 
(Crueger  and  Crueger;  1989). 
Antibiotics  have  also  been  used  in  animal  husbandry,  both  as  growth 
promoters  and  in  veterinary  medicine.  Animal  feed  is  processed  more  efficiently 
by  the  animal's  digestive  system  if  the  antibiotic  additive  is  used  at 
subtherapeutic  concentrations.  Weight  gain  may  also  be  accelerated  (Crueger 
and  Crueger;  1989).  The  cause  of  this  growth  promotion  may  be  traced  to 
changes  in  the  microflora  of  the  gastrointestinal  tract.  Originally,  large  quantities 
of  therapeutically-useful  antibiotics  such  as  penicillins,  tetracyclines  and 
erythromycins  were  added  to  the  feed  but  such  extensive  use  of  common 
antibiotics  enhanced  the  risk  of  rapid  development  of  antibiotic  resistance  in 
consumers  of  animal  products.  Government  regulations  were  established 
therefore  aimed  at  eliminating  parallel  use  of  antibiotics  in  human  medicine  and 
in  animal  feed.  Specific  antibiotics  were  subsequently  assigned  for  use  solely  in 
veterinary  work.  Bacterial  resistance  to  a  wide  range  of  antibiotics  has 
heightened  the  need  for  either  the  emergence  of  previously  undiscovered  natural 
antibiotics  or  the  production  of  synthetic  molecules,  which  are  non-toxic  to  the 
consumer  (reviewed  in  Crueger  and  Crueger;  1989). 
A  number  of  non-antibiotic  but  bioactive  metabolites  which  have  emerged 
from  Streptomyces  in  modern  screening  procedures  may  be  of  clinical  importance. 
An  example  is  triacsin,  an  inhibitor  of  acetyl-CoA  synthetase,  isolated  from 
Streptomyces  sp.  SK-1894,  capable  of  potentiating  platelet-activating  factor 
production  of  A23187-treated  rat  polymorphonuclear  leukocytes  (Omura;  1992). 
These  non-antibiotic  metabolites  could  prove  to  be  more  useful  than  antibiotics 
in  the  future  as  their  spectrum  of  uses  grow.  At  present  there  are  more  new 
discoveries  of  these  new  kinds  of  metabolites  than  of  antibiotics. 
Besides  the  above  mentioned  major  research  areas,  the  last  few  years  has 
seen  the  emergence  of  an  interest  in  Streptomyces  as  a  possible  host  organism  for 
the  production  and  secretion  of  recombinant  proteins.  The  free-living 
saprophytic  Streptomyces  species  are  well-known  producers  of  a  great  variety  of 
extracellular  enzymes,  including  amlyases,  cellulases,  xylanases,  phosphatases, 
lipases,  proteinases  and  nucleases,  as  well  as  numerous  secreted  proteinaceous 
enzyme  inhibitors  (Molnar;  1994).  Their  simple,  Gram-positive  type,  cell  wall 
structure  allows  the  exported  proteins  to  be  localised  directly  into  the  culture 
medium  instead  of  being  trapped  in  the  periplasmic  space,  in  an  insoluble  form, 
as  in  E.  soli  (Malek  et  al.,  1990).  Streptomyces  cultures  remain  metabolically-active 
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in  the  stationary  phase  and  continue  to  synthesise  and  secrete  secondary 
metabolites  in  large  amounts.  The  natural  ability  of  Streptomyces  strains  to 
secrete  extracellular  enzymes  derived  from  their  heterotrophic  existence  is, 
however,  likely  to  limit  the  commerical  exploitation  of  heterologous  protein 
secretion  by  these  microbes.  Streptomyces  lividans  is  the  most  commonly  used 
host,  due  primarily  to  the  relatively  low  amount  of  extracellular  and  intracellular 
proteases  (Aretz  et  al.,  1989).  Limited  success  has  already  been  achieved  in  the 
production  of  large  recombinant  proteins  and  work  is  actively  underway  to 
produce  a  Streptomyces  host  which  is  free  of  the  major  protease  products 
observed  in  the  culture  media  (Malek;  pers.  comm.  ).  Classified  as  a  'safe' 
microrganism,  the  handling  of  recombinant  streptomycete  systems  makes  it  an 
attractive  host  organism  well  worth  further  investigation. 
1.3  The  Streptomyces  Life  Cycle 
In  contrast  to  the  extensively-studied  bacterium  Escherichia  coli,  which  has 
a  virtually  synonymous  cell  cycle  and  life  cycle,  certain  bacteria  have  a  life  cycle 
which  goes  beyond  the  cell  cycle.  This  is  illustrated  with  Streptomyces  species. 
Streptomyces  undergo  a  complex  lifestyle,  the  initial  phase  of  which  is  growth  as 
substrate  mycelium.  Growth  occurs  mainly  by  cell-wall  extensions  at  the  hyphal 
tips.  The  hyphal  compartments  (especially  the  tip  cells)  contain  many  copies  of 
the  genome  with  very  few  sites  of  cell  division.  This  produces  a  coherent 
multicellular  mat  of  branching  hyphae  on  a  solid  medium.  As  the  colonies  grow, 
the  parts  farthest  from  the  advancing  edge  may  accumulate  various  kinds  of 
storage  materials  such  as  glycogen,  lipids,  and  polyphosphate  (Brana  et  al., 
1986).  These  parts  of  the  colony  probably  grow  more  slowly,  either  because  of 
nutrient  limitation  or  because  conditions  have  become  inhibitory  to  growth.  It  is 
at  this  point  that  the  colony  reaches  its  first  stationary  phase. 
The  second  stage  of  growth  begins  with  the  formation  first  of  an  aerial 
mycelium  growing  (both  physically  and  nutritionally)  on  the  substrate 
mycelium.  Aerial  growth  is  accompanied  by  physiological  changes  in  the 
colony,  typified  by  the  production  of  a  range  of  secondary  metabolites  that 
include  a  multitude  of  antibiotics,  extracellular  enzymes  (described  in  the 
previous  section)  and  various  polymeric  storage  compounds  such  as  glycogen. 
Aerial  growth  follows  a  short  period  of  reduced  macromolecular  synthesis 
(Granozzi  et  al.,  1990)  and  seem  to  involve  the  reuse  of  material  first  assimilated 
into  the  substrate  mycelium  either  as  macromolecules  such  as  DNA  and  proteins 
or  as  storage  compounds  (Brana  et  al.,  1986).  Thus,  as  aerial  hyphae  grow,  many 
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cells  in  the  substrate  mycelium  die  (Wildermuth;  1970).  The  growth  of  aerial 
hyphae  is  thought  to  be  driven  by  the  osmotic  potential  generated  through  the 
solubilisation  of  macromolecules  such  as  glycogen  (Chater;  1993). 
The  extension  aerial  hyphae  growth  stops  eventually  as  the  cell  enters  the 
second  stationary  phase.  Regularly-spaced  and  simultaneously-formed 
crosswalls  subdivide  the  orderly  fragmentation  of  individual  aerial  hyphae  into 
coiled  chains  of  hydrophobic  spores.  The  sporulation  septa  typically  consist  of 
two  membrane  layers  separated  by  a  double  layer  of  cell-wall  material,  an 
arrangement  which  eventually  permits  the  separation  of  adjacent  spores.  During 
the  rounding  up  of  spores,  the  spore  wall  thickens,  and  in  most  species,  a 
pigment  is  deposited  in  the  wall.  Spore  chains  may  consist  of  many  tens  of 
spores,  each  spore  compartment  containing  one  nucleoid  (Figure  1.1).  In  adverse 
conditions,  the  spores  will  mature  with  increasing  grey  pigment  and  be  released 
into  the  air  in  order  to  colonise  more  favourable  habitats  and  begin  a  new  micro 
cycle  (reviewed  in  Chater;  1993). 
1.4  Regulation  of  Differentiation  in  Streptomyces 
The  complex  regulatory  mechanisms  governing  the  temporally-  and 
spatially-arranged  processes  of  morphogenesis  and  biochemical  differentiation  in 
Streptomyces,  and  the  closely-linked  switch  from  primary  to  secondary 
metabolism  have  received  a  great  deal  of  interest.  Many  scientists  have  focussed 
on  specific  aspects  of  the  wide  range  of  secondary  metabolic  processes. 
However,  to  understand  fully  the  switch  from  primary  to  secondary  metabolism, 
the  regulation  of  primary  metabolism  also  needed  to  be  investigated.  The  most 
intensively  studied  strain,  S.  coelicolor  A3(2)  provides  examples  of  global 
regulation.  Two  series  of  mutants  have  been  isolated,  bald  (bld)  mutants,  which 
do  not  form  aerial  mycelium  and  do  not  produce,  with  the  exception  of  b1dC,  any 
antibiotics  (Piret  and  Chater;  1985),  and  white  (whi)  mutants,  which  form  aerial 
mycelium  and  produce  antibiotics  but  do  not  form  pigmented,  mature  spores 
(Chater;  1989b).  Such  mutant  phenotypes  suggest  that  antibiotic  production  and 
spore  formation  may  be  regulated  by  common  molecular  mechanisms. 
At  least  seven  different  classes  of  bald  mutants  fail  to  produce  aerial 
mycelium.  The  rarity  of  S.  coelicolor  mutants  defective  only  in  aerial  mycelium 
development  (only  bldC),  suggests  that  either  very  few  biochemical  features  are 
peculiar  to,  and  necessary  for,  aerial  hyphae  to  grow,  or  there  is  genetic 
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Figure  1.1 
Spore  chains  developing  on  aerial  hyphae.  The  central  panel  is  a  scanning 
electron  micrograph  of  aerial  hyphae  S.  lividans  before,  during  and  after  the 
process  of  sporulation  septation.  The  outer  panels  are  thin  sections  of  S.  coelicolor 
at  later  stages.  Photographs  were  taken  from  Chater  (1989a). 
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redundancy  for  such  features  so  that  mutants  are  not  isolated  readily  by  normal 
genetic  procedures.  Mutants  bldA,  D,  G  andH  have  been  termed  'conditionally 
bald'.  They  are  capable  of  producing  normal  sporulating  aerial  mycelium  when 
grown  on  mannitol  (instead  of  the  normal  glucose  source).  However,  only  bldH 
mutants  recover  antibiotic  production  in  these  conditions  (reviewed  in  Chater; 
1989a).  The  b1dA  loci  of  five  independent  bidA  mutants  were  cloned,  sequenced 
and  found  to  carry  mutations  within  16  bp  of  each  other,  none  of  which  were 
within  a  potential  protein  coding  region.  Computer  analysis  revealed  that  all 
five  encode  a  putative  tRNA  needed  for  the  translation  of  a  leucine  codon  (UUA), 
rarely  seen  in  the  G+C  rich  Streptomyces  genome  (Lawlor  et  al.,  1987). 
Circumstantial  evidence  suggests  that,  since  there  are  no  TTA  codons  in  the 
known  genes  involved  in  normal  growth,  sporulation  and  antibiotic  production, 
the  bldA-specified  tRNA,  which  is  mainly  produced  after  rapid  vegetative 
growth  is  completed  (Lawlor  et  al.,  1987),  is  needed  to  translate  the  UUA  codon- 
containing  mRNA  for  one  or  more  regulatory  proteins  that  are  themselves 
directly  or  indirectly  involved  in  activating  the  expression  of  genes  involved  in 
sporulaton  and  antibiotic  production  (Chater;  1990).  The  few  known  TTA-coding 
genes  are  nearly  all  resistance  or  regulatory  genes  from  clusters  of  antibiotic 
biosynthetic  genes  (Leskiw  et  al.,  1991),  including  actll-ORF4  from  the 
actinorhodin  cluster  (Fernandez-Moreno  et  al.,  1991).  This  theory  has  lost  some 
credibility  in  recent  years  however  when  Bibb  (1990)  showed  that  bldA  is 
expressed  during  growth.  It's  utility  of  the  tRNA  may  be  subject  to  maturation. 
Growth  next  to  a  wild-type  strain  can  cause  a  number  of  the  bld  mutants 
to  produce  aerial  mycelium,  providing  evidence  for  a  diffusible  extracellular 
factor.  A  possible  candidate  may  be  the  SapB  protein.  Spore  associated  proteins 
(Saps)  are  associated  with  the  surface  of  aerial  hyphae  and  spores,  serving  a 
variety  of  functions  including  providing  directionality  in  hyphal  growth, 
preventing  the  desiccation  of  aerial  hyphae  and  providing  a  hydophobic  surface 
to  the  spores  (Guijarro  et  al.,  1988).  The  sapB  gene  has  proved  difficult  to  clone. 
However,  antibodies  were  made  and  two  mutants  were  found  that  did  not 
produce  SapB  on  rich  medium.  These  mutants  also  did  not  produce  aerial 
mycelium.  Subsequent  investigation  with  the  previously-identified  bld  A,  B,  C,  D, 
G,  H,  and  I  mutants  revealed  that  they  failed  to  produce  SapB.  A  colony 
overproducing  SapB  grown  in  close  proximity  to  these  bld  mutants  resulted  in 
the  production  of  aerial  mycelium  (Willey  et  al.,  1991).  Further  complementation 
studies  using  pairwise  combinations  of  different  bld  mutants  grown  near  to  each 
other  on  rich  medium  showed  extracellular  complementation,  such  that  one  of 
the  pairs  produced  both  aerial  mycelium  and  SapB  (Willey  et  al.,  1991).  Four 
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complementation  groups  have  been  found  and  are  interpreted  in  terms  of  a 
cascade  of  extracellular  signals  reminiscent  of  those  exchanged  during  fruiting 
body  development  in  Myxococcus  xanthus  (Kaiser  et  al.,  1989).  Following  this 
hypothesis,  the  bld  mutants  might  conceivably  be  defective  primarily  in  elements 
of  this  cascade  (Wiley  et  al.,  1991). 
Formation  of  aerial  hyphae  in  S.  coelicolor  is  accompanied  by  a  change  in 
the  surface  of  the  colony,  which  adopts  a  hairy  white  appearance.  When 
sporulation  takes  place,  this  aerial  mycelium  becomes  grey,  because  of  a  spore- 
associated  pigment.  Thus  mutants  (whi)  blocked  in  sporulation  retain  the 
immature  white  colony  colour  even  after  prolonged  incubation  (Hopwood  et  al., 
1970).  The  process  of  sporulation  of  aerial  hyphae  involves  at  least  eight 
sporulation-specific  genetic  loci  (the  whi  genes).  The  switch  from  continued 
extension  of  aerial  hyphae  to  their  development  into  chains  of  spores  is 
controlled  by  aa  factor,  QWhiG.  Sequence  analysis  confirmed  the  general 
organisation  typical  of  sigma  factors  (Chater  et  al.,  1989b).  Inactivation  of  whiG 
leads  to  complete  failure  of  the  sporulation  process.  Conversely,  a  high-copy 
number  of  whiG  leads  to  abundant  sporulation,  and  causes  the  spores  to  be 
produced  even  in  the  substrate  hyphae  growing  into  the  agar  and  in  cultures 
growing  in  liquid  medium  (Chater  et  al.,  1989c).  Throughout  its  length  Qwh'G 
closely  resembles  another  factor,  0D,  of  B.  subtilis,  especially  in  the  so-called  2.4 
and  4.2  regions  (Chater  et  al.,  1990),  which  in  other  sigma  factors  appear  to  make 
base-specific  contacts  with  cognate  promoters  (Helmann  et  al.,  1988).  This 
suggests  that  the  owhiG  and  QD  RNA  polymerase  holoenzymes  might  recognise 
similar  promoters.  Mutants  of  B.  subtilis  deficient  in  QD  remain  filamentous  and 
non-motile,  very  similar  phenotypically  to  the  whiG  mutants,  which  are  unable  to 
develop  beyond  the  aerial  hyphal  stage.  This  family  of  o  factors  may  play  a  role 
in  the  dispersal  of  bacteria  during  nutrient  limitation. 
The  whiE  locus  consists  of  a  gene  duster  of  seven  open  reading  frames, 
most  encoding  recognisable  homologues  of  proteins  involved  in  the  biosynthesis 
of  polyketide  antibiotics  such  as  actinorhodin,  oxytetracycline,  tetracenomycin 
and  granaticin  (Hopwood  and  Sherman;  1990).  Disruption  of  the  wild-type  whiE 
locus  with  cloned  DNA  generated  from  the  mutant  phenotype  resulted  in  non- 
pigmented  spores  suggesting  that  the  gene  product  of  thewhiE  locus  is 
responsible  for  spore  pigment  synthesis.  The  remarkable  number  of  conserved 
genes  with  the  biosynthesis  of  polyketide  antibiotics  and  spore  pigments 
suggests  that  an  ancient  evolutionary  split  occurred  between  the  two  classes  of 
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genes  before  the  antibiotic  clusters  diverged  from  each  other  (Blanco  et  al.,  1993). 
The  regulatory  mechanisms  probably  also  diverged  at  about  the  same  time. 
The  remainder  of  this  chapter  will  focus  on  the  large  group  of  secondary 
metabolites,  the  antibiotics.  Particular  emphasis  will  be  placed  on  the  polyketide 
class  of  antibiotics,  culminating  in  a  discussion  of  the  specific  gene  functions  of 
oxytetracycline  duster  produced  by  S.  rimosus. 
1.5  The  Architecture  of  Antibiotic  Biosynthetic  Gene  Clusters 
It  is  a  common  feature  of  antibiotic  biosynthetic  and  antibiotic  resistance 
genes  that  they  are  situated  adjacent  to  each  other  as  a  cluster  on  the 
chromosome,  implying  that  they  have  evolved  as  a  unit  (Maplestone  et  al.,  1992). 
An  exception  to  this  rule  is  the  genes  encoding  methylenomycin  production. 
Although  the  production  genes  are  clustered,  they  are  very  unusual  in  being 
plasmid-located;  in  two  different  hosts  they  are  found  on  different 
extrachromosomal  elements,  one  of  which,  SCP1,  is  a  350  kb  linear  plasmid  in  S. 
coelicolor  (Kirby  and  Hopwood;  1977).  The  pathways  for  the  biosynthesis  of 
antibiotics  are  complex  and  consist  of  around  10-30  steps,  requiring  a 
corresponding  number  of  gene  products.  Therefore,  the  clustering  of  structural 
genes  increases  the  probabilities  of  them  being  passed  on  as  a  single  unit  to 
subsequent  generations  or  to  other  species  (Stone  and  Williams,  1992).  Evidence 
so  far  suggests  that  gene  clusters  for  antibiotic  biosynthesis  will  rarely  be  found 
to  represent  single  transcription  units  (Chater;  1993).  Instead,  the  gene  clusters 
that  have  been  studied  are  organised  as  groups  of  operons,  some  monocistronic 
and  others  polycistronic,  and  some  transcribed  from  DNA  in  each  direction. 
Examples  are  seen  for  the  biosynthesis  of  methylenomycin  in  S.  coelicolor  A3(2) 
(Chater  et  al.,  1989b),  streptomycin  in  S.  griseus  (Piepersberg  et  al.,  1988)  and 
tylosin  in  S.  fradiae  (Hershberger  et  al.,  1989).  The  gene  dusters  for  actinorhodin 
and  methylenomycin  in  S.  coelicolor  A3(2)  are  shown  in  figure  1.2  and  discussed 
in  detail  below. 
For  the  actinorhodin  cluster,  six  possible  transcription  units  were 
identified  by  in  vivo  disruption  of  the  actinorhodin  cluster  and  S1  nuclease 
mapping  (Fernandez-Moreno  et  al.,  1991).  Mutational  cloning,  using  att-deleted 
4  C31  derivative  phage,  to  integrate  into  the  chromosome  via  a  homologous  DNA 
fragment  cloned  in  the  vector,  revealed  the  approximate  location  of  transcripts 
(Fernandez-Moreno  et  al.,  1991).  Si  mapping  was  then  used  to  define  the 
direction  and  length  of  transcripts.  A  complete  description  of  all  mutant  classes 
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Figure  1.2 
The  organisation  of  two  gene  clusters  for  antibiotic  production  in  S.  coelicolor 
A3(2).  Open  reading  frames  are  represented  by  stippled  arrows  and  the  position 
and  extent  of  transcription  is  represented  by  wavy  lines.  Mutant  lasses  in  the 
actinorhodin  cluster  are  represented  by  roman  numerals.  Data  taken  from 
Chater,  1992. 
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mentioned  here  can  be  found  in  section  1.7.2.  On  the  right  side,  reading  from  left 
to  right,  is  a  large  (6.5  knt)  polycistronic  transcript  corresponding  to  genes  of 
mutant  classes  I,  VII  and  IV  (as  well  as  VB).  A  small  transcript  (0.8  knt) 
corresponding  to  the  gene  of  class  III  was  found  to  read  in  the  opposite  direction. 
A  long  transcript  (-9  knt)  covers  the  two  genes  (VI  and  VA)  on  the  left  side, 
reading  towards  the  centre  of  the  cluster.  The  class  II  genes  appear  to  contain 
three  transcripts  encoding  four  open  reading  frames  (ORFs).  The  first  ORF  is 
transcribed  towards  the  VI  and  VA  transcript,  ORFs  2  and  3  are  transcribed  in 
the  opposite  direction  as  a  single  message  and  the  final  ORF  is  also  transcribed  in 
the  same  direction.  However  it  appears  to  be  contained  on  a  separate  transcript. 
The  methylenomycin  resistance  gene,  mmr,  is  embedded  in  the  cluster  of 
production  genes  (Chater  et  al.,  1985),  see  figure  1.2.  Transcription  of  mmr  is  from 
a  monocistronic  mRNA  reading  from  left  to  right,  and  is  flanked  on  both  sides  by 
large  rightwards  transcripts  of  about  6.5  knt  (right)  and  9.5  knt  (left).  The  major 
mmr  transcriptional  start  point  (tsp)  is  separated  by  only  81  bp  from  a  divergent 
production  gene.  A  pattern  of  direct  and  inverted  repeats  in  the  nucleotide 
sequence  in  this  region  may  play  a  part  in  co-ordinating  resistance  to,  and 
production  of,  methylenomycin.  A  single  end-to-end  transcript  has  also  been 
detected  reading  left-to-right.  The  3'  end  of  the  mmr  transcript  and  another 
production  gene  overlap  by  20-30  nt.  The  common  region  contains  a  stable  stem- 
loop  structure  and  has  shown  in  vitro  termination  activity  in  at  least  one  direction 
(Neal  and  Chater;  1991). 
While  a  gene  for  actinorhodin  resistance  is  presumed  to  be  present  in  the 
act  cluster,  it  has  not  been  localised.  On  the  other  hand,  it  is  clear  that  resistance 
to  methylenomycin  is  encoded  by  a  gene  placed  approximately  in  the  centre  of 
the  cluster  and  is  transcribed  divergently  from  a  presumed  biosynthetic 
transcript.  This  feature  is  seen  in  several  other  resistance  genes;  ermE  gene  of  the 
eythromycin  producer  Saccharopolyspora  erythraea  (Bibb  et  al.,  1986);  the  aph  gene 
of  the  neomycin  producer,  S.  fradiae  (Janssen  et  al.,  1989);  and  the  sph  gene  of  the 
hydroxystreptomycin  producer,  S.  glaucescens  (Vögtli  et  al.,  1987).  The  possible 
significance  of  such  an  arrangement  may  be  to  ensure  that  resistance  is  always 
operational  when  the  organism  is  exposed  to  its  own  product,  that  is,  when 
synthesis  of  the  biosynthetic  gene  products  is  occurring,  and  may  even  play  an 
intimate  part  in  the  complex  regulation  of  antibiotic  production  (Chater  et.  al 
1989a). 
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1.6  Pathway-Specific  Regulation 
Insight  into  the  regulation  of  trancription  of  closely-linked  genes  has  been 
obtained  from  studies  of  mutations  within  clusters  of  production  genes  that 
interfere  with  the  functions  of  most  or  all  of  the  other  genes  in  the  region.  For 
instance,  in  the  act  cluster,  actll  seems  to  encode  a  positive  regulator,  since  point 
mutations  in  actII  appear  to  abolish  (or  at  least  reduce  significantly)  transcription 
of  the  other  act  genes,  while  extra  copies  of  the  actl7  region  enhance  production  of 
actinorhodin  (Malpartida  et  al.,  1986).  In  contrast,  studies  of  pleiotropic 
mutations  have  provided  information  about  the  regulation  by  unlinked  genes, 
since  these  mutations  affect  antibiotic  production  as  well  as  other  characteristics 
that  are  known  to  be  developmentally-regulated,  for  example  the  formation  of 
aerial  mycelia  and  spores.  As  described  above  (Section  1.5),  B1dA  mutants  of  S. 
coelicolor  strains  exhibit  defects  in  both  the  formation  of  aerial  mycelia  and  the 
production  of  antibiotics.  Lawlor  et  al.,  (1987)  suggested  that  these  properties 
may  be  mediated  by  the  bldA  product  in  the  wild-type  strain  via  a  novel  type  of 
translational  control.  The  S.  coelicolor  afsR  gene  seems  to  bridge  the  actions  of 
actll  and  bldA,  since  afsR  can  modulate  the  function  of  two  antibiotic  clusters  in  S. 
coelicolor,  actinorhodin  (act)  and  undecylprodigiosin  (red)  (and  possibly  A-factor 
production  [Horinouchi  et  al.,  1984]),  but  has  no  proven  role  in  development 
(Horinouchi  et  al.,  1990). 
The  afsR  gene  of  S.  coelicolor,  like  actll-ORF4,  can  stimulate  the 
transcription  of  the  act  genes.  The  afsR  gene,  in  turn,  appears  to  be  induced  by 
the  kinase  activity  of  afsK,  located  immediately  downstream  of  afsR  (Horinouchi 
and  Beppu;  1992).  This  was  demonstrated  when  purified  AfsR  became 
radiolabelled  when  incubated  with  [y-32P]  ATP  and  cell-free  extracts  of  S. 
coelicolor  or  S.  lividans  (Hong  et  al.,  1991).  This  suggests  that  an  uncharacterised 
extracellular  signal  is  perceived  by  AfsK,  which  is  stimulated  to  phosphorylate, 
and  thereby  activate,  AfsR.  Similar  regulatory  systems  have  been  detected  in  S. 
griseus  (strR)  (Piepersberg  et  al.,  1988);  S.  hygroscopicus  (brpA)  (Anzai  et  al.,  1987); 
and  S.  peucetius  (dnrR)  (Stutzman-Engwall  et  al.,  1992).  These  systems  exhibit  the 
characteristic  features  of  two-component  regulatory  systems.  Such  systems, 
made  up  of  genes  for  sensor  (protein  kinase)  and  response  regulator 
(transcriptional  activator)  proteins,  are  common  in  bacteria  and  reflect  the  ability 
of  an  organism  to  orchestrate  multifaceted  responses  to  specific  environmental 
changes  (Stock  et  al.,  1989). 
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1.7  Polyketide  Biosynthesis 
Polyketides  represent  a  large  class  of  secondary  metabolites.  This  very 
diverse  group  include  flavonoids  from  plants,  aflatoxins  from  fungi  and 
hundreds  of  compounds  of  different  structures  that  exhibit  antibacterial, 
antifungal  and  antihelminthic  properties  (figure  1.3).  The  formation  of 
polyketides  was  first  elucidated  by  Birch  (1967).  The  process  is  catalysed  by 
polyketide  synthases  (PKS)  in  a  manner  that  is  conceptually  similar  to  the 
biosynthesis  of  long-chain  fatty  acids  catalysed  by  the  fatty  acid  synthases  (FAS), 
found  in  all  organisms.  Comprehensive  reviews  can  be  found  in  Hopwood  and 
Sherman  (1990)  and  Katz  and  Donadio  (1993).  The  known  mechanism  of  FAS 
will  be  described  briefly  to  provide  a  basis  for  the  discussion  of  polyketide 
biosynthesis. 
The  essence  of  fatty  acid  biosynthesis  (and  polyketide  biosynthesis)  is  a 
repeated  decarboxylative  condensation  in  which  simple  carboxylic  acids  are 
joined  in  a  head  to  tail  fashion  to  produce  a  carbon  chain  of  6-50  atoms  in  length, 
with  each  building  unit  contributing  2  carbon  atoms  to  the  growing  chain.  The 
general  reactions  carried  out  by  the  FAS  are  outlined  in  figure  1.4.  The  starter 
unit,  acetyl-CoA,  is  condensed  with  a  malonyl-extender  unit,  to  yield  a4  carbon 
intermediate  and  CO2.  For  condensation  to  occur,  an  acyltransferase  moves  the 
starter  acetyl  unit  from  the  4'-phosphopantetheine  thiol  of  CoA  to  that  of  the  acyl 
carrier  protein  (ACP),  also  part  of  the  FAS.  The  acetyl-ACP  is  then  transferred  to 
the  active  site  cysteine  of  the  (3-ketoacyl  ACP  synthase  (KS),  the  condensing 
enzyme,  leaving  the  thiol  of  the  ACP  free  to  receive  a  malonyl  extender  unit, 
transferred  from  malonyl-CoA  by  malonyltransferase  (MT).  The  resulting  ACP- 
bound  (3-ketoacyl  chain  undergoes  three  successive  processing  steps;  a  (3- 
ketoreduction,  a  dehydration  and  an  enoylreduction  catalysed  by  1- 
ketoreductase  (KR),  dehydratase  (DH),  and  enoylreductase  (ER),  respectively. 
The  growing  chain  returns  to  the  thiol  of  the  KS  and  a  new  cycle  begins.  After 
the  correct  number  of  cycles,  the  completed  carbon  chain  leaves  the  FAS,  either 
by  transfer  back  to  CoA  or  by  hydrolysis  to  the  free  acid  catalysed  by  a 
thioesterase  (TE).  Therefore,  the  FAS  complex,  along  with  the  4'- 
phosphopantetheine  containing  ACP,  is  made  up  of  eight  enzymatic  processes, 
the  condensing  enzyme  (3-ketoacyl  ACP  synthase  (KS),  malonyltransferase  (MT), 
(3-ketoreductase  (KR),  dehydratase  (DH),  enoylreductase  (ER),  thioesterase  (TE) 
and  two  acyltransferases. 
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The  diverse  structures  of  selected  polyketides. 
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Schematic  representation  of  the  reactions  in  fatty  acid  and  polyketide  formation. 
The  acyl  carrier  protein  (ACP)  and  (3-ketoacyl  synthase  (KS)  both  carry  thiol 
groups.  Chiral  centres  are  denoted  by  a  dot.  From  Katz  and  Donadio  (1993). 
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Polyketides  are  formed  by  enzymatic  reactions  similar  to  those 
responsible  for  the  formation  of  long-chain  fatty  acids.  However,  there  are  a 
number  differences  which  set  them  apart.  Firstly,  in  the  simpliest  example,  long- 
chain  fatty  acids  are  generally  derived  by  the  sequential  addition  of  acetate  units 
from  an  acetyl  unit.  In  reality,  alternative  starter  units  such  as  isopropyl  or 
isobutyryl,  are  employed  in  some  of  the  branched  fatty  acids  (reviewed  in 
Hopwood  and  Sherman;  1990).  In  many  of  the  polyketides  the  starter  unit  can 
also  be  quite  complex  with  linear  or  branched  carboxylic  acids,  aromatic  and 
aliphatic  rings.  Examples  include  a  propionyl-CoA  starter  for  daunorubicin 
(Kitamura  et  al.,  1981)  and  malonamyl-CoA  in  oxytetracycline  (Gatenbeck,  1961; 
Thomas  and  Williams,  1983).  Secondly,  in  the  synthesis  of  saturated  fatty  acids, 
all  of  the  keto  groups  brought  to  the  growing  chain  after  condensation  (except 
that  of  the  terminal  carboxyl)  are  removed  during  carbon  chain  assembly  by  the 
reduction-dehydration-reduction  cycle.  In  contrast,  the  synthesis  of  polyketides 
requires  a  highly-programmed  PKS  which  may  or  may  not  'choose'  to  fully 
complete  the  cycle  following  condensation.  The  most  cited  example  of  the 
complexity  of  polyketide  biosnthesis  is  that  of  the  PKS  responsible  for  the 
formation  of  the  Streptomyces  ionophore,  monensin  A  (Hopwood  and  Sherman; 
1990).  This  enzyme  uses  an  acetate  starter  unit,  but  the  extender  units  vary  and 
are  used  in  a  defined  sequence.  They  include  not  only  acetate  residues  but 
propionate  from  methylmalonyl-CoA  (thus  introducing  a  methyl  side  chain)  and 
butyrate  from  ethylmalonyl-CoA,  leaving  a  ethyl  side  chain.  The  PKS  for 
monensin  A  also  handles  the  post-condensation  'programming'  of  12  keto 
groups;  in  this  case  two  remain  intact  implying  that  the  entire  reduction- 
dehydration-reduction  cycle  has  been  aborted;  three  are  reduced  to  hydroxyls,  by 
curtailment  of  the  cycle  before  the  dehydration  step;  three  go  on  to  form  double 
bonds,  indicating  ketoreduction  and  dehydration  but  no  enoyl  reduction  and 
four  keto  groups  are  modified  to  an  alkyl  function  by  completion  of  the  entire 
cycle.  Finally,  termination  of  synthesis  is  usually  accompanied  by  further 
modifications  of  functional  groups.  These  can  include  folding  and  cyclisation, 
lactonisation,  or  the  formation  of  an  amide  bond  with  an  amino  acid,  all  of  which 
are  believed  to  occur  while  the  acyl  chain  is  still  bound  to  the  PKS.  It  is  these 
features  of  the  PKSs  that  account  for  the  huge  structural  diversity  found  in 
polyketide  metabolites.  Figure  1.5  shows  the  varied  architecture  of  the  genes 
which  encode  both  the  fatty  acid  and  polyketide  synthases. 
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Figure  1.5 
The  architecture  of  genes  encoding  fatty  acid  and  polyketide  synthases.  (a)  Type 
II  PKSs.  The  clusters  are  drawn  approximately  to  scale  except  for  the  gap 
between  the  ACP  and  ketoreductase  of  the  otc  duster,  which  is  longer  than 
shown.  (b)  Type  I  FASs  and  PKSs,  arranged  to  show  the  conservation  of  the 
linear  order  of  active  sites  between  vertebrate  Type  I  FASs  and  the  PKSs.  (c) 
Chalcone/resveratrol  synthases,  drawn  to  the  same  scale  as  the  Type  I  FASs  in 
(b).  They  each  may  represent  a  single  condensing  enzyme  that  may  be 
evolutionarily  unrelated  to  other  ketosynthases.  (a)  Type  II  PKSs  (act, 
actinorhodin;  gra,  granaticin;  tcm,  tetracenomycin;  otc,  oxytetracycline  and  fren, 
frenolicin);  (b)  Type  I  PKSs  (ery,  erythromycin  and  6-MSAS,  6-methylsalicylic 
acid).  Taken  from  Hopwood  and  Khosla  (1992),  and  references  within. 
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1.8  Classification  of  FAS  and  PKS 
The  very  diverse  range  of  both  FAS  and  PKS  systems  has  led  them  to 
being  separated  into  various  classes.  FASs  can  be  classified  into  two  categories, 
type  I  and  type  II  (reviewed  by  McCarthy  and  Hardie;  1984).  Type  I  enzymes, 
typified  by  vertebrate  FASs,  consist  of  three  domains  carried  on  a  single, 
multifunctional  polypeptide.  Domain  I  contains  the  acetyl/malonyl  transferase 
and  (3-ketoacyl  synthase  activities  and  thus  catalyses  fatty  acid  chain  initiation 
and  extension;  domain  II  contains  the  ACP,  dehydrase,  enoyl  and  ketoreductase 
activities  and  is  involved  in  the  post-condensation  reactions  when  the  acyl  chain 
is  still  bound  to  the  4'-phosphopantetheine  arm  of  the  ACP;  domain  III  contains 
the  thioesterase  activity  that  terminates  chain  construction.  The  Type  I  FASs  of 
S.  cerevisiae  distribute  their  domains  on  two  large  polypeptides,  a  pentafunctional 
(3-subunit  and  a  trifunctional  a-subunit.  Type  II  FASs,  found  in  certain  bacteria 
(including  E.  coli)  and  plants,  consist  of  a  multienzyme  complex  of  at  least  eight 
monofunctional  polypeptides,  each  responsible  for  a  separate  enzyme  reaction. 
PKSs  have  been  organised  into  three  categories,  Type  I,  Type  II  and  Type 
III.  Type  I  and  Type  II  are  found  in  bacteria  and  fungi  and  closely  resemble  their 
FAS  counterparts.  They  consist  of  complexes  of  multi-functional  or 
monofunctional  proteins,  respectively,  that  are  believed  to  act  on  covalently- 
bound  substrates  attached  by  thioesters  to  an  ACP  domain  or  a  separate  ACP. 
Polyketides  which  are  synthesised  by  Type  I  PKS  include  the  simplest 
polyketides  such  as  6-methylsalicylic  acid  from  Penicillium  (Wang  et  al.,  1990)  and 
more  complex  ones  such  as  erythromycin  from  Saccharopolyspora  erythraea  (Cortes 
et  al.,  1990).  Several  aromatic  antibiotics  are  synthesised  by  the  type  II  enzyme 
system,  for  example,  actinorhodin  from  S.  coelicolor,  tetracenomycin  from  S. 
glaucescens  and  oxytetracycline  from  S.  rimosus  (Hopwood  and  Sherman,  1990). 
Type  III  PKSs,  distributed  in  plants,  do  not  appear  to  require  an  ACP.  The 
successive  condensation  of  malonyl-CoA  onto  the  starter  unit  is  catalysed  by  a 
single  polypeptide  very  similar  to  the  condensing  enzyme  alone  in  FAS  systems 
(Hahlbrock;  1981).  The  two  sections  that  follow  will  show  the  organisation  and 
"programming"  of  two  distinct  types  of  enzyme  systems,  the  Type  I  PKS  of  the 
erythromycin  producing  Saccharopolyspora  erythraea  and  the  Type  II  PKS  of  the 
actinorhodin  producing  S.  coelicolor.  (For  a  comprehensive  review,  see  Katz  and 
Donadio;  1993). 
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1.8.1  Erythromycin,  A  Type  I  PKS 
Erythromycin  is  composed  of  the  14-membered  polyketide-derived 
macrolactone  ring,  6-deoxyerythronolide  B  (6dEB),  to  which  are  attached  two 
deoxysugars.  The  biosynthesis  of  erythromycin  occurs  by  condensation  of  a 
starter  unit  of  propionyl-CoA  with  six  methylmalonyl-CoA  extender  units  to 
produce  the  earliest  14-membered  macrolactone  ring  intermediate,  (6dEB),  by  a 
Type  I  PKS  multienzyme  complex.  Following  C-6  hydroxylation  of  6dEB, 
addition  of  glucose-derived  deoxysugars,  mycarose  and  desosamine  takes  place 
at  the  C-3  and  C-5  hydroxyls,  respectively;  then  O-methylation  of  the  mycarosyl 
moiety  and  C-12  hydroxylation  of  the  ring  produces  erythromycin  A. 
The  Type  I  PKS  enzyme  required  for  the  synthesis  of  the  macrolide 
antibiotic  erythromycin  is  very  complex.  The  genes  thus  far  characterised  consist 
of  three  repeat  units,  eryAl,  eryAll,  and  eryAlll.  These  repeat  units  have  been 
designated  "modules"  and  the  corresponding  protein  segments,  synthase  units 
(SU).  Each  repeat  unit  carries  two  "modules"  of  information  (for  a  total  of  six), 
each  carrying  sites  for  the  ACP,  ketosynthase  and  acyltransferase  activity.  Each 
of  the  six  modules,  also  carries  a  unique  combination  of  post-condensation 
enzymes.  Modules  1,2,5  and  6  encode  only  a  KR  domain,  module  3  lacks  a 
functional  KR  although  much  of  the  sequence  is  present,  and  module  4  carries 
the  full  complement  of  KR,  DH  and  ER  domains.  In  addition,  extra  AT  and  ACP 
domains  are  found  at  the  N-terminus  of  module  1  and  a  TE  domain  is  located  at 
the  C-terminus  of  module  6  (Donadio  et  al.,  1991)  [Figure  1.6].  Bearing  in  mind 
that  the  assembly  of  erythromycin  requires  6  successive  condensation  reactions 
and  that  there  are  6  modules,  the  modular  hypothesis  suggests  the  genetic  order 
of  the  modules  corresponds  to  the  sequence  in  which  the  SU's  are  employed  in 
the  synthesis  of  complex  polyketides  such  as  macrolides.  The  modular 
hypothesis,  has  recently  lost  credibility  as  illustrated  with  the  avermectin  PKS, 
which  consists  of  12  SU's  (and  the  FK506  enzyme,  which  carries  an  additional 
ten),  whose  genetic  order  reads  from  the  left  for  6  SU's  and  then  jumps  right  to 
the  end  and  reads  the  remaining  six  from  the  right  (Katz  and  Donodio;  1993). 
After  each  chain  extension  and  any  programmed  post-condensation  reactions 
specific  for  that  particular  module,  the  acyl  substrate  would  be  transferred  to  the 
active  site  thiol  of  the  [3-ketoacyl  synthase  of  the  next  module,  where 
condensation  would  occur  with  the  specific  chain  elongation  unit  required  for 
that  particular  step  in  the  pathway  (reviewed  in  Katz  and  Donadio;  1993). 
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Figure  1.6 
Organisation  of  Type  I  systems.  The  'programmed'  assembly  of  6- 
deoxyerythronolide  B(  the  precursor  of  erythromycin)  on  the  three 
multifunctional  proteins,  encoded  by  open  reading  frames  1,2  and  3  of  the  eryA 
locus  of  Saccharopolyspora  erythraea.  AT,  acyltransferase;  ACP,  aryl  carrier 
protein;  KS,  (3-ketoacyl-ACP  synthase;  KR  (3-ketoacyl-ACP  reductase;  DH, 
dehydrase;  ER,  enoyl  reductase;  and  TE,  thioesterase.  (The  figure  is  based  on 
data  of  Cortes  et  al.,  1990  and  Donodio  et  al.,  1991,  taken  from  Hopwood  and 
Khosla,  1992). 
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The  pathway  of  erythromycin  biosynthesis  has  been  the  subject  of 
extensive  biochemical  and  genetic  studies  (Donadio  et  al.,  1992).  The  biosynthetic 
genes  for  erythromycin(ery)  are  clustered  in  a  ca.  45  kb  region  of  the  Sac.  erythraea 
chromosome  that  also  contains  ermE,  the  erythromycin  resistance  gene  (Donadio 
et  al.,  1991).  The  PKS  genes  responsible  for  the  formation  of  6dEB  make  up  more 
than  70%  of  this  cluster  and  through  hybridisations  with  specific  probes,  the 
components  of  each  module  were  identified.  If  the  final  molecular  structure  is 
programmed  by  the  number  and  composition  of  the  different  SU's  then  it  follows 
that  alterations  in  a  single  SU  would  affect  only  that  portion  of  the  PKS  template. 
This  was  confirmed  when  Donadio  et  al.  (1991)  introduced  a  mutation  in  the  KR 
of  the  SU5  and  the  unaltered  SU6  acted  upon  the  "unnatural"  SU5  derivative.  If 
any  SU  can  be  altered  without  affecting  the  synthetic  makeup  of  the  other  SUs, 
the  potential  then  exists  for  creating  a  whole  new  series  of  hybrid  antibiotics  with 
yet  uncharted  antibacterial  capabilities. 
1.8.2  Actinorhodin,  A  Type  II  PKS 
The  most-studied  aromatic  polyketide  is  actinorhodin.  This  is  due 
primarily  to  its  characteristic  properties  as  a  red-blue  acid-base  indicator  which 
allows  for  easy  visual  inspection  of  mutants  and  clones  altered  in  its  production. 
Actinorhodin  is  one  of  at  least  four  antibiotics  produced  by  S.  coelicolor  A3(2),  the 
others  being  undecylprodigiosin  (red)  methylenomycin  (mmy)  and  calcium 
dependent  antibiotic  (cda)  (Hopwood  et  al.,  1986).  The  biochemical  and  genetic 
pathways  of  the  biosynthesis  of  actinorhodin  have  both  been  elucidated  (figure 
1.7). 
The  genetic  map  of  the  act  cluster  was  determined  by  a  series  of  seven 
blocked  mutants.  Pairwise  cosynthesis  studies  in  which  precursors  secreted  by 
later-blocked  mutants  are  converted  by  earlier-blocked  mutants  into 
actinorhodin,  permitted  the  mutants  to  be  placed  in  sequential  order;  I,  III,  VII1 
IV,  VI,  and  V  (Rudd  and  Hopwood;  1979),  class  V  was  later  subdivided  into  VA 
and  VB  (Cole  et  al.,  1987).  The  seventh  class,  II,  has  a  phenotype  consistent  with  a 
mutation  in  a  positively-acting  regulatory  gene  for  the  biosynthesis  of 
actinorhodin,  as  described  earlier.  The  actl  and  actIII  mutants  did  not  secrete  any 
biosynthetic  intermediate  which  could  be  converted  to  actinorhodin  by  any  of 
the  other  mutant  classes,  but  were  able  to  convert  intermediates  secreted  by  all 
the  other  mutant  classes  to  actinorhodin.  This  suggested  that  both  actl  and  actIll 
mutants  were  defective  in  the  earliest  enzymatic  steps  of  the  pathway.  A  red 
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Organisation  of  the  act  cluster  and  pathway  for  actinorhodin  formation.  ORFs 
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1989. 
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pigment  was  accumulated  by  the  actlll  mutants  whereas  no  pigment  at  all  was 
seen  with  the  actl  mutants.  From  this  information,  it  was  concluded  that  actl 
mutants  were  blocked  at  an  earlier  step  than  the  actIII  mutants  of  the 
actinorhodin  pathway  (Rudd  and  Hopwood;  1979).  The  genes  for  the  entire 
synthesis  of  actinorhodin,  including  the  act  II  gene,  were  mapped  and  shown  to 
be  clustered  in  a  region  of  the  chromosome  of  approximately  26  kb  (Malpartida 
and  Hopwood,  1984;  1986). 
Shunt  metabolites  produced  by  the  blocked  mutants  have  been  used  to  the 
elucidate  the  biochemical  pathway  and  potential  gene  functions  of  each  class  of 
mutant.  The  starter  unit,  acetyl-CoA,  requires  the  addition  of  seven  acetate  units 
to  produce  the  first  isolatable  intermediate,  a  hypothetical  octaketide  with  a 
reduced  keto  group  at  C-9,  that  has  undergone  a  spontaneous  C-7:  C-12  ring 
closure  through  an  aldol  condensation.  The  actlll  mutant  has  been  assigned  the 
KR  function.  Act!  mutants  were  thought  to  occur  even  earlier  in  the  pathway 
and  were  therefore  assigned  with  the  KS  function.  A  number  of  post-PKS 
functions  are  also  required  and  include;  a  dehydration  at  C-8:  C-9  and  C-5:  C-14 
ring  closure  with  the  concomitant  aromatisation  of  the  first  ring  through  loss  of 
water  at  C-7:  C-12  by  a  putative  cyclase/dehydratase  (act  VII);  a  C-5:  C-14 
dehydration  (actlV);  followed  by  reduction  at  C-3  to  form  the  pyran  ring  (actVa). 
Prior  to  dimerization,  the  molecule  is  hydroxylated  at  C-6  and  a  final 
hydroxylation  at  C-8  yields  actinorhodin  (actVA).  ActVA  is  composed  of  6  ORFs, 
ORF1  appears  to  encode  a  transmembrane  protein  responsible  for  export  the 
antbiotic,  ORFs  2,4,5,  and  6  are  likely  involved  in  the  two  hydroxylation  steps. 
The  dimerization  function  has  been  assigned  to  the  actVB  class  (reviewed  in  Katz 
and  Donadio,  1993). 
The  Type  II  PKS  required  for  the  synthesis  of  actinorhodin  is  composed  of 
three  polypeptides,  each  reponsible  for  a  discrete  step,  ORF1,2  and  3.  The 
predicted  protein  sequences  of  both  ORF1  and  2  show  convincing  similarity  to 
the  fatty  acid  (3-ketoacyl  synthase  of  E.  coli,  encoded  by  fasB  (reviewed  by  Katz 
and  Donadio;  1993).  Although  ORF1  and  ORF2  are  very  similar,  ORF1  carries  an 
active-site  serine,  characteristic  of  (3-ketoacyl:  ACP  synthase,  not  found  in  ORF2 
and  thus  was  assigned  the  role  of  catalysing  the  condensation  reactions  between 
the  growing  acyl-CoA  chain  and  the  malonyl-CoA  extenders.  ORF1  and  2  are 
translationally  coupled  and  the  role  of  ORF2  is  thought  to  be  in  dictating  the 
chain  length.  This  was  demonstated  elegantly  by  McDaniel  et  al.,  (1993),  from 
hybrid  studies  of  act  and  fren  PKSs.  Various  combinations  of  act-  and  fren  -ORF1, 
2,  and  3  were  cloned  into  an  ACT-mutant  of  S.  coelicolor.  When  the  act-ORF2 
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was  used  an  actinorhodin-like  product  was  detected.  However,  when  free-ORF2 
was  employed  with  fren-ORF1  and  act-ORF3  frenolicin-like  products  were 
detected.  The  predicted  protein  sequence  of  ORF3  is  less  than  100  amino  acids  in 
length  and  contains  the  highly  conserved  DLxGyDS  motif  characteristic  of  the  4'- 
phospopantotheine  attachment  site  of  the  ACP.  Two  post-condensation  enzymes 
are  the  KR  and  bifunctional  cyclase/dehydrogenase  which  flank  the  ORF1,2, 
and  3  cluster.  The  similarity  to  FAS  type  I  is  striking.  However,  no  separate  AT 
or  TE  ORFs  were  located  in  the  actinorhodin  PKS.  Fernandez-Moreno  et  al., 
(1992)  have  located  a  GHSxG  motif,  typical  of  AT  functions,  in  the  C-terminal 
half  of  ORF1,  but  it  has  not  been  established  whether  an  AT  or  TE  (which  also 
carries  this  motif)  is  associated  with  ORF1. 
Notwithstanding  the  sequence  conservation  across  the  PKSs  and  FASs,  a 
fundamental  difference  has  emerged  in  the  mechanisms  by  which  the  enzymes 
determine  the  structure  for  fatty  acids  and  simple  aromatic  polyketides  on  one 
hand  and  those  for  complex  polyketides,  such  as  macrolides,  on  the  other.  In  the 
macrolide  case,  each  round  of  carbon  chain  assembly  and  modification  is 
catalysed  by  a  distinct  active  site  (Donadio  et  al.,  1991).  Thus,  the  sequence  of 
biosynthetic  reactions  is  overtly  programmed  into  the  DNA  that  encodes  the 
PKS.  In  contrast,  for  the  aromatic  polyketides,  a  single  set  of  reiteratively  used 
active  sites  of  the  PKS  must  determine  the  number  of  extender  units  to  add  and 
the  extent  of  post-condensation  modifications.  The  programming  of  this  class 
still  remains  obscure.  In  an  attempt  to  elucidate  the  programming  mechanism  of 
aromatic  polyketides,  a  number  of  groups  have  constructed  a  series  of  hybrid 
polyketide  synthases  (Khosla  et  al.,  1993;  Sherman  et  al.,  1992).  The  conservation 
of  the  PKS  genes  within  the  Type  II  aromatic  antibiotics  is  striking  (figure  1.8) 
with  good  end  to  end  similarity.  This  does  not  extend  to  the  Type  I  PKSs 
however.  A  DNA  probe  containing  actl  has  been  used  for  identification  and 
cloning  of  PKS  genes  for  13  different  actinomycetes  including  granaticin 
(Sherman  et  al.,  1989),  and  frenolicin  (Malpartida  et  al.,  1984).  The  replacement  of 
the  ACP  homologues  for  the  act  ACP  in  S.  coelicolor  has  led  to  the  expression  of 
functional  synthases,  and  the  recombinants  synthesized  derivatives  with 
actinorhodin-like  properties,  albeit,  with  varying  levels  of  different  metabolites. 
These  studies  are  only  in  their  preliminary  stages  and  with  further  work  by  Shen 
and  Hutchinson  (1993),  using  cell  free  systems  to  demonstrate  the  potential  to 
reconstitute  a  functional  Type  II  PKS  in  vitro  from  its  constitutent  proteins,  the 
biochemical  properties  of  the  PKSs  may  soon  be  elucidated. 
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Dendrogram,  using  the  PILEUP  program  of  GCG  (Devereux  et  al.,  1984), 
showing  the  relationships  of  Type  II  PKS  components  ORF1  and  ORF2.  Data 
compiled  from  Yu  et  al.,  1994. 
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1.9  The  tetracycline  family 
The  tetracyclines  were  the  first  major  group  of  antimicrobial  agents  for 
which  the  term  'broad-spectrum'  was  used,  i.  e.  they  exhibit  activity  against  both 
Gram-positive  and  Gram-negative  bacteria.  The  broad  spectrum  activity  and 
relative  lack  of  toxicity  of  tetracyclines  has  led  to  their  wide-spread  use  in 
fighting  infections  in  man,  animals  and  even  certain  plants.  All  members  of  the 
tetracycline  family  are  synthesized  by  actinomycetes.  The  main  producers  are  S. 
aureofaciens  and  S.  rimosus.  S.  aureofaciens  produces  a  mixture  of  chlortetracycline 
(CTC)  and  tetracycline  (TC)  whereas  S.  rimosus  produces  oxytetracycline  (OTC) 
and  a  small  amount  of  tetracycline  (see  recent  review  from  Behal  and  Hunter, 
1994). 
Structurally,  tetracyclines  are  composed  of  a  4-ring  carbocyclic  structure 
which  differ  from  each  other  in  the  functional  groups  present  at  carbons  C5,  C6, 
and/or  C7  (Figure  1.9),  whereby  each  possesses  a  different  pharmacological 
property  (Levy;  1984).  Slight  structural  variations  make  these  chemicals  unique 
pharmacologically,  but  all  possess  the  same  basic  mode  of  action.  The 
tetracyclines  inhibit  bacterial  growth  primarily  by  inhibiting  protein  synthesis  at 
the  level  of  the  ribosome  (Ohnuki  et  al.,  1985).  Inhibition  of  protein  synthesis 
results  from  the  disruption  of  the  codon-anticodon  interactions  between  tRNA 
and  mRNA  so  that  binding  of  aminoacyl-tRNA  to  the  ribosomal  acceptor  site  is 
prevented.  The  precise  mechanism  by  which  they  prevent  binding  is  not  fully 
understood.  However,  it  is  likely  to  result  from  interactions  with  the  30S 
ribosomal  subunit  because  the  majority  of  the  tetracyclines  are  known  to  bind 
strongly  to  a  single  site  on  the  30S  subunit  (Chopra;  1985). 
Bacterial  resistance  to  tetracyclines,  which  is  often  transposon-  or  plasmid- 
borne,  can  be  acquired  by  a  population  as  a  result  of  the  selective  pressure  placed 
on  it  by  the  administration  of  tetracyclines  for  chemotherapy  in  humans  and 
animals.  Tetracycline  resistance  is  the  most  frequently  encountered  in  nature.  In 
Gram-negative  bacteria,  five  genetically  different  classes  of  tetracycline  resistance 
determinants  have  been  defined.  In  Gram-positive  streptococci,  three  distinct 
tetracycline  resistance  genes  have  been  identified  (Chopra  et  al.,  1992).  This  may 
ultimately  limit  the  usefulness  of  the  family.  Therefore  a  complete  biochemical 
and  genetic  understanding  of  the  organism  and  the  antibiotic  that  it  produces, 
may  eventually  led  to  the  construction  of  hybrid  molecules.  The  biochemical  and 
genetic  knowledge  of  the  tetracycline  family  of  antibiotics  accumulated  to  date  is 
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Chemical  structures  of  tetracycline  family. 
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outlined  below.  Particular  emphasis  will  be  placed  on  the  oxytetracycline  (OTC) 
pathway  in  later  sections. 
A  pausible  biosynthetic  pathway  for  the  tetracylines  was  first  proposed  in 
the  1960's  by  McCormick  and  Jensen  at  the  Lederle  Laboratories  (Figure  1.10).  By 
using  blocked  mutants,  intermediates  in  the  pathway  were  obtained  and 
purified.  The  earliest  intermediate  that  could  be  detected  was  6- 
methylpretetramid  (6-MPT).  Prior  to  this  stage,  the  PKS  catalyses  the 
condensation  of  the  starter  unit,  malonamyl-CoA,  and  eight  actetate  units  (which 
are  derived  from  malonyl-CoA)  to  form  the  primary  carbon  skeleton  of  OTC, 
(Gatenbeck;  1961).  Post-condensation  reactions  include  a  reduction  and  a 
dehydration  at  C-8  to  form  the  7-8  double  bond  and  subsequent  cyclisation  to 
form  a  naphthacene  nucleus.  This  was  thought  to  take  place  in  a  stepwise 
fashion  as  more  than  one  shunt  product  was  detected  and  cosynthesis  activity  of 
each  these  mutants  converted  tetracycline  biosynthetic  intermediates  effectively. 
A  third  post-condensation  reaction,  which  introduces  a  methyl  group  at  the  C-6 
position,  was  confirmed  to  occur  before  the  first  isolatable  intermediate  since  it 
was  observed  that  both  wild-type  and  non-methylating  mutants  were  able  to 
convert  the  6-methylated  precursors  into  6-methyl  tetracyclines  (McCormick  et 
al.,  1963). 
The  biochemical  analysis  of  a  further  six  mutant  classes  allowed 
elucidation  of  the  remainder  of  the  oxytetracycline  biosynthetic  pathway;  (i)  4- 
hydroxy-6MPT,  formed  from  the  hydroxylation  at  C-4  of  6-MPT;  (ii)  4- 
ketodedimethyl  anhydrotetracycline  (4-keto-ATC),  formed  from  a  C-12 
hydroxylation  of  4-keto-ATC;  (iii)  4-amino-ATC,  produced  by  C-4 
transamination  of  4-keto-ATC;  (iv)  ATC,  produced  stepwise  by  methylation  of 
the  amino  group,  methylation  of  the  methylamino  group  and  reduction  of  a 
double  bond  at  C-4-4a;  (v)  5a,  lla-dehydrotetracycline  (DHTC),  produced  by 
hydroxylation  at  C-6  (vi)  5-hydroxy-5a,  11a-dehydrotetracycline  (DHOTC), 
formed  from  a  5-hydroxylation  of  DHTC;  and  finally,  5-hydroxytetracycline 
(oxytetracycline),  by  reduction  at  the  5a,  11a  of  DHOTC  (McCormick  et  al.,  1962; 
Miller  et  al.,  1965).  At  least  13  stages  are  required  in  the  formation  of  OTC.  An 
in-depth  discussion  of  each  individual  step  can  be  found  in  Thamchaipenet 
(1994). 
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Oxytetracydine  pathway  and  assignment  of  blocked  mutants  (data  of  Rhodes  et 
al.,  1981). 
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1.10  Biosynthesis  of  OTC 
A  number  of  independent  groups  have  reported  mutants  impaired  in  OTC 
production  (Delic  et  al.,  1969;  Alikanian  et  al.,  1961)  and  a  preliminary  genetic 
map  was  produced  (Boronin  and  Mindlin;  1971,  Alacevic,  1976).  However,  it 
was  not  until  1981  that  Rhodes  et  al.,  carried  out  a  combined  biochemical  and 
genetic  study.  This  group  from  Pfizer  laboratories  produced  a  series  mutants, 
unable  to  produce  OTC,  by  exposure  to  chemicals  or  UV.  Classification  of  57 
mutants  was  done  employing  the  principles  of  cosynthesis,  in  much  the  same 
way  as  Rudd  and  Hopwood  (1979)  had  employed  in  the  elucidation  of  the 
biosynthetic  pathway  for  actinorhodin.  Pairwise  combination  of  the  mutants 
grown  both  on  the  surface  of  agar  plugs  and  together  in  liquid  culture,  resulted 
in  nine  different  types  of  mutations.  The  mutations  were  all  thought  to  be 
located  in  the  structural  genes  encoding  biosynthetic  enzymes,  since  all  the 
mutants  could  cosynthesise  OTC  with  other  mutants.  Representatives  of  the  nine 
classes  (otc-4,  -19,  -20,  -25,  -56,  -75,  -90,  -151  and  -155)  were  chosen  to  try  to 
determine  the  sequence  of  the  biosynthetic  blocks.  The  mutants  could  be  divided 
into  two  classes  based  on  their  cosynthetic  patterns.  Class  I  mutants  (otc-19,  -56 
and  -155)  were  shown  to  produce  OTC  when  fed  culture  filtrate  of  the  Coenzyme 
F420-producing  strain  S.  aureofaciens  ATCC  13190.  This  suggests  that  these  otc 
mutants  were  blocked  in  the  synthesis  of  this  cosynthetic  factor  (CSF1),  which  is 
essential  for  the  final  step  on  OTC  biosynthesis.  The  class  II  mutants  (otc-4,  -20, 
-25,  -75,  -90,  and  -151)  did  not  produce  OTC  when  CSF1  was  added  and  were, 
therefore,  presumed  to  be  blocked  at  six  different  steps  in  the  main  OTC  pathway 
(Rhodes  et  al.,  1981). 
The  sequential  order  of  dass  II  mutants  was  elucidated  by  supplying  OTC 
precursors  to  liquid  cultures  of  all  class  II  mutants.  If  the  supplied  compound 
was  converted  to  OTC,  the  mutant  was  assumed  to  be  blocked  at  a  step  in  the 
OTC  biosynthetic  pathway  prior  to  that  intermediate.  The  nature  of  the  impaired 
step  was  defined  in  three  mutants  in  this  way.  Mutant  otc-25  was  the  only 
mutant  which  could  not  convert  a  derivative  of  the  penultimate  intermediate,  7- 
chloro-DHTC,  into  7-chloro-OTC.  DHTC  is  an  unstable  intermediate  and  S. 
rimosus  had  previously  shown  the  ability  to  convert  7-chloro-DHTC,  into  7- 
chloro-OTC  (Martin  et  al.,  1966).  Although  there  were  two  stages  in  which  the 
mutant  could  be  blocked,  it  was  argued  that  if  the  defect  occurred  between 
DHTC  and  DHOTC,  a  shunt  antibiotic,  tetracycline,  would  have  been  detected, 
which  was  not  the  case.  Mutant  otc-25  was  presumed  to  be  blocked  in  the 
reduction  step  which  converts  DHOTC  to  OTC.  Mutant  otc-25  and  -75  were  the 
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only  two  mutants  which  were  unable  to  convert  ATC  to  OTC.  Mutant  otc-75  was 
however  able  to  convert  7-chloro-DHTC  to  7-chloro-OTC  and  therefore  must  be 
blocked  in  the  C-6  hydroxylation  that  forms  DHTC.  Through  similar  methods  of 
elimination,  mutant  otc-4  was  found  to  be  blocked  in  the  N-methylation  of  4- 
amino-ATC  because  it  was  unable  to  convert  4-amino-ATC  to  OTC  but  was  able 
to  convert  ATC  to  OTC.  The  other  three  mutant  classes  were  all  unable  to 
convert  the  earlier  precursors,  4-hydroxy-6MPT  or  6-MPT,  to  OTC  and  it  was 
concluded  that  they  were  blocked  before  the  formation  of  4-amino-ATC. 
Previous  cosynthetic  tests  in  liquid  culture  showed  that  they  were  blocked  at 
different  stages,  the  pale  non-pigmented  mutant  class,  otc-90,  was  assigned  the 
earliest  blockage.  The  mutant  classes  represented  by  otc-4,  -20,  -25,  -75,  -90  and 
-151  were  assigned  to  putative  loci  otcD,  otcX,  otcA,  otcC,  otcY  and  otcZ, 
respectively  (Figure  1.10)  [Rhodes  et  al.,  1981]. 
Genetic  mapping  experiments,  employing  representatives  of  each  class, 
suggested  that  the  production  genes  for  OTC  were  clustered  on  the  chromosome. 
At  the  time,  the  interpretation  of  the  data  implied  there  were  two  clusters  of 
genes  (Rhodes  et  al.,  1981).  One  cluster,  located  at  4  o'clock  on  the  circular 
genetic  map,  was  responsible  for  the  'early'  genes  in  the  pathway,  otcD,  otcX, 
otcY,  otcZ  and  the  OTC-resistance  determinants  (see  below).  The  other  cluster, 
including  otcA,  otcB,  otcC  and  CSF1  biosynthetic  genes,  the  'late'  genes,  was 
located  at  10  o'clock  on  the  map. 
Early  experiments  to  clone  the  OTC  resistance  gene  were  undertaken  in  an 
OTC-sensitive  mutant  of  S.  rimosus  by  simply  constructing  a  gene  bank  in  a  high- 
copy  number  vector  and  selecting  for  recombinants  that  were  now  resistant  to 
the  drug.  Surprisingly  two  resistance  determinants  were  cloned  and  shown, 
independently,  to  encode  resistance  to  OTC  (Rhodes  et  al.,  1984).  Two  resistance 
genes  were  also  cloned  from  another  strain  of  S.  rimosus  (Ohnuki  et  al.,  1985)  by 
screening  a  genomic  library  in  S.  griseus,  a  host  which  was  sensitive  to  OTC. 
Advances  in  recombinant  DNA  techniques  for  use  in  the  genetic  manipulation  of 
Streptomyces  (Hopwood  et  al.,  1985),  made  it  feasible  for  the  Pfizer  group  to  clone 
the  otc  genes  as  a  prelude  to  overexpressing  them  by  first  locating  the  resistance 
genes  and  then  "chromosome  walking"  to  find  the  linked  biosynthetic  genes 
(Butler  et  al.,  1990).  A  producer  of  an  antibiotic  must  be  resistant  to  the  antibiotic 
it  makes;  otherwise  it  will  be  suicidal.  Butler  et  al.,  (1989)  went  about  cloning  the 
OTC  production  genes  on  the  premise  that  production  genes  and  resistance 
genes  are  frequently  linked.  Southern  blotting  of  a  cosmid  library  revealed  that 
the  two  resistance  genes  were  located  around  30  kb  apart  on  the  genome  of  S. 
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rimosus.  The  structural  genes  for  the  bioysnthesis  were  confirmed  to  be  located 
between  them  when  mutants  blocked  in  the  'early'  part  of  the  biochemical 
pathway  (Rhodes  et  al.,  1981)  were  capable  of  producing  OTC  when 
complemented  with  different  segments  of  DNA  from  within  the  region  between 
the  two  resistance  markers  (Butler  et  al.,  1989). 
The  Pfizer  group  then  turned  their  attention  to  those  functions  involved  in 
the  conversion  of  ATC  to  OTC.  The  product  of  the  otcC  gene  is  ATC  oxygenase 
whose  activity  can  be  assayed  easily.  A  'reverse  genetics'  approach  was  taken  to 
clone  this  gene,  thought  to  be  located  at  the  10  o'clock  position  of  the  genomic 
map  of  S.  rimosus.  The  enzyme  was  purified  and  the  N-terminus  of  the  protein 
sequenced.  Oligonucleotides  were  then  designed  from  this  sequence  and  used  as 
probes  to  clone  the  corresponding  otcC  genomic  DNA.  Hybidisation  results 
contradicted  earlier  genetic  mapping  data  of  Rhodes  et  al.,  (1981),  when  it  was 
discovered  that  otcC  mapped  within  the  'early'  cluster  for  the  OTC  biosynthesis 
(Binnie  et  al.,  1989).  The  formal  possibility  that  all  the  structural  genes  for  the 
production  of  OTC  were  located  within  a  single  cluster  was  then  addresssed  by 
Binnie  et  al.,  (1989).  They  cloned  a  large  segmentiDNA,  including  both  the 
resistance  genes,  into  a  low-copy  number  vector  and  transformed  it  into  both  S. 
lividans  and  S.  albus.  The  resulting  transformants  produced  OTC,  confirming  all 
of  the  structural  genes  necessary  to  specify  OTC  biosynthesis  reside  in  a  single 
cluster  (Figure  1.11). 
The  'late'  cluster  is  now  assumed  to  encode  the  genes  for  the  synthesis  of 
the  5-deazaflvin  cofactors  necessary  for  the  last  step  in  the  biosynthesis  (see 
earlier  section).  The  ability  of  S.  lividans  and  S.  albus  to  produce  OTC  without 
these  genes  being  specifically  introduced  on  the  plasmid  implies  that  they 
already  carries  CSF  genes  (Binnie  et  al.,  1989).  It  has  already  been  observed  that 
this  unusual  class  of  cofactor  has  a  widesread  distribution  with  the  Actinomyces 
(Daniels  et  al.,  1985). 
1.10.1  Gene  Functions 
Recombinational  analysis  by  Rhodes  et  al.,  (1981)  concluded  that  the  genes 
for  the  biosynthesis  of  OTC  were  clustered.  In  fact,  the  entire  cluster  has  been 
located  on  a  34  kb  EcoRI  fragment  (Binnie  et  al.,  1989).  The  nucleotide  sequence 
has  been  obtained  for  much  of  the  cluster.  Two  resistance  genes  flank  the  cluster, 
otrA  and  otrB.  The  resistance  gene  product  of  otrA  protects  the  ribosomes  from 
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Figure  1.11 
Restriction  map  of  the  oxytetracycline  cluster  of  S.  rimosus.  The  dosed  boxes 
show  the  minimum  DNA  segments  that  can  complement  the  OTC-negative 
classes  of  mutants  (Butler  et  al.  1989).  The  line  delineates  the  region  of  DNA 
which  confers  the  ability  to  produce  OTC  when  introduced  in  S.  lividans  and  S. 
albus  (Binnie  et  al.  1989).  Abbreviations:  B,  Barn  HI;  Bg,  BgIII;  E,  EcoRI;  H,  Hin  dill; 
K,  Kpnl;  P,  PstI;  R,  EcoRV;  S,  SstI;  Sp,  SphI.  Modified  from  Butleret  al.  1990. 
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translational  arrest  by  OTC,  while  the  product  of  otrB  resistance  gene  results  in 
decreased  accumulation  (increased  efflux)  of  the  antibiotic  from  the  mycelium 
(Ohnuki  et  al.,  1985).  The  nucleotide  sequence  of  otrA  showed  a  deduced  amino 
acid  sequence  very  similar  to  that  of  the  elongation  factor  (EF-G)  from  E.  coli 
(Zengel  et  al.,  1984).  Doyle  et  al.,  (1991)  proposed  that  the  otrA  gene  may  function 
as  an  alternative  EF-G,  which  substitutes  for  the  usual  EF-G  that  is  presumed  to 
be  inhibited  by  tetracycline.  The  nucleotide  sequence  for  otrB  has  also  been 
determined  and  has  strong  similarity  to  other  exporter  genes  (McGregor;  pers. 
comm.  ). 
The  left-hand  side  of  the  cluster  has  been  characterised  by  McDowall  et  al., 
(1991).  The  region  that  has  been  sequenced  includes  the  otcZ  and  otcX  loci.  The 
deduced  amino  acid  sequence  of  otcZ  has  significant  similarity  to  the  carboxy- 
terminal  domain  of  TcmN  of  the  tetracenomycin  C  cluster  in  S.  glaucescens,, 
which  has  been  assigned  the  putative  function  of  O-methyltransferase  (Summers 
et  al.,  1992).  As  the  otcZ  mutant  was  blocked  at  some  point  before  4-amino-ATC 
(Rhodes  et  al.,  1981),  it  was  originally  thought  that  this  gene  product  was 
involved  in  6-methylation  of  pretetramid,  which  is  the  only  methylation  step 
prior  to  4-amino-ATC  (McDowall  et  al.,  1991).  However,  the  recent 
characterisation  of  the  genes  in  chlorotetracycline  biosynthetic  duster  (Ryan  et  al., 
1994)  suggest  that  otcZ  may  be  involved  in  the  amino-dimethylation  in  the 
conversion  of  4-amino-ATC  to  ATC  (see  figure  1.11).  Ryan  et  al.,  (1994)  were  able 
to  isolate  separate  mutants  deficient  in  both  the  6-methylation  of  the  pretetramid 
and  the  amino-dimethylation.  The  otcZ  mutant  was  unable  to  convert  either 
6MPT  or  4-hydroxy-6MPT  to  OTC  (Rhodes  et  al.,  1981)  which  implied  that  it  may 
contain  mutations  at  more  than  one  locus.  Separate  mutants/,  both  the  6- 
methylation  of  the  pretetramid  and  the  amino-dimethylation  were  not  isolated  in 
the  otc  cluster.  Recent  sequence  analysis  within  the  otcY  locus,  see  below,  has 
revealed  a  second  methylase  gene  (Thamchaipenet;  pers.  comm.  ).  It  is  proposed 
that  this  may  be  the  gene  involved  in  the  6-methylation  of  pretetramid,  its 
physical  location  among  the  early  biosynthetic  gene  locus  gives  it  credibility. 
The  otcX  locus  encodes  two  gene  products.  One,  OtcX-ORF1  is  similar  to  the 
gene  product  ActVA-ORF2,  which  is  involved  in  ring-hydroxylation  in  the 
biosynthesis  of  actinorhodin  (McDowall  et  al.,  1991;  Caballero  et  al.,  1991).  The 
second,  OtcX-ORF2  is  significantly  similar  to  an  ORF  (of  unknown  function) 
immediately  downstream  of  the  ferredoxin  gene  of  Sac.  erythraea  (Donadio  et  al., 
1991). 
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Moving  right  to  the  OtcD  loci,  previous  sequencing  (Thamchaipenet;  1994) 
has  revealed  two  ORFs.  Both  OtcD-ORF1  and  ORF2  are  transcribed  from  the 
right  toward  the  otcD  locus.  The  OtcD-ORF1  shows  good  similarity  to  other 
cyclase/dehydrases  and  may  catalyse  at  least  one  of  the  subsequent  cyclisation 
mechanisms  to  yield  an  aromatic  ring  product.  The  gene  product  of  OtcD-ORF2 
appears  to  be  involved  in  steps  after  pretetramid  formation  and  was  similar  in 
deduced  amino  acid  sequence  to  several  bacterial  flavin-dependent 
hydroxylases. 
The  OtcY  loci  can  be  divided  into  two  regions,  otcYl  and  otcY2.  The  left- 
hand  region,  otcY2,  is  composed  of  OtcY2-ORF1,  which  reads  right  to  left  along 
with  the  two  otcD  gene  products,  and  OtcY2-ORF2,  ORF3  and  ORF4,  which  are 
transcribed  in  that  order  in  the  opposite  direction.  Through  predicted  amino 
acid  sequence  determination  and  similarities  to  genes  of  known  function,  the 
following  functions  have  been  assigned.  The  OtcY2-ORF1  gene  product  is 
thought  to  encode  the  (3-ketoacyl  reductase,  responsible  for  a  ketoreduction  at  the 
C-9  position  on  the  OTC  polyketide  chain.  The  OtcY2-ORF2,  a  putative 
dioxygenase,  was  similar  to  the  (3-subunit  of  toluene  and  benzene  dioxygenases 
from  Pseudomonas  and  the  actVI-ORFA  and  fren-ORFX  gene  products  from  the 
actinorhodin  and  frenolicin  gene  clusters.  OtcY2-ORF3,  a  putative  combination 
malonamate:  CoA  ligase  enzyme.  The  OtcY2-ORF4  gene  product  was 
significantly  similar  to  one  of  the  subunits  of  tetracycline  dehydrogenase  which 
is  required  in  the  late  stages  of  tetracycline  biosynthesis  in  S.  aureofaciens 
(Thamchaipenet;  1994). 
At  the  right  end  of  the  otcY  locus  is  a  coding  region  with  strong  similarity 
to  actl  genes  of  the  actinorhodin  cluster.  This  region  has  been  sequenced  (Kim  et 
al.,  1994)  and  the  deduced  amino  acid  sequences  correspond  to  the  presumed 
heterodimeric  ß-ketoacyl  synthase  and  the  acyl  carrier  protein  found  in  other 
type  II  (multi-component)  PKS  systems  that  specify  construction  of  acetate- 
derived  polyketide  antibiotics  including  tetracenomycin  (Bibb  et  al.,  1989)  and 
granaticin  gene  dusters  (Sherman  et  al.,  1989). 
Situated  between  the  OtcY  loci  and  the  OtrB  loci  is  a  putative  repressor 
(McGregor;  per.  comm).  It  surprisingly  does  not  look  similar  to  other  tetracyline- 
type  repressors  but  is  more  similar  to  the  E.  coli  multi-drug  resistant  repressors. 
One  or  two  gaps  were  left  to  be  sequenced  in  the  otc  cluster,  most  notably 
between  the  OtcX  and  OtcD  loci,  before  the  entire  pathway  was  to  be  eludicated. 
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Definitive  gene  functions  had  also  to  be  determined,  this  could  be  accomplished 
genetically  by  gene  disruption  experiments. 
1.11  Scope  of  Present  Work 
The  work  presented  in  this  thesis  is  mainly  concerned  with  the 
development  of  a  'workable'  integration  strategy  to  help  deduce  putative  gene 
functions  of  the  oxytetracycline  pathway  of  S.  rimosus.  Specific  aims  were  to 
sequence  the  region  between  the  OtcX  and  OtcD  loci  and  determine  the 
transcriptional  pattern  of  this  region.  One  of  the  genes  in  this  region  was  then 
the  subject  of  gene  disruption  and  replacement  experiments,  by  integration  in  the 
S.  rimosus  chromosome. 
During  the  course  of  this  work  various  methods  to  improve  the  level  of 
foreign  DNA  accepted  by  the  S.  rimosus  host  were  also  investigated. 
35 Chapter  2 
Chapter  2 
Materials  and  Methods 
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INTRODUCTION 
Experiments  which  form  the  basis  of  this  thesis  were  carried  out  by 
the  following  general  procedures.  The  chapter  is  laid  out  in  three  main 
sections.  The  first  two  sections  divide  the  manipulations  related  to 
Escherichia  coli  and  Streptomyces.  The  third  section  contains  bacterial 
strains,  plasmids  and  bacteriophages. 
2.1  STANDARD  MICROBIOLOGICAL  TECHNIQUES  FOR  Ecoli 
All  E.  coli  procedures  can  be  found  in  "Molecular  Cloning,  a 
Laboratory  Manual"  (Sambrook  et  al.,  1989)  unless  otherwise  stated. 
Chemicals  of  good  quality  were  used  in  the  preparation  of  the 
growth  media  and  solutions;  AnalaR  grade  when  available.  The  sources  of 
many  of  the  chemicals  varied  during  the  course  of  this  work.  The  most 
common  suppliers  were  BDH  Chemicals  Ltd,  Poole,  Dorset;  Difco 
Laboratories,  Detriot,  Michigan,  USA  and  Sigma  Chemical  Co.  Ltd,  Poole, 
Dorset. 
2.1.1  STANDARD  MEDIA  FOR  THE  PROPAGATION  OF  E.  coli 
L-Broth:  10g  tryptone,  5g  yeast  extract,  5g  NaCl  and  1g  glucose  made  up 
to  1  litre  in  distilled  water  and  adjusted  to  pH  7.0  with  NaOH. 
L-Agar:  As  L-Broth  without  glucose  and  the  addition  of  15g.  L-1  agar. 
2YT-Broth:  10g  bacto-tryptone,  10g  yeast  extract,  5g  NaCl  made  up  to  1 
litre  in  distilled  water. 
Minimal  Agar:  7g  K2HPO4,2g  KH2PO4,4g  (NH4)2504,0.25M  trisodium 
citrate,  O.  lg  MgSO4.7H20,17.5g  agar  made  up  to  1  litre  in  distilled  water. 
Minimal  Medium  Supplements:  glucose  and  thiamine  were  added  to 
give  concentrations  of  2mg.  mL-1  and  20µg.  mL-1,  respectively. 
Davis  and  Mingioli  (D&M)  Salts  (X4):  28g  K2HPO4,8g  KH2PO4,16g 
(NH4)2SO4,1g  trisodium  citrate,  0.4g  MgSO4.7H20,  made  up  to  1  litre  with 
distilled  water. 
2.1.2  STERILISATION 
All  growth  media  were  sterilised  by  heating  to  1200C  for  15  mins  in  an 
autoclave.  Supplements  and  buffer  solutions  were  heated  to  1080C  and  CaCl2 
. 37 Chapter  2 
to  1140C  for  10  mins.  Heat-labile  solutions,  such  as  amino  acids,  were 
sterilized  by  filtration  through  Nalgene  0.22  µm  pore  membranes. 
2.1.3  GROWTH  CONDITIONS  FORE.  coli 
Liquid  cultures  of  E.  coli  strains  from  which  plasmids  were  to  be 
isolated  were  grown  in  L-broth  with  the  appropriate  antibiotic  selection 
(usually  ampicillin  at  100 
. g.  mL-1).  The  volume  of  broth  inoculated 
depended  on  the  quantity  of  plasmid  required.  Routinely,  2mL  and  100mL 
cultures  were  used  for  small  and  large  scale  plasmid  preparations, 
respectively  (see  section  2.1.9).  For  the  preparation  of  competent  cells,  liquid 
cultures  of  E.  coli  TG1  were  grown  in  2YT.  To  maximise  aeration  of  the 
culture,  the  volume  of  the  Ehrlenmeyer  flask  was  at  least  five  times  that  of 
the  broth.  All  cultures  were  incubated  at  370C  in  an  orbital  shaker  at  ca.  250 
rpm.  E.  coli  strains  were  also  propagated  on  L-agar  or  Minimal  Medium  agar 
plates  (containing  supplements)  with  the  appropriate  selection.  Plates 
contained  ca.  25m1  of  agar  and  were  incubated  overnight  at  37°C. 
2.1.4  ANTIBIOTICS  AND  INDICATORS 
The  antibiotic  concentrations  used  throughout  for  both  liquid  and  plate 
selection  were  as  follows: 
----------------------------------------------------------- ----------------------------------------------------------- 
DRUG  FINAL  STOCK  STORAGE 
CONCENTRATION  SOLUTION  TEMP. 
--------------- --------------- 
Ampicillin 
------------- ------------- 
100  µg.  mL-1 
--------------------- --------------------- 
20  mg.  mL-1  (water) 
--------- --------- 
-200C 
Kanamycin  50  µg.  mL-1  20  mg.  mL-1  (water)  -20°C 
Tetracycline  50  µg.  mL-1  4  mg.  mL-1  (ethanol)  -200C 
Neomycin  10  µg.  mL-1  10mg.  mL-1  (water)  -20°C 
Nalidixic  Acid  200  . tg.  mL-1  20mg.  mL-1  (water)  -200C 
Chloramphenicol  25  µg.  mL-1  34mg.  mL-1  (ethanol)  -200C 
Streptomycin  50  µg.  mL-1  20mg.  mL-1  (water)  -200C 
Stock  solutions  were  added  to  molten  agar,  which  had  been  cooled  to  55°C. 
5-bromo-4-chloro-3-indolyl-ß-galactosidase  (X-gal)  was  used  in 
conjunction  with  IPTG  to  identify  E.  coli  strain  TG1  containing  pIBI  or 
M13mp  vectors  with  inserts  in  their  multiple  cloning  sites.  The  insert 
containing  recombinants  are  generally  white  while  those  lacking  inserts  are 
blue.  X-gal  was  stored  at  a  concentration  of  20mg.  mL-1  in 
dimethylformamide  (DMF)  at  -200C  while  IPTG  was  stored  at  a  concentration 
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of  20mg.  mL-1  in  dH2O  at  -20°C.  X-gal  and  IPTG  were  added  to  L-agar  plates  to  a 
final  concentration  of  20µg.  mL4  and  50  µg.  mL-'  respectively. 
2.1.5  PRESERVATION  OF  E.  coli  STRAINS 
E.  coli  strains  were  stored  in  glycerol.  An  800µl  aliquot  of  an  overnight 
culture  was  mixed  with  an  equal  volume  of  40ß6  (v/v)  glycerol,  2%  (w/v) 
peptone  and  frozen  at  -70°C.  The  strains  were  revived  by  scraping  the  surface 
of  the  frozen  suspension  with  a  toothpick  and  either  inoculating  liquid  broth 
or  streaking  onto  agar  to  isolate  a  single  colony. 
2.1.6  INTRODUCTION  OF  PLASMID  DNA  INTO  E.  coli 
Two  methods  of  preparing  competent  cells  were  routinely  carried  out; 
the  procedure  described  by  Hanahan  (1983)  gave  higher  efficiencies  but  could 
not  be  stored.  Cells  made  competent  by  CaC12  were  stored  at  -700C  routinely. 
An  efficiency  of  106-107  ampicillin-resistant  trans  formants.  µg-1  plasmid  was 
typically  achieved  using  either  method. 
Preparation  of  competent  cells  by  CaC12  treatment:  An  overnight 
culture  of  the  recipient  strain  was  diluted  1  in  100  into  5OmL  2YT  broth  and 
incubated  for  120-150  min  to  a  density  of  approximately  108.  mL-1  cells  (OD600 
0.45-0.55).  The  cells  were  harvested  by  a  centrifugation  (12000g,  5  min,  4°C) 
and  resuspended  in  10mL  of  ice-cold  100mM  MgCl2.  The  cells  were  kept  on 
ice  for  5  min  and  pelleted  again,  resuspended  in  10mL  of  ice-cold  100mM 
CaC12  and  kept  on  ice  for  at  least  15  min  before  being  pelleted  a  third  time. 
The  cells  were  resuspended  in  2  mLs  of  ice-cold  CaC12.  At  this  stage  glycerol 
could  be  added  to  the  cells  to  20%  (v/v)  and  200µ1  aliquots  frozen  at  -70°C. 
The  cells  retained  their  competence  over  several  months  without  any 
significant  decrease  in  transformation  efficiency. 
Preparation  of  competent  cells  by  Hanahan  (1983)  -a  modified  version: 
Reagents:  TFB;  10mM  2[N-morpholino]ethanesulphonic  acid  (MES)  buffer 
(pH  6.3),  10mM  KCI,  45mM  MnC12.4H20,10mM  CaC12.2H20,  DTT/KAc; 
2.25mM  dithiothreitol,  40  mM  potassium  acetate  (pH  6.0). 
An  overnight  culture  of  the  recipient  strain  was  diluted  1  in  100  into 
50mL  2YT  broth  and  incubated  for  2.5  hrs  to  a  density  of  ca.  108..  mL-1  cells 
(OD6000.45-0.55).  The  cells  were  cooled  on  ice  for  60  min  and  then  harvested 
by  centrifugation  (7000g,  10  min,  4°C).  The  pellets  were  resuspended  in  IOmL 
of  TFB  and  chilled  for  a  further  30  min.  The  cells  were  pelleted  again, 
resuspended  in  2mL  of  TFB  and  70  µl  of  fresh  DMSO.  The  cells  were  left  on 
. 
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ice  for  5  mins  before  155µl  of  DTT/KOAc  was  added.  After  a  10  min 
incubation  on  ice,  70  µl  of  fresh  DMSO  was  added  and  the  incubation 
continued  for  a  further  5  minutes. 
Transformation  with  plasmid  DNA:  Plasmid  DNA  (1-100ng)  in  a 
volume  less  than  1041,  was  added  to  100µl  aliquots  of  the  competent  cells, 
mixed  gently  by  inverting  the  microfuge  tube  and  incubated  on  ice  for  up  to  1 
hour.  The  cells  were  heated  to  420C  for  1  min  and  returned  to  ice  for  a  further 
minute.  A  30041  aliquot  of  2YT  broth  was  added  and  the  cell  suspension 
incubated  at  370C  for  30  min  to  allow  expression  of  the  plasmid  resistance 
genes.  For  selection  with  ampicillin,  an  expression  stage  was  not  required. 
The  cells  were  spread  on  L-agar  plates  containing  the  appropriate  antibiotic. 
2.1.7  CONJUGATION  OF  E.  coli 
The  donor  culture  was  grown  to  mid  log  phase  and  the  recipient  to  a 
late  log  or  stationary  phase.  The  two  cultures  were  mixed  at  a  1:  1  ratio  and 
plated  on  a  nutrient  agar  plate  (stiff  and  dry).  The  plate  was  incubated  at  370C 
for  3  hours.  The  nutrient  agar  plate  was  then  flooded  with  1mL  of  2YT  media 
and  the  culture  removed.  A  series  of  dilutions  were  made  and  plated  onto 
selective  media.  The  resulting  exconjugants  were  counted  after  overnight 
incubation  at  37°C. 
2.1.8  TRANSFECTION  OF  F.  coli  TG1  WITH  BACTERIOPHAGE  M13 
The  modified  version  of  the  protocol  developed  by  Hanahan  (1983)  was 
used  to  prepare  competent  cells  of  E.  coli  TG1  for  transfection  with  the 
replicative  form  of  M13. 
Transfection  of  E.  coli  TG1  with  bacteriophage  M13mp:  The  procedure 
followed  the  plasmid  transformation  protocol  described  above,  up  to  and 
including  the  heat-shock  stage.  After  this  step,  2001Al  of  a  fresh  exponential 
TG1  culture  was  added  to  the  transfected  cells,  followed  by  4µl  of  IPTG 
(200mg.  mL-1)  and  40µl  X-gal  (20mg.  mL-1).  The  cells  were  then  mixed  and 
added  to  2.5mL  of  molten  water-agar  (0.7%  w/v,  pre-cooled  to  45°C),  which 
were  poured  onto  thoroughly-dried  L-agar  plates. 
2.1.9  ISOLATION  OF  PLASMID  DNA  FROM  E  coli 
Protocols  based  on  the  alkaline  lysis  method  (Birnboim  and  Doly,  1979) 
were  used  for  the  isolation  of  plasmid  from  both  small  (5  mL)  and  large  (50- 
200  mL)  culture  volumes  of  E.  coll. 
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Reagents:  Birnboim  Doly  I  (BDI);  50mM  glucose,  25mM  Tris-HC1  (pH  8.0), 
10mM  EDTA.  Lysozyme  was  added  immediately  before  use  to  a  final 
concentration  of  1-4mg.  mL-1.  Birnboim  Doly  II  (BDII);  0.2M  NaOH,  1%  (w/v) 
SDS  which  was  stored  in  a  plastic  container.  Birnboim  Doly  III  (BDIII);  5\i 
KOAc  (pH  4.8);  prepared  by  mixing  equal  volumes  of  3M  CH3COOK  and  2'_ßi 
CH3COOH.  Phenol;  The  phenol  was  redistilled,  buffered  against  0.5M 
Tris.  HC1  (pH  8.0)  and  contained  0.1%  (w/v)  8-hydroxyquinoline. 
Phenol.  Chloroform;  50  parts  phenol,  49  parts  chloroform,  1  part  isoamyl 
alcohol.  DNAase-free  RNAase;  Pancreatic  RNAase  (RNAase  A)  was  dissolved 
at  a  concentration  of  10mg.  mL-1  in  dH2O,  heated  to  100°C  for  15min  and 
allowed  to  cool  slowly  to  room  temperature.  The  RNAase  was  then  aliquoted 
and  stored  at  -20°C. 
Large-scale  plasmid  preparations:  200mL  cultures  of  stationary  phase 
cells  were  harvested  using  a  centrifuge  (12000g,  5min  at  4°C).  The  pellet  was 
resuspended  in  4mL  of  Birnboim-Doly  I  solution.  Cultures  were  incubated  on 
ice  for  5min.  Then  8mL  of  Birnboim-Doly  II  solution  was  added  and  the 
solution  was  left  on  ice  for  5-10  min  before  6mL  of  cold  Birnboim-Doly  III 
solution  was  added.  The  suspension  was  mixed  gently  and  left  on  ice  for  15-30 
min.  The  cell  debris  and  most  of  the  chromosomal  DNA  was  removed  by 
centrifugation  (32000g,  5  min  at  40C).  The  remaining  nucleic  acid  was 
precipitated  by  the  addition  of  an  equal  volume  of  isopropanol  and  then 
harvested  by  centrifugation  (  39200g,  15  min).  The  nucleic  acid  pellet  was 
washed  with  70%  (v/v)  ethanol.  The  plasmid  DNA  was  further  purified  by 
equilibrium  density  centrifugation  on  a  caesium  chloride  ethidium  bromide 
(CsC1.  EtBr)  gradient.  The  nucleic  acid  pellet  was  redissolved  in  1  mL  of 
dH20and  4.5g  of  CsC1  dissolved  in  3.5mL  of  dH2O.  The  DNA  and  CsCI 
solutions  were  combined  with  250µ1  of  EtBr  (10mg.  ml-1),  creating  a  solution 
with  a  density  of  1.58g.  mL-1.  The  nucleic  acid-CsC1  solution  was  spun  in  a 
Beckman  Ti70  angled  rotor  at  289000g  for  16  hours  at  20°C.  Two  bands  were 
visible  in  the  gradients  after  centrifugation,  a  lower  supercoiled  plasmid  band 
and  an  upper  chromosomal  and  relaxed  plasmid  DNA  band.  The  lower  band 
was  removed  using  a  1mL  syringe  and  the  EtBr  removed  by  repeated 
extractions  with  water-saturated  butanol.  After  dilution  with  3  volumes  of 
dH2O,  9  volumes  of  absolute  ethanol  were  added.  The  precipitate  was 
recovered  by  centrifugation  (27000g,  40C  for  30min).  The  resulting  plasmid 
pellet  was  washed  twice  with  70%  (v/v)  ethanol  and  dried  in  vacuo  before 
being  redissolved  in  1mL  dH2O.  This  procedure  yielded  very  large  amounts  of 
pure  plasmid  DNA  (up  to  1mg  ),  suitable  for  all  in  vitro  manipulations. 
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Small-scale  plasmid  preparations:  Routinely,  plasmids  were  isolated  from 
1.5mL  of  E.  coli  cultures.  The  cells  were  harvested  by  centrifugation  in  a 
1.5mL  microfuge  tube  (12000g  for  30s)  and  resuspended  in  100µ1  of  BDI, 
containing  lysozyme  at  a  concentration  of  1mg.  mL-1,  using  a  vortex  mixer. 
This  was  followed  by  the  addition  of  200µl  of  BDII  and  repeated  inversion  of 
the  microfuge  tube  to  mix  the  suspension  thoroughly.  Immediately 
afterwards,  150µl  of  prechilled  BDIII  was  added  to  the  viscous  bacterial  lysate, 
mixed  gently  on  the  vortex  mixer  and  placed  on  ice  for  5-10  min.  The  cell 
debris  and  most  of  the  chromosomal  material  was  removed  by  centrifugation 
(12000g,  40C  for  10min).  The  supernatant  was  transferred  to  a  fresh  tube  and 
extracted  with  half  volumes  of  phenol.  chloroform  and  chloroform.  The 
nucleic  acid  was  then  precipitated  by  the  addition  of  2  volumes  of  ethanol  and 
incubated  at  room  temperature  for  3-5  min.  The  precipitate  was  harvested  by 
centrifugation  in  a  microfuge  (12000g,  40C  for  at  least  15min).  The  resulting 
pellet  was  rinsed  twice  with  70%  (v/v)  ethanol  before  it  was  allowed  to  dry  by 
leaving  the  tube  open  on  the  bench.  The  nucleic  acid  was  then  resuspended 
in  50µl  dH2O  containing  DNAase-free  RNAase  (20µg.  mL-1).  The  typical  yield 
of  high  copy  number  plasmids  such  as  pUC  from  E.  coli  was  2-54g. 
2.1.10  QUANTIFICATION  OF  NUCLEIC  ACID 
The  concentration  and  purity  of  the  nucleic  acid  was  determined  by 
spectrophotometry;  an  A260  of  1  is  equivalent  to  40µg.  mL-1  RNA  and 
50µg.  mL-1  double  stranded  DNA.  Pure  preparations  of  RNA  and  DNA  have 
an  A260/A280  of  1.8  and  2.0,  respectively.  Contaminating  protein  or  phenol 
lowers  these  values  significantly. 
2.1.11  DIGESTION  OF  DNA  WITH  RESTRICTION  ENDONUCLEASES 
Digestion  of  DNA  was  performed  in  a  total  volume  of,  typically,  20111 
containing  0.25-1.0µg  of  DNA  and  1-10  units  of  restriction  endonuclease  per 
µg  DNA  in  the  appropriate  buffer  (provided  by  BRL  the  main  enzyme 
supplier).  For  the  digestion  of  larger  amounts  of  DNA,  the  volumes  were 
scaled  up  accordingly.  The  reactions  were  allowed  to  proceed  for  1  to  2  hours 
at  the  temperature  recommended  by  the  supplier.  Reactions  were  stopped 
either  by  the  addition  of  gel  loading  buffer  or  by  heating  to  700C  for  5  min, 
followed  by  cooling  on  ice. 
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2.1.12  PARTIAL  DIGESTION  OF  DNA  WITH  RESTRICTION 
ENDONUCLEASE  USING  ETHIDIUM  BROMIDE 
A  series  of  tubes  were  set  up  all  containing  the  same  amount  of  DNA 
and  reaction  buffer.  Varying  amounts  of  EtBr  (100ng  -  500ng)  in  a  constant 
volume  of  dH2O  were  added  to  the  DNA.  Finally,  the  appropriate  restriction 
enzyme  was  added  last.  An  uncut  and  completely-cut  sample  (without  EtBr) 
were  always  run  as  controls.  The  reactions  were  digested  for  1  hr  at  the 
optimal  digestion  temperature  for  the  restriction  enzyme. 
2.1.13  FILLING  IN  OF  5'  OVERHANGING  BASES  RESULTING  FROM 
RESTRICTION  DIGESTIONS 
After  digestion,  11AI  of  a  solution  containing  all  4  dNTP's  at  a  2mM 
concentration  and  1-2U  of  T4  DNA  polymerase  was  added  to  the  2Oµ1  reaction 
and  incubated  at  120C  for  15  minutes.  The  dNTP's  were  be  removed  before 
ligations  by  gel  electrophoresis. 
2.1.14  LIGATION  OF  DNA  FRAGMENTS 
The  ligation  of  DNA  fragments  was  carried  out  at  a  DNA  concentration 
of  6mg.  mL-1.  The  molar  ratio  of  insert  fragment  to  vector  was  2:  1,  when  the 
vector  could  not  ligate  to  itself,  but  only  with  the  insert  fragment.  A  molar 
ratio  of  10:  1  was  used  when  the  ends  of  the  vector  could  ligate  to  each  other. 
Ligations  were  performed  in  2Oµ1  of  1X  BRL  ligation  buffer,  containing  1U  of 
T4  DNA  ligase.  µg-1  of  DNA.  The  reactions  were  incubated  for  4  hours  at  room 
temperature  or  overnight  at  160C. 
2.1.15  ADDITION  OF  LINKERS  TO  BLUNT-ENDED  FRAGMENTS 
The  molar  ratio  of  linkers  to  blunt-end  vector  fragment  must  be  200:  1, 
starting  with  2-5pmoles  of  vector.  The  ligations  were  set  up  in  2Oµ1  of  1X  BRL 
ligation  buffer  containing  1mM  ATP,  50µg/mL  BSA  and  2U  of  T4DNA  ligase 
µg_1  of  DNA.  The  reaction  was  incubated  overnight  at  room  temperature. 
80µl  of  H2O  was  added  before  the  reaction  was  heated  at  700C  for  15min  to 
inactivate  the  enzyme.  A  routine  restriction  digestion  was  then  carried  out  to 
remove  any  concatemerized  linkers. 
2.1.16  REMOVAL  OF  THE  5'  PHOSPHATE  FROM  LINEARISED  DNA 
10X  CIP  Buffer:  200mM  Tris.  HC1  (pH  8.0),  10mM  MgCl2,10mM  ZnC12 
and  0.5mg.  mL-1  Bovine  Serum  Albumin. 
Procedure:  Calf  Intestinal  Alkaline  phosphatase  (CIP)  was  used  to 
remove  the  5'  phosphate  from  DNA.  Five  pmoles  of  5-terminal 
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phosphorylated  DNA  with  5'  protruding  ends  (approximately  74g  of  a  5kb 
molecule)  were  incubated  in  1X  CIP  buffer,  containing  0.1U  of  CIP  at  370C  for 
30min.  The  reaction  was  terminated  by  heating  to  650C  in  1X  gel  loading 
buffer  for  10min.  The  dephosphorylated  DNA  was  purified  from  an  agarose 
gel  after  electrophoresis. 
2.1.17  REMOVAL  OF  PROTEIN  FROM  NUCLEIC  ACID  SOLUTIONS  USING 
ORGANIC  SOLVENTS 
Reagents:  Phenol;  All  phenol  used  in  the  purification  of  DNA  or  RNA 
was  redistilled,  buffered  against  500mM  Tris.  HCl  (pH  8.0)  and  contained  0.1% 
(w/v)  8-hydroxyquinoline. 
Procedure:  Proteins  were  removed  from  nucleic  acid  solutions  by 
extracting  first  with  phenol.  chloroform  and  then  chloroform.  Half  volumes 
of  the  solvents  were  added  to  the  nucleic  acid  solution,  mixed  using  a  vortex 
mixer  and  the  phases  separated  by  centrifugation  (12,000g  for  3min).  Proteins 
were  retained  in  the  organic  phase.  Subsequent  precipitation  of  the  nucleic 
acid  in  the  aqueous  phase  using  isopropanol  or  ethanol  removed  any 
residual  solvent. 
2.1.18  AGAROSE  GEL  ELECTROPHORESIS 
Both  DNA  and  RNA  were  visualized  on  horizontal  neutral  agarose 
gels.  Although  0.8%  (w/v)  gels  were  most  commonly  used,  1-2%  (w/v)  gels 
were  occasionally  used  to  separate  fragments  of  <1.5kb.  Gels  were  routinely 
prepared  and  run  in  TAE  buffer. 
10X  TAE  Buffer  pH  8.2;  48.4g  Tris,  16.4g  Na  acetate,  3.6g  Na2EDTA.  2H20, 
made  up  to  1  litre  in  distilled  water,  pH  adjusted  to  8.2  with  glacial  acetic  acid. 
5X  Agarose  gel  loading  (AGL)  buffer  (pH  7.4);  0.025%  (w/v)  bromophenol 
blue,  0.025%  (w/v)  xylene  cyanol,  25%  (w/v)  ficoll,  0.5%  (w/v)  SDS,  50mM 
EDTA. 
2.1.18.1  MINI  GELS 
BRL  model  H6  gel  kits  were  used  for  the  rapid  analysis  of  DNA  after 
digestion  with  restriction  enzymes  or  precipitation  steps.  0.16g  agarose  was 
added  to  20mL  of  1X  TAE 
, 
boiled  then  cooled  to  60°C.  EtBr  was  added  to 
200ng.  mL-1  and  the  molten  agarose  poured  into  a  7.6cm  X  5.1cm  gel  caster 
with  an  8  well  slot  former  (4.1  X  0.8mm  wells).  After  the  gel  had  set,  the  slot 
former  was  removed  and  the  gel  placed  in  the  tank  with  500mL  of  IX  TAE. 
Depending  on  the  time  available  and  the  level  of  resolution  required  the 
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DNA  was  separated  by  electrophoresis  for  30-45min  with  an  applied  voltage 
of  2-10V.  cm-1.  The  separated  DNA  molecules  were  visualised  on  a  302nm  UV 
transilluminator. 
2.1.18.2  LARGE  GELS 
100mL  gels  were  also  used  to  ensure  good  separation  of  DNA 
fragments  for  accurate  sizing  and/or  Southern  analysis.  They  were  made  by 
pouring  100ml  of  molten  agar  containing  200µg  EtBr,  into  a  16.5  X  23cm  gel 
former  with  a  14  space  slot  former.  The  gels  were  run  overnight  at  20V  in  1X 
TAE  buffer  in  gel  tanks  with  a  capacity  of  1  litre.  DNA  samples  were  mixed 
with  1/5  volume  of  5X  AGL  buffer  before  loading  onto  the  gel. 
2.1.19  PHOTOGRAPHY  OF  RESOLVED  NUCLEIC  ACIDS 
Gels  stained  with  ethidium  bromide  were  viewed  on  a  302nm  UV 
transilluminator  and  photographed  using  Polaroid  type  67  land  film  or  using 
a  Pentax  35mm  SLR  loaded  with  Ilford  HP5  film.  Both  cameras  were  fitted 
with  Kodak  Wratten  filters  (No.  23A). 
2.1.20  RECOVERY  OF  DNA  FROM  AGAROSE  GELS 
The  DNA  band  were  exised  from  the  agarose  gel  and  loaded  into  the 
top  chamber  of  a  Spin-XTT''  column  (0.45  µm  cellulose  acetate,  Costar).  The 
tube  was  incubated  at  -200C  for  15  min.  After  15  min  the  tube  was  spun  at 
10,000  rpm  for  5  min.  The  fragment  DNA  was  now  in  the  bottom  chamber 
and  the  top  chamber  could  be  discarded.  Recovery  levels  ranged  between  57 
and  69%. 
2.1.21  NON-RADIO-LABELLED  PROBES  AND  DETECTION 
Analysis  of  DNA  on  agarose  gels  by  Southern  blotting  employed  the 
digoxygenin  (DIG)-DNA  labelling  and  luminescent  detection  kit  from 
Boehringer  Mannheim  Biochemica.  In  principle,  DIG  is  bound  via  a  spacer 
arm  to  uridine-nucleotides  (DIG-dUTP)  and  incorporated  enzymatically  into 
DNA  probes  by  random-primed  DNA  labelling  (see  below).  After  blocking 
and  hybridisation,  DIG-labelled  probes  are  detected  by  a  high  affinity  anti-DIG 
-antibody  Fab-fragments  conjugated  to  alkaline  phosphatase.  Alkaline 
phosphatase  dephosphorylates  the  chemiluminescent  substrate  AMPPD 
which  upon  decomposition  via  an  unstable  intermediate  emits  light  which 
can  be  detected  on  X-ray  film. 
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2.1.21a  RANDOM  PRIMED  DNA  LABELLING  METHOD 
Labelling  of  DNA  fragments  with  digoxigenin  11-dUTP  was  set  up 
following  the  procedure  of  Boehringer  Mannheim: 
1  µg  DNA  of  denatured  DNA  fragment  in  a  volume  less  than  lOµ1 
(denatured  by  heating  for  10min  at  950C  with  subsequent  cooling  on 
ice). 
2p1  of  hexanudeotide  mix  (10X  concentrated  ). 
2µl  of  dNTP  labeling  mix  (10X  concentrated) 
1µl  (1U)  of  Klenow  enzyme,  labelling  grade 
Made  up  to  20µl  total  volume  with  dH2O. 
The  reaction  mixture  was  incubated  at  370C  for  at  least  60  minutes 
(overnight  was  preferred  to  increase  the  amount  of  labelled  DNA),  and 
stopped  by  addition  of  2  µl  of  0.2M  EDTA  (pH  8.0).  The  labelled  DNA 
fragments  were  precipitated  with  2.5  µl  of  4M  lithium  chloride  and  75  µl  of 
prechilled  (-20°C)  ethanol  and  harvested  by  centrifugation  in  a  microfuge 
(12,000g  40C  for  10min).  The  DNA  pellet  was  washed  twice  with  70%  (v/v) 
ethanol,  dried  in  an  open  microfuge  tube  at  room  temperature  and  dissolved 
in  50  µl  of  TE  buffer  (ca.  250  ng  of  labelled  DNA  was  expected).  The  labelled- 
DNA  could  be  kept  at  -200C  for  a  very  long  period. 
2.1.22  TRANSFER  OF  DNA  FROM  E.  coli  COLONIES  TO  AMERSHAM 
TM 
HYBOND-N  MEMBRANES 
Reagents:  20X  SSC;  3M  NaCI,  0.3M  Tri-sodium  citrate.  Denaturing 
solution;  1.5M  NaCI,  0.5M  NaOH.  Neutralising  solution;  1.5M  NaCI,  0.5M 
Tris.  HC1  (pH  7.2),  1mM  EDTA. 
Procedure:  A  Hybond-NTM  membrane  was  cut  to  the  correct  size  and 
placed  onto  the  surface  of  a  L-agar  plate  containing  the  appropriate  antibiotic. 
The  E.  coli  clones  to  be  screened  were  streaked  out  on  top  of  the  membrane 
and  the  plate  incubated  at  370C  overnight.  The  membrane  was  then  removed 
and  placed,  colony  side  up,  on  a  pad  of  absorbent  filter  paper  soaked  in 
denaturing  solution  and  left  for  7min.  Next  the  membrane  was  transferred  to 
a  pad  of  filter  paper  soaked  in  neutralising  solution  and  left  for  3min.  This 
step  was  then  repeated,  with  a  fresh  pad  soaked  in  neutralising  solution.  The 
membrane  was  washed  in  2X  SSC,  transferred  to  dry  filter  paper  and  air  dried, 
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colony  side  up.  Finally,  the  samples  were  fixed  to  the  membrane  by  baking  in 
an  oven  at  80°C  for  2  hours. 
2.1.23  CAPILLARY  TRANSFER  OF  DNA  TO  HYBOND' 
After  electrophoresis  and  photography,  the  resolved  DNA  fragments 
were  transferred  under  alkali  conditions  to  Hybond-NTm  (adapted  from 
Southern;  1975). 
Reagents:  Alkali  transfer  buffer;  0.25M  NaOH,  1.5M  NaCI.  Denaturing 
solution  and  20X  SSC;  as  described  in  Section  2.1.22. 
Procedure:  The  gel  was  rinsed  in  dH2O,  placed  in  enough  denaturing 
solution  to  immerse  it  completely  and  left  for  30min.  The  gel  was  removed, 
excess  liquid  removed  by  blotting  and  equilibriated  for  10-15min  in  alkaline 
transfer  buffer.  The  membrane,  cut  to  the  appropriate  size,  was  placed  on  top 
of  the  gel  on  a  raised  platform  with  wicks  passing  from  underneath  the  gel  to 
a  reservoir  of  transfer  buffer.  The  filter  was  then  overlaid  with  absorbant 
pads  and  weighted  down.  After  blotting  for  a  least  4  hours  the  membrane  was 
washed  briefly  in  2X  SSC  to  remove  any  adhering  agarose.  The  membrane 
was  then  air  dried  for  at  least  30  minutes. 
2.1.24  CONDITIONS  FOR  AQUEOUS  PREHYBRIDIZATION  AND 
HYBRIDIZATION 
The  procedures  which  follow  were  suitable  for  DNA  immobilised  on 
filters  from  colony  lifts  and  Southern  transfer  and  follow  protocols  outlined 
in  "The  DIG  System  User's  Guide  for  Filter  Hybridization"  produced  by 
Boehringer  Mannheim. 
Prehybridization  and  hybridization  conditions:  The  hybridization 
temperature  is  dependent  on  the  application.  However  all  hybridizations  in 
this  work  were  done  at  420C.  The  appropriate  volume  of  DIG  Easy  HyB  `M 
(approx.  20mL/104cm2)  was  prewarmed  to  420C  and  then  incubated  with  the 
blot  for  30  minutes.  The  prehybridization  solution  was  poured  off  and  the 
hybridization  solution  added.  5-25ng/mL  of  DIG-labeled  probe  was  denatured 
at  950C  for  5  minutes  and  then  added  to  prewarmed  DIG  Easy  HyBTM 
. 
The 
volume  of  the  hybridization  solution  depended  on  the  size  of  the  filters; 
2.5m1  was  added  for  every  100cm2  of  membrane.  Ensuring  that  all  air  bubbles 
were  removed,  the  blot  was  incubated  overnight  with  gentle  agitation. 
Washing  of  membranes  after  hybridization:  The  nylon  membrane  was 
washed  twice  in  200mL  of  2X  SSC,  0.1%  (w/v)  SDS  at  room  temperature  for 
47 Chapter  2 
5min  each.  It  was  then  washed  in  200mL  of  0.1X  SSC,  0.1%  (w/v)  SDS  at  680C 
for  15  min  each  under  constant  agitation. 
The  probe  could  be  stripped  from  the  filter  (provided  the  filter  was  kept  moist 
after  hybridization)  by  washing  in  0.4M  NaOH  at  450C  for  30min.  The  filter 
was  then  washed  in  0.1X  SSC,  0.2M  Tris.  HC1  (pH  7.4)  and  0.1%  (w/v)  SDS  for 
15min  and  stored  in  a  sealed  plastic  bag  until  required. 
2.1.25  DETECTION  OF  DIG-LABELLED  NUCLEIC  ACIDS 
Chemiluminescent  detection  was  carried  out  with  LumigenTMPPD. 
Reagents:  Bufferl  100mM  maleic  acid,  150  mM  NaCl;  pH  7.5  Buffer  2:  1% 
Blocking  Reagent  dissolved  in  buffer  1.  Buffer  3:  100mM  Tris-HC1,  pH9.5, 
100mM  NaCl,  50mM  MgCl.  2Washing  Buffer:  Buffer  1,0.3%  Tween®  20. 
Blocking  Reagent:  A  10%  stock  solution  is  made  up  in  Buffer  1.  The 
following  solutions  are  supplied  with  the  Detection  kit:  Blocking  Reagent, 
Anti-digoxigenin-AP  Fab  fragments  and  LumigenTmPPD. 
Procedure:  After  the  post-hybridization  washes  the  membrane  was 
equilibrated  in  Buffer  1  for  1  minute.  The  membrane  was  then  transferred  to 
a  clean  dish  and  incubated  in  Buffer  2  for  30  min.  The  Anti-digoxigenin-AP 
Fab  fragments  were  diluted  1:  10,000  in  Buffer  2.  Buffer  2  was  poured  off  and 
the  membrane  '  was  incubated  in  the  antibody  solution  for  30  min.  The 
antibody  solution  was  then  discarded  and  the  membrane  washed  twice  for  15 
min  each  in  washing  buffer.  The  membrane  was  equilibrated  for  2  minutes 
in  Buffer  3.  LumigenTMPPD  was  diluted  1:  100  in  buffer  3  and  500µl  was  added 
directly  to  the  filter  and  incubated  for  5  min.  The  excess  liquid  was  poured  off 
and  the  filter  sealed  in  a  plastic  bag.  It  was  incubated  for  15  minutes  at  370C  to 
initiate  the  reaction  catalysed  by  alkaline  phosphatase.  The  membrane  was 
then  exposed  to  standard  X-ray  film. 
2.1.26  PREPARATION  OF  SINGLE-STRANDED  M13  DNA 
The  single-stranded  M13  templates  were  prepared  as  described  in  the 
"M13  Cloning/Dideoxy  Sequencing  Instruction  Manual"  published  by 
Bethesda  Research  Laboratories. 
Minipreparations:  A  single  M13  plaque  was  used  to  infect  5m1  of  2X  YT 
broth  containing  200µ1  of  an  overnight  culture  of  E.  coli  TG1.  This  was  grown 
at  370C  for  4.5  hours  with  vigorous  shaking,  then  transferred  to  a  microfuge 
tube  and  harvested  by  centrifugation  at  room  temperature  for  5min.  The 
supernatant,  containing  the  phage  particles,  was  recovered  and  respun.  The 
supernatant  (1mL)  that  remained  was  mixed  with  300µl  of  a  solution  of  20ß6 
48 Chapter  2 
(w/v)  PEG  (6000)/2.5M  NaCl  and  left  to  stand  at  room  temperature  for  15min 
to  precipitate  the  phage  particles.  These  were  recovered  by  centrifugation  at 
room  temperature  in  a  microfuge  for  15min.  The  supernatant  was  discarded, 
the  pellet  respun  and  all  traces  of  supernatant  removed.  The  pellet  was  then 
resuspended  in  100µ1  dH2O  and  extracted  twice  with  phenol.  chloroform  and 
twice  with  chloroform.  The  DNA  was  then  ethanol  precipitated  with  ethanol 
and  redissolved  in  30  µl  dH2O. 
2.1.27  DNA  SEQUENCING 
Dideoxy  sequencing  (Sanger  et  al.,  1975)  was  carried  out  on  single- 
stranded  M13  templates  using  a  Sequenase'  kit  supplied  by  United  States 
Biochemical  Corporation  (USB).  T7  DNA  polymerase  was  supplied  by 
Pharmacia  Ltd. 
Annealing  template  and  primer:  In  a  1.5mL  microfuge  tube,  1µg  of 
single-stranded  template,  lµl  of  sequencing  primer  (0.5pmoles)  and  2µl  of 
reaction  buffer  were  combined  and  the  volume  made  up  to  10µl  with  dH2O. 
After  denaturing  at  850C  for  2min,  the  primer  was  annealed  to  the  template 
by  incubating  at  450C  for  10min.  After  annealing  was  complete,  the  tube  was 
placed  on  ice  and  used  within  ca.  2  hours. 
Labelling  reaction:  The  T7  DNA  polymerase  enzyme  was  diluted  1:  6 
with  reaction  buffer  containing  0.5µ1  of  pyrophosphatase. 
To  the  annealed  template-primer,  the  following  were  added  on  ice: 
Volume  (pl) 
7-deaza-dGTP  labelling  mix  2 
[35S]dATP  (1000-15000i.  mmol-1)  0.5 
diluted  T7  DNA  polymerase  (2  units)  2 
DTT  (0.1M)  1 
The  above  were  mixed  and  incubated  at  room  temperature  for  5min.  To  read 
sequences  close  to  the  primer  annealing  site,  Manganese  Buffer  (supplied 
with  the  kit),  was  used. 
Termination  reactions:  Immediately  after  the  labelling  reaction  was 
completed,  3.5µl  aliquots  were  dispensed  into  four  microfuge  tubes 
containing  one  of  the  four  7-deaza-dGTP  termination  mixtures;  ddATP, 
ddCTP,  ddGTP  and  ddTTP,  respectively.  The  contents  were  mixed  as  quickly 
as  possible  and  incubated  at  370C  for  5min.  After  the  reactions  were  complete, 
4µl  of  stop  loading  buffer  was  added  and  then  they  were  stored  on  ice  until 
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the  sequencing  gel  was  ready  to  load.  The  samples  were  heated  to  700C  for  2-5 
min,  cooled  rapidly  on  ice  and  loaded  immediately  onto  the  gel  (see  below). 
Approximately  2-3µl  of  the  sequencing  products  were  loaded  per  track. 
2.1.28  DENATURING  POLYACRYLAMIDE  GEL  ELECTROPHORESIS 
A  BRL  sequencing  unit  (Model  S2)  was  used  for  high  voltage 
polyacrylamide  gel  electrophoresis. 
Reagents:  5X  Sequencing  gel  loading  buffer  (pH  8.2);  0.1%  (w/v) 
bromophenol  blue,  0.1%  (w/v)  xylene  cyanol,  10mM  Na2EDTA,  95%  (v/v) 
formamide  (de-ionized  with  a  mixed-bed  resin).  40%  Acrylamide  stock 
solution:  purchased  from  Severn  Biotech.  Ltd  containing  a  19:  1  acrylamide  : 
bis  ratio.  10X  TBE  Buffer:  108gm  Tris  Base,  55  gm  Boric  acid,  40m1  0.5M  EDTA 
pH  8.0  and  dH2O  to  1  litre. 
Preparation  of  polyacrylamide  gels:  6%  (w/v)  denaturing 
polyacrylarnide  gels  were  used  for  sequencing.  The  gels  were  prepared  from 
the  following  stock  solutions: 
40%  (w/v)  acrylamide  stock  9  mL 
urea  30  g 
1OX  TBE  6  mL 
dH2O  21  mL 
ca.  60  mL 
The  urea  was  dissolved  by  heating  the  mix  to  370C  and  then  cooling  to 
room  temperature.  The  sequencing  gel  solution  could  be  stored  at  40C  for 
several  weeks  before  use.  Before  pouring  the  gel,  3001l  of  freshly  prepared 
10%  (w/v)  ammonium  persulphate  and  30µl  of  TEMED  were  added  to  6OmL 
of  the  stock  solution. 
Preparation  of  glass  plates  and  pouring  the  gel:  The  plates  (40cm  X 
33cm)  were  cleaned  thoroughly  with  water  and  alcohol.  One  plate  was  treated 
with  a  commercial  non-stick  baking  grease  and  then  assembled  using  three 
spacers  (0.4mm  thick)  along  the  vertical  sides  and  the  bottom  of  the  gel.  The 
entire  assembly  was  held  in  place  by  clamps.  The  gel  solution  was  poured 
using  a  60mL  syringe  down  one  edge  of  the  plates  while  tilting  the  plates  at  an 
angle  of  about  300.  The  plates  were  then  laid  at  an  angle  of  50  and  the  sharks 
tooth  combs  inserted  upside  down  to  give  a  flat  top.  The  gel  polymerized 
usually  within  30  min  at  room  temperature. 
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Electrophoresis  of  sequencing  gels:  The  gel  was  pre-electrophoresed  for 
30min  at  a  constant  power  of  60W.  Prior  to  loading,  the  samples  prepared  as 
described  in  Section  2.1.27  were  heated  to  950C  for  5  min,  placed  on  ice  and 
loaded  on  to  the  gel.  6%  (w/v)  gels  were  run  for  1.75-2hrs  to  read  the  first  100 
nucleotides  and  for  4.5-5hrs  to  read  up  to  400  nucleotides.  At  the  completion 
of  the  runs,  the  plates  were  disassembled  and  the  gel  soaked  in  12% 
methanol,  10%  acetic  acid  for  30  min.  The  gels  were  then  dried  under 
vacuum  for  30  min  before  being  exposed  to  autoradiographic  film. 
2.1.29  OLIGONUCLEOTIDE  DEPROTECTION 
Oligonucloides  were  synthesized  on  a  Applied  Biosystems 
International  (ABI)  391  DNA  synthesizer  PCR-MateTT'.  The  columns  and 
chemicals  were  purchased  from  Cruachem  Ltd. 
Procedure:  The  columns  were  carefully  broken  open  with  the  use  of  a 
spatula  and  the  powdery  glass  bead  support  was  tapped  into  a  2.  OmL  screw- 
capped  tube.  One  mL  of  30%  aqueous  ammonia  was  added  and  the  tube  left  at 
room  temperature  for  1-2  hours.  The  ammonia  solution  must  be  fresh,  kept 
tightly  sealed  and  stored  at  -20°C.  After  2  hours  the  contents  of  the  tube  were 
mixed  and  then  centrifuged  in  a  microfuge  for  a  few  seconds.  The 
supernatant  was  then  transfered  to  a  fresh  screw-capped  tube.  A  further  lmL 
of  30%  ammonia  was  added  and  the  tube  sealed  firmly  with  parafilmTM.  The 
tube  was  incubated  overnight  at  500C  and  allowed  to  cool  before  opening. 
The  DNA  was  then  precipitated  with  2  volumes  of  ethanol  after  making  the 
solution  to  0.5M  ammonium  acetate.  Precipitation  could  be  completed  at 
-700C  in  1  hour.  The  pellet  was  washed  after  spinning  for  15  min  at  40C.  The 
dried  pellet  was  resuspended  in  100µl  of  sterile  dH2O.  The  appropriate 
dilutions  were  made  after  quantification. 
2.1.30  AUTORADIOGRAPHY 
Autoradiography  was  performed  in  metal  cassettes  (medical  chest  X-ray 
type)  using  Kodak  X-OMATS  film.  Enhancement  in  the  intensity  of  the 
autoradiographic  images  was  obtained  when  the  film  was  exposed  at  low 
temperature  (-700C)  in  close  contact  with  a  du  Pont  Cronex  Lightening  Plus 
intensifying  screen.  The  X-ray  films  were  developed  using  a  Kodak  X-OMAT 
automatic  processor,  Model  ME-I. 
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2.1.31  POLYMERASE  CHAIN  REACTION 
The  polymerase  chain  reactions  (PCR)  were  carried  out  in  a  Perkin 
-Elmer  Cetus  DNA  Thermal  Cycler.  A  typical  reaction  requires: 
DNA  template  14l 
10X  Taq  reaction  buffer  541 
20%  Glyercol  251il 
2X  primers  at  100pmol 
each  241 
dNTP's  (@1.25mM)  841 
dH2O  9u1 
ca.  50µl 
One  drop  of  oil  was  added  to  the  tube.  The  thermal  cycler  was  programmed 
in  a  series  of  files.  The  first  file  was  set  to  give  one  cycle  at  940C  for  4  mins  to 
denature  the  template.  The  second  file  was  set  to  denature  at  940C  for  30  sec., 
anneal  at  Tm-50C  for  30  sec.,  and  extend  for  2mins  at  720C  for  a  total  of  30 
cycles.  The  third  file  was  one  cycle  of  denaturing  at  940C  for  30  sec., 
annealling  at  Tm-50C  for  1  min.  and  extending  at  720C  for  5  mins.  The  final 
file  cooled  the  machine  to  40C  for  15  mins. 
The  Tm  was  calculated  using  the  following  equation  (Sambrook;  1989): 
Tm=  81.5-16.6(log10[Na+])  +  [0.41(G+C)]  %-  600  =  OC 
L 
The  PCR  products  were  analyzed  by  running  5µl  on  an  agarose  gel. 
2.2  STANDARD  MICROBIOLOGICAL  TECHNIQUES  FOR  Streptomyces 
All  procedures  can  be  found  in  "Genetic  Manipulation  of 
Streptomyces:  A  laboratory  manual"  (Hopwood  et  al.,  1985),  unless  otherwise 
stated. 
2.2.1  STANDARD  MEDIA  FOR  THE  PROPAGATION  OF  Streptomyces 
Emersons  agar:  purchased  as  a  powder  and  prepared  as  directed  by  the 
manufacturer  (Difco). 
Hopwood's  Minimal  Medium  (HMM):  0.5g  L-asparagine,  0.2g  K2HPO4, 
0.2g  MgSO4.7H2O,  0.01g  FeSO4.7H20,10g  glucose,  10g  agar,  made  up  to  1  litre 
with  distilled  water. 
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Liquid  Complete  Medium  (LCM):  10g  glucose,  5g  yeast  extract,  15g 
lactalbumin  hydrolysates,  2.8g  sucrose,  1g  calcium  chloride,  made  up  to  1  litre 
with  distilled  water. 
R2  Medium:  R2A-  44g  agar,  0.5g  K2SO4,20.2g  MgC12.6H20,5.9g 
CaC12.2H20,20g  glucose,  6g  proline,  0.2g  casamino  acids,  4ml  trace  elements 
solution  (Hopwood  et  al.,  1985a),  made  up  to  1  litre  in  distilled  water.  R2B- 
11.5g  MOPS,  10g  yeast  extract,  203g  sucrose,  adjusted  to  pH  7.4  with  NaOH, 
made  up  to  1  litre  in  distilled  water.  Equal  volumes  of  R2A  (melted  and 
cooled  to  55°C)  and  R2B  plus  1mL  of  1%  (w/v)  KH2PO4  per  200mL  of  agar, 
were  combined  prior  to  use. 
R9  Medium:  R9A-  44g  agar,  0.5g  K2SO4,8.2g  MgSO4.6H20,4.7g 
CaC12.  H20,4g  NaNO3,1g  KCI,  0.4g  MgSO4,20g  glucose,  0.8g  casamino  acids, 
4m1  trace  elements  solution  (Hopwood  et  al.,  1985a),  2m1  FeSO4  (1%  [w/v] 
solution),  made  up  to  1  litre  in  distilled  water.  R9B-  11.5g  MOPS,  10g  yeast 
extract,  410g  sucrose,  adjusted  to  pH7.4  with  NaOH,  made  up  1  litre  with 
distilled  water.  Equal  volumes  of  R9A  (melted  and  cooled  to  55°C)  and  R9B 
were  mixed  with  1mL  of  1%  (w/v)  KH2PO4  per  200mL  of  agar,  prior  to  use. 
Soya  Mannitol  Agar  (SM):  20g  mannitol,  20g  soya  bean  flour,  16g  agar, 
made  up  to  1  litre  using  tap  water. 
Tryptone  Soya  Broth  (TSB):  30g  of  Oxoid  tryptone  soya  broth  powder 
made  up  to  1  litre  in  distilled  water. 
Yeast  extract-Malt  extract  (YEME):  3g  Difco  yeast  extract,  5g  Difco  bacto 
peptone,  3g  Oxoid  malt  extract,  10g  glucose,  340g  sucrose,  made  up  to  1  litre  in 
distilled  water. 
Inoculum  Medium  for  OTC  Production:  The  exact  chemical 
composition  of  this  medium  cannot  be  revealed  as  it  is  used  commercially  by 
Pfizer  for  strain  improvement. 
Tetracycline  Soluble  Medium  (TSM6):  glucose,  MOPS,  Ca(N03)2.4H20, 
NaNO3,  NH4NO3,  KC1,  MgSO4.7H20,  ZnSO4.7H20,  NH4Fe(SO4)2.12H20, 
MnS04.4H20,  CuSO4.5H20,  Na2MoO4.2H20,  and  CaC12.6H20,  (adjusted  to  pH 
6.9  with  NaOH)  with  addition  of  K2HPO4  and  KH2PO4  prior  to  use.  The  exact 
composition  of  this  medium  cannot  be  revealed  as  it  is  used  commercially  by 
Pfizer  for  strain  improvement. 
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2.2.2  PREPARATION  OF  Streptomyces  SPORE  SUSPENSIONS 
Concentrated  spore  suspensions  were  required  for  inoculating  liquid 
cultures  of  S.  lividans  and  S.  rimosus.  The  protocol  described  by  Hopwood  et 
al.,  (1985a)  was  followed  with  minor  modifications. 
Procedure:  S.  lividans  and  S.  rimosus  strains  used  during  this  work 
sporulated  exceptionally  well  on  Soya  Mannitol  (SM)  agar.  A  boiling  tube 
containing  a  slant  of  SM  agar  (produced  by  pouring  ca.  15mL  of  molten  agar 
into  the  tube  and  allowing  it  to  solidify  with  the  tube  held  at  50  from  the 
horizontal)  was  inoculated  with  1501.  Ll  of  a  suspension  of  spores  or  mycelial 
fragments  and  incubated  at  30°C.  After  4-7  days  the  surface  of  the  culture  was 
covered  in  a  dark  grey  mass  of  spores.  The  slant  was  then  sealed  using 
parafilmTM  and  frozen  at  -20°C.  Spores  could  then  be  harvested  immediately 
or  stored  at  -200C  indefinitely.  The  spores  were  harvested  by  adding  5mL  of 
20%  (v/v)  glycerol  to  the  frozen  slant  and  rubbing  the  surface  of  the  slant 
with  a  10mL  glass  pipette.  When  the  surface  had  been  scraped  dean  of  spores, 
the  spore  suspension  was  decanted  into  a  sterile  universal.  The  slant  was 
rinsed  with  an  additional  5mL  of  20%  (v/v)  glycerol  to  remove  any  spores 
remaining  from  the  first  wash.  The  spore  suspension  (ca.  10mL)  thus 
produced  was  dark  grey  in  colour.  Contaminating  agar  or  mycelial  fragments 
were  removed  by  a  single  passage  through  a  cotton  wool  filter,  as  described  in 
Hopwood  et  al.,  (1985a).  The  filtered  spore  suspension  was  then  divided  into 
aliquots  and  frozen  at  -20°C.  Aliquots  were  thawed  and  thoroughly  mixed 
using  a  vortex,  prior  to  use.  The  titre  of  the  spore  suspension  was  determined 
after  storage  at  -200C  overnight  by  spreading  out  serial  dilutions  onto  plates 
containing  Emersons  agar.  Titres  remained  stable  over  several  months. 
Solid  growth  media  other  than  SM  agar  were  conducive  to  sporulation.  R2 
agar  was  used  sometimes  for  S.  lividans  strains  and  R9  agar  was  used 
occasionally  for  S.  rimosus  strains. 
2.2.3  PREGERMINATION  OF  Streptomyces  SPORES 
Pregermination  media  (double  strength);  1%  Difco  yeast  extract;  1% 
Difco  Casamino  acids;  autoclave  and  then  add  sterile  0.01M  CaC12.0.05M  TES 
buffer;  pH  8.0. 
Procedure;  A  dense  spore  suspension  was  prepared  and  the  spores  pelleted  in 
a  bench  top  centrifuge.  Spores  were  recovered  in  5mL  of  TES  buffer  and 
heated  to  500C  for  10  mins.  The  tube  was  then  cooled  quickly  under  a  cold  tap. 
An  equal  volume  of  double  strength  pregermination  media  was  added  and 
the  mixture  incubated  in  a  370C  shaker  for  2-3  hours.  The  pregerminated 
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spores  were  recovered  in  a  bench  top  centrifuge  and  resuspended  in  water  or 
TES  buffer.  The  suspension  was  agitated  on  a  vortex  mixer  to  disperse  the 
clumps  and  was  then  inoculated  in  growth  media  to  give  an  OD450  of  0.03- 
0.05. 
2.2.4  GROWTH  OF  Streptomyces  MYCELIUM 
Ehrlenmeyer  flasks  were  used  for  growing  liquid  cultures  of 
Streptomyces.  YEME  broth  was  used  for  growing  Streptomyces  lividans 
strains  and  TSB  broth  used  for  growing  Streptomyces  rimosus  strains. 
Cultures  required  for  formation  of  S.  lividans  or  S.  rimosus  protoplasts  also 
contained  0.5%  (w/v)  glycine  and  5mM  MgC12.  The  volume  of  the  culture 
depended  on  the  final  use  of  the  mycelium.  The  formation  of  protoplasts 
required  30  to  5OmL  of  broth,  while  200mL  of  broth  or  multiples  thereof  were 
used  for  plasmid  isolation.  Routinely,  100µ1  of  a  dense  spore  suspension  (105- 
106  spores)  were  used  to  inoculate  50mL  of  broth.  The  flask  volume  was  at 
least  five  times  the  volume  of  the  broth  to  facilitate  good  aeration  when 
incubated  in  an  orbital  shaker  (30°C  at  ca.  250  rpm). 
2.2.5  ANTIBIOTICS  AND  INDICATORS 
The  antibiotic  concentrations  used  throughout  for  both  liquid  and  plate 
selection  were  as  follows: 
----------------------------------------- ----------------------------------------- 
DRUG  FINAL  STOCK 
CONCENTRATION  SOLUTION 
Thiostrepton  50  µg.  mL 
Gentamicin  200  µg.  mL 
Erythromycin  200  µg.  mL 
10mg.  mL-1  (DMSO) 
200mg.  mL-1  (water) 
10%  solution  (EtOH) 
STORAGE 
TEMP. 
40C 
-20°C 
40C 
Stock  solutions  were  added  to  molten  agar,  which  had  been  cooled  to 
55°C. 
2.2.6  PRESERVATION  OF  Streptomyces  STRAINS 
Streptomyces  strains  were  preserved  by  freezing  agar  slants  covered  in 
spores  at  -200C.  The  Streptomyces  strains  used  in  this  work  remained  viable 
indefinitely  under  these  conditions.  Small  slants  made  in  5mL  bijous  were 
used  for  the  long-term  storage  of  strains.  However,  few  spores  could  be 
harvested  from  these  slants  and  it  was  therefore  necessary  to  inoculate  large 
slants  (ca.  15mL)  in  order  to  generate  sufficient  spores  for  most  purposes. 
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2.2.7  INTRODUCTION  OF  PLASMID  DNA  INTO  Streptomyces 
Plasmids  were  introduced  into  Streptomyces  spp.  by  genetic 
transformation  using  the  polyethylene-glycol-mediated  protocol  described  by 
Hunter  (1985). 
Reagents:  Trace  element  solution;  Per  litre,  40mg  ZnC12,200mg 
FeC12.6H20,10mg  CuC12.2H20,10mg  MnC12.4H20,10mg  Na2B4O7.10H20  and 
10mg  (NH4)6Mo7O24.4H20.  Medium  P;  5.73g  N-tris[Hydroxymethyl]methyl-2- 
aminoethanesulfonic  acid  (TES),  103g  sucrose,  2.93g  MgC12.7H20,0.5g  KZSO4, 
3.68g  CaC12.2H20,2mL  trace  element  solution.  Adjust  to  pH  7.4  with  NaOH 
and  made  up  to  1  litre  in  distilled  water.  Lysozyme  solution;  10%  (w/v) 
sucrose,  25mM  TES  buffer  (pH  7.2),  2.5mM  K2SO4,2mL  trace  elements 
(Hopwood  et  al.,  1985a),  2.5mM  MgC12,2.5mM  CaC12,  K2HPO4  (0.005%  [w/v]) 
and  lysozyme  (0.3mg.  mL-1)  were  added  immediately  prior  to  use.  PEG 
solution;  1g  of  polyethylene  glycol  1540  (supplied  by  BDH)  was  melted  in  a 
500C  waterbath  and  then  mixed  with  3mL  of  medium  P. 
Preparation  of  protoplasts:  30mL  cultures  were  grown  in  the 
appropriate  medium  at  300C.  The  optimal  time  to  harvest  the  mycelium  in 
order  to  recover  the  most  competent  protoplasts  was  species-dependent  i.  e.  S. 
lividans  mycelium  was  harvested  after  65hr  and  S.  rimosus  after  40hr.  The 
mycelium  was  pelleted  at  3000g  for  15  minutes  and  washed  twice  in  10.3% 
(w/v)  sucrose.  The  pellet  was  then  resuspended  in  4mL  of  lysozyme  solution 
and  incubated  at  370C  for  15-30  min.  The  formation  of  protoplasts  was 
monitored  using  a  microscope,  the  reaction  terminated  by  adding  5mL  of  P 
medium  and  the  protoplasts  triturated  twice.  The  protoplasts  were  then 
filtered  through  cotton  wool  (Hopwood  et  al.,,  1985a),  pelleted  using  a 
centrifuge  (3000g  for  15  minutes)  and  washed  twice  in  P  medium.  Finally, 
they  were  resuspended  in  4mL  of  medium  P,  dispensed  into  200µ1  aliquots 
and  frozen  at  -700C. 
Transformation  of  protoplasts:  The  protoplasts  were  thawed  at  370C 
and  placed  on  ice.  DNA  was  added  in  a  volume  of  less  than  10µ1  and  the 
mixture  incubated  on  ice  for  30s.  PEG  solution  (400µ1)  was  added,  the 
solution  incubated  for  a  further  lmin  on  ice  and  finally,  medium  P  (800µl) 
was  added.  Dilutions  of  the  transformation  mix  were  then  made  in  medium 
P. 
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Regeneration  of  transformed  protoplasts:  The  method  used  to  prepare 
the  regeneration  medium  for  the  protoplasts  was  standardised.  The  medium 
was  stored  in  two  parts,  RA  and  RB  ;  the  former  solid  and  the  latter  liquid. 
Both  parts  were  placed  in  a  steam  bath  until  the  RA  portion  melted.  The  two 
components  were  allowed  to  cool  to  500C  before  they  were  combined  and 
1mL  of  1ß6(w/v)K2HPO4  (pH  7.0)  added.  The  complete  regeneration  medium 
was  mixed  by  swirling  and  then  poured  into  petri  dishes  (diameter  9cm).  On 
average  8  plates  were  obtained  from  200mL  of  medium.  The  plates  were 
dried  in  a  laminar  flow  hood  to  minimise  air  borne  contamination  by  leaving 
the  lids  half  open  for  90min.  The  plates  were  covered  and  left  overnight  at 
300C.  The  next  day,  any  plates  which  showed  any  signs  of  contaminating 
growth  were  discarded  and  the  rest  used  for  the  regeneration  of  protoplasts. 
The  only  drug  resistance  used  for  plasmid  selection  after 
transformation  into  Streptomyces  was  thiostrepton  (obtained  from  E.  R. 
Squibb,  New  Jersey,  USA).  It  was  dissolved  in  DMSO  to  make  a  1%  (w/v) 
stock  solution.  Transformed  protoplasts  were  selected  after  16-22  hrs  of  non- 
selective  growth  at  300C  by  overlaying  the  regeneration  plates  with  1  mL  of  a 
220.  tg.  mL-4  thiostrepton  solution  in  10.3%  (w/v)  sucrose  solution. 
S.  lividans  protoplasts  were  regenerated  on  R2  agar  plates  and  R9  plates 
were  used  for  the  regeneration  of  S.  rimosus. 
2.2.8  ELECTROTRANSFORMATION  OF  Streptomyces  STRAINS 
2.2.8.1  PREPARATION  OF  MYCELIUM 
Electrotransformation  of  Streptomyces  following  the  procedure 
outlined  by  Pigac  and  Schrempf  (1995). 
Reagents:  CRM;  10  g  Glucose,  15g  Tryptic(ase)  soya-broth,  103g  Sucrose, 
10.15g  MgC12.6H20,5g  yeast  extract.  ET-Buffer;  30%  PEG  1000(or  1500),  10% 
glycerol,  6.5%  Sucrose. 
Preparation  of  Mycelium:  100  mLs  of  CRM  or  YEME  +  Glycine  was 
inoculated  with  1/  100  volume  of  a  fresh  24hr  culture.  The  mycelium  was 
then  allowed  to  grow  for  48hrs  at  300C  with  vigorous  shaking.  To  harvest, 
the  flask  was  chilled  on  ice  for  15-30  mins,  and  centrifuged  in  a  cold  rotor 
(10,000  rpm)  for  15  mins.  The  pellets  were  resuspended  in  a  total  of  100mL  of 
a  cold,  low  ionic  strength  wash  medium  such  as  10%  sucrose.  The  mycelium 
was  again  pelleted  and  washed  in  50  mL  of  ice-cold  10%  sucrose.  The  pellet 
was  washed  in  20mL  of  15%  ice-cold  glycerol,  and  the  resuspended  in  a  final 
volume  of  10mL  of  15%  glycerol.  Lysozyme  was  added  to  give  a  final 
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concentration  of  400µg/mL  (for  S.  rimosus)  and  the  tube  was  incubated  at 
370C  for  30  mins.  The  mycelium  was  washed  once  again  in  20mL  of  15% 
glycerol  and  resuspended  in  a  final  volume  of  1-5  mL  of  E-T  buffer.  50µ1 
aliquots  could  be  stored  by  immediately  freezing  in  a  dry  ice/MeOH  bath 
before  storing  at  -70°C. 
Electrotransformation:  The  cells  were  thawed  at  room  temperature 
before  placing  them  on  ice.  DNA  (1-2µl  in  a  low  ionic  strength  buffer,  such  as 
TE)  was  added  to  the  cell  suspension  and  the  mixture  allowed  to  stand  on  ice 
for  1  minute.  The  Gene  Pulser  (Biorad)  apparatus  was  set  to  25µF  and  2.  OkV. 
The  pulse  controller  was  set  at  400Q.  The  mixture  of  cells  and  DNA  was 
transfered  to  a  cold,  electroporation  cuvette  (0.2cm  size).  The  cuvette  was  the 
placed  in  the  chilled  safety  chamber  slide  and  the  slide  pushed  into  the 
chamber  until  the  cuvette  was  set  between  the  contacts  in  the  base  of  the 
chamber.  One  pulse  was  administered  with  a  time  constant  of  6-9msec,  with 
a  field  strength  of  10kV/cm.  The  cuvette  was  removed  from  the  chamber  and 
750µ1  of  CRM  was  added  to  the  cuvette.  This  cell  suspension  was  then 
transferred  to  a  bijou  bottle  and  incubated  at  300C  with  shaking  for  4  hours. 
After  incubation,  200µ1  of  CRM  was  added  to  the  bijou  bottle  and  mixed.  The 
suspension  was  then  ready  to  plate  on  selective  media,  either  TSB  or  SM, 
with  50µg/mL  of  thiostrepton. 
2.2.9  CONJUGATION  OF  Streptomyces 
2.2.9.1  Conjugation  with  Spores 
Fresh  Streptomyces  spores  were  pregerminated  (See  Section  2.2.3), 
pelleted  by  centrifugation  and  resuspended  in  2YT  to  a  concentration  of 
108spores/mL.  The  E.  coli  donor  was  prepared  by  overnight  incubation  at 
370C  in  2YT  supplemented  with  the  appropriate  antibiotic.  The  cells  were 
washed  twice  in  2YT  before  resuspending  in  the  original  volume  of  2YT.  An 
equal  volume  of  donor  and  recipient  were  mixed  and  plated  on  LB  plates. 
The  plates  were  incubated  at  300C  from  6  hrs  to  overnight  (duration  of 
incubation  was  strain-dependent).  The  plates  were  flooded  with  1mL  of  LB 
broth  and  the  E.  coli  was  carefully  scraped  off  the  plate,  ensuring  that  the 
streptomycetes  remained  attached  to  the  agar.  The  plates  were  then  overlayed 
with  100µg  of  neomycin  and  200µg  of  nalidixic  acid.  Exconjugants  were 
counted  6-10  days  later. 
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2.2.9.2  Conjugation  with  Mycelium 
The  Streptomyces  mycelial  cultures  were  inoculated  into  TSB 
supplemented  with  glycine  and  MgCl2,  to  weaken  the  cell  walls,  and  grown  at 
300C  for  72  hrs.  Two  mLs  of  culture  was  homogenised  and  transferred  to  18 
ml  of  fresh  medium.  This  was  grown  at  300C  for  a  further  16  hrs.  The  culture 
was  again  homogenised,  1  mL  transferred  to  9  ml  of  fresh  medium  and 
grown  for  a  further  3  hrs.  The  mycelium  was  recovered  by  centrifugation  and 
washed  once  in  TSB  medium  and  resuspended  in  a  final  volume  of  2  mL. 
The  E.  coli  donor  was  prepared  as  described  above.  Equal  volumes  of  donor 
and  recipient  were  mixed  and  plated  onto  TSB  plates  for  S.  rimosus  and  LB 
plates  for  S.  lividans.  The  plates  were  incubated  overnight  at  300C  and  then 
covered  with  3-4  mLs  of  soft  nutrient  agar  containing  1.5  mg  nalidixic  acid 
and  1.5  mg  of  thiostrepton.  Dilutions  of  the  recipient  and  donor  cells  were 
plated  as  controls. 
2.2.10  ISOLATION  OF  PLASMID  DNA  FROM  Streptomyces 
Plasmid  isolation  by  Alkaline  Lysis  was  outlined  by  Kieser  (1984) 
without  modification. 
Reagents:  Lysozyme  solution;  2mg/ml  lysozyme  (Sigma)  in  0.3M 
sucrose,  25mM  Tris  (pH  8.0),  25mM  EDTA,  0.02%  bromocresol  green,  501.  tg/ml 
RNase  (heat  treated).  Alkaline  SDS;  0.3M  NaOH,  2%  SDS.  Acid 
Phenol/Chloroform;  5g  phenol,  5mL  chloroform,  1mL  H2O,  5mg  8- 
hydroxyquinoline  (AnalaR),  Neutral  Phenol/Chloroform;  acid  phenol/ 
chloroform  equilibrated  first  with  0.5  vol  1M  Tris  pH  8.8  and  then  1vol  0.1M 
Tris  pH  8.0.  Unbuffered  3M  Sodium  Acetate,  100mM  Spermine-HCI;  sterilized 
by  filtration.  Extraction  Buffer;  0.3M  sodium  acetate,  10mM  MgC12.  TE  Buffer; 
10mM  Tris-HC1  pH  8.0,1mM  EDTA  pH  8.0. 
Procedure  for  Standard  version:  The  standard  version  is  based  on  the 
volume  of  bacteria  spun  down  in  a  1.5mL  tube.  The  bacteria  were 
resuspended  in  a  total  volume  of  5001A1  of  lysozyme  solution.  The  tube  was 
incubated  at  370C  for  30  min.  After  incubation,  250µ1  of  the  alkaline  SDS 
solution  was  added.  Complete  and  immediate  mixing  was  essential.  The 
tubes  were  then  incubated  at  700C  for  15  min  or  30min  at  55°C  for  plasmids 
larger  than  20  kb.  The  tubes  were  allowed  to  cool  before  adding  80µ1  of  acid 
phenol  /chloroform  and  mixing  thoroughly.  A2  min  spin  separated  the 
phases.  The  upper  aqueous  phase  was  then  removed  to  a  fresh  tube 
containing  70  µl  of  3M  unbuffered  sodium  acetate  and  700µl  of  isopropanol. 
The  tube  was  mixed  by  inversion  and  allowed  to  stand  at  room  temperature 
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for  5  rains  before  being  spun  for  2  min.  After  centifugation,  all  of  the  liquid 
was  removed  and  the  pellet  dissolved  was  in  50µl  of  TE.  Unbuffered  3M 
sodium  acetate  (5p1)  was  added  to  the  tube  along  with  25µ1  of  neutral 
phenol/chloroform.  The  tube  was  vortexed  to  mix  the  phases  and  spun  for  2 
min.  The  upper  phase  was  then  transferred  to  a  fresh  tube  containing  50µl  of 
isopropanol.  The  DNA  was  again  precipitated  by  spinning  for  2  min.  All  of 
the  liquid  was  removed  and  the  pellet  dissolved  in  5001.  L1  of  TE  buffer  and 
25µl  of  100mM  spermine-HCI.  The  mixture  was  allowed  to  stand  at  room 
temperature  to  precipitate  the  DNA  and  centrifuged  again  for  2  min  to 
remove  all  the  liquid.  The  pellet  was  then  dispersed  in  300µ1  of  extraction 
buffer,  700µ1  of  ethanol  was  added,  mixed  and  the  tube  left  at  room 
temperature  for  60  min.  A  final  centrifugation  of  5  min  pelleted  the  DNA. 
The  pellet  was  resuspended  in  a  final  volume  of  501l  of  TE.  This  procedure 
was  easily  scaled  up  10-fold. 
The  typical  yield  of  high-copy-number  plasmids  such  as  pIJ486  from 
Streptomyces  was  2-5µg  of  plasmid.  Plasmid  prepared  in  this  way  could  be 
used  for  most  in  vitro  manipulations. 
Large-scale  plasmid  preparations:  Reagents:  as  defined  in  Section  2.1.9. 
Procedure;  200mL  cultures  of  stationary  phase  cells  were  harvested  using  a 
centrifuge  (12000g,  5min  at  4CC).  The  pellet  was  resuspended  in  4mL  of 
Birnboim-Doly  I  solution.  At  this  stage,  Streptomyces  preparations  were 
treated  with  lysozyme.  The  amount  of  lysozyme  that  resulted  in  the 
optimum  recovery  of  plasmid  was  determined  for  each  strain.  S.  lividans 
and  S.  rimosus  strains  were  incubated  at  370C  for  20min  with  4mg.  mL-1  and 
1mg.  mL-1  lysozyme  solutions,  respectively.  Birnboim-Doly  II  solution  was 
added  (8mL)  and  the  solution  left  on  ice  for  5-10min.  Six  mL  of  cold 
Birnboim-Doly  III  solution  was  then  added.  The  suspension  was  mixed 
gently  and  left  on  ice  for  15-30  min.  The  cell  debris  and  most  of  the 
chromosomal  DNA  was  removed  by  centrifugation  (32000g,  5  min  at  40C). 
The  remainder  of  the  procedure  is  identical  to  the  isolation  of  E.  coli  DNA, 
and  can  be  found  in  Section  2.1.9.  Large  amounts  of  pure  plasmid  DNA  (up 
to  100µg  from  Streptomyces  cultures)  can  be  obtained,  suitable  for  all  in  vitro 
manipulations. 
2.2.11  ISOLATION  OF  CHROMOSOMAL  DNA  FROM  S.  rimosus 
The  small  scale  total  DNA  preparation  developed  by  S.  Fisher  (1984)  starts 
with  50  mg  of  wet  mycelia  in  a  1.5ml  microfuge  tube.  The  mycelia  was 
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resuspended  in  500µ1  of  a  lysozyme  solution  containing  0.3M  sucrose,  25mM 
Tris  (pH  8.0),  25mM  EDTA  (pH  8.0),  50µg/mL  RNase  and  4  mg/mL  lysozyme. 
It  was  incubated  at  370C  until  the  cells  cleared,  approximately  1  hour.  After 
1hr,  250µl  of  2%  SDS  was  added  and  the  mixture  vortexed  for  1  min.  250µl  of 
a  neutral  1:  1  phenol  /chloroform  mixture  was  added  to  the  tube  and  again 
vortexed  for  30  seconds.  The  phases  were  separated  by  spinning  at  13,000  rpm 
for  4min  in  a  microcentrifuge.  The  phenol/  chloroform  extracts  were 
repeated  until  no  interface  was  seen.  The  DNA  was  precipitated  by  adding  0.1 
volume  of  3M  NaOAc  pH  4.8  and  1  volume  of  isopropanol.  The  solution  was 
mixed  thoroughly,  left  at  room  temperature  for  5  min  and  then  spun  10  min 
at  13,000  rpm.  The  DNA  was  resuspended  in  TE  (10:  1). 
2.2.12  ISOLATION  OF  TOTAL  RNA  FROM  S.  rimosus 
This  procedure  is  based  on  that  of  Kirby  et  al.,  (1976)  with  extensive 
modifications  by  Covey  and  Smith  (see  Hopwood  et  al.,  , 
1985a).  RNAase  is  a 
very  persistent  enzyme  and  precautions  were  taken  against  contamination  of 
equipment  and  solutions.  Prior  to  use,  all  glassware  was  incubated  overnight 
at  200°C.  All  solutions  were  prepared  from  DEPC-treated  water  and  chemicals 
reserved  for  RNA  work. 
Reagents:  Phenol;  as  described  previously.  Phenol.  Chloroform;  as 
described  previously.  Kirby  mixture;  1g  tri-isopropylnapthalene  sulphonate, 
6g  4-amino  salycilate  (Na  salt),  50mM  Tris-HC1  (pH  8.3),  6mL  phenol,  made 
up  to  100mL  in  distilled  water. 
Procedure:  RNA  was  always  isolated  from  5OmL  liquid  cultures  of  the 
appropriate  organism,  grown  in  250mL  Ehrlenmeyer  flasks.  When  the 
culture  reached  the  appropriate  stage  of  growth,  the  contents  were 
immediately  decanted  into  a  5OmL  flask  containing  20mL  of  dH2O,  which  had 
been  frozen  at  -200C  ,  rapidly  lowering  the  temperature  to  ca.  OTC.  As  much  of 
the  chilled  culture  as  possible,  including  any  residual  ice,  was  then  transferred 
to  an  unused  polypropylene  centrifuge  tube.  The  mycelium  were  then 
harvested  using  a  centrifuge  in  a  prechilled  rotor.  The  pellet  was 
resuspended  in  5mL  Kirby  mix  (prechilled  on  ice)  containing  12g  of  0.45mm 
diameter  glass  beads  and  agitated  thoroughly  on  a  vortex  mixer  for  1-2  min. 
Five  mL  of  phenol.  chloroform  (stored  at  room  temperature)  was  then  added 
and  the  mixture  agitated  for  a  further  1-2  min.  The  homogenate  was  then 
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spun  in  the  centifuge  (9000g,  40C  for  10  min)  to  separate  the  phases.  The 
aqueous  phase  was  removed,  using  a  baked  Pasteur  pipette,  to  a  fresh 
centrifuge  tube  containing  5mL  of  phenol.  chloroform  and  mixed  for  1  min 
on  the  vortex  mixer.  The  phases  were  then  separated  as  before.  At  this  stage, 
the  nucleic  acid  solution  could  be  stored  at  -700C  without  any  degradation 
being  detectable.  To  remove  DNA  from  the  preparation,  the  RNA  was 
pelleted  by  centrifugation  in  caesium  chloride  . 
Pelleting  the  RNA  through  a  dense  caesium  chloride  solution: 
Homogenate  (ca.  3.5mL)  from  the  Kirby  lysis  was  layered  carefully  on  top  of  a 
5.7M  CsCl-0.1M  EDTA  cushion  (1.5mL,  density  1.707g.  mL-1)  in  a 
ultracentrifuge  tube  (5mL,  Beckman,  PolyallomerTM).  The  RNA  was  then 
pelleted  by  centrifugation  (35,000rpm,  200C  for  16  hours)  using  a  Beckman 
SW50.1  rotor.  After  centrifugation,  the  supernatant  was  removed  using  a 
baked  pasteur  pipette.  The  tube  was  then  inverted  to  drain  away  the 
remaining  fluid.  Using  a  fresh  scalpel  blade  to  cut  the  centrifuge  tube,  the 
bottom  was  isolated  in  the  form  of  a  small  cup.  The  pellet  was  dissolved  in 
4O0µ1  of  dH2O  and  extracted  with  half  volumes  of  phenol.  chloroform  and 
chloroform.  The  RNA  was  precipitated  by  the  addition  of  1/50  volume  of  5M 
NaCl  and  two  volumes  of  absolute  ethanol,  and  harvested  by  centrifugation 
in  a  microfuge  (12,000g,  40C  for  10  min).  The  RNA  pellet  was  washed  twice 
with  700C  (v/v)  ethanol,  dried  in  the  open  microfuge  tube  at  room 
temperature  and  dissolved  in  100  to  2O0µ1  of  dH2O.  The  RNA  concentration 
was  estimated  spectrophotometrically,  reprecipitated  and  stored  at  -70°C. 
2.2.13  TRANSCRIPT  MAPPING  USING  COMPLEMENTARY  SINGLE- 
STRANDED  DNA  PROBES 
Mapping  of  RNA  transcripts  was  undertaken  using  single-stranded 
probes  derived  from  M13  (Calzone  et  al.,  , 
1987),  as  described  by  Sambrook  et 
al.,  (1989). 
Reagents:  1X  Hybridization  buffer:  40mM  PIPES  adjusted  to  pH  7.4 
with  NaOH,  400mM  NaCl,  1mM  EDTA,  80%  (v/v)  formamide  (de-ionized 
with  mixed-bed  resin).  Stored  at  -700C.  10X  S1  nuclease  digestion  buffer: 
2.8M  NaCl,  500mM  NaCH3000  (pH  4.5),  45mM  Tris.  HC1  (pH  7.8),  500mM  KCl 
and  100mM  EDTA  (pH  8.0).  Denatured  Salmon  sperm  DNA:  prepared  by 
dissolving  in  dH20,  extracting  any  protein  with  phenol.  chloroform,  shearing 
by  passage  through  a  narrow  gauge  hypodermic  needle  and  precipitating  the 
DNA  with  ethanol.  The  fragmented  DNA  was  then  redissolved  in  dH20  to  a 
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concentration  of  10mg.  mL-1,  boiled  for  10  min  and  stored  at  -200C  in  small 
aliquots.  Prior  to  use,  the  DNA  was  denatured  partially  by  heating  to  100CC 
for  5  min  and  chilling  rapidly  on  ice.  Carrier  tRNA:  prepared  by  dissolving 
commerically-available  yeast  tRNA  in  dH2O,  extracting  any  protein  with 
phenol.  chloroform,  precipitating  and  redissolving  in  dH2O  to  a  final 
concentration  of  10mg.  mL-1.  S1  nuclease  stop  buffer:  500mM  Tris.  HC1  (pH 
8.0),  125mM  EDTA. 
Synthesis  of  Probe:  1.0  pmole  of  template  ssDNA  was  mixed  with  6 
pmoles  of  an  oligonucleotide  primer  in  a  volume  of  16µl,  containing  2µ1  of 
lOX  BRL  REact  2  buffer,  and  then  annealed  by  heating  to  850C  for  5  min  and 
cooled  slowly  to  370C.  The  extension  reaction  was  then  carried  out  at  370C  for 
30  min  by  adding: 
Volume  (µl) 
100mM  dithiothreitol  2 
50µCi  of  [a-32P]  dATP 
(sp.  act.  3000  Ci.  mmole-1)  5 
40µM  solution  of  dATP  1 
20µM  solution  of  dCTP, 
dGTP  and  dTTP  1 
Klenow  (1  U.  µ1-1)  5 
The  above  reaction  was  then  "chased",  by  adding  1µl  of  a  20mM  dATP 
solution  and  incubating  for  a  further  20  min.  After  synthesis,  the  reaction 
was  heated  to  680C  for  10  min  to  inactivate  the  Klenow  enzyme.  The  probe 
was  then  digested  at  a  restriction  site,  within  or  beyond  the  insert,  by  the 
addition  of  20µ1  of  restriction  digest  solution  containing  the  appropriate 
restriction  endonuclease  (20U)  and  buffer.  The  reaction  was  incubated  for  2 
hours  at  the  optimal  temperature  for  the  enzyme.  The  nucleic  acid  was  then 
precipitated  with  ethanol  and  recovered  by  centrifugation  in  a  microfuge. 
Hybidization:  The  single-stranded  probe  (ca.  0.1-0.2  pmol)  and  the 
Streptomyces  RNA  (5-204g)  were  co-precipitated,  washed  with  70%  (v/v) 
ethanol  and  dried  by  leaving  the  tube  open  on  the  bench,  until  the  last  traces 
of  ethanol  had  evaporated.  The  probe/RNA  pellet  was  resuspended  in  20µl 
of  1X  hybidization  buffer.  The  solution  was  pipetted  up  and  down  many  (20- 
30)  times  and  heated  to  600C  for  30  min.  to  ensure  that  the  pellet  was 
dissolved  completely.  The  hybridization  solution  was  then  heated  to  850C  for 
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10  min,  to  denature  the  nucleic  acids  and  incubated  at  55-650C  overnight. 
After  overnight  incubation,  the  hybridization  mixture  was  treated  with  Si 
nuclease. 
S1  Nuclease  digestion:  280µl  of  ice-cold  1X  S1  digestion  buffer, 
containing  10µg  of  partially-denatured  Salmon  sperm  DNA,  was  added  to  the 
hybridization  reaction  and  mixed  by  inverting  the  microfuge  tube  several 
times.  As  quickly  as  possible,  250  units  of  S1  nuclease  (1-2  µl)  were  added,  the 
reaction  mixture  pooled  by  centrifugation  and  incubated  at  370C  for  30  min. 
The  reaction  was  terminated  by  the  addition  of  7541  stop  buffer  and  10µg 
carrier  tRNA.  The  reaction  mixture  was  then  extracted  with 
phenol.  chloroform  and  chloroform,  ethanol  precipitated,  washed  with  70% 
(v/v)  ethanol,  dried  in  vacuo  and  resuspended  in  741  1X  sequencing  loading 
buffer.  The  sizes  of  products  were  analysed  by  electrophoresis  in  1%  (w/v) 
agarose  gels. 
COMPUTER-ASSISTED  SEQUENCE  ANALYSIS 
The  DNA  sequences  in  this  thesis  were  analysed  using  the  "Sequence 
Analysis  Software  Package,  Version  7.3"  from  the  Genetics  Computer  Group 
at  the  University  of  Wisconsin  (UWGCG)  (Devereux  et.  al,  1984).  See 
"Program  Manual  for  GCG"  for  references. 
CODON  PREFERENCE:  is  a  frame-specific  gene  finder  that  tries  to 
recognize  protein  coding  sequence  by  virtue  of  the  similarity  of  their  codon 
usage  to  a  codon  frequency  table  or  by  the  bias  of  their  composition  (usually 
GC)  in  the  third  position  of  each  codon. 
FASTA:  searches  for  similarity  between  a  query  sequence  and  any 
group  of  sequences  using  a  Pearman  and  Lipman  algorithm  (1985). 
FOLD:  finds  an  optimum  secondary  structure  for  RNA  molecules 
using  the  method  of  Zucker  (1981). 
FRAME  analysis:  uses  the  algorithm  of  Bibb  et.  al.  (1984)  to  find 
potential  protein  coding  regions  for  nucleotide  sequences  of  Streptomyces. 
GAP:  uses  the  algorithm  of  Needleman  and  Wunsch  to  find  the 
alignment  of  two  complete  sequences  that  maximises  the  number  of  matches 
and  minimises  the  number  of  gaps. 
PILEUP:  creates  a  multiple  sequence  alignment  from  a  group  of  related 
sequences  using  progressive,  pairwise  alignments.  It  can  also  plot  a  tree 
showing  the  clustering  relationships  used  to  create  the  alignment. 
STEMLOOP:  finds  inverted  repeats  within  a  sequence  which  could 
form  secondary  structure. 
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TFASTA:  translates  nucleotide  sequences  held  in  a  database  in  all  six 
frames,  before  searching  for  any  sequence  similarity  to  a  query  peptide 
sequence  using  a  Pearman  and  Lipman  algorithm  (1985). 
2.3  BACTERIAL  STRAINS  AND  VECTORS 
The  bacterial  stains,  plasmids  and  bacteriophages  used  in  this  study 
are  listed  in  Tables  2.1,2.2  and  2.3  respectively. 
TABLE  2.1  Bacterial  strains 
----------------------------------------------------------- ----------------------------------------------------------- 
STRAIN  GENOTYPE  REFERENCE/SOURCE 
Escherichia  coli  strains 
CB51  dam-3,  ara-14,  thi-1,0(lac-pro)  C.  Boyd,  University  of 
Edinburgh 
DS649  R751  in  C600  D.  Sherratt,  University  of 
Glasgow 
DS801  thr-1,  leu6,  thi  1,  lacYI,  galK2,  D.  Sherratt,  University  of 
ara14,  xyll-5,  mtll,  proA2,  Glasgow 
his4,  argE2,  str3l,  tsx33 
Lambda-Lambdas 
DS941  recF143,  proA7,  str3l,  thrl,  D.  Sherratt,  University  of 
leu6,  tsx33,  mt12,  his4,  argE3,  Glasgow 
lacY+,  lacZiM15,  lacfl,  galK2, 
ara14,  supE44,  xyl5. 
GM31  thr  -1,  ara-14,  leuB6,  tonA31, 
lacYl,  tsx-78,  gin  V44,  ga1T22, 
thi-1,  rpsL136,  hisG4,  mtl-1, 
xyl-5,  dcm-6  (F-)  Marinus  et.  al..  (1994) 
ET12567  F-  dam-13::  Tn  9,  dem-6,  hsdM,  MacNeil  (1992) 
hsdR,  recF143,  Tn  10,  galk2, 
galT22,  ara-14,  lacYl,  xyl-5, 
leuB6,  thi-1,  tonA31,  rpsL136 
hisG4,  tsx-78,  mtl-1,  gln44 
TG1  supE,  hsd05,  thi,  0(lac-proAB),  Gibson  (1984) 
F  [traD36,  proAB+,  laclq, 
lacZOM15]. 
Streptomyc  es  lividans  strains 
TK24  str6.  Hopwood  et  al.,  (1985a) 
TK64  pro2,  str6.  Hopwood  et  al.,  (1985a) 
Streptomyces  rimosus  strains 
M4018  OTCR  Rhod  es  et  al.  (1981) 
MV9  OTCS  J.  Pigac  (Pliva  Inc.  ) 
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TABLE  2.2  Plasmids 
---------------------------- ---------------------------- 
PLASMID  DESCRIPTION  REFERENCE/SOURCE 
pGEM7  Promega 
pGM160  Muth  et  al.,  (1989) 
pIBI24/25  --  Dente  et  al,  (1983) 
pIJ486  --  Ward  et  al.,  (1986) 
pIJ680  --  Hopwood  et.  al.  (1985) 
pIJ699  --  Kieser  and  Melton 
(1988) 
pIJ702  --  Hopwood  et.  al.  (1985) 
pLST14  --  Skeggs  et.  al.  (1987) 
pLUC801  C.  Chen  (pers.  comm.  ) 
pPM803  Mazodier  et.  al.  (1989) 
pPZ103  Pfizer  UK  Ltd. 
pPZ105  Pfizer  UK  Ltd. 
pT7BLUE(R)  Novagen 
pUC18/19  --  Yanisch-Perron  et  al., 
(1985) 
pXED3-13  Ingram  et.  al.  (1989) 
pSRG1  5.4kb  Sst124-29  fragment  from 
pPZ103  in  pIBI24  Chapter  3 
pSRG2  1.7kb  ermE  fragment  in  the 
KpnI  site  of  pSRG1 
pSRG3  5.9kb  PstI17-25  fragment  from 
pPZ103  in  pIBI24  Chapter  3 
pSRG4  2.2kb  KpnI19-23  fragment  from 
pPZ105  Chapter  3 
pSRG5  2.1kb  SstI  fragment  from 
pSRG3  Chapter  3 
pSRG6  3.6kb  Sstl-  SphI  fragment 
from  pSRG1  Chapter  3 
pSRG6X  KpnI  site  converted  to  XbaI 
site  in  pSRG6  Chapter  6 
pSRG7  1.5kb  Kpnl-  Sphl  fragment 
from  pSRG1  Chapter  3 
pSRG9  1.8kb  SaII-  SphI  fragment  from 
pSRG1  Chapter  3 
pSRG10  0.7kb  PvuII-  Sstl  fragment  from 
pSRG3  Chapter  3 
p501 
Chapter  6 
p502  Chapter  6 
p503  Chapter  6 
p504  Chapter  6 
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p505  Chapter  6 
p5O6  Chapter  6 
p507  Chapter  6 
pmrA  Chapter  6 
pmrB  Chapter  6 
pCMR  Chapter  6 
p509  Chapter  6 
p510  Chapter  6 
p511  Chapter  6 
p512  Chapter  6 
the  numbering  system  used  to  designate  restriction  sites  in  this  thesis  is  not 
that  of  Butler  et  al.,  (1989) 
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TABLE  2.3  Bacteriophages 
BACTERIOPHAGE  DESCRIPTION  REFERENCE/SOURCE 
M13mp18/19  --  Yanisch-Perron 
et  al.,  (1985) 
18-SRG1  1.5kb  Psttl-Kpnl  fragment  in  Chapter  3 
M13mp18 
19-SRG1  1.5kb  PsttI-Kpnl  fragment  in  Chapter  3 
M13mp19 
18-SRG1.1  0.6kb  SstI-  Pstl  fragment  in  Chapter  3 
M13mp18 
19-SRG1.1  0.6kb  SstI-  Pstl  fragment  in  Chapter  3 
M13mp19 
18-SRG5  0.22kb  Sstl-  KpnI  fragment  in  Chapter  3 
M13mp18 
19-SRG5  0.22kb  SstI-  KpnI  fragment  in  Chapter  3 
M13mp19 
18-SRG5.1  0.9kb  Sphl-  SstI  fragment  in  Chapter  3 
M13mp18 
19-SRG5.1  0.9kb  Sphl-  Sstl  fragment  in  Chapter  3 
M13mp19 
18-SRG6  0.9kb  PvuII-  SaII  fragment  in  Chapter  3 
M13mp18 
19-SRG6  0.9kb  PvuII-  SaII  fragment  in  Chapter  3 
M13mp19 
18-SRG7  0.35kb  KpnI-PvuII  fragment  in  Chapter  3 
M13mp18 
19-SRG7  0.35kb  KpnI-PvuII  fragment  in  Chapter  3 
M13mp19 
19-SRG8  1.8kbSaIl-  Sphl  fragment  in  Chapter  3 
M13mp19 
18-SRG9  1.3kb  Sphl-  Pstl  fragment  in  Chapter  4 
M13mp18 
19-SRG9  1.3kb  Sphl-  Pstl  fragment  in  Chapter  4 
M13mp1 
18-PCR1  0.28kb  fragment  P1-P9  Chapter  4 
inclusive,  in  M13mp18 
19-PCR1  0.28kb  fragment  P1-P9  Chapter  4 
inclusive,  in  M13mp18 
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Chapter  3 
Deduction  of  Functions  of  Genes  Surrounding  the  otcD  locus 
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3.1  Introduction 
Rhodes  et  al.,  (1981)  isolated  a  series  of  OTC  non-producing  mutants.  The 
basis  of  classification  with  respect  to  the  biochemical  pathway  is  shown  in  figure 
1.10.  The  pathway  clearly  shows  more  steps  are  involved  in  the  synthesis  of 
OTC,  than  the  number  of  mutant  classes  recovered.  Some  mutants  would  not  be 
selected  in  the  screening  process  used  by  Rhodes  et  al.,  (1981)  because  an 
antibiotic-negative  phenotype  was  sought.  This  was  demonstrated  when  no 
mutants  which  were  unable  to  hydroxylate  DHTC  in  the  5-position  were  found. 
A  blockage  at  this  step  would  have  produced  the  shunt  metabolite,  tetracycline. 
An  intensified  investigation  into  the  cloning  and  physical  characterisation  of  the 
otc  cluster  by  Butler  et  al.,  (1989)  resulted  in  the  cloning  of  two  resistance 
determinants  otrA  and  otrB,  and  led  subsequently  to  the  isolation  of  the 
biosynthetic  genes  and  the  formation  of  a  genetic  map  (figure  1.11).  The  precise 
location  and  function  of  each  locus  is  described  elsewhere  (see  Chapter  1.10.1). 
The  physical  characterisation  of  the  cluster,  along  with  hybridisation  studies 
which  compared  the  ACT  and  OTC  clusters  was  then  sufficiently  advanced  to 
characterise  the  genes  further  by  DNA  sequencing. 
A  concerted  effort  was  then  undertaked  in  Iain  Hunter's  laboratory 
(Glasgow)  to  sequence  the  OTC  duster.  Chapter  1  gives  a  detailed  description  of 
all  the  genes  uncovered  to  date.  A  3.0  kb  region  between  the  otcX  and  otcD  loci  is 
the  subject  of  the  current  chapter.  No  OTC  non-producing  mutant  mapped  to 
this  region  and,  consequently,  no  preliminary  dues  into  possible  functions  could 
be  gained.  Hence  the  genes  were  to  be  sequenced.  Nucleotide  sequence  and 
deduced  amino  acid  sequences  would  be  compared  with  other  known  sequences 
and  possible  gene  functions  assigned.  It  was  hoped  that  knowledge  of  gene 
functions  would  lead  to  a  better  understanding  of  the  genes  in  the  OTC 
biosynthetic  pathway  of  S.  rimosus. 
3.2  Results  and  Discussion 
3.2.1  Nucleotide  Sequencing  of  the  region:  KpnI23  to  right  of  KpnI26 
A  summary  of  the  strategy  for  sequencing  of  the  3.0  kb  DNA  fragment 
extending  from  Kpn123  to  right  of  Kpn126  in  the  OTC  cluster  is  shown  in  figure  3.1 
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Figure  3.1 
M13  templates  used  to  sequence  the  KpnI23  to  MlUI26b  region  of  the  otc  duster. 
Above  the  restriction  map  are  the  ("  "`ý)  regions  of  the  otc  duster  which 
complement  the  otc  mutants  (Butler  et  al.,  1989;  Rhodes  et  al.,  1981),  and  the 
deduced  open  reading  frames  (&mý  )  resulting  from  analysis  of  sequence. 
The  long  arrows  above  the  deduced  ORFs  show  the  direction  of  translation. 
The  template  designations  are  given  below  the  lines  and  the  short  arrows 
indicate  the  direction  and  length  of  primed  synthesis  during  the  nucleotide 
sequence  analysis.  Arrowheads  alone  represent  the  universal  primer  of  the 
sequence. 
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The  subcloning  of  DNA  fragments  was  carried  out  routinely,  as  described  in 
Materials  and  Methods,  2.1.6,2.1.9,2.1.11  and  2.1.14. 
Plasmid  pPZ104  (Pfizer)  carries  the  SstI24  to  SstI29  fragment  of  the  otc 
duster  in  the  high-copy  number  plasmid  pIJ702.  To  facilitate  cloning,  this  5.4  kb 
Sstl  fragment  was  cloned  into  pIBI24  to  generate  pSRG1  (figure  3.2).  The 
plasmid  pPZ105  (Pfizer)  carries  the  PstI17  to  PstI25  fragment  of  the  otc  cluster,  also 
in  the  high  copy  number  plasmid  pIJ702.  It  was  digested  with  Pstl  and  the  5.0  kb 
fragment  was  ligated  into  pIBI24,  resulting  in  the  pSRG3  clone  (figure  3.2). 
Plasmids  pSRG1  and  pSRG3  were  used  as  the  primary  clones  for  all  of  the 
templates  for  sequencing.  Subclones  were  made  as  required  to  facilitate 
sequencing.  The  subclones  generated  from  pSRG1  include:  a  3.6  kb  SstI24-SphI27 
fragment  to  produce  pSRG6,  a  1.5  kb  KpnI26-SphI27  fragment  to  produce  pSRG7 
and  1.8  kb  SalI2_,  5c-SphI27  fragment  to  produce  pSRG9.  Subclones  generated  from 
pSRG3  include:  a  2.1  kb  Sstl  fragment  to  produce  pSRG5  and  a  0.7  kb  SstI24- 
PvU1125a  fragment  to  produce  pSRG10  (figure  3.2). 
Single-stranded  templates  were  employed  for  all  sequencing  reactions. 
The  G+C  content  of  Streptomyces  tends  to  produce  numerous  compressions  and 
unreadable  sequence.  However,  single-stranded  templates  allow  the  primers  to 
anneal  and  extend  with  greater  efficiency  than  double-stranded  templates  which 
have  a  tendency  to  reanneal  with  complementary  strands,  also  present  in  the 
reaction,  rather  than  the  primer.  The  largest  contiguous  template  generated  was 
a  1.5  kb  PstI25-KpnI26  fragment  cloned  into  both  M13mp18  and  M13mp19  (18- 
SRG1  and  19-SRG1  respectively).  Primers  P1,  P5,  P10  and  the  universal  (figure 
3.1)  were  used  to  obtain  sequence  from  18-SRG1  and  primers  P2,  P4,  P8,  P9  and 
the  universal  (figure  3.1)  were  used  to  obtain  sequence  from  19-SRG1.  A  further 
series  of  templates  was  created  to  confirm  sequence  within  this  region.  These 
include,  18-SRG6  and  19-SRG6  (0.9  kb  PUUII25a  SalI25b  fragment)  and  19-SRG8  (1.8 
kb  SalI25c  SphI27  fragment).  To  the  left  of  this  region,  the  templates  18-SRG1.1 
and  19-SRG1.1  were  generated  which  contain  a  0.55  kb  SstI24-PstI25  fragment. 
Primary  sequence  with  the  universal  primer  was  later  confirmed  using  P6  oligo 
on  18-SRG1.1  and  P7  oligo  on  19-SRG1.1.  A  0.22  kb  KpnI23-SstI24  fragment  (18- 
SRG5  and  19-SRG5),  was  sequenced  through  completely  using  the  universal 
primer  on  both  strands.  Templates  18-SRG5.1  and  19-SRG5.1  (containing  a  0.9  kb 
SphI22-SstI24  fragment)  confirmed  this  sequence.  The  right  hand  region  was 
sequenced  off  a  series  of  templates  which  carry  the  0.35  kb  Kpn  I26-PVU  II26a 
fragment.  The  resulting  templates  were  18-SRG7  and  19-SRG7.  The  universal 
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Figure  3.2 
Subclones  generated  from  the  Kpn123  to  MIUI26b  region  of  the  otc  cluster. 
Above  the  restriction  map  are  the  (")  regions  of  the  otc  cluster  which 
complement  the  otc  mutants  (Butler  et  al.,  1989;  Rhodes  et  al.,  1981),  and  the 
deduced  open  reading  frames  ()  resulting  from  analysis  of  sequence. 
The  long  arrows  above  the  deduced  ORFs  show  the  direction  of  translation. 
The  subclone  designations  are  given  below  the  lines. 
-I Chapter  3 
primer  was  used  initially  and  the  sequence  was  confirmed  with  P12  and  P13 
primers.  The  region  to  the  right  of  the  PuuII26a  site  was  initially  sequenced  by  K. 
Linton  and  confirmed  with  a  long  run  using  P12  primer  and  19-SRG7. 
The  sequence  consists  of  3012  bp  with  a  base  composition  of  72.8  mol% 
G+C.  The  annotated  sequence,  including  the  amino  acid  sequences  of  the 
potential  protein  coding  regions  (PPCRs),  putative  ribosome  binding  sites,  the 
oligonucleotides  used  for  sequencing  and  the  locations  of  restriction  sites 
referred  to  in  the  text  are  shown  in  figure  3.3. 
Sequencing  reactions  and  polyacrylamide  gels  were  set  up  as  described  in 
Materials  and  Methods  (2.1.27).  All  the  templates  were  sequenced  twice.  The 
autoradiographs  were  read  using  a  gel  digitiser  which  automatically  enters  the 
data  into  computer  files.  The  sequences  were  aligned  and  edited  by  the 
sequence/editor  program  SEQED  (Devereux  et.  al.,  1984).  The  autoradiographs 
were  read  twice  and  entered  independently  into  two  separate  files  which  were 
compared  using  the  GAP  program  to  eliminate  "input"  errors. 
3.2.2  Potential  Protein  Coding  Sequences 
An  open  reading  frame  (ORF)  is  defined  as  a  string  of  triplets,  which  does 
not  contain  any  translation  stop  codons  (i.  e.  UAA,  UGA  or  UAG).  Only  ORF's 
which  include  an  'in-frame'  translation  start  codon  at  the  5'  end  can  be 
considered  as  potential  protein  coding  regions  (PPCRs).  In  Streptomyces,  as  in  E. 
coli,  the  most  common  initiation  codon  is  AUG  (82%).  Some  genes  in 
Streptomyces  initiate  with  the  codon  GUG.  With  the  high  G+C  content,  it  is 
understandably  more  frequent,  being  present  in  approximately  18%  of  genes 
compared  to  the  3%  in  E.  coli.  Translational  initiation  at  other  codons  has  not 
been  identified  in  Streptomyces  genes.  However,  in  E.  coli,  a  very  small  number 
of  proteins  are  initiated  by  the  UUG  codon  and  the  AUU  codon  (Gold  et  al.,  1981; 
Stromo;  1986).  Of  the  Streptomyces  genes  which  have  been  sequenced  completely, 
67%  are  terminated  by  UGA,  29%  by  UAG  and  4%  by  UAA  (Bibb;  pers.  comm.  ). 
Potential  protein  coding  regions  (PPCRs)  within  the  3.0  kb  region  were 
identified  using  two  independent  programs.  The  first  program, 
CODONPREFERENCE  (Devereux  et  al.,  1984),  exploits  the  non-random 
distribution  of  bases  within  codons  to  identify  PPCRs.  The  nature  of  this 
distribution  depends  on  the  base  composition  of  the  coding  sequence.  The  high 
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CCCGCCCTCGCCGACCCCGACGACGCTCTGCGGCAGACCCTCGGCGTCCCTCCCGGCGGC 
1  ---------+---------+---------+---------+---------+---------+  60 
GGGCGGGAGCGGCTGGGGCTGCTGCGAGACGCCGTCTGGGAGCCGCAGGGAGGGCCGCCG 
TGGGCGCTGATCAGGCCGGACGGCTATCTGGCCGCGAAGGGGCAGCGGTCCGGCACCACC 
. 
61  ---------+---------+---------  +---------+---------+---------+  120 
ACCCGCGACTAGTCCGGCCTGCCGATAGACCGGCGCTTCCCCGTCGCCAGGCCGTGGTGG 
ACCCTGACCGCCCGGCTCCAGGCACTGCACCTGCTCCCGGAGGACACCGCGCCCGGCGCC 
121  ---------+---------+---------+---------+---------+---------+  180 
TGGGACTGGCGGGCCGAGGTCCGTGACGTGGACGAGGGCCTCCTGTGGCGCGGGCCGCGG 
GGTGACTCTGCCGGCCGGCCCGCGCCGGACGGCACACGCCGGGGCGTGACGACCGAATGA 
181  ---------+---------+---------+---------+---------+---------+  240 
CCACTGAGACGGCCGGCCGGGCGCGGCCTGCCGTGTGCGGCCCCGCACTGCTGGCTTACT 
rbs  M1uI  otcDorf3 
CCAAGGAGGACACGCGTATGACAGCGATCAACGGCGCACCGGCGGCAGGCGGTTCGGTGG 
241  ---------+---------+---------+---------+---------+---------+  300 
GGTTCCTCCTGTGCGCATACTGTCGCTAGTTGCCGCGTGGCCGCCGTCCGCCAAGCCACC 
MTAINGAPAAGGSVA 
CACTGGTCATCGGCGGCACCCGCGGCATCGGGCTGGCCGCCGCCCGCAAACTGAGCGCGG 
301  ---------+---------+---------+---------+---------+---------+  360 
GTGACCAGTAGCCGCCGTGGGCGCCGTAGCCCGACCGGCGGCGGGCGTTTGACTCGCGCC 
LVIGGTRGIGLAAARKLSAA 
CGGGCAGCGAGGTGCTGCTCAACTACGCGCACGACGAGGACGGCGCGCTGGCGGCCGAAC 
361  ---------+---------+---------+---------+---------+---------+  420 
GCCCGTCGCTCCACGACGAGTTGATGCGCGTGCTGCTCCTGCCGCGCGACCGCCGGCTTG 
GSEVLLNYAHDEDGALAAER 
PvuII 
GGCAGCTGTCCGAGGAGGGCGGCAAGGTACGGCTGATGCGCGCGGACATCGGCCGCCCCG 
421  ---------+---------+---------+---------+---------+---------+  480 
CCGTCGACAGGCTCCTCCCGCCGTTCCATGCCGACTACGCGCGCCTGTAGCCGGCGGGGC 
QLSEEGGKVRLMRADIGRPA 
CCGGTGTGGTGCGGCTGCTGGAGGACATCCGGCGCACCCACGGCCGGCTGGACGTCCTGG 
481  ---------+---------+---------+---------+---------+---------+  540 
GGCCACACCACGCCGACGACCTCCTGTAGGCCGCGTGGGTGCCGGCCGACCTGCAGGACC 
GVVRLLEDIRRTHGRLDVLV 
P13 
TGCACGCAGCCGGTTCCTTCCATCCGGCGCCGACCGCGTCCCCGCACATCGGCAAGTACC 
541  ---------+---------+---------+---------+---------+---------+  600 
ACGTGCGTCGGCCAAGGAAGGTAGGCCGCGGCTGGCGCAGGGGCGTGTAGCCGTTCATGG 
HAAGSFHPAPTASPHIGKYL 
TGGGCGACGGCGCCGTGGCGGTCGGACCGCTGCTGTACGGGGCGGCGCGCCTGGGCACCC 
601  ---------+---------+---------+---------+---------+---------+  660 
ACCCGCTGCCGCGGCACCGCCAGCCTGGCGACGACATGCCCCGCCGCGCGGACCCGTGGG 
P12 
GDGAVAVGPLLYGAARLGTL 
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TGATGACCCCGGACACGGGCCGTATCGTCGCCGTCTCCAGCATCGGCGCCCGGACGGTCG 
661  ---------+---------+---------+---------+--------  ,  20  ACTACTGGGGCCTGTGCCCGGCATAGCAGCGGCAGAGGTCGTAGCCGCGGGCCTGCCAGC 
MTPDTGRIVAVSSIGARTVV 
KpnI 
TCCCCGGCTACGCGGGTCTGGGCATGGCCAAGGCGGCCTTGGAGACGCTGGTGCGC" 
721  --  +---------+---------+---------+---------+---------+  780 
AGGGGCCGATGCGCCCAGACCCGTACCGGTTCCGCCGGAACCTCTGCGACCACGCCATGG 
PGYAGLGMAKAALETLVRYL 
TGGCGGTGGAACTCGCCGGGAAGGGCGTCGCGGTGAACGCGGTGGCCGCGGGCAAGATCG 
781  ---------+---------+---------+---------+---------+---------+  840 
ACCGCCACCTTGAGCGGCCCTTCCCGCAGCGCCACTTGCGCCACCGGCGCCCGTTCTAGC 
AVELAGKGVAVNAVAAGKIA 
CCGACGGCGGTCCCGTACCGGCCCAGGTACTGGAGGGCCTGCTGCGGCGGACCCCGACGG 
841  ---------+---------+---------+---------+---------+---------+  900 
GGCTGCCGCCAGGGCATGGCCGGGTCCATGACCTCCCGGACGACGCCGCCTGGGGCTGCC 
DGGPVPAQVLEGLLRRTPTG 
GGCGGCTGGCGACTGCCGAAGAGGTGGCCGACGTGGTGGCGCTGCTGTGCCGCCCCGAGG 
901  ---------+---------+---------+---------+---------+---------+  960 
CCGCCGACCGCTGACGGCTTCTCCACCGGCTGCACCACCGCGACGACACGGCGGGGCTCC 
RLATAEEVADVVALLCRPEA 
CCGGCGGCCTGCACGGACAGGTGCTCACCGTGGACGGCGGGGCCTGCCTGCGGTAGGCGC 
961  ---------+---------+---------+---------+---------+---------+  1020 
GGCCGCCGGACGTGCCTGTCCACGAGTGGCACCTGCCGCCCCGGACGGACGCCATCCGCG 
GGLHGQVLTVDGGACLR* 
rbs  otcDorf4  P2  Sail 
CCGGAAGGACCGACATGCGCATCATCGATCTGZCLACAACCGTGGACGCCGGCCGGTGGG 
1021---------+---------+---------+---------+---------+---------+  1080 
GGCCTTCCTGGCTGTACGCGTAGTAGCTAGACAGCTGTTGGCACCTGCGGCCGGCCACCC 
MRIIDLSTTVDAGRWE 
AGGTCGATCCGGTCGAACACGAAATCCTCACCCCGGCCGAGGGCGGCCGGCACATGGCCG 
1081---------+---------+---------+---------+---------+---------+  1140 
TCCAGCTAGGCCAGCTTGTGCTTTAGGAGTGGGGCCGGCTCCCGCCGGCCGTGTACCGGC 
VDPVEHEILTPAEGGRHMAE 
AGGGGATGCGGCGCCACCACGGCATCGACTTCGACCCCGCCGACCTCCCGGACGGCGAAC 
1141---------+---------+---------+---------+---------+---------+  1200 
TCCCCTACGCCGCGGTGGTGCCGTAGCTGAAGCTGGGGCGGCTGGAGGGCCTGCCGCTTG 
GMRRHHGIDFDPADLPDGEL 
Sall 
TGCTGTCCCTCGACACCCTGCGGCTGACCACCCACACCGGCACCCACGTCGACGCCCCGT 
1201---------+---------+---------+---------+---------+---------+  1260 
ACGACAGGGAGCTGTGGGACGCCGACTGGTGGGTGTGGCCGTGGGTGCAGCTGCGGGGCA 
LSLDTLRLTTHTGTHVDAPS 
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P4 
CGCACTACGGGTCCCGCGCGCGCTACGGCACGCCGCGCCACATCGACCAGATGCCACTGG 
1261---------+---------+---------+---------+---------+----------  1320 
GCGTGATGCCCAGGGCGCGCGCGATGCCGTGCGGCGCGGTGTAGCTGGTCTACGGTGACC 
HYGSRARYGTPRHIDQMPLD 
ACTGGTTTCTGCGGCCGGGCCTCAAGCTCGACCTTACCGACGAGCCGGTGGGCGCCATCG 
1321---------+---------+---------+---------+---------+---------t  1380 
TGACCAAAGACGCCGGCCCGGAGTTCGAGCTGGAATGGCTGCTCGGCCACCCGCGGTAGC 
WFLRPGLKLDLTDEPVGAIG 
GAGCCGACCGGATACGGCGGGCCCTCGACGAAGCGGGCCGCGACCCGCGTCCGTACGACA 
1381---------+---------+---------+---------+---------+---------+  1440 
CTCGGCTGGCCTATGCCGCCCGGGAGCTGCTTCGCCCGGCGCTGGGCGCAGGCATGCTGT 
ADRIRRALDEAGRDPRPYDI 
TCGTGCTGCTGCACACCGGCGCGGACCGGCGGGCCGGAAAGCCGGAGTACTTCACCGAGT 
1441---------+---------+---------+---------+---------+---------+  1500 
AGCACGACGACGTGTGGCCGCGCCTGGCCGCCCGGCCTTTCGGCCTCATGAAGTGGCTCA 
VLLHTGADRRAGKPEYFTEF 
TCGCCGGCCTGGACGCCGCGGCGACCCACCTGCTGCTCGACTTCGGCGTCCGGGTCATCG 
1501---------+---------+---------+---------+---------+---------+  1560 
AGCGGCCGGACCTGCGGCGCCGCTGGGTGGACGACGAGCTGAAGCCGCAGGCCCAGTAGC 
P10 
AG  L"  DAAATHLLLDFGVRVIG 
P8 
GCACCGACGCCTTCAGCCTCGACGCCCCGTTCGGGCACATGATCAAGGAGTACCAGGAGC 
1561---------+---------+---------+---------+---------+---------+  1620 
CGTGGCTGCGGAAGTCGGAGCTGCGGGGCAAGCCCGTGTACTAGTTCCTCATGGTCCTCG 
TDAFSLDAPFGHMIKEYQER 
GCACCGGCGACCGCGGTGTGCTGTGGCCCGCCCACTTCGTGGGACGGGAGCGCGAGTACT 
1621---------+---------+---------+---------+---------+---------+  1680 
CGTGGCCGCTGGCGCCACACGACACCGGGCGGGTGAAGCACCCTGCCCTCGCGCTCATGA 
TGDRGVLWPAHFVGREREYC 
GCCAGATCGAGCGGCTGGACAACCTCGGCGCGCTGCCCGGACCGGACGGCTTCTTGGTCT 
1681---------+---------+---------+---------+---------+---------+  1740 
CGGTCTAGCTCGCCGACCTGTTGGAGCCGCGCGACGGGCCTGGCCTGCCGAAGAACCAGA 
QIERLDNLGALPGPDGFLVS 
P9 
CCTGCTTTCCGTTCAAGATCGCGGGAGCGGGGGCGGGGTGGACGCGGGCGGTGGCGGTGG 
+---------+---------+  1800  1741---------+---------+---------+--------- 
GGACGAAAGGCAAGTTCTAGCGCCCTCGCCCCCGCCCCACCTGCGCCCGCCACCGCCACC 
CFPFKIAGAGAGWTRAVAVV 
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TGGAGGAGTAGGGACGGACGGGTGAACGGGCGCCCCCGGAGCATCCTGGGGCGCCCGTCC 
1801---------+---------+---------+---------+---------+---------+ 
1860 
ACCTCCTCATCCCTGCCTGCCCACTTGCCCGCGGGGGCCTCGTAGGACCCCGCGGGCAGG 
EE* 
rbs  otcD 
GCACGGCTTCCACGGAATCCGCCACGGCCCACCTGCGATGGCGGTCGAATGGCAGTATGC 
1861---------+---------+---------+---------+---------+---------+  1920 
CGTGCCGAAGGTGCCTTAGGCGGTGCCGGGTGGACGCTACCGCCAGCTTACCGTCATACG 
MR 
orf  5 
GAAACCGGCGGAGTCAGCAGTTGCACCGCGTGGTCCGGCGCGCTTCCCGGGCCGGGAACG 
1921---------+---------+---------+---------  +  1980 
CTTTGGCCGCCTCAGTCGTCAACGTGGCGCACCAGGCCGCGCGAAGGGCCCGGCCCTTGC 
NRRSQQLHRVVRRASRAGNG 
P11 
GCCCGCCACCGGCCGGCAGCGTCCCTCCGCGTCCGGAGCTGGGCTGGGCCCGTCTGATCG 
1981---------+---------+---------+---------+---------+---------+  2040 
CGGGCGGTGGCCGGCCGTCGCAGGGAGGCGCAGGCCTCGACCCGACCCGGGCAGACTAGC 
P1 
PPPAGSVPPRPELGWARLIE 
AGCTGACTTCGGTACTGCTCGCCTCGGTCGTCGCCGTGCTGAGCCTCTGGTTCTCCAACC 
2041---------+---------+---------+---------+---------+---------+  2100 
TCGACTGAAGCCATGACGAGCGGAGCCAGCAGCGGCACGACTCGGAGACCAAGAGGTTGG 
LTSVLLASVVAVLSLWFSNR 
GCCAGGTGGGCAACCAGTTGCGGATCGCCCAGGGCGAGCTGAGCACCACCAGGGAAGGTC 
2101---------+---------+---------+---------+---------+---------+  2160 
CGGTCCACCCGTTGGTCAACGCCTAGCGGGTCCCGCTCGACTCGTGGTGGTCCCTTCCAG 
QVGNQLRIAQGELSTTREGQ 
PvuII 
AGATCACCGAGCGGTACACCGCGGCCGTGGGCCAGCTGGGCGAGGATTCGGTGGACGTGC 
2161---------+---------+---------+---------+---------+---------+  2220 
TCTAGTGGCTCGCCATGTGGCGCCGGCACCCGGTCGACCCGCTCCTAAGCCACCTGCACG 
ITERYTAAVGQLGEDSVDVR 
PstI 
GCCTGGGCGGCATCTACGCCCTGCAGGGCAACATGGAGGACCTCCCCCGCGACCACCCCA 
2221---------+---------+---------+---------+---------+---------+  2280 
CGGACCCGCCGTAGATGCGGGACGTCCCGTTGTACCTCCTGGAGGGGGCGCTGGTGGGGT 
LGGIYALQGNMEDLPRDHPT 
CCATCGCCGACGTCCTGGCCGCCTATATCCGCACCCACGCCGGCACCCCGCCGAAAGGCG 
2281---------+---------+---------+---------+---------+---------+  2340 
GGTAGCGGCTGCAGGACCGGCGGATATAGGCGTGGGTGCGGCCGTGGGGCGGCTTTCCGC 
IADVLAAYIRTHAGTPPKGG 
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GCAAACGGGTGCCACCCGATGTCCTGGCCGCGCTCGACGTGATCAGCGGCCGGAACTCCG 
2341---------+---------+---------+---------+---------+----------  2400 
CGTTTGCCCACGGTGGGCTACAGGACCGGCGCGAGCTGCACTAGTCGCCGGCCTTGAGGC 
KRVPPDVLAALDVISGRNSA 
P7 
CCCATGACGGCTCCTTCGTTCCCGACCTCCGCTCCACCCACCTGCCCGGCGTCGAACTGG 
2401-------------------+---------+---------+---------+---------+  2460 
GGGTACTGCCGAGGAAGCAAGGGCTGGAGGCGAGGTGGGTGGACGGGCCGCAGCTTGACC 
HDGSFVPDLRSTHLPGVELG 
GGTGGGACCGTTCGTCTCCCGTCGCCGCCGACCACAAGCGGGCCCAGTTGCGCGGAGCGA 
2461---------+---------+---------+---------+---------+---------+  2520 
CCACCCTGGCAAGCAGAGGGCAGCGGCGGCTGGTGTTCGCCCGGGTCAACGCGCCTCGCT 
WDRSSPVAADHKRAQLRGAI 
TCCTCCGTGACTGCGACCTGAGGGACGCGCGTCTGAGCGGCGCGGACCTGCGAGGCGCGA 
2521---------+---------+---------+---------+---------+---------+  2580 
AGGAGGCACTGACGCTGGACTCCCTGCGCGCAGACTCGCCGCGCCTGGACGCTCCGCGCT 
P6 
LRDCDLRDARLSGADLRGAR 
GGCTCGCACGCGCCGATCTGGCCGACGCGGATCTGCGCGAGGCGGACCTCCGGGAAGCCA 
2581---------+---------+---------+---------+---------+---------+  2640 
CCGAGCGTGCGCGGCTAGACCGGCTGCGCCTAGACGCGCTCCGCCTGGAGGCCCTTCGGT 
LARADLADADLREADLREAT 
CTCCGGCGCGGGCGAACCTGCGCGACGCGGACTTGTCCGACGCCAACGTGCGCAAGGCGG 
2641---------+---------+---------+---------+---------+---------+  2700 
GAGGCCGCGCCCGCTTGGACGCGCTGCGCCTGAACAGGCTGCGGTTGCACGCGTTCCGCC 
PARANLRDADLSDANVRKAD 
ACCTGAGGTTCGCGGATCTTCGCGGCGTGGACCTGTGGGGCACCGATCTGCGCGGCGCGG 
2701---------+---------+---------+---------+---------+---------+  2760 
TGGACTCCAAGCGCCTAGAAGCGCCGCACCTGGACACCCCGTGGCTAGACGCGCCGCGCC 
LRFADLRGVDLWGTDLRGAV 
SstI 
TCCTGTACCGGGCGAAACTGGCCGGCCTGGAGCTCAGCGAGGCGCACCTGGACGGAGCCG 
2761---------+---------+---------+---------+---------+---------+  2820 
AGGACATGGCCCGCTTTGACCGGCCGGACCTCGAGTCGCTCCGCGTGGACCTGCCTCGGC 
LYRAKLAGLELSEAHLDGAD 
ACCTCCGCGGTGCTGATCTCACGGACGCGGCGGTGGCACGGAGCCAGGTCCTCGCGAGCC 
2821---------+---------+---------+---------+---------+---------+  2880 
TGGAGGCGCCACGACTAGAGTGCCTGCGCCGCCACCGTGCCTCGGTCCAGGAGCGCTCGG 
LRGADLTDAAVARSQVLASR 
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GCATCGACGCGGAGACCAGGCTCCCACCGGACATCGCCCGCGATCCGGAGGTGCGGGCCC 
2881---------+---------+---------+---------+---------+----------  2940 
CGTAGCTGCGCCTCTGGTCCGAGGGTGGCCTGTAGCGGGCGCTAGGCCTCCACGCCCGGG 
IDAETRLPPDIARDPEVRAR 
GGATCGCTCAGGCCGAGGCGGAGGACGATGGTTTCTGATCGCCGCCTCACCCTCCTCAGG 
2941---------+---------+---------+---------+---------+---------+  3000 
CCTAGCGAGTCCGGCTCCGCCTCCTGCTACCAAAGACTAGCGGCGGAGTGGGAGGAGTCC 
IAQAEAEDDGF* 
KpnI 
GAATCCGGTACC 
3001---------+--  3012 
CTTAGGCCATGG 
Figure  3.3 
Annotated  reverse  complement  sequence  of  the  3,012  bp  KpnI23-MluI26b  region  of 
the  oxytetracycline  cluster.  The  predicted  amino  acid  sequences  of  OtcD-ORF3, 
OtcD-ORF4  and  OtcD-ORF5  are  shown  corresponding  to  the  nucleotide 
sequences.  The  oligonucleotides  designed  as  primers  for  sequencing  are  bold. 
The  putative  ribosome  binding  sites  (rbs)  for  the  predicted  proteins  are 
underlined.  The  restriction  sites  referred  to  in  the  text  are  underlined. 
-  '17-S  was  or,  j%.  Y  W1  $eý.  eýýed  by  K.  Lýý+ý..  ,º  wc5  cý.  ýý,.,.,,  edcý+ 
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G+C  content  of  Streptomyces  (typically  73%  mol  G+C)  allows  for  particularly 
reliable  predictions  of  the  reading  frame  based  on  position-specific  differences.  It 
was  proposed  that  a  reading  frame  could  be  established  if  the  there  is  a  high 
mol%  G+C  content  at  the  third  codon  position,  a  much  lower  one  at  the  second 
position  and  an  intermediate  one  at  the  first  (Bibb  et  al.,  1984).  The  intervening 
regions  between  the  coding  sequences  have  a  random  distribution  of  bases 
within  consecutive  triplets.  The  CODONPREFERENCE  program  scans  the  DNA 
sequence  and  determines  the  mol%  G+C  composition  at  the  first,  second  and 
third  positions  of  a  number  of  triplets  from  a  "window",  which  usually  contains 
25  to  50  triplets.  A  "window"  is  a  fixed  length  of  sequence  within  which  a 
statistical  calculation  is  performed.  The  mol%  G+C  for  each  of  the  three  base 
positions  within  the  "window"  are  then  plotted  against  a  linear  representation  of 
the  sequence,  above  the  first  nucleotide  of  the  "window".  The  "window"  is  then 
moved  along  one  triplet  and  the  calculation  is  repeated.  This  procedure  is 
continued  until  the  entire  sequence  has  been  analysed.  The  resulting  output 
presents  all  the  three  reading  frames  graphically  and  any  potential  ORF's  are  also 
displayed  (Bibb  t  al.,  1984).  The  second  program,  FRAME,  utilises  much  the 
same  principles  of  base  distribution  within  the  codons.  However,  the  results 
could  only  be  displayed  in  tabular  form  with  current  computer  co4+  . 
The  size 
of  the  "window"-  can  also  be  adjusted  to  further  investigate  smaller  regions  of  the 
sequence.  This  program  was  utilised  primarily  to  determine  the  orientation  of 
any  PPCRs  and  the  CODONPREFERENCE  program  to  determine  the  reading 
frame. 
The  3.0  kb  KpnI23-PVUII26b  sequence  was  subjected  independently  to  these 
two  frame-analysis  programs.  The  FRAME  program  determined  that  there  were 
three  PPCRs.  Starting  from  the  right-hand  side  of  the  sequence,  the  0.63  kb 
PvulI-SaII  fragment  showed  a  clearly-defined  PPCR,  the  orientation  of  which 
was  determined  by  the  mol%  G+C  in  each  position.  The  series  of  "windows" 
showed  a  low  mol%  G+C  at  position  1,  a  medium  mol%  G+C  at  position  2  and  a 
high  mol%  G+C  at  position  3.  This  indicated  that  the  PPCR  read  from  right  to 
left  in  the  second  frame.  This  was  confirmed  with  a  plot  using  the 
CODONPREFERENCE  program  shown  in  figure  3.4.  For  simplicity,  the  reverse 
complement  is  displayed  in  both  figure  3.3  and  3.4  to  parallel  the  direction  of 
translation.  The  stop  codon  (UAG)  was  located  at  position  1014  (figure  3.3).  The 
start  of  the  PPCR  was  not  within  this  sequence.  A  look  167  bp  to  the  right  of  the 
PvuII  site  (position  258)  revealed  in  a  AUG  codon'in  frame'  with  the  rest  of  the 
sequence.  Also  'in  frame'  a  further  21  bp  upstream  (position  237)  was  another 
81 Chapter  3 
2.0 
1.. 
1.  J  - 
0.5  " 
0.0 
U 
w 
O 
C 
0.5 
O 
O  0.0  - 
2.  J 
0.  i 
0.0  - 
CODONPREFERENCR  of:  otc24/126.  txt  Ck:  688-,  1  tc  3032  Oc.:  cer  29,1194  10:  0b 
Codon  Table:  otc24/strep.  cod  Prei"nindcw:  25  Rare  ýcn  Threshold:  0.10 
BiasWindow:  25  Density:  99.5 
o  1,000  33o 
'1X11.  I- 
y  ý  , 
.  --;  --I. 
S. 
----  J.  ý---; 
-  Y 
u  aFi  l 
.l 
_ýlýl 
"  r-I  I.  r 
7--a 
L  '_T"_ 
ý- 
r 
1 
1r  l  ,it,  a  hl0 
I  111  1  1I  x11111111  11  M  111  111111.11  111111  1111U1113111  1/IIIII  II  II  11111111   I/I  aI  a   ag  111  I  II  IVlll  11/1119  1111/1111  1  1111111  1  II  I111III/111 
11 
r 
Iv, 
11l  IY  J\,  r  Itl 
ilrl 
\  " 
ý 
k`t  +1ý.  1 
\ý\_ 
r  1  1  `  '  "4  "  '  1/  Ilq"It  ,  J..  L 
I-"---  I  "4  1  h" 
i.  l  "  \.  y  ý  `ý 
ýf  J  l  "1ýý. 
L 
IIIIIIIIII  I  /1l1/11=1o/I  viol  UIIIII/III/m  IIIItt  I51n1t1o11Um1111ýý1r  11  ýl  ýltf/ýI11ý1//  "  III  IU  .3  11.  EU  1U11/111/III  It1111,  ý  Ill  ýllilrilt  ý.  /.  I 
_  =1 
"J 
1  r 
r"  l 
-'  1  - 
"I,  r,  a  ,  1, 
If  ý2  \ 
'i  r1  ,  .  -tl  rr".  II"'  L 
1 
E 
1"  ýýL  n  _ 
Otcl)or[3  OtcDorN  OIcDürI5 
ulIS  IIl  llu  I1I  11  II1111111111  II1  Il  III1  1111  UI1  111111  11  II  11  1  1114  11  11II.  II.  .I  III  1111.1 
J.  i 
-  J.  0 
N 
0 
U 
U 
ti. 
01,000  2,  UUo  ..., 
Figure  3.4 
Open  reading  frames,  OtcD-ORF3  and  ORF-4  ORF-5  deduced  by 
CODONPREFERENCE  analysis  from  nucleotide  sequence  from  Figure  3.3. 
The  arrows  indicate  the  probable  direction  of  transcription. 
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potential  start  codon  (AUG).  The  AUG  at  position  258  was  preceded  by  a 
reasonable  ribosome  binding  site  (AGGAGG)  with  a  high  degree  of 
complementarity  to  a  region  close  to  the  3'  end  of  the  16S  rRNA  from  S.  lividans 
(sequenced  by  Bibb  and  Cohen;  1982).  This  putative  ribosome  binding  site  (rbs) 
is  separated  from  the  AUG  triplet  by  8  nt  and  is  within  the  limits  of  5-9  nt  for 
Shine-Dalgarno  interactions  (Gold  et  al.,  1987).  No  significant  complementarity 
to  the  3'  terminus  of  16S  rRNA  of  S.  lividans  was  found  within  the  sequence 
immediately  upstream  of  the  second  AUG  codon.  Therefore,  it  was  concluded 
that  the  AUG  at  position  258  nt  was  the  probable  translation  initiation  codon  for 
OtcD-ORF3. 
The  FRAME  analysis  proceeding  left  from  the  stop  codon  of  OtcD-ORF3 
(position  1014)  was  initially  diverse  but  quickly  fell  into  a  recognisable  PPCR. 
The  region  between  the  two  PPCRs  was  only  18  nt.  The  pattern  produced  from 
the  FRAME  analysis  program  was  similar  to  the  previous  PPCR,  a  low  mol% 
G+C  at  position  1,  a  medium  mol%  G+C  at  position  2  and  a  high  mol%  G+C  at 
position  3.  Again  there  were  two  possible  initiation  start  sites,  an  AUG  start  at 
position  1035  and  a  GUG  start  at  position  1062.  The  AUG  codon  was  preceded 
by  a  reasonable  rbs  (GGAAGG)  6  nt  upstream  from  the  AUG  start.  The  GUG 
codon,  although  'in  frame',  was  not  preceded  by  a  potential  rbs.  774  nt 
downstream  from  the  AUG  start  was  an  UAG  stop  codon,  located  at  position 
1809.  Therefore  it  was  concluded  that  OtcD-ORF4  reads  from  right  to  left  from 
an  AUG  initiation  start  site  (position  1035)  to  an  UAG  stop  site  (position  1809). 
The  FRAME  analysis  of  the  left  most  region  of  the  3.0  kb  sequence  showed 
great  diversity  immediately  following  the  UAG  of  OtcD-ORF4.  There  were  three 
potential  AUG  start  sites,  all  in  different  reading  frames.  The  FRAME  program 
showed  that  the  PPCR  read  in  the  same  direction  and  reading  frame  as  the 
previous  two  PPCRs.  A  possible  rbs  was  located  4  nt  upstream  of  the  AUG  and 
the  PPCR  extended  to  a  UGA  stop  codon  at  position  2976.  It  was  concluded  that 
the  third  PPCR,  OtcD-ORF5  was  1059  nt  in  length  running  from  position  1917  to 
2976.  The  region  sequenced  was  completed  at  the  KpnI23  site,  37  nt  downstream 
of  the  OtcD-ORF5  translational  stop  codon.. 
3.2.3  Comparisons  of  Amino  Acid  Sequence 
Analysis  of  the  predicted  amino  acid  sequences  for  all  three  PPCRs  was 
done  by  comparison  with  sequences  in  the  databases.  Each  PPCR  will  be 
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discussed  separately.  To  ensure  that  the  comparison  is  a  valid  one,  the  databases 
used  should  be  updated  frequently  and  for  maximum  sensitivity,  the  database 
searches  should  be  performed  using  a  range  of  scoring  tables  and  other 
parameters.  It  was  hoped  that  the  result  of  database  searches  would  bring  an 
indication  of  a  structural,  functional  or  evolutionary  relationship  with  some  other 
sequence  for  which  additional,  direct  experimental  information  was  readily 
available.  The  two  systems  employed  here  for  data  searching  were  TFASTA 
(Devereux  et  al.,  1984)  and  BLAST  (Altschul  et  al.,  1990).  TFASTA  is  a  family  of 
programs  based  on  the  idea  that  strong  similarities  will  be  marked  by  high 
concentrations  of  short  runs  of  exact  matches.  If  there  are  gaps  in  an  alignment, 
these  matches  will  not  lie  on  a  single  diagonal  of  the  comparison  surface  but  if 
the  length  of  gap  is  small  then  they  will  lie  on  adjacent  diagonals.  TFASTA 
operates  in  several  phases;  a  rapid  initial  scan  identifies  regions  of  the  database 
in  which  there  are  diagonal  bands  of  good  match  to  the  query  sequence.  A 
second  scan  applies  the  complete  Needleman-Wunsch-Sellers  (NWS)  (Sellers; 
1980)  algorithm  to  this  limited  subset.  The  shortfall  to  this  program  is  that  the 
first  scan  is  sensitive  only  to  exact  matches  and  for  more  distantly-related 
sequences,  their  similarity  may  be  expressed  significantly  in  conservative 
substitutions  of  amino  acids.  The  second  program,  BLAST,  attempts  to  take  the 
conservative  substitution  into  account.  It  also  works  by  scanning  rapidly  for 
good  matches  in  short,  fixed-length  'words'  but,  in  addition  to  looking  for  exact 
matches  to  the  words  in  the  query  sequence,  BLAST  also  looks  at  a  larger  set 
derived  from  them  by  generating  all  words  that  score  above  a  threshold  when 
accessed  with  a  general  similarity  table.  Local  similarities  discovered  in  this  way 
are  then  added  in  the  same  registry  until  the  aggregate  score  falls  below  the 
threshold  level.  Gaps  are  not  allowed  directly.  However  when  several  strong, 
ungapped  alignments  are  found  in  one  database  sequence,  the  probability  that 
this  has  occurred  by  chance  is  assessed  in  terms  of  a  Poisson  distribution.  For  a 
comprehensive  discussion  of  high-performance  searching  of  biosequence 
databases,  see  Coulson  (1994). 
3.2.3.1  OtcD-ORF3 
The  predicted  amino  acid  sequence  of  OtcD-ORF3  is  252  amino  acids  in 
length  with  a  predicted  molecular  weight  of  25,274  D.  The  OtcD-ORF3  gene 
product  has  an  average  21.8%  identity  and  43.6%  similarity  with  FAS-type 
ketoreductases,  such  as,  NodG  (nodG)  from  Rhizobium  meliloti  (Fisher  et  al.,  1987) 
and  E.  coli  FabG((3-ketoacyl  acyl  carrier  protein  reductase)  (Cronon  et  al.,  1992). 
A  much  greater  similarity  to  type  II  PKS  ketoreductases  is  seen,  with  an  amino 
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acid  sequence  identity  of  31%  and  similarity  of  51.0%  for  O  tc  Y-ORF  1 
(Thamchaipenet;  1994),  32.2%  identity,  55.6%  similarity  for  DauB  (Ye  et  al.,  1994), 
30.8%  identity,  56.2%  similarity  for  Actlll  (Hallam  et  al.,  1988),  30%  identity, 
52.4%  similarity  for  Gra-ORF5  and  32%  identity,  53.7%  similarity  for  Gra-ORF6 
(Sherman  et  al.,  1989).  All  are  aromatic  polyketide  reductases,  some  with  greater 
sequence  identity  to  OtcD-ORF3  than  others.  The  dendrogram  shown  in  figure 
3.6  shows  OtcY-ORF1,  also  from  the  otc  cluster,  is  grouped  with  those  showing  a 
lower  sequence  identity  suggesting  that  there  is  more  than  one  ketoreductase 
function  in  the  biosynthesis  of  OTC.  A  comparison  of  the  amino  acid  alignments 
of  the  deduced  peptide  sequence  of  OtcD-ORF3  with  the  other  enzymes  was 
displayed  using  the  program  PILEUP  (figure  3.5).  The  degree  of  similarity  and 
the  conservation  of  several  core  sequences  in  a  defined  order  shows  that  all  of 
these  proteins  are  homologous.  A  consensus  NADP(H)  binding  motif,  Gly-X- 
Gly-X-X-Ala  (where  X  is  any  amino  acid)  (Scrutton  et  al.,  1990),  is  found  in  the 
gene  product  of  OtcY2-ORF1  but  not  OtcD-ORF3.  A  similar  motif  is  also  present 
at  the  same  position  in  ActIII,  DauB  and  Gra-ORF5  (Hopwood  and  Sherman; 
1990)  [underlined  in  figure  3.5].  It  was  proposed  as  a  consensus  NADP(H) 
binding  motif  of  those  putative  ketoreductases  (Hopwood  and  Sherman;  1990). 
NADPH  may  be  a  cofactor  for  act-,  gra-,  dau-  and  otc-ketoreductase  systems. 
However,  this  fnotif  is  apparently  not  conserved  at  the  same  position  in  other 
reductases  (figure  3.5).  A  second  conserved  motif,  Gly-3(X)-Gly-X-Gly-3(X)-Ala- 
6(X)-Gly  (where  X  is  any  amino  acid)  was  found  at  residues  18-35  of  the  OtcD- 
ORF3  gene  product  (figure  3.5).  This  motif  is  also  conserved  in  the  sequences 
from  the  other  seven  proteins  compared  in  figure  3.5.  (marked  by  asterisks; 
figure  3.5).  It  situated  dose  to  the  N-terminal  region,  is  very  glycine  rich,  and 
was  previously  proposed  as  the  potential  NADP(H)-binding  fold  in  acetoacetyl- 
CoA  reductase  (phbB;  Peoples  and  Sinskey;  1989)  and  3-ketoacyl-ACP  reductase 
(fabG;  Rawlings  and  Cronan;  1992).  Thus,  this  motif  is  also  likely  to  be  a  binding 
site  for  NADPH.  The  GXGXXA  motif  that  is  conserved  only  in  those 
ketoreductases  underlined  in  figure  3.5,  is  associated  with  Type  II  PKS's. 
Representative  of  this  class  of  ketoreductases  is  the  ActIII  reductase  from 
the  actinorhodin  cluster  of  S.  coelicolor.  Biochemical  genetic  analysis  of  the 
actinorhodin  (act)  biosynthetic  pathway  identified  seven  classes  of  mutants 
blocked  at  different  stages  which  allowed  an  ordered  biosynthetic  sequence  to  be 
deduced:  I,  III,  VII,  IV,  VI,  VA  and  VB  (Rudd  et  al.,  1979).  (A  full  description  of 
the  pathway  is  given  in  Chapter  1.9.2).  ActI  and  III  mutants  failed  to  secrete  any 
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act111 
gra5 
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otcYorf1 
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otcYorf  1 
fabg 
nodg 
grab 
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act111 
gra5 
daub 
otcYorf  1 
fabg 
nodg 
gra6 
otcDorf  3 
50 
..........  .  MATQDSEVA  LVTGATSGIG  LEIARR.  LGK  EGLRVFV.  CA 
MTTATATATA  TPGTAAKPVA  LVTGATSGIG  LAIARR.  LAA  LGARTFL.  CA 
..........  .  MSDAADRVA  LVTGGTSGIG  LAVGRRKLAL  DGTRVFL.  CA 
..........  MTTSATPRTA  LVTGGTSGIG  AVV..  KTLAA  RGLRVFL.  CA 
..........  ..  MNFEGKIA  LVTGASRGIG  RAIA.  ETLAA  RGGKVIG.  TA 
..........  .  MFELTGRKA  LVTGASGAIG  GAIA.  RVLHA  QGAIVGL.  HG 
.........  M  ATDAPEAPVA  LVTGSSSGIG  QTVAQR.  LAA  EGYRVVVNSA 
.....  MTAIN  GAPAAGGSVA  LVIGGTRGIG  LAAARK.  LSA  AGSEVLLNYA 
51 
RGEEGLRTTL  KELREAGVEA  DGRTCDVRSV 
RDEERLAQTV  KELRGEGFDV  DGTVCDVADP 
RDESAVTGTV  KELQASGLEV  EGTSCDVRST 
RSRENVDAVV  KELRDQGLQV  AGCEGDVRSR 
TSENGAQAIS  DYL...  GANG  KGLNLNVTDP 
TQIEKLETLA  TEL...  GDRV  KLFPANLANR 
RSVEDGEKTA  AALPDALY.. 
..  VRADVSEE 
HDEDGALAAE  RQLSEEGGKV  RLMRADIGRP 
101 
VNNAGRPGGG  ATAELAD... 
VNNAGRSGGG  ATAEIAD... 
VNNAGRGGGG  VTAQITD... 
VNNAGRSGGG  VTARIPD... 
VNNAGITRDN  LLMRMKD... 
VNNAGITKDG  LFLHMAD... 
VNNAGRTRAI  PHADLAAATP 
VHAAGSFHPA  PTA...  SPHI 
1  51 
GT.  GRIVNIA  STGGKQGVVH 
KR.  GRIINIA  STGGKQGVVH 
GW.  GRIINIA  STGGKQGVAL 
GVDGRIISIA  STGGKQGVPL 
KRHGRIITIG  SVVGTMGNGG 
RRNGRIINVT  SVAGAIGNPG 
SGNGSVVNVS  SIAGSRPAGS 
PDTGRIVAVS  SIGARTVVPG 
100 
PEIEALVAAV  VERYGPVDVL 
AQIRAYVAAA  VQRYGTVDIL 
DAVDRLVRTA  RNPLRAIDIV 
ESVERVVRAA  VDRFGPLSVL 
ASIESVLEKI  RAEFGEVDIL 
DEVKALGQRA  EADLEGVDIL 
ADARRLVDTA  VEHYGRLDVL 
AGVVRLLEDI  RRTHGRLDVL 
150 
ELWLDVVETN  LTGVFRVTKQ  VLKAGGMLER 
ELWLDVITTN  LTSVFLMTKE  VLNAGGMLAK 
DLWSDVVDTN  LGGAFRVTRA  VLTGGGMQEH 
ELWYDVIDTN  LNSAFLVTRE  ALTTGGLERA 
EEWNDIIETN  LSSVFRLSKA  VMRA...  MMK 
PDWDIVLEVN  LTAMFRLTRE  ITQQ...  MIR 
EVWREILGLN  VIGTWQTTVA  AMPH...  LAR 
GKYLGDGAVA  VGPLLYGAAR  L....  GTLMT 
200 
AAPY.  SASKH  GVVGFTKALG  LELARTGITV 
AVPY.  SASKH  GVVGLTKALG  LELARTGITV 
GAPY.  SASKS  GLIGFTKAVA  LELARTGITV 
GAPY.  SASKA  GLIGFTKAXG  QGLAPTGVTV 
QANYAAAAKA  GLIGFSKSLA  REVASRGITV 
QTNY.  CASKA  GMIGFSKSLA  QEIATRNITV 
SIPY.  AVSNG  GHRAQTRLLA  NTVGP.  AVRV 
YAGL.  GMAKA  ALETLVRYLA  VELAGKGVAV 
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daub 
otcYorf1 
fabg 
nodg 
gra6 
otcDorf  3 
201 
NAVCPGFVET 
NAVCPGFVET 
NAVCPGYVET 
NAVCPGYVET 
NVVAPGFIET 
NCVAPGFIES 
NAVAPGLIET 
NAVAAGKIAD 
PMAASVREHY 
PMAERVREHY 
PMAQGVRQRY 
PMAVRVRQAY 
DMTRAL.... 
AMT.  DL.... 
P.....  WTQN 
G......... 
SDIWEVSTEE  AFDRITARVP 
AGIWQVSEEE  TFDRITNRVP 
AAFWGITEDD  VLEKFRAKIP 
AATWDTTEED  VLSRFNDKIP 
.......  SDD  QRAGILAQVP 
.......  NHK  QKEKIMVAIP 
SDFFAPIAEH 
....  VRQTTP 
....  GPVPAQ  VLEGLLRRTP 
250 
IGRYVQPSEV 
LGRYVETREV 
LGRYSTSDEV 
LGRYSTPEEV 
AGRLGGAQEI 
IHRMGTGTEV 
LRRTGRPEDV 
TGRLATAEEV 
act111 
gras 
daub 
otcYorf1 
fabg 
nodg 
gra6 
otcDorf  3 
251 
AEMVAYLIGP 
AAMVEYLVAD 
AGMVHYLVSD 
AALVGHLAGD 
ANAVAFLASD 
ASAVAYLASD 
AEAVLGLV.. 
ADVVALLCRP 
280 
GAAAVTAQAL  NVCGGLGNY. 
DAAAVTAQAL  NVCGGLGNY* 
SADSITAQAI  NVCGGLGSY. 
EAGSITAQAL  NVCGGLGIY. 
EAAYITGETL  HVNGGMYMV. 
HAAYVTGQTI  HVNGGMAMI. 
RATYTTGQVL  LVDGGAHLL. 
EAGGLHGQVL  TVDGGACLR* 
Figure  3.5 
Linear  alignment  of  amino  acid  sequences  of  ActIII  from  S.  coelicolor,  GraORF5 
and  GraORF6  from  S.  violaceoruber,  3-oxoacyl-[acyl  carrier  protein]  reductase 
(FabG)  from  E.  coli,  nodulation  protein  G  (NodG)  from  Rhizobium  meliloti,  DauB 
from  Streptomyces  sp.  C5  and  OtcY2-ORF1  and  OtcD-ORF3  from  S.  rimosus  with 
amino  acid  numbering  indicated.  The  motif  G1y-3(X)-Gly-X-Gly-3(X)-Ala-6(X)- 
Gly  is  indicated  by  asterisks  and  the  motif  Gly-X-Gly-X-X-Ala  is  underlined  (see 
text  for  detail). 
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Figure  3.6 
Dendrogram  deduced  from  the  alignment  of  amino  acid  sequences  derived  by 
the  PILEUP  analysis  (Fig.  3.5)  of  Actlll,  GraORF5  and  GraORF6,  NodG,  FabG, 
DauB,  OtcY-ORF1  and  OtcD-ORF3  (see  also  legend  of  Figure  3.5  and  see  text  for 
references). 
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biosynthetic  intermediate  active  in  co-synthesis  with  the  other  classes  of  mutants, 
while  being  able  to  convert  actinorhodin  intermediates  secreted  by  the  other 
mutant  classes.  This  indicates  that  actl  and  III  mutants  are  likely  defective  in  the 
genes  which  encode  enzymes  catalysing  the  construction  of  the  pol}vketide 
carbon  skeleton  of  actinorhodin.  The  nucleotide  sequence  of  actlll  was 
determined  and  database  searches  showed  similarity  to  the  ribitol 
dehydrogenase  gene  from  Klebsiella  aerogenes  and  the  alcohol  dehydrogenase 
gene  from  Drosophila  melanogaster  (Hallam  et  al.,  1988).  Malpartida  et  al.,  (1987) 
had  previously  hypothesised  that  the  actlll  gene  encoded  a  polyketide  reductase 
which  reduces  a  keto  group  of  the  polyketide  intermediate  in  the  biosynthesis  of 
actinorhodin.  After  this  reduction  a  hydroxyl  group  would  be  lost  from  this 
position  during  ring  closure  and  aromatisation,  and  the  resulting  compound 
would  lack  an  oxygen  in  that  position  (Chapter  1.9.2).  This  hypothesis  was 
substantiated  in  work  by  Bartel  et  al.,  (1990b),  who,  in  an  attempt  to  generate 
hybrid  antibiotics  by  transforming  discrete  restriction  fragments  of  the 
actinorhodin  biosynthetic  gene  cluster  into  various  Streptomyces  strains,  found 
that  anthraquinone  was  produced  by  the  recombinant  Streptomyces  that  normally 
do  not  produce  the  compound.  The  function  of  the  actIII  gene  product  was 
shown  therefore  to  be  a  polyketide  reductase  which  reduces  a  keto  group  at 
position  C-9  at  the  carboxy  terminus  of  the  assembled  polyketide  to  the 
corresponding  secondary  alcohol.  According  to  the  theories  of  polyketide 
formation  (See  Chapter  1  for  a  full  description),  these  compounds  are  formed  by 
the  successive  additions  of  acetyl  groups  (from  malonyl-CoA)  to  a  starter  unit  (7 
additional  acetates  for  actinorhodin  and  8  additional  acetates  for 
oxytetracycline).  The  fact  that  catalysis  by  the  actlll  gene  product  occurs  at  the 
ninth  carbon  from  the  end  of  the  molecule,  implies  that  this  enzyme  does  not 
reduce  the  carbonyl  group  until  the  entire  chain  is  assembled.  Hypothetically 
then,  the  polyketide  reductase  might  'measure'  the  distance  from  the  carboxyl 
end  of  the  completely  assembled  chain  and  reduce  the  proper  keto  group. 
During  otc  biosynthesis,  reduction  occurs  at  the  ninth  carbon,  counting  from  the 
carboxyl  end  of  the  mature  polyketide  chain.  If  no  reduction  were  to  take  place 
at  C-9  before  ring  cyclisation,  an  analogue  of  OTC  would  be  predicted  to  contain 
a  hydroxyl  group  in  that  position.  Indeed,  some  of  the  antibiotics  of  the 
tetracycline  family  have  an  oxygen  remaining  at  the  C-9  position  in  a  methoxy 
form,  for  example  2'-N-methyl-8-methoxychortetracycline  produced  by 
Actinomadura  brunnea  (Patel  et  al.,  1987a)  and  4a-hydroxy-8- 
methoxychlortetracycline  from  Dactylosporangium  sp.  (Patel  et  al.,  1987b).  In  both 
cases  mentioned  here,  the  reduction  occurs  at  a  carbon  which  is  part  of  the  first 
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ring  formed  during  the  biosynthesis  of  these  various  polyketide  compounds. 
Bartel  et  al.,  (1990)  also  showed  that  anthracyclines  are  also  reduced  at  the  ninth 
carbon  position  by  a  enzyme  showing  strong  similarity  to  the  actIII  gene, 
although  this  may  just  be  coincidence.  It  was  therefore,  on  the  basis  of  the  strong 
similarity  to  the  actlll  gene  product,  the  two  conserved  motifs  and  the  position  of 
ketoreduction  within  the  duster  that  OtcY2-ORF1  was  assigned  as  the  polyketide 
reductase  which  reduces  a  keto  group  at  the  C9  position  of  the  otc  intermediate. 
In  the  biosynthesis  of  OTC,  three  oxidoreductase  steps  are  required.  One, 
already  mentioned  above,  at  position  C9,  one  at  position  C6  in  the  conversion  of 
4-keto-ATC  to  ATC  and  one  at  the  last  step  of  the  pathway,  OTC  dehydrogenase. 
Mutants  blocked  in  the  final  step  of  the  pathway  require  the  addition  of  CSF1. 
CSF1  (cosynthetic  factor  1)  a  flavin-like  cofactor,  is  required  along  with  NADPH 
to  reduce  5a,  lla-dehydrooxytetracycline  to  oxytetracycline.  This  was  first 
demonstrated  by  Miller  et  al.,  (1960),  with  certain  mutants  of  S.  aureofaciens  which 
were  unable  to  produce  chlortetracycline  because  they  lacked  this  cofactor  and 
then  subsequently  with  S.  rimosus  as  the  identical  biochemial  steps  occur  in  both 
chlorotetracycline  and  oxytetracycline  biosynthesis.  By  amino  acid  comparisons 
of  the  available  polyketide  reductase  genes,  there  is  strong  similarity  of  OtcD- 
ORF3  to  a  group  of  reductases  which  carry  a  conserved  motif  at  the  N-terminus, 
see  figure  3.5.  More  than  one  reductase  has  been  found  in  a  number  of  strains 
including  granaticin  (Sherman  et  al.,  1989)  and  daunorubicin  (Strohl; 
unpublished).  OtcD-ORF3  shows  slightly  greater  similarity  to  Gra-6  (55.7  %) 
then  Gra-5  (49.3  %).  This  leads  to  the  conclusion  that  Gra-5  is  involved  in  the 
PKS  region  of  the  granaticin  biosynthetic  pathway  and  that  Gra-6  is  a  tailoring 
enzyme  which  carries  out  a  role  similar  to  OtcD-ORF3.  Sequence  similarity  to 
two  other  reductases  found  in  the  daunorubicin  producing  strain  C5  (Strohl; 
unpublished)  would  help  to  establish  a  second  reductase  sub-family. 
3.2.3.2  OtcD-ORF4 
The  predicted  amino  acid  sequence  of  OtcD-ORF4  consists  of  258  amino 
acids  with  a  deduced  molecular  weight  of  28,571  D.  When  the  deduced  amino 
acid  sequence  was  searched  using  the  BLAST  program,  a  strong  similarity  was 
found  to  ORF1  in  the  lkmB  region  of  the  daunorubicin  biosynthetic  gene  cluster 
of  Streptomyces  griseus  (Krügel  et  al.,  1993).  Direct  comparison  with  the  amino 
acid  sequences  employing  the  BESTFIT  program  (Devereux  et  al.,  1984),  revealed 
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Figure  3.7 
Dot-plot  analysis  of  the  PILEUP  comparison  (Devereux  et  al.,  1984)  of  the 
deduced  amino  acidsequence  of  OtcD-ORF4  with  Streptomyces  griseus  ORF1 
(stringency,  21;  window,  30). 
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a  79.7%  similarity  and  66.9%  identity  with  lkmB  (referred  later  in  this  text  as  Dau- 
ORF1).  The  Dau-ORF1  consists  of  259  amino  acids  with  a  molecular  weight  of 
28.7  kD,  similar  to  OtcD-ORF4.  A  dot-plot  analysis  of  the  PILEUP  comparison 
(Devereux  et  al.,  1984)  between  OtcD-ORF4  and  Dau-ORF1  is  shown  in  figure  3.7 
(stringency  21,  window,  30).  S.  griseus  strains  IMET  JA3933,  JA5142  and  JA5570 
produce  a  complex  of  anthracycline  antibiotics  that  has  been  named 
leukaemomycin  (Krügel  et  al.,  1993).  The  main  component  of  this  complex  is 
daunorubicin.  Wagner  et  al.,  (1984)  showed  that  the  first  stable  intermediate  in 
the  biosynthetic  pathway,  after  cyclisation  and  aromatization,  is  aklanonic  acid. 
Aklanonic  acid  is  then  converted  to  aklavinone  and  e-rhodomycinone.  After  UV 
and  nitrosoguanidine  treatment  39  mutants  blocked  in  different  steps  of  the 
pathway  were  isolated.  LkmB  mutants  fail  to  make  any  detectable  intermediate 
of  the  daunorubicin  pathway  and  show  no  typical  red  colour.  They  are  able 
however,  to  convert  aklanonic  acid  and  the  compounds  secreted  by  other  classes 
of  lkm  mutants  into  e-rhodomycinone  and  daunorubicin.  This  suggests  that  the 
early  steps  of  the  pathway  have  been  disrupted  in  all  these  mutants.  Sequence 
analysis  of  ORF1  in  the  mutant  shows  aC  to  T  transition  at  position  1172  causing 
an  amino  acid  change  from  glycine  to  aspartic  acid.  No  function  has  been 
assigned  to  this  gene  product.  Dau-ORF1  was  shown  to  complement  in  trans  the 
lkm  mutation  which  seems  to  affect  an  early  step  in  daunorubicin  biosynthesis. 
ORF1  of  the  1km  region  also  shows  significant  similarity  to  dnrY  in  the 
daunorubicin  pathway  of  S.  peucetius.  This  gene  also  complements  a  mutation  is 
S.  griseus  that  blocks  an  early  step  in  the  biosynthetic  pathway  (CR.  Hutchinson; 
pers.  comm.  ). 
3.2.3.3  OtcD-ORF5 
The  predicted  amino  acid  sequence  of  OtcD-ORF5  is  a  longer  peptide  of 
353  amino  acids  with  a  deduced  molecular  weight  of  38,113  D.  When  the 
deduced  amino  acid  sequence  was  searched  using  the  BLAST  program, 
similarity  to  an  ORF  from  the  Bacillus  subtilis  genome  was  obtained.  It  was 
sequenced  by  Ogasawara  et  al.,  (1994)  as  part  of  the  systematic  sequencing 
project  of  the  B.  subtilis  genome.  It  is  located  within  a  180  kb  region  of  the 
chromosome  containing  the  replication  origin.  Due  to  the  nature  of  this  project, 
the  elucidation  of  functions  for  all  ORFs  sequenced  is  not  a  priority  if  no 
homology  is  found  immediately.  Interestingly  located  within  the  same  180  kb 
region  are  a  number  of  other  tetracycline-like  biosynthetic  gene  products,  namely 
a  tetracycline  resistance  gene  and  an  acyltransferase  gene.  An  acyltransferase 
gene  product  has  recently  been  located  immediately  downstream  of  the  OtcD- 
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B.  sub-ORF1  LTRLSKERLL  TLQVDEHRAE  VNEWLLKTSE  LVRAQARHPK 
OtcD-ORF5  LRGAILRDCD  LRDARLSGýAD  LRGARLARAD  LADADLREAD 
B.  sub-ORF1  LPKKVSRGVS  LIGAKLKGILD  LRGANLRGAL  LIAADLRNAD 
OtcD-ORF5  LREATPARAN  LRDADLSDAN  VRKADLRFAD  LRGVDLWGTD 
B.  sub-ORF1  LRMTDFIGAD  MRDADLSGAD  LTG 
OtcD-ORF5  LRGAVLYRAK  LAGLELSEAH  LDGADLRGAD  LTDAAVARSQ 
Figure  3.8 
Alignment  of  OtcD-ORF5  with  a  B.  subtilis  ORF  of  unknown  function.  The 
sequence  similarity  is  confined  to  a  small  region  of  repeat  sequences  with  an 
overall  consensus  sequence  LRGAD. 
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ORF5,  with  the  opposite  direction  of  translation  (Hunter;  pers.  comm.  ).  The 
sequence  similarity  was  confined  to  a  short  stretch  of  the  sequence  located  at 
position  2472  through  to  position  2927.  A  BESTFIT  comparison  of  this  region 
showed  a  57%  similarity  and  46%  identity  (figure  3.8).  Similarity  is  seen  over  76 
amino  acids  in  a  series  of  direct  repeats  of  5  amino  acids  with  a  consensus 
sequence  of  'LRGAD'.  This  region  was  run  through  both  the  PROSITE  and 
MOTIFS  (Devereux  et  al.,  1984)  programs  with  no  matches.  This  amino  acid 
region  is  very  hydrophobic  and  secondary  structure  analysis  has  revealed  a 
helix-turn-helix.  This  preliminary  information  may  suggest  some  sort  of  binding 
site  in  which  the  leucine  residues  may  play  an  important  part.  It  is  apparent  that 
this  region  is  significantly  unvsýC!.  to  warrant  further  investigation,  and  will  be 
discussed  further  in  Chapter  4. 
A  series  of  cosmid  libraries  of  S.  peucetius  and  S.  galilaeus  were  generated 
at  Glasgow  University  by  Ranjan  Prasad.  Several  Streptomyces  species,  including 
S.  peucetius  and  S.  galilaeus  produce  7,8,9,10-tetrahydro-5,12-naphthacene 
quinone  glycosides,  commonly  known  as  anthracyclines  (Ye  et  al.,  1994).  Three 
such  anthracyclines  are  doxorubicin,  daunorubicin,  and  aclacinomycin.  The 
biosynthetic  pathway  of  the  anthracyclines  has  been  determined  with  the  use  of 
blocked  mutants  (Eckardt  and  Wagner;  1988).  Aklavinone  is  produced  by  the 
condensation  of  nine  acetyl  equivalents  with  a  propionyl-CoA  starter  molecule. 
Aklavinone  is  glycosylated  directly  to  produce  aklavin  and  aclacinomycin  A  (Oki 
et  al.,  1979;  Strohl  et  al.,  1989).  In  the  formation  of  daunorubicin,  however, 
aklavinone  is  hydroxylated  to  form  e-rhodomycin,  a  red-pigmented  compound 
(McGuire  et  al.,  1980),  which  is  then  converted  to  the  final  product  via  several 
reactions.  Mutants  which  accumulate  aklanonic  acid  can  be  found  in  both  S. 
peucetius  and  S.  galilaeus.  It  thus  appears  that  aklanonic  acid  is  a  primary 
intermediate  in  the  aklavinone  pathway  of  several  organisms  (Eckardt  and 
Wagner;  1988). 
Hybridisation  studies  were  carried  out  with  these  Streptomyces  spp.  to 
determine  if  similar  gene  products  to  OtcD-ORF5  could  be  found.  Positive  clones 
were  obtained  from  Ranjan  Prasad.  The  cosmid  library  was  constructed  from 
DNA  of  the  S.  galilaeus,  which  produces  aclacinomycin  A.  An  800  bp  PvuII-Sstl 
fragment  from  pSRG4  (See  figure  3.2)  labelled  with  digoxigenin  was  used  as  a 
probe  against  6  cosmid  colony  blots.  Clone  number  6  hybridised  well  against  the 
probe.  The  colony  was  restreaked  to  obtain  single  colonies,  DNA  was  purified 
from  two  colonies  and  digested  with  Bam  HI.  As  controls,  S.  peucetius,  S.  galilaeus 
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Figure  3.9 
Hybridisation  analysis  of  the  a  cosmid  clone  from  a  S.  galilaeus  cosmid  library 
using  theSstI24-PvuII25aDNA  fragment  from  the  otc  duster  as  a  probe  (lanes  b 
&  c).  Genomic  DNA's  from  S.  peucetius  (lane  a)  S.  galilaeus  (lane  d),  and  S. 
lividans  (lane  e)  were  used  as  controls. 
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and  S.  lividans  genomic  DNA  were  also  digested.  The  same  probe  was  employed 
and  a  band  of  approximately  9  kb  was  detected  in  both  cosmid  clones  (figure 
3.9).  Although  not  visible  on  this  blot,  bands  were  seen  in  both  S.  peucetius  and  S. 
galilaeus  genomic  lanes  after  a  much  longer  exposure.  However,  no  band  was 
seen  in  the  S.  lividans  genomic  lane.  The  differences  in  intensities  of  the  bands 
are  explained  by  the  fact  that  the  cosmid  clones  produce  multiple  copies  of  the 
DNA  segment  whereas  the  DNA  segment  is  present  only  in  a  single  copy  in  the 
genomic  DNA  samples.  Confirmation  of  the  positive  results  was  obtained  with  a 
dot-blot  analysis  of  genomic  DNA  of  S.  peucetius,  S.  galilaeus,  S.  lividans  and  S. 
rimosus  4018  as  well  as  pSRG1,  which  carries  the  homologous  sequence  of  the 
probe,  and  pIBI24  vector  sequence.  Signals  were  seen  in  DNA  from  pSRG1,  S. 
peucetius,  S.  galilaeus,  and  S.  rimosus  4018  but  not  S.  lividans  or  pIBI24.  It  is 
evident  that  this  region  of  the  OTC  cluster  contains  DNA  homologous  in 
hybridisation  with  antibiotic  producing  strains  S.  peucetius  and  S.  galilaeus.  S. 
peucetius  and  S.  galilaeus  produce  the  anthracyclines,  daunorubicin  and 
aclacinomycin  A,  respectively.  An  anthraquinone  intermediate,  similar  to 
aklanonic  acid,  also  has  been  implicated  in  oxytetracycline  biosynthesis  (Thomas 
et  al.,  1983).  This  suggests  that  aklanonic  acid  or  analogous  anthraquinones  may 
be  universal  intermediates  in  the  formation  of  various  naphthacenequinone 
polyketides.  At  this  point  it  is  pure  speculation  to  suggest  that  the  OtcD-ORF5 
gene  product  may  be  involved  in  production  of  this  intermediate,  as  there  are 
other  gene  products  in  common  with  the  biosynthetic  pathways.  Once  again, 
disruption  of  this  gene  product,  or  overexpression  and  purification  of  the 
protein,  would  give  more  credibility  to  any  further  sPzýýl  cd,  ';  -5. 
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Transcriptional  Analysis  of  the  otcX  and  otcD  loci 
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4.1  Introduction 
In  the  complex  life  cycle  of  Streptomyces  spp.,  the  variety  of  morphological 
and  biochemical  differentiation  processes  must  be  co-ordinated.  This  can  be 
achieved  at  a  number  of  molecular  levels,  the  primary  one  of  which  is 
transcription.  Efficient  assembly  of  complete  transcripts  occurs  with  the 
transcribing  enzyme  (RNA  polymerase)  forming  a  stable  complex  with  the  DNA 
template  until  it  reaches  termination.  Regulation  of  this  transcription  can  allow 
the  selective  expression  of  the  encoded  genetic  information.  Early  studies  by 
Burgess  et  al.,  (1969),  found  that  a  stimulatory  factor,  known  as  sigma  (a),  was 
also  required  to  initiate  transcription  leading  to  the  possibility  that  a  factors 
perform  a  crucial  function  in  regulation. 
Sigma  factors  can  be  classified  broadly  into  two  families  of  bacterial 
proteins:  those  related  in  protein  sequence  to  (j70'  the  primary  sigma  factor  in  E. 
coli,  and  those  related  in  protein  sequence  to  Q54,  an  alternative  E.  coli  sigma 
involved  in  transcribing  nitrogen-related  genes.  The  existence  of  alternative 
sigma  factors  appears  to  provide  a  way  of  co-ordinately  regulating  gene 
expression.  Sigma  functions  by  binding  to  the  core  RNA  polymerase  to  form  a 
RNA  polymerase  holoenzyme  which  is  capable  of  initating  transcription.  Other 
auxilliary  proteins  such  as  NusA,  an  elongation  factor,  play  a  role  in  modulation 
of  the  efficiency  of  initiation  by  binding  competitively  to  the  core  polymerase. 
The  sigma  appears  to  recognise  the  DNA  only  after  it  has  undergone 
conformational  changes  brought  about  by  binding  to  the  core  polymerase.  There 
is  little  information  about  the  role  of  sigma  in  opening  of  strands  of  DNA, 
binding  of  the  initiating  nucleotide,  and  dissociation  during  promoter  clearance, 
although  previous  studies  (Burgess  et  al.  1969),  show  that  sigma  is  essential 
because  core  RNA  polymerase  alone  is  unable  either  to  locate  promoters  or  to 
catalyse  strand  opening  on  covalently-closed  circular  DNA.  A  complete  review 
of  bacterial  sigma  factors  can  be  found  in  Gross  and  Lonetto,  1992.  The  role  of 
sigma  in  promoter  recognition  has  been  studied  in  more  detail  and  will  be 
discussed  below. 
The  primary  sigma  factor  in  E.  coli,  a  0,  Ea70,  has  been  sequenced  and 
comparisons  with  sigma  factors  in  other  organisms,  both  Gram-negative  and 
Gram-positive,  have  produced  a  family  of  G70-related  sigma's  with  similar 
structure  and  function  (reviewed  in  Gross  et  al.,  1992).  RNA  holoenzyme 
containing  a70-type  sigma  factors  recognises  promoters  which  have  two 
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conserved  blocks  of  sequence  about  10  bp  and  35  bp  upstream  of  the 
transcriptional  start  site  and  are  separated  by  15-20  bp  of  non-conserved 
sequence.  In  a  genetic  approach  to  determine  which  regions  might  interact  with 
the  promoter  sequence,  mutant  070-type  sigmas  were  constructed.  Single  base 
changes  in  the  helix-turn-helix  motif  found  in  region  4  of  the  sigma  sequence 
were  found  to  be  involved  in  recognising  the  -35  bp  region  (Gardella  et  al.,  1989) 
and  a  putative  a-helix  located  in  region  2.4  of  sigma  was  found  to  be  involved  in 
recognising  the  -10  region  (Zuber  et  al.,  1989). 
DNA  sequences  involved  in  regulating  transcription  are  fairly  well 
understood  for  some  bacterial  systems  such  as  E.  coli  and  B.  subtilis  but  little  is 
known  about  such  processes  in  Streptomyces  spp.  In  E.  coli,  extensive  DNA 
manipulation  of  regions  surrounding  promoters  has  been  undertaken  by  a 
number  of  groups.  Stefano  et  al.,  (1982)  investigated  the  spacing  between  the  -35 
and  -10  regions  of  published  E.  coli  promoter  sequences  and  found  that  the 
majority  were  separated  by  16-18  nucleotides.  Altering  the  spacing  between  the 
-35  and  -10  regions  was  shown  subsequently  to  decrease  the  activity  of  the 
promoter.  Jaurin  et  al.,  (1984)  showed  that  increasing  the  spacing  from  16  to  17  in 
the  E.  coli  ampC  promoter  also  increased  the  promoter  activity  16-fold.  This, 
along  with  work  of  Siebenlist  et  al.,  (1980),  helped  to  confirm  the  premise  of 
Losick  et  al.,  (1981),  that  sigma  factors  generally  contact  nucleotides  in  both  the 
-10  and  -35  hexamers.  The  conservation  of  sequences  at  these  two  sites  also 
appears  to  be  essential  in  E.  coli  promoters;  at  the  -10  region,  TATAAT  and  at  the 
-35  region,  TTGACA  (Hawley  et  al.,  1983).  The  compilation  of  promoter 
sequences  of  streptomycetes  by  Strohl  (1992),  has  shown  that  although  some 
consensus  sequences  in  specific  regions  can  be  identified,  streptomycete 
promoters  are  much  more  diverse  in  sequence  and  regulation  of  transcription 
may,  therefore,  be  more  complex.  Of  the  139  DNA  sequences  associated  with 
apparent  transcriptional  start  sites  in  streptomycetes,  29  promoters  appeared  to 
be  similar  to  those  recognised  by  the  eubacterial  RNA  polymerases  containing 
a70-like  subunits.  Consensus  sequences  at  the  -10  region  [TAg(Pu)  (Pu)T]  and  -35 
region  [TTGAC(Pu)]  were  observed.  Mutational  analysis  of  the  3'  T  in  the  -10 
region  showed  this  base  to  be  significant  (Janssen  et  al.,  1989),  as  it  is  in  the 
consensus  sequence  in  E.  coli  (Gardella  et  al.,  1989).  Interestingly  enough, 
mutational  analysis  of  the  -35  region  did  not  affect  significantly  the  promoter 
activity  suggesting  that  this  region  plays  only  a  minor  role  in  the  interaction  of 
the  DNA  with  RNA  polymerase  (Janssen  et  al.,  1989).  Earlier  transcription  work 
of  Thamchaipenet  (1994),  in  the  OtcY  region  of  the  otc  cluster  in  S.  rimosus, 
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showed  divergent  promoters  separated  by  134  nt.  The  putative  promoter  regions 
(-10  and  -35)  have  been  identified  with  a  longer  spacing  of  19-20  nucleotides 
between  them,  different  from  those  E.  coli  promoters  that  are  recognised  by  Eoi0 
RNA  polymerase.  The  -10  and  -35  regions  of  Pactl  and  PactIIl  of  actinorhodin 
also  show  a  longer  spacer  distance  (21  nucleotides)  (Parro  et  al.,  1991)  which  may 
explain  why  neither  promoter  is  active  in  E.  coli  (Parro  et  al.,  1991).  Although  the 
promoters  from  both  E.  coli  and  streptomycetes  are  recognised  by  RNA 
polymerase  containing  o70-like  subunits,  the  specific  sequences  recognised  in 
each  organism  are  unique,  and  in  the  case  of  E.  coli,  rigid.  It  is  understandable, 
therefore,  that  not  all  streptomycetes  promoters  are  recognised  in  E.  coll.  A  good 
example  of  this  is  the  gentamicin  gene  employed  for  gene  disruption 
experiments  described  in  Chapter  6. 
A  second  category  of  promoter  sequences  are  recognised  by  the  RNA 
holoenzyme  containing  Ea  54-type  sigma  factors,  similar  to  an  alternative  E.  coli 
sigma  involved  in  nitrogen  regulation.  Promoters  which  fall  into  this  category 
consist  of  two  blocks  of  conserved  sequence  located  12  bp  and  24  bp  upstream  of 
the  transcriptional  start  site  and  are  separated  by  only  5  bp  (for  review,  see  Gross 
et  al.,  1992).  Alternative  sigma  factors  do  not,  however,  share  the  same  high  level 
of  similarity  as  the  o70-type  sigma  factors.  Eo  interacts  with  cognate  promoters 
to  form  a  complex  that  is  easily  detected  in  vivo  and  in  vitro.  The  complex 
formation  requires  the  presence  of  an  appropriate  activator  and  ATP  (Sasse- 
Dwight  and  Gralla;  1988).  The  mechanism  of  activation  of  the  a54-type  sigma 
factors  involves  contact  between  an  activator  protein  and  the  RNA  polymerase 
rather  than  a  conformational  change  in  the  DNA  brought  about  by  binding  the 
activator  protein,  as  with  the  primary  a70-type  sigma  factors.  Eon  transcription 
is  completely  dependent  on  the  presence  of  an  activator,  where  the  location  of 
the  activator  binding  is  less  critical  and  can,  in  fact,  be  remote  from  the  RNA 
polymerase  binding  site  (Gralla;  1991).  At  least  eight  different  a54-type  RNA 
polymerase  holoenzymes  have  been  found  in  Bacillus  subtilis,  several  of  which 
have  active  roles  in  the  regulation  of  morphological  development  (Errington; 
1991).  Similarly,  seven  different  alternative  RNA  polymerase  holoenzymes  have 
been  found  in  Streptomyces,  some  involved  in  global  regulation  and  others  in 
regulating  more  specific  functions  (Buttner;  1989).  Described  below  is  an 
example  of  the  complex  transcriptional  regulation  found  in  Streptomyces. 
In  S.  coelicolor,  the  dagA  gene  encodes  an  extracellular  agarase  gene. 
Trancription  analysis  of  the  dagA  gene  has  revealed  four  separate  promoters, 
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each  of  which  is  recognised  by  a  separate  sigma  factor  (Buttner;  1989).  The  most 
upstream  promoter  dagAP4  is  recognised  by  a  holoenzyme  containing  the 
vegatative  a  factor,  QhrdB,  dagAP3  is  recognised  by  Ea52,  dagAP2  is  recognised  by 
EQE,  (formally  Eß28),  and  dagAP1,  although  not  classified,  appears  to  be 
recognised  by  a  different  and  distinct  a  factor  (Buttner  et  al.,  1990)  Recent  studies 
with  EQE,  by  Lonetto  et  al.,  (1994),  have  revealed  a  distinctive  subfamily  of  070- 
type  a  factors,  all  of  which  function  as  effector  molecules  responding  to 
extracytoplasmic  stimuli  and  thus  have  been  designated  as  the  ECF 
(extracytoplasmic  function)  subfamily.  Other  sigma  factors  in  this  subfamily 
include  CarQ  from  Myxococcus  xanthus,  A1gU  from  Pseudomoas  aeruginosa  and 
SigX  from  Bacillus  subtilis  (Lonetto  et  al.,  1994  and  references  therein.  ).  Sequence 
similarity  is  conserved  across  three  of  the  four  conserved  regions  of  the  070 
family.  What  makes  this  family  distinct  is  that  the  ECF  a  factors  regulate  and 
respond  to  extracytoplasmic  conditions  and  with  many  of  these  genes,  the 
regulation  is  controlled  negatively  by  gene  products  within  their  own  operons. 
Nucleotide  sequencing  of  numerous  antibiotic  biosynthetic  gene  clusters 
has  lead  investigators  to  consider  pathway-specific  regulation  at  the  DNA  level. 
Divergent  promoters  have  been  found  at  a  number  of  loci  in  Streptomyces 
antibiotic-producing  strains,  for  example  in  the  redD  and  actl  andIII  loci  in  S. 
coelicolor  (Narva  et  al.,  1990;  Parro  et  al.,  1991)  and  the  aph  locus  in  S.  fradiae 
(Janssen  et  al.,  1989).  Recent  transcriptional  analysis  work  on  the  otc  duster  by 
McDowall  (1991)  and  Thamchaipenet  (1994)  have  uncovered  two  sets  of 
divergent  promoters  at  different  locations  in  the  cluster.  Back-to-back  promoters 
were  found  for  the  otcC  and  otcX  genes  (McDowall,  1991).  The  otcCpl  directs 
transcription  of  the  otcC-otcZ-otrA  polycistronic  message  whereas  the  otcX  pl 
directs  transcription  of  otcX  and  perhaps  genes  further  downstream  (McDowall; 
1991).  The  otcY2pl  and  otcY2p2  promoters  the  OtcY  locus,  are  also  arranged 
back-to-back.  Tandem  repeat  regions  have  been  found  in  the  upstream  -35 
region  at  both  loci.  These  repeated  patterns  strikingly  resemble  the  common 
phosphate  box  sequences  identified  in  E.  coli  (Makino  et  al.,  1986).  Physiological 
evidence  previously  showed  that  anhydrotetracycline  (ATC)  oxygenase  (encoded 
by  otcC)  is  repressed  by  phosphate  (Behal  et  al.,  1979;  MJ.  Butler,  pers.  comm.  ), 
suggesting  that  these  repeats  may  act  as  regions  subject  to  regulation  by 
phosphate  (McDowall,  1991). 
Termination  of  transcription  can  also  be  important  for  the  regulation  of 
gene  expression.  Many  genes  are  regulated  by  attenuation  (Jensen  et  al.,  1986), 
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while  the  presence  of  weak  terminators  may  allow  differential  expression  of 
genes  within  a  given  operon.  In  spite  of  the  high  stability  of  the  transcription 
complex,  there  are  points  where  the  stability  drops  sufficiently  for  the  transcript 
to  dissociate  spontaneously.  These  are  the  transcriptional  stop  points  of  intrinsic 
terminators  (reviewed  in  Richardson,  1993).  Once  the  RNA  polymerase  has 
dissociated  from  the  complex  it  can  not  reattach  in  a  way  which  allows  continued 
transcription.  The  best  characterised  intrinsic  terminators  are  those  found  in  E. 
coli.  A  second  mechanism  of  termination  in  E.  coli  requires  the  binding  of  specific 
protein  factors  to  terminate  RNA  synthesis  efficiently.  One  such  factor  is  the  rho 
factor  (reviewed  in  Pratt,  1994).  Therefore,  terminators  in  E.  coli  can  be  classified 
as  rho-dependent  or  rho-independent.  Rho-independent  termination  often 
occurs  at  a  series  of  uridine  residues  after  a  hairpin  structure  has  been  formed  by 
the  nascent  RNA  molecule.  One  theory  of  intrinsic  termination  proposed  by  von 
Hippel  and  Yager  (1991)  is  that  the  formation  of  the  stem-loop  causes  the  RNA 
polymerase  to  pause  and  the  less  stable  pairing  of  the  A  to  U  residues  contributes 
to  destabilisation  of  the  transcription  complex,  resulting  in  dissociation  of  the 
RNA  polymerase.  However,  not  all  rho-independent  terminators  fit  this 
generalisation.  This  will  be  discussed  further,  later  in  the  chapter.  In  contrast, 
from  the  known  sequences  compiled  to  date,  the  rho-dependent  terminators  do 
not  appear  to  conform  to  any  consensus  structure  or  sequence.  The  best- 
characterised  termination  factor  is  the  rho  protein  from  E.  coli,  whose  discovery 
was  reported  more  than  two  decades  ago  (Roberts;  1969).  Rho  is  an  essential 
cellular  protein  that  is  necessary  for  transcriptional  termination  at  particular 
sites.  In  brief,  it  acts  by  binding  to  the  nascent  RNA  chains  upstream  of  the 
termination  sites,  in  regions  that  are  relatively  unstructured  and  usually  rich  in 
cytosine  residues.  The  binding  of  rho  to  RNA  activates  a  nucleoside 
triphosphatase  (NTPase)  activity  essential  for  rho-dependent  termination.  The 
NTPase  activity,  primarily  ATPase,  is  thought  to  provide  energy  for  translocation 
of  rho  along  the  RNA  toward  the  polymerase  and  for  unwinding  the  RNA-DNA 
duplex  in  the  transcription  bubble  to  facilitate  release  of  RNA  from  the 
transcription  complex  (reviewed  in  Richardson;  1993). 
Little  is  known  thus  far  about  transcription  termination  in  Streptomyces. 
Glycerol  catabolism  in  S.  coelicolor  is  determined  by  two  structural  genes  gyliA  , 
glycerol  kinase,  and  gylB,  glycerol-3-phosphate  dehydrogenase.  The  two  genes 
are  induced  coordinately  by  growth  on  glycerol  and  repressed  by  growth  on 
glucose.  Genetic  analysis  confirmed  that  they  constitute  an  operon  and 
transcriptional  ananlysis  of  the  operon  was  carried  out  (Smith;  1985).  A  gyl  '0.9' 
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knt  transcript  was  found,  by  low-resolution  S1  mapping,  to  end  shortly  after  an  inverted  repeat.  The  termination  point  of  the  transcript  for  the  hyg  (hygromycin 
phosphotransferase)  gene  of  S.  hygroscopicus  was  also  determined  and  the 
sequences  of  the  Streptomyces  aph,  tsr  and  vph  genes  also  contain  inverted  repeats 
which  might  be  transcriptional  terminators  (Thompson  et  al.,  1983;  Bibb  et  al., 
1985).  In  all  the  above  mentioned  sequences,  none  of  these  inverted  repeats  was 
followed  by  a  run  of  thymidines,  characteristic  of  the  rho-independent 
terminators  in  E.  coll. 
A  number  of  potential  stem-loop  structures  have  been  located  in  the  otc 
cluster  just  after  putative  translational  stop  codons  (McDowall,  1991; 
Thamchaipenet,  1994).  One  has  been  located  following  each  of  the  two  resistance 
genes,  OtrA,  and  OtrB,  and  one  after  OtcYl-ORF3  in  the  OtcY  locus.  In  this 
chapter,  preliminary  transcriptional  analysis  ofOtcX  and  OtcD  was  undertaken. 
4.2  Results 
4.2.1  Total  Preparation  of  RNA  from  S.  rimosus  M4018 
S.  rimosus  M4018,  which  is  a  former  OTC  production  strain  (obtained  from 
Pfizer),  was  used  to  prepare  RNA  for  the  transcription  analysis  described  in  this 
chapter.  Thamchaipenet  (1994),  had  previously  determined  the  optimal 
conditions  for  growth  to  produce  extracts  with  good  quality  RNA.  These  are 
summarised  briefly  below.  OTC  is  produced  at  a  high  level  in  cultures  grown  in 
TS1  (production  medium  developed  by  Pfizer).  However,  attempts  to  prepare 
intact  RNA  from  such  cultures  were  not  successful.  Alternatively,  the  total  RNA 
was  prepared  from  cultures  grown  on  tetracycline  soluble  medium  (TSM6; 
Section  2.2.1).  RNA  was  isolated  more  easily  from  this  medium  than  TS1,  which 
formed  colloidal-like  compounds,  although  the  amount  of  mycelium  and 
production  of  OTC  were  considerably  lower  than  in  the  TS1  production  medium 
(I.  S.  Hunter;  pers.  comm.  ).  McDowall  (1991),  analysed  the  RNA  isolated  from 
cultures  of  S.  rimosus  M15883,  a  production  strain  descended  in  the  Pfizer  lineage 
from  M4018,  at  different  stages  during  the  production  phase  of  OTC  by  high 
resolution  Si  nuclease  protection  assays  and  found  that  the  level  of  otcC-otcZ- 
otrA  o  otcX  transcripts  increased  by  a  factor  of  4  between  22-46  hours  and 
steadily  declined  over  the  next  two  time  points  of  69  and  93  hours.  Similar 
results  were  seen  with  S.  rimosus  M4018  (Thamchaipenet;  1994).  Therefore,  the 
samples  for  isolation  of  RNA  from  S.  rimosus  M4018  were  harvested  at  40  hrs 
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Figure  4.1 
A  schematic  representation  of  the  single-stranded  templates  used  to 
transcriptionally  map  the  SphI22  to  PVUI126a  region  of  the  otc  duster.  Above  the 
restriction  map  are  the  ()  genetic  loci,  as  described  by  Butler  et  al.  (1989), 
and  the  deduced  open  reading  frames  (ýý)  resulting  from  sequence  analysis. 
The  long  arrows  above  the  deduced  ORFs  show  the  direction  of  probable 
transcription/translation.  The  arrowheads  in  show  the  direction  of  M13  DNA 
probes  in  which  the  transcripts  are  protected. 
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fermentation  in  TSM6  media.  Total  RNA  was  prepared  and  used  in  low-  and 
high-resolution  Si  nuclease  mapping. 
4.2.2  Low-Resolution  Mapping 
Transcriptional  analysis  of  the  region,  SphI22  to  right  of  Kpn126  in  the  otc 
cluster  (for  sequence  analysis  see  chapter  3),  was  performed  by  low-resolution 
mapping  experiments  using  a  series  of  single-stranded  DNA  templates.  Figure 
4.1  shows  the  region  mapped  and  the  templates  used.  Mapping  was  carried  out 
in  three  separate  experiments  as  described  below. 
4.2.2a  Low-Resolution  Mapping  of  the  KpnI26-PVUII26a  region 
The  single-stranded  M13  templates  18-SRG7  and  19-SRG7  (figure  4.1) 
were  prepared  under  RNAase-free  conditions.  The  length  of  insert  (350  bp) 
contains  within  it  part  of  open  reading  frame  OtcD-ORF3.  One  µg  of  each 
template  was  hybridised  to  20µg  of  total  RNA.  Templates  hybridised  to  10µg  of 
carrier  tRNA  and  to  each  other  served  as  controls.  After  S1  nuclease  treatment, 
as  described  in  Materials  and  Methods  section  2.2.12,  all  samples  were 
electrophoresed:  The  blotted  gel  was  probed  with  a  DIG  labelled  350  bp  KpnI26- 
PVUII26a  fragment  isolated  from  pSRG7.  The  resulting  blot  is  shown  in  figure  4.2. 
The  positive  control  lane  shows  the  expected  protected  fragment  of  350  bp.  A 
protected  fragment  can  also  be  seen  in  the  lane  containing  template  18-SRG7. 
Even  after  prolonged  exposure,  not  bands  were  visible  in  the  19-SRG7  lane. 
4.2.2b  Low-Resolution  Mapping  of  the  PstI25  -KpnI26  region 
The  templates  employed  in  the  second  low  resolution  experiment  were  18- 
SRG1  and  19-SRG1  (figure  4.1).  The  insert  length  is  1.5  kb  and  contains  within  it 
the  C-terminus  of  OtcD-ORF3,  the  entire  DNA  sequence  of  OtcD-ORF4  and  the 
N-terminus  of  OtcD-ORF5.  The  Si  digestion  was  done  under  RNAase-free 
conditions,  electrophores  d  and  the  samples  blotted  onto  membrane.  The  DIG- 
labelled  probe,  a  1.5  kb  PstI25-KpnI26  fragment  from  pSRG1,  -it>  the  expected 
1.5  kb  fragment  in  the  positive  control  lane  (figure  4.3).  The  probe  also 
hybridised  to  two  bands  in  the  19-SRG1  containing  lane.  The  size  of  the  lower 
band  was  calculated  to  be  1.1  kb  and  the  upper  band  1.6  kb.  A  band  size  of  1.6 
kb  does  not  seem  plausible.  Unexplained  higher  molecular  weight  artefacts  have 
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Figure  4.2 
Low-resolution  S1  mapping  of  transcripts  in  the  Kpn126  to  Pvull26a  region  of  the 
otc  cluster  using  total  RNA  isolated  from  S.  rimosus  M4018  grown  on  Tetracycline 
Soluble  Medium  (TSM6).  20  µg  of  RNA  were  hybridised  with  single-stranded 
templates  18-SRG7  (lane  b)  and  19-SRG7  (lane  c).  20  µg  of  tRNA  were  used  as  a 
control  to  hybridise  with  18-SRG7  (lane  e)  and  19-SRG7  (lane  f).  A  fully-protected 
fragment,  18-SRG7  hybridised  to  19-SRG7  is  shown  in  lane  d.  The  size  markers,  1 
Kb  ladder  (BRL)  occupy  the  outside  lanes  (a  &  g).  The  exposure  time  for  lane  d 
was  15  mins,  all  others  were  2  hrs. 
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Figure  4.3 
Low-resolution  S1  mapping  of  transcripts  in  the  PstI25  to  Kpn126  region  of  the  otc 
cluster  using  total  RNA  isolated  from  S.  rimosus  M4018  grown  on  Tetracycline 
Soluble  Medium  (TSM6).  20  pg  of  RNA  were  hybridised  with  single-stranded 
templates  18-SRG1  (lane  c)  and  19-SRG1  (lane  d).  20  pg  of  tRNA  were  used  as  a 
control  to  hybridise  with  18-SRG1  (lane  b)  and  19-SRGI  (lane  e).  A  fully- 
protected  fragment,  18-SRG1  hybridised  to  19-SRGI,  is  shown  in  lane  f.  The  size 
markers,  1  Kb  ladder  (BRL)  occupy  the  outside  lanes  (a  &  g).  The  exposure  time 
for  lane  f  was  15  mins,  all  others  were  2  hrs. 
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been  seen  previously  in  S1  nuclease  protection  assays  (C.  Ingham,  pers.  comm.  ). 
It  may  be  a  fully  protected  fragment,  indicating  readthrough  of  termination  from 
the  smaller  termination  product  seen  by  the  detection  of  the  smaller  1.1  kb  band. 
A  second  explanation  could  be  an  artefact.  Low-  and  high-resolution  mapping  of 
the  region  and  the  fragments  downstream  c_tck  1'  interpretation  4-ti-data. 
4.2.2c  Low-Resolution  Mapping  of  the  SphI22-Pstl25  region 
The  final  fragment  to  undergo  low-resolution  mapping  was  contained  in 
the  18-SRG9  and  19-SRG9  templates  with  1.3  kb  inserts  (figure  4.1).  Contained 
within  it  are  OtcD-ORF5  reading  from  right  to  left  and  a  putative  acyltransferase 
(I.  S.  Hunter;  pers.  comm.  )  which  reads  from  left  to  right.  There  is,  therefore,  a 
presumed  terminator  separating  these  two  converging  open  reading  frames.  The 
S1-digested  fragments  were  separated  by  electrophoresis.  The  blotted  gel  was 
probed  with  a  DIG-labelled  1.3  kb  SphI22-PstI25  fragment  isolated  from  pSRG9. 
The  results  are  shown  in  figure  4.4.  The  positive  control  of  the  two  hybridised 
templates  gave  the  expected  band  of  1.3  kb.  A  longer  exposure  of  the 
experimental  lanes  revealed  a  single  band  in  the  18-SRG9  lane  of  approximately 
1.3  kb.  No  band  was  seen  in  the  19-SRG9  lane. 
4.2.3  High-Resolution  Mapping  of  a  Putative  Termination  Region 
From  figure  4.3,  a  smaller  protected  fragment  was  observed  for  19-SRG1 
containing  the  Pstl-Kpnl  region  of  the  otc  cluster  (see  figure  4.7).  Estimated  sizes 
indicated  that  the  protected  fragment  was  1.1  kb,  0.4  kb  smaller  than  the  full 
length  protected  fragment  size.  To  pinpoint  the  termination  point,  a  higher 
resolution  mapping  experiment  was  under  ý_keri.  Two  oligonucleotides, 
previously  used  for  sequence  analysis,  were  employed  to  produce  a  PCR  product 
of  the  region  encoding  the  putative  termination  site.  Oligos  P1  and  P9  (See  figure 
3.1  for  location  of  the  primers)  have  been  designed  to  bind  to  opposite  strands  of 
the  DNA,  281  bp  apart.  A  PCR  fragment  was  generated  using  18-SRG1  as  the 
template  and  adding  P1  and  P9  as  the  primers.  The  resulting  PCR  product  was 
then  ligated  to  a  linearised  pT7Blue(R)  vector  (Novagen).  pT7Blue  has  been 
engineered  to  simplify  cloning  of  PCR  products  generated  with  Taq  DNA 
polymerase.  Taq  DNA  polymerase  leaves  a  single  3'  A-nucleotide  which 
overhangs  the  reaction  products  (Clark;  1988).  pT7Blue(R)  has  been  prepared  for 
T-cloning  by  digestion  with  EcoRV,  followed  by  the  addition  of  single  3'  dT 
residues  at  each  end.  A  blue/white  selection  process  allows  easy  identification 
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Figure  4.4 
Low-resolution  Si  mapping  of  transcripts  in  the  Sphl22  to  PstI25  region  of  the  otc 
cluster  using  total  RNA  isolated  from  S.  rimosus  M4018  grown  on  Tetracycline 
Soluble  Medium  (TSM6).  20  pg  of  RNA  were  hybridized  with  single-stranded 
templates  18-SRG9  (lane  b)  and  19-SRG9  (lane  c).  20  µg  of  tRNA  were  used  as  a 
control  to  hybridize  with  18-SRG9  (lane  e)  and  19-SRG9  (lane  f).  A  fully- 
protected  fragment,  18-SRG9  hybridised  to  19-SRG9,  is  shown  in  lane  d.  The  size 
markers,  1  Kb  ladder  (BRL)  occupy  the  outside  lanes  (a  &  g).  The  exposure  time 
for  lane  d  was  15  mins,  all  others  were  2  hrs. 
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of  insert-containing  products  on  indicator  plates.  A  full  description  of  the 
blue/white  selection  process  is  found  in  Sambrook  et  al.,  (1989).  Of  the  10 
colonies  picked,  6  clones  contained  the  correct  size  of  insert.  One  clone  was 
chosen,  digested  with  PstI  and  SstI  to  excise  the  fragment,  and  cloned  into 
M13mp18  and  M13mp19.  The  single-stranded  DNA  was  then  sequenced  to 
confirm  the  integrity  and  orientation  of  the  PCR  product  within  the  vector. 
The  PCR  product  cloned  in  M13mp19  (19-PCR1)  was  used  as  template  to 
generate  a  single-stranded  DNA  probe  for  high-resolution  S1  mapping.  The 
primer  used  was  a  biotinylated  universal  primer.  Biotin  is  attached  to  the  end  of 
the  primer  as  it  is  synthesised.  A  biotinylated  primer  was  required  to  utilise  the 
Dynal  magnetic  bead  separation  system.  This  system  uses  dynabeads  M-280 
conjugated  to  Streptavidin,  for  simple  and  efficient  separation  of  biotinylated 
compounds  such  as  proteins,  DNA  or  RNA.  Dynabeads  M-280  Streptavidin  are 
uniform  superparamagnetic,  polystyrene  beads  with  streptavidin  covalently 
attached  to  the  bead  surface.  The  Streptavidin  protein,  made  up  of  4  identical 
subunits,  contains  a  high-affinity  binding  site  for  biotin  and  when  the  Dynabeads 
are  placed  next  to  a  Dynal  MPC®  (Magnetic  Particle  Concentrator)  the  target 
biotin-containing  molecules  can  be  isolated  in  a  highly  specific  manner  because 
they  bind  efficiently  to  the  streptavidin  carried  on  the  magnetic  beads.  The 
primer,  therefore  is  attached  to  the  magnetic  dynabead  and  immobilised  by  a 
magnet  field  therefore  eliminating  the  need  for  gel  electrophoresis  to  purify 
radioactive  products. 
After  digestion  with  PstI,  the  beads  (containing  the  attached  probe),  were 
separated  away  from  the  unincorporated  label  and  excess  nucleotides.  The  beads 
were  washed  thoroughly  with  RNAase-free  solutions  before  hybridisation  with 
total  RNA.  The  labelled  template  was  divided  into  two  aliquots,  one  for  the 
experimental  sample  and  one  for  the  control  sample.  The  negative  control  used 
throughout  this  experiment  was  carrier  tRNA.  Total  RNA  isolated  from  an  otc- 
mutant  would  have  been  an  ideal  negative  control  in  this  experiment,  but  was 
not  available.  S1  nuclease  treatment  digested  the  single-stranded  DNA  probe  at 
the  attachment  site  of  the  bead  and  the  protected  fragment  was  separated  away 
from  the  beads  by  the  introduction  of  a  magnetic  field.  The  resulting  supernatant 
was  precipitated  and  resuspended  in  loading  buffer  before  being  separated  on  a 
6%  (w/v)  polyacylamide  gel.  A  sequencing  ladder  of  18-PCR1  primed  with  oligo 
P9  was  used  as  a  control.  The  gel  was  run  for  two  hours  and  the  resulting 
overnight  film  exposure  is  seen  in  Figure  4.5.  Different  exposure  times  were 
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Figure  4.5 
High-resolution  mapping  of  the  3'  end  of  the  RNA  transcript  in  the  region  3'  of 
OtcD-ORF4  in  the  otc  cluster  using  total  RNA  isolated  from  S.  rimosus  M4018 
grown  on  Tetracycline  Soluble  Medium  (TSM6).  20  pg  of  RNA  were  hybridized 
with  a  radiolabelled  single-stranded  template,  19-PCR1  (lane  2).  20  pg  of  tRNA 
were  used  as  a  control  to  hybridize  to  the  radiolabelled  template  (lane  1).  A 
sequencing  ladder  from  the  strand  complementary  to  the  probe  DNA  using  the 
same  oligo  primer  is  found  in  lane  3.  Lanes  1&2  were  exposed  for  10  days  at 
-700C  and  lane  3  was  exposed  overnight  at  RT. 
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Figure  4.6 
The  predicted  steh-  loop  structure  of  the  putative  terminator.  The  free  energy 
formation  is  calculated  at  -57.0  kcal/mol  according  to  the  rules  of  Tinoco  et  al. 
1973.  The  UAG  in  bold  indicates  the  stop  codon  of  OtcD-ORF4  and  the 
AAUCC  sequence  underlined  in  bold  is  the  predicted  transcriptional  stop 
region. 
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required  to  visualise  the  sequencing  ladder  and  experimental  samples. 
Overnight  exposure  was  sufficient  for  the  ladder,  10  days  was  required  to  see  the 
protected  fragment.  Multiple  bands  were  observed  corresponding  to  the 
sequence  CGGAATCCGCCA.  Those  bases  underlined  indicate  the  approximate 
site  of  termination.  Direct  comparison  between  the  sequencing  ladder  and  the 
sample  could  be  made  because  the  primer  used  to  generate  the  PCR  product  was 
also  used  to  prime  the  sequencing  reaction.  FOLD  (Devereux  et  al.,;  1984),  a 
program  that  finds  an  optimum  secondary  structure  for  RNA  molecules  using 
the  method  of  Zucker  (1981)  showed  a  strong  inverted  repeat  immediately 
preceding  this  stretch  of  sequence.  Figure  4.6  gives  the  stem-loop  structure  of  the 
putative  terminator  showing  both  the  translational  and  transcriptional  stops. 
The  terminator  has  an  estimated  free  energy  formation  at  250C  of  -57.0  kcal/mol, 
according  to  the  rules  of  Tinoco  et  al.,  (1973)  and  Borer  et  al.,  (1974). 
4.4  Discussion 
Low-resolution  protection  assays  using  S1  nuclease  described  in  this 
chapter  suggest  that  both  the  OtcD-ORF3  and  OtcD-ORF4  gene  products  are 
transcribed  from  a  single  message  (figure  4.7).  These  protection  assays  are  in 
agreement  with  the  predicted  direction  of  translation  using  the 
CODONPREFERENCE  program  (Devereux  et  al.,  1984).  The  promoter  otcY2pl  is 
located  immediately  upstream  of  the  OtcY2-ORF1  gene.  It  is  located  upstream 
and  reads  in  the  same  direction  as  OtcD-ORF3  and  OtcD-ORF4.  Immediately 
downstream  of  the  OtcY2-ORF1  are  the  ORFs,  OtcD-ORF1  and  OtcD-ORF2. 
These  ORFs  are  translationally  coupled  and  do  not  appear  to  contain  any 
potential  stemloop  structures  or  putative  promoter  sequences  (Thamchaipenet; 
1994).  Therefore,  it  is  presumed  that  the  following  ORFs  are  read  from  the  same 
6.2knt  transcript,  reading  from  right  to  left  on  otc  duster  map  (figure  7.1);  OtcY2- 
ORF1,  OtcD-ORF1,  OtcD-ORF2,  OtcD-ORF3  and  OtcD-ORF4.  Immediately 
downstream  of  the  OtcD-ORF4  is  a  stable  stemloop-forming  structure. 
The  region  surrounding  the  translational  stop  of  OtcD-ORF4  was 
examined  further  using  high-resolution  mapping.  The  low-resolution  S1 
mapping  showed  a  smaller  protected  fragment  than  the  expected  full  length 
control  sample.  Initial  computer  analysis  of  the  region  using  the  FOLD  and 
STEMLOOP  programs  (Devereux  et  al.,  1984),  suggested  that  there  may,  indeed, 
be  a  terminator  present.  Caution  must  always  be  taken  when  analysing  possible 
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Figure  4.7 
A  partial  transcription  map  of  the  otcX  and  otcD  region  of  the  otc  cluster  in  S. 
rimosus.  Fully-protected  fragments  are  shown  in  bold,  the  Si  nuclease  maping 
results  are  given  below,  the  direction  and  length  are  also  indicated.  Dashed  lines 
show  putative  transcripts,  the  *  indicates  termination  of  transcription. 
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terminator  structures  in  Streptomyces  mainly  due  to  the  high  G+C  content  which 
gives  an  increased  probability  of  stem-loop  predictions.  The  high-resolution 
study  revealed  a  protected  fragment  within  the  trancriptional  termination  point 
predicted  by  the  FOLD  program  (Devereux  et  al.,  1984).  The  transcription  seems 
to  end  at  a  series  of  positions  lying  within  a  few  residues  of  each  other,  rather 
than  at  a  single  nucleotide.  The  presence  of  multiple  Si  nuclease-generated  bands 
is  not  uncommon.  Deng  et  al.,  (1987)  also  found  six  clustered  bands  of  similar 
relative  intensity  in  high-resolution  experiments  in  determining  the  transcription 
termination  end  point  of  a  250  bp  fragment  of  the  pIJ101  plasmid.  Determination 
of  termination  end-points  by  Si  mapping  is  complicated  by  the  general  problem 
that  the  3'  ends  of  transcripts  are  indistinguishable  from  the  3'  ends  generated  by 
endo-  or  exonucleolytic  cleavage.  During  RNA  degradation,  specific  fragments 
accumulate  either  because  of  endonucleolytic  cleavage  or  through  stalling  of 
exonucleases  at  hairpin  structures  (reviewed  by  Higgins  and  Smith;  1986). 
Termination  of  transcription  occurs  when  the  complex  between  RNA 
polymerase  and  DNA  is  destabilised.  In  E.  coli,  RNA  polymerase  displays 
'intrinsic'  transcription  termination  activity  just  downstream  from  sites  that 
correspond  in  the  RNA  itself  to  hairpin  loop  structures  followed  by  a  stretch  of 
uridine  residues.  The  theory  of  von  Hippel  and  Yager  (1991)  suggests  that  the 
RNA  polymerase  is  destabilised  by  both  the  hairpin  structures  and  the  relatively 
weak  base  pairing  of  uridines  to  adenine  residues.  Consequently,  the  RNA 
polymerase  falls  off  the  transcription  complex.  Sequences  following  the  run  of 
dA  residues  on  the  DNA  template  may  also  play  a  role  in  termination  (Lee  et  al., 
1990),  by  influencing  either  the  unwinding  of  the  DNA  or  just  the  progression  of 
the  enzyme  along  the  molecule.  In  other  cases  the  transcription  of  RNA  is 
terminated  only  in  the  presence  of  certain  termination  factors,  such  as  the  rho 
protein  in  E.  coli,  which  act  perhaps  to  compensate  for  some  missing  structural 
element(s)  of  the  intrinsic  signal.  The  question  of  whether  the  rho  protein  is 
essential  in  all  organisms  has  been  the  subject  of  a  recent  paper  by  Opperman 
and  Richardson  (1994).  Because  transcription  can  be  terminated  intrinsically 
some  organisms  may  not  require  a  rho-type  mechanism.  A  compilation  of 
sequences  from  diverse  bacteria  such  as  Pseudomonas  fluorescens,  Chromatium 
vinosum,  Micrococcus  luteus  and  Bacillus  subtilis  (Quirk  et  al.,  1994)  has  revealed 
that  Rho  homologues  are  highly  conserved  (Opperman  and  Richardson,  1994). 
PCR  primers  were  designed  against  conserved  protein  motifs  of  rho  gene  from 
Micrococcus  luteus,  an  organism  with  a  high  G+C  DNA  content,  similar  to 
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Streptomyces  to  done  and  sequence  the  rho  homologue  in  Streptomyces  (C. 
Ingham,  unpublished  results). 
Until  the  recent  discovery  of  a  rho-like  protein  in  S  trep  tom  yces, 
transcription  termination  had  not  been  extensively  studied  in  Streptomyces.  Early 
high-resolution  S1  mapping  studies  on  various  resistance  genes  such  as  aph  and 
tsr  have  revealed  that  termination  end  points  were  located  just  distal  to  inverted 
repeats,  which  may  be  terminators  (Thompson  and  Gray,  1983;  Bibbet  al.,  1985). 
None  of  these  inverted  repeats  in  the  DNA  sequence  is  followed  by  a  run  of 
thymidines  (or  uridines  in  RNA).  The  lack  of  extensive  runs  of  uridine  was  also 
observed  in  three  terminators  located  in  the  intergenic  regions  from  the  early 
region  of  actinophage  4)C31  (Ingham  et  al.,  1994).  It  appears  to  be  more  of  a  rule 
than  an  exception  in  the  case  of  Streptomycete  terminators.  Deng  et  al.,  (1987) 
hwve_  demonstrated  that  a  205  bp  fragment  from  the  plasmid  pIJ101  has  in  vivo 
terminator  activity  in  both  S.  lividans  and  E.  coll.  In  both  organisms,  the 
termination  end  point  occurs  precisely  at  the  same  nucleotide,  as  detected  by 
high-resolution  mapping.  This  suggests  that  despite  the  absence  of  a  poly-U  tail, 
the  E.  coli  polymerase  can  recognise  the  terminator  from  a  G-C  rich  organism 
suggesting  a  common  mechanism  in  both  organisms. 
Regulation  of  transcription  of  antibiotic  biosynthetic  gene  clusters  is  a 
complicated  process  with  numerous  promoter  and  terminator  sequences. 
Within  the  otc  cluster,  a  number  of  putative  terminator  sequences  have  been 
identified.  Terminators  have  been  located  at  either  end  of  the  cluster 
immediately  following  the  antibiotic  resistance  genes.  A  third  putative 
terminator  has  also+  r  found  at  the  end  of  a  polycistronic  message  within  the 
otcY  locus.  The  otrA  terminator  has  been  analysed  by  high-resolution  S1 
mapping  and  a  termination  end  point  was  detected  immediately  after  a  large 
stem-loop  structure  (Doyle;  1987).  However,  only  computer  analysis  of  a 
potential  stem-loop  structure  was  used  as  the  basis  for  determining  the  otcY 
(Thamchaipenet;  1994)  and  otcB  terminator  sequences  (Reynes  et  al.,  1988).  A 
fourth  potential  termination  end  point  was  located  by  high-resolution  mapping 
of  the  region  following  OtcD-ORF4.  As  with  the  work  of  Deng  et  al.,  (1987)  a 
precise  end  point  could  not  be  determined,  however  a  protected  fragment  was 
observed  corresponding  to  a  termination  end-point  just  distal  to  a  very  stable 
stem-loop  structure.  Comparison  of  the  four  OTC  terminators  analysed  to  date 
is  found  in  figure  4.8.  All  have  high  free  energy  of  formation;  Otr.  a 
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-62kcal/mol;  OtcY  -65  kcal/mol;  OtcB  -54  kcal/mol  and  otcD  -57  kcal/mol.  The 
striking  similarities  found  in  all  four  tempts  one  to  suggest  that  the  mechanisms 
involved  in  termination  may  be  specific  to  the  antibiotics  they  produce.  This  is 
encouraged  by  the  alignment  of  two  tetracenomycin  terminators,  also  shown  in 
figure  4.8.  The  dissimilarity  between  the  tcm  and  otc  cluster  terminators  may 
also  be  significant.  A  closer  look  at  downstream  sequence  did  not  reveal  any 
obvious  similarities. 
Preliminary  data  from  low-resolution  Si  mapping  suggested  a  read- 
through  product  of  the  PstI-KpnI  region  of  pSRG1  (figure  4.3),  and  one  might 
expect  to  see  it  on  the  high-resolution  S1  mapping,  however  no  band  was 
detected.  This  may  be  due  to  the  conditions  used  to  run  the  gel.  A  third  low- 
resolution  experiment  to  examine  the  region  immediately  downstream,  the 
SphI-Pstl  fragment  from  pSRG9,  also  showed  no  transcript  reading  in  the  same 
direction  as  the  read-through  product.  The  size  of  the  read-through  product  was 
slightly  higher  than  the  fully  protected  fragment  and  could  easily  have  been  an 
artefact.  Within  this  region  is  also  the  OtcD-ORF5  gene.  No  transcript  was 
detected  in  RNA  isolated  from  40  hr  cultures.  A  closer  look  at  the  sequence 
reveals  a  significant  ribosome  binding  site  and  a  -10  and  -35  region  with  good 
similarity  to  the  consensus  sequences  for  Streptomyces.  Strohl  (1992),  produced  a 
consensus  sequence  of  the  -10  region  [TAg(Pu)  (Pu)T],  the  -10  sequence  of  OtcD- 
ORF5  is  TGCGAT.  The  -35  region  (TTCCAC),  is  also  in  good  agreement  with  the 
consensus  -35  region  [TTGAC(Pu)]  defined  by  Strohl,  (1992).  The  spacing 
between  the  two  regions  is  20  bp,  also  well  within  the  distance  of  the  previously 
observed  promoter  regions  in  Streptomyces.  Further  computer  analysis  of  the 
OtcD-ORF5  sequence  has  revealed  a  number  of  interesting  features.  The  very 
hydrophobic  repetitive  region  of  predicted  leucine  residues  in  the  C-terminal  half 
of  the  protein  has  some  resemblance  to  leucine  zippers,  which  are  involved  in 
DNA  binding  (Csank  et  al.,  1992).  The  spacing  of  leucines  every  fifth  amino  acid 
does  not  rigidly  conform  to  the  leucine  zipper  motif  of  every  seventh  amino  acid. 
However  secondary  structure  analysis  does  reveal  a  helix-turn-helix  in  this 
region.  Leucine  zippers  have  been  associated  with  regulatory  functions  which 
may  also  be  the  role  of  the  OtcD-ORF5  and  thus  would  explain  why  low- 
resolution  S1  mapping  showed  no  transcript.  Transcription  of  regulatory  genes 
is  generally  at  a  low  level  and  for  only  a  short  period  of  time.  The  fact  that  this 
gene  is  located  in  the  middle  of  the  cluster  may  suggest  that  it  would  be 
transcribed  in  association  with  production  of  OTC.  McDowall  (1991)  showed 
that  transcripts  originating  from  OtrApl  accounted  for  greater  than  95%  of  the 
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total  otrA  transcription  at  24  hours  but  by  32  hours  the  level  had  dropped  to  80% 
and  by  56  hours  had  dropped  to  51%.  The  transcriptional  analysis  was  further 
complicated  however  when  otrA  was  shown  to  transcribed  from  two  mRNA's 
(McDowall,  1991).  The  production  of  OTC  is  not  detected  until  late  in  the  growth 
phase,  approximately  48  hours  after  cultures  are  inoculatd  with  spores.  Further 
S1  mapping  studies  using  RNA  isolated  from  earlier  time  points  may  show  a 
transcript  in  the  OtcD-ORF5  region.  It  is  not  likely  that  this  is  a  completely 
inactive  gene, 
A  protected  fragment  was  detected  in  the  low-resolution  S1  mapping 
experiment  with  the  opposite  strand  template.  Preliminary  sequence  analysis  of 
OtcX-ORF3  shows  good  similarity  with  the  acyltransferase  of  the  daunorubicin- 
producing  C5  strain  (Ye  et  al.,  1994).  It  contains  the  'serine'  active  site  motif 
LGHSIGEM.  Since  this  is  a  converging  transcript,  a  transcriptional  terminator  is 
expected.  A  good  stem-loop  structure  has  not  been  located  but  preliminary 
sequencing  in  one  direction  has  proved  very  difficult  and  could  indicate  strong 
secondary  structures.  Sequencing  in  the  opposite  direction  usually  solves  this 
problem  but  has  not  been  carried  out  as  yet.  The  fully-protected  fragment  of  18- 
SRG9  would  indicate  that  the  transcriptional  stop-point  is  to  the  right  of  the 
PstI25  site.  No  potential  stemloops  are  seen  in  this  vicinity,  however  a  strong 
probable  RNA  stem-loop  (with  a  free  energy  formation  of  -54.0  kcal/mol)  is  seen 
approximately  200  bp  further  downstream.  If  this  were  the  case,  one  would 
expect  a  protected  fragment  of  200  bp  with  the  18-SRG1  template  (figure  4.3). 
Unfortunately  the  gel  running  conditions  used  would  not  allow  such  a  small 
fragment  to  be  seen. 
If  the  above  speculations  are  accurate,  then  the  transcript  encoding  18- 
SRG9  template  would  overlap  almost  the  entire  OtcD-ORF5  gene.  The 
translational  stop  codons  for  both  the  OtcD-ORF5  and  putative  acyltransferase 
genes  2'  b,  p  o+arf  ..  A  potential  stem-loop  within  the  putative 
acyltransferase  (with  a  free  energy  formation  of  -62kcal/mol)  is  a  possible 
termination  end-point  for  the  OtcD-ORF5  gene  product  but  again  there  would  be 
transcriptional  overlap.  Figure  4.7  shows  the  overall  transcriptional  results  of 
this  chapter.  The  analysis  here  has  shown  just  how  complicated  these  systems 
can  be.  A  number  of  experiments  are  warranted  to  help  decipher  the 
trancriptional  control.  Pinpointing  the  transcriptional  stop  of  18-SRG9  would 
initially  require  a  low-resolution  mapping  experiment  gel 
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(electrophoresis  followed  by  high-resolution  S1  mapping.  The  OtcD- 
ORF5  transcript  will  have  to  be  found  using  samples  of  total  RNA  isolated  at 
various  time  points.  It  is  possible  that  the  transcript  will  only  be  seen  very  briefly 
and  at  a  low  level.  To  show  that  all  the  potential  terminators  described  here  are 
active,  a  series  of  in  vivo  experiments  using  variations  of  promoter  probe  vectors 
are  required.  Ingham  et  al.,  (1994)  have  produced  a  vector  which  will  evaluate 
the  level  of  termination  by  preventing  the  read  through  of  a  tipA  promoter. 
These  experiments  may  help  to  clear  up  the  transcriptional  regulation  of  the  otc 
duster. 
A  repressor-like  gene  product  has  been  located  next  to  the  otrB  gene  (S. 
McGregor;  pers.  comm.  ).  It  shows  good  similarity  with  E.  coli  multi-drug 
resistance  repressors  (IS  Hunter,  pers.  comm.  ).  Sequencing  the  region  between 
the  two  c4istance  markers  is  almost  complete  and  no  'typical'  activator  has  been 
found.  The  antibiotic  clusters  studied  to  date  all  contain  regulatory  genes, 
generally  located  in  the  middle  of  the  cluster,  which  appear  to  be  pathway- 
specific  activators.  An  example  of  an  activator  is  the  actll-ORF4  gene  of  the  act 
cluster,  described  in  Chapter  1.6.  The  only  exception  is  the  negatively-regulated 
methylenomycin  (mmy)  cluster,  also  noted  in  Chapter  1.6.  More  than  one 
activator  has  also  been  located  within  the  chlorotetracycline  (CTC)  cluster  (Ryan 
et  al.,  1994).  The  location  of  the  OtcD-ORF5  gives  support  to  the  speculation  that 
it  may  be  a  variant  on  the  typical  activator  structure.  A  simple  experiment 
would  be  to  introduce  multicopies  of  the  gene  on  a  plasmid  and  look  for  an 
increase  in  OTC  levels.  Gene  knock  out  experiments  could  also  be  done  because 
preliminary  transcriptional  analysis  indicates  it  is  a  monocistronic  message.  In 
either  case,  an  answer  can  be  sought  to  test  this  theory. 
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Improving  the  Methods  of  Introducing  DNA  in  the  S.  rimosus  host 
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5.1  Introduction 
Butler  et  al.,  (1989)  reported  the  cloning  and  characterisation  of  the  DNA 
linking  the  two  otc  resistance  determinants  from  S.  rimosus.  However  the 
approach  was  very  labour  intensive.  A  cosmid  library  of  total  genomic  DNA 
was  constructed  in  E.  coli  with  the  intention  of  shunting  clones  containing  otc 
DNA  into  non-producing  S.  rimosus  mutants  to  assess  the  ability  of  the  clones  to 
complement  and  produce  oxytetracydine.  This  proved  to  be  unsuccessful  as  no 
transformants  were  obtained,  presumably  because  the  E.  coli  derived  DNA  was 
restricted  by  the  host  strain.  Consequently,  attempts  to  employ  E.  coli-type 
vectors  were  abandoned  in  favour  of  Streptomyces  vectors.  These  Streptomyces- 
based  subclones,  carrying  overlapping  fragments  of  otc  DNA,  were  passaged 
through  S.  lividans  to  avoid  the  highly-active  host  restriction  system  in  S. 
rimosus.  DNA  from  S.  lividans  was  then  transformed  into  a  restriction-minus 
strain  of  S.  rimosus  (Hunter  et  al.,  1984)  and  the  resulting  transformants  were  then 
used  to  complement  the  non-producing  mutant  strains.  The  inability  to 
transform  DNA  originating  from  E.  coli  greatly  hampers  further  characterisation 
of  the  duster.  By  understanding  more  about  the  mechanisms  of  the  S.  rimosus 
restriction  system,  we  aim  to  deliver  E.  coli  derived  DNA  into  the  S.  rimosus  host 
M4018. 
A  host  restriction/  modification  system,  by  which  exogenous  DNA  is 
degraded  efficiently,  has  been  seen  in  a  number  of  Streptomyces  species.  (Bailey  et 
al.,  1986;  Qin  et  al.,  1994).  Most  restriction-modification  (R-M)  systems  are 
composed  of  a  methylase  and  an  endonuclease.  The  methylases  catalyse  the 
addition  of  a  methyl  group  to  a  specific  sequence  of  four  or  more  bases  along  the 
host  DNA  molecule.  The  accompanying  endonuclease  will  introduce  nicks  in 
both  DNA  strands,  causing  subsequent  DNA  degradation,  to  any  unmodified 
foreign  DNA  at  or  near  this  specific  sequence  (Bickle  et  al.,  1993).  There  are  two 
different  types  of  restriction  systems:  (1)  the  classical  R-M  systems,  in  which 
cellular  DNA  is  protected  from  restriction  by  modification  through  methylation 
of  adenosyl  or  cytosyl  residues  within  the  sequences  recognized  by  the  restriction 
enzymes,  and  (2)  systems  which  cleave  only  DNA  that  carries  specific 
modifications.  In  the  latter  case,  host  cell  DNA  is  not  restricted  because  it  is  not 
modified  (Bickle  et  al.,  1993).  The  classical  R-M  systems  of  E.  coli  are  organised 
into  type  I,  II  and  III  R-M  systems  (for  a  comprehensive  review,  see  Bickle  et  al.,; 
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1993).  Type  I  R-M  systems  have  only  been  found  in  members  of  the 
Enterobacteriaceae  family  and  are  grouped  in  genetically-related  families  (Bickle  et 
al.,  1993).  The  main  enzyme  is  a  multifunctional,  multisubunit  protein  encoding 
three  structural  genes,  which  cuts  randomly  far  from  asymmetrical  recognition 
sites.  Type  II  R-M  systems  are  the  simplest,  with  two  separate  enzymes  for 
restriction  and  modification.  These  enzymes  cut  at  fixed  positions  within 
symmetrical  recognition  sites  and  have  made  them  indispensible  in  many 
branches  of  molecular  biology.  Type  III  R-M  systems  are  the  smallest  group  of 
restriction  enzymes  which  contain  two  subunits,  one  of  which,  the  mod  gene 
product,  can  function  alone  as  a  modification  methylase.  The  second,  the  res 
gene  product,  is  only  active  when  complexed  with  Mod.  The  endonuclease 
activity  of  each  of  these  R-M  systems  require  Mg2+  as  a  cofactor. 
A  second  group  of  restriction  systems,  distinct  from  the  classical  type  I,  II, 
and  III  R-M,  have  been  found  in  E.  coli.  The  classical  restriction  systems  operate 
by  recognising  and  destroying  DNA  that  does  not  carry  strain-specific 
modification.  The  second  set  of  restriction  systems  operate  specifically  on 
modified  DNA.  These  enzymes  recognise  and  cut  DNA  carrying  the  DNA 
modification  signature  of  other  strains  and,  as  a  consequence,  are  not 
accompanied  by  the  equivalent  of  a  classical  modification  enzyme.  Three  such 
systems  in  E.  coli  are:  McrA,  McrBC  and  Mrr.  The  McrBC  (for  methyl-cytosine 
restricting)  is  the  most  extensively  studied  system.  It  contains  two  genes,  mcrB 
and  mcrC  organised  in  a  operon.  The  products  of  both  genes  are  necessary  for 
restriction.  McrBC  restricts  DNA  containing  5-methyl  cytosine  (5-meC),  N4 
methyl  cytosine  (N4meC),  or  hydroxymethylcytosine  (hmC)  in  specific  sequence 
contexts.  TheMcrBC  locus  is  located  next  to  the  hsd  genes  that  code  for  the 
classical  type  I  R-M  systems,  and  another  methyl-dependent  restriction  system, 
mrr,  (restricting  both  5-meC  and  N6meA  containing  DNA),  is  located  on  the 
other  side  of  the  hsd  genes.  The  genes  for  these  three  independent  restriction 
systems  are  clustered  in  this  small  region  of  the  genome  and  have  thus  been 
dubbed  the  immigration  control  region  (Kelleher  et  al.,  1991).  The  recognition 
sequence  for  mcrBC  has  not  yet  been  defined,  but  it  seems  clear  that  the  nature  of 
the  modification  is  rather  flexible,  targets  include  R-mC,  where  "m"  is  one  of  the 
three  cytosine  modifications  and  R  is  either  adenine  or  cytosine  (Raleigh  et  al., 
1986).  The  second  locus,  mcrA,  is  located  far  away  from  the  clustered  restriction- 
modification  genes.  McrA  codes  for  a  single  polypeptide  and  restricts  only  DNA 
which  is  methylated  by  the  Hpa  II  and  Sss  I  cytosine  methylases.  The  Mrr  system 
arte  DNA  containing  methylated  by  the  HhaII  or  Pstl  modification  enzyme 
123 Chapter  5 
(Heitman  and  Model;  1987).  Both  enzymes  methylate  adenosyl  residues  at  the 
N6  methyl  adenosine  (N6meA). 
Restriction  systems  are  common  in  Streptomyces,  (Matsushima  et  al.,  1987; 
Sanchez  et  al.,  1985)  In  a  number  of  Streptomyces  species,  the  restriction  system  is 
specific  for  modified  DNA.  This  unmodified  DNA  transformed  into  these  strains 
will  be  tolerated  but  DNA  containing  either  5-methylcytosine  or  N6- 
methyladenine  will  be  restricted.  MacNeil  et  al.,  (1988),  investigated  the 
restriction  systems  of  a  number  of  Streptomyces  strains,  with  particular  emphasis 
on  the  S.  avermetilis  strain.  The  aim  was  to  characterise  the  methyl-specific 
restriction  system  of  S.  avermetilis  and  subsequently  develop  an  E.  coli  host 
which  produced  compatible  unmethylated  DNA  which  could  readily  be 
transformed  into  the  Streptomyces  host.  The  slow  growth  rates  of  most 
Streptomyces  strains  have  made  E.  coli  shuttle  vectors  an  essential  tool  in 
recombinant  DNA  technology.  Of  the  nine  Streptomyces  spp.  tested,  seven  strains 
had  methyl-dependent  restriction  systems,  including  S.  coelicolor  and  S.  lividans. 
Only  S.  avermetilis  restricted  DNA  modified  at  either  N6meA  or  5meC.  The  other 
methyl-dependent  strains  restricted  DNA  only  at  one  site,  some  proving  to  be 
more  restrictive  than  others.  S.  lividans,  although  restrictive  to  N6m  eA 
methylated  DNA,  has  a  very  weak  restriction  barrier  and  can  accept  Ecoli  DNA 
with  little  effect  on  transformation  efficiencies  and  therefore  has  become  a 
popular  Streptomyces  host. 
Transformation  protocols  have  been  optimised  for  the  genetically  well- 
characterised  strains  like  S.  lividans  and  S.  coelicolor.  However,  they  are  not 
readily  applicable  to  many  other  Streptomyces  strains.  The  transformation 
procedure  of  Thompson  et  al.,  (1982)  is  used  for  S.  lividans  and  is  also  applicable 
to  S.  rimosus.  The  varying  levels  of  transformation  efficiency  between  hosts  (>107 
for  S.  lividans  and  106  for  S.  rimosus)  has  forced  researchers  to  look  for  other  more 
efficient  means  of  genetic  transfer. 
Conjugation  is  a  highly-specific  process  whereby  DNA  is  transferred 
unidirectionally  from  a  donor  to  a  recipient  bacterium  by  a  mechanism  involving 
cell  to  cell  contact.  In  E.  coli,  the  donor  cell  usually  carries  a  self-transmissible 
plasmid  which  encodes  the  capacity  to  carry  out  the  transfer  functions.  The  tra 
itsLc,  encodes  cell  surface  components  as  well  as  mobilisation  proteins  (mob  gene 
products)  which  promote  DNA  transfer  by  interaction  with  a  cis-acting  sequence 
known  as  the  origin  of  transfer  (oriT)  (Willetts  et  al.,  1984).  Conjugation  between 
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Gram-negative  and  Gram-positive  bacteria  was  first  demonstrated  by  Trieu-Cuot 
et  al.,  (1987).  Gene  transfer  between  distantly-related  bacteria  has  been  widely 
demonstrated  (Heinemann  et  al.,  1989;  Kreps  et  al.,  1990).  Of  particular  interest  is 
the  demonstration  of  conjugation  between  E.  coli  and  Streptomyces  (Mazodier  et 
al.,  1989  and  Bierman  et  al.,  1992).  The  transfer  depended  on  the  presence  of  a 
760-base-pair,  cis-acting,  oriT-containing  fragment  and  on  RP4  (IncP)  functions 
supplied  in  trans.  The  recipient  strain  in  the  Mazodier  et  al.,  (1989)  study  was  S. 
lividans.  Bierman  et  al.,  (1992),  employed  S.  fradiae,  a  strain  that  is  notoriously 
difficult  to  transform  by  PEG-mediated  protoplast  transformation. 
Mazodier  et  al.,  (1989)  utilised  a  specially-designed  E.  col"  donor  to  transfer 
the  plasmid  pPM803  to  a  S.  lividans  host.  The  E.  coli  donor,  S17-1  (Simon  et  al., 
1983)  was  created  initially  to  demonstrate  conjugation  between  E.  coli  and  other 
Gram-negative  bacteria.  It  carries  the  transfer  functions  of  the  broad  host  range 
plasmid  RP4  to  mobilise  plasmids.  To  prevent  self-transfer  of  RP4  plasmid  into 
the  recipient,  it  was  immobilised  in  the  donor  strain  by  integration  into  the  E.  coli 
chromosome.  This  feature  is  not  essential  when  conjugating  E.  coli  and 
Streptomyces  because  the  RP4  plasmid  has  no  origin  of  replication  for 
Streptomyces.  However,  Mazodier  et  al.,  (1989)  used  this  donor  and  mobilised  the 
pPM803  into  freshly-germinating  spores  ofS.  lividans  TK24.  Exconjugates  were 
selected  by  resistance  to  neomycin  and  nalidixic  acid  (Mazodier  et  al.,  1989).  The 
neomycin  resistance  gene  was  carried  by  pPM803  and  the  natural  resistance  of 
many  Streptomyces  to  nalidixic  acid  was  used  to  counterselect  the  sensitive  E.  coli 
donor.  Bierman  et  al.,  (1992)  used  the  same  donor  and  mobilised  plasmids 
containing  the  760bp  oriT  fragment  from  the  IncP  plasmid,  RK2.  Whereas 
Mazodier  et  al.,  (1989)  used  freshly-germinating  spores  of  the  streptomycete, 
Bierman's  conjugational  recipient,  S.  fradiae,  was  prepared  from  vegetative 
mycelia.  Thus,  the  system  works  well  with  those  Streptomyces  strains  which  do 
not  sporulate  well. 
5.2  Objectives 
The  objective  of  this  chapter  was  to  characterise  the  restriction  system  of  S. 
rimosus  and  find  the  most  efficient  means  of  introducing  DNA  into  the  S.  rimosus 
host. 
The  immediate  aims  of  the  experiments  discussed  in  this  chapter  were  as 
follows: 
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i)  to  assess  three  different  methods  of  introducing  DNA  into  M4018: 
conjugation,  transformation  and  electrotransformation. 
ii)  to  determine  the  characteristics  of  the  restriction  barrier  of  S.  rimosus 
strain  M4018. 
5.3  Methodology 
Two  plasmids,  pXED3-13  and  pIJ699,  were  employed  throughout  the 
investigation  of  the  host  restriction  system  in  S.  rimosus.  Both  are  bifunctional 
plasmids,  carrying  an  origin  of  replication  for  both  Streptomyces  and  E.  coli. 
pXED3-13  (figure  5.1a)  is  a  SCP2*-based  plasmid  with  a  copy  number  of 
one  to  two  per  cell.  A  5.9  kb  fragment  of  DNA  containing  the  E.  coli  replicon,  a 
galPI  promoter  fused  to  a  xylE  reporter  gene  and  an  ampicillin  resistance  marker, 
was  inserted  "w,  the  EcoRI¬HindIII  sites  of  the  Streptomyces-based  plasmid.  The 
resulting  17.5  kb  plasmid,  contained  the  SCP2  replication  and  stability  functions 
along  with  the  thiostrepton  resistance  gene  (Ingram  et  al.,  1989).  pIJ699  (figure 
5.1b)  is  a  high-copy  number  plasmid  (40-300  copies  per  chromosome)  developed 
by  Kieser  and  Melton  (1988).  The  vector  comprises  both  an  E.  coli  (P15A)  and 
streptomycete  (pIJ101)  origin  of  replication,  separated  by  transcriptional 
terminators  from  phage  fd.  The  plasmid  is  9.6  kb  in  size  and  selectable  in 
Streptomyces  by  resistance  to  thiostrepton  and  in  E.  coli  with  kanamycin  by  virtue 
of  the  kanamycin/neomycin  phosphotransferase  gene.  The  neomycin  resistance 
gene  is  promoterless  and  is  therefore  not  functional. 
At  the  outset  of  this  investigation,  two  E.  coli  hosts  were  available,  DS941 
and  ET12567.  DS941  is  a  host  capable  of  producing  fully-methylated  DNA. 
ET12567  is  a  methylation-deficient  host;  it  is  dam::  Tn9,  dcm  -,  hsdM::  Tn10,  created 
by  MacNeil  et  al.,  (1988)  to  overcome  the  restriction  barrier  of  S.  avermetilis. 
ET12567  is  poorly  transformed  by  methylated  DNA  because  hemimethylated 
DNA  is  replicated  very  poorly  by  DNA  polymerase.  Thus,  some  transformants 
will  select  for  dam+  revertants,  selection  on  CAM  ensured  the  presence  of 
dam::  Tn9.  (MacNeil;  pers.  comm.  ). 
A  protoplast  transformation  procedure  developed  for  S.  rimosus  by  Butler 
et  al.,  (1989)  routinely  yielded  5X106  transformants/µg  of  DNA.  The 
electrotransformation  procedure  developed  by  J.  Pigac  (Pigac  and  Schrempf; 
1994)  yielded  transformation  efficiencies  of  the  order  of  5X106/µg  of  DNA.  In  all 
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Figure  5.1 
Plasmids  pXED3-13  (a)  [Ingram  et  al.  19891  and  pIJ699  (b)  [Kieser  and 
Melton;  1988)  used  in  the  investigation  of  the  S.  rimosus  restriction  system. 
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transformation  experiments,  a  duplicate  dilution  series  was  plated  out  from  100 
through  10-3.  The  average  colony  counts  were  based  on  at  least  200  colonies  per 
plate. 
5.4  Results 
5.4.1  Characterisation  of  S.  rimosus  Restriction  System 
Many  Streptomyces  spp.  restrict  methylated  DNA  originating  from  E.  coli 
hosts  (MacNeil  et  al.,  1988).  In  fully-methylated  strains  of  E.  coli,  the  dam 
methylase  converts  adenine  to  6-methyladenine  in  the  sequence  GATC  and  the 
dem  methylase  converts  the  second  cytosine  residue  in  the  sequence,  CC(A/T)GG 
to  5-methylcytosine(Sambrook  et  al.,  1989).  Therefore,  DNA  prepared  in  E.  coli, 
with  various  levels  of  methylation,  were  tested  for  their  relative  ability  to 
transform  S.  rimosus  protoplasts. 
The  efficiency  of  transformation  of  S.  rimosus  strain  M4018  protoplasts 
was  tested  with  the  high-copy  number  plasmid  pIJ699  which  had  been  isolated 
from  S.  lividans  TK24.  In  two  separate  experiments  the  average  transformation 
efficiency  was  5:  8x105  transformants/µg  DNA. 
DNA  was  isolated  initially  from  two  different  E.  coli  hosts,  DS941  and 
ET12567.  Colonies  from  the  E.  coli  strain  ET12567  were  tested  on  CAM  plates  to 
ensure  the  retention  of  the  dam::  Tn9  transposon.  The  transformation  efficiencies 
from  S.  rimosus,  of  the  high-  and  low-copy  number  plasmids,  pIJ699  and  pXED3- 
13,  were  also  tested.  Previous  experiments  had  shown  that  there  was  a  >103  fold 
difference  in  transformation  efficiency  between  high-  and  low-copy  number 
plasmids  for  strain  M4018  whereas  no  difference  was  shown  for  the  S.  lividans 
strain  TK24.  (IS  Hunter;  pers.  comm.  ). 
The  transformation  procedure  was  carried  out  as  described  in  the 
Materials  and  Methods  (section  2.2.7).  Ten  ng  of  DNA  was  transformed  into 
100µl  of  protoplasts.  The  experiment  was  done  in  duplicate  and  the  average 
numbers  of  transformants  obtained  were  recorded  in  each  case  (Table  5.1).  The 
pIJ699  plasmid  isolated  from  ET12567  transformed  with  an  efficiency 
approximately  equal  to  the  control  plasmid  pIJ699  derived  from  TK24.  No 
transformants  were  obtained  with  the  low  copy  number  plasmid.  A 
transformation  efficiency  of  less  than  102.  µg-1  would  not  be  picked  up  because 
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Plasmid  Trarsformants.  µg-1  DNA  (X1GS) 
pXED3-13  (DS941)  <1 
pXED3-13  (ET12567)  ýý 
pIJ699  (DS941)  <1 
pIJ699  (ET12567)  Qq 
pIJ699  (S.  lividans)  5,8. 
Table  5.1 
Transformation  efficiency  of  low-copy  number  plasmids  (pXED3-13)  and 
high-copy  number  plasmids  (pIJ699)  in  S.  rimosus  strain  M4018.  The  DNA 
originated  from  two  different  E.  coli  hosts;  DS941  which  produces  fully- 
methylated  DNA  and  ET12567  which  produces  methylation-deficient  DNA. 
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only  lOng  of  DNA  was  used  in  the  original  transformation  and  since  Butler  et  al., 
(1989)  found  the  transformation  efficiencies  of  SCP2*  based  plasmids  were  at 
least  100-fold  less  than  multi-copy  plasmids,  this  is  not  surprising. 
Confirmation  that  an  intact  Streptomyces  origin  of  replication  (ori)  was 
present  in  the  plasmids,  came  when  DNA's  from  all  5  plasmids  in  the  initial 
experiment  were  transformed  into  S.  lividans  TK24.  This  strain  was  chosen  as  the 
host  because  it  was  the  most  permissive  host  available.  Table  5.2  shows  that  the 
Streptomyces  on  is  functional  and  the  number  of  transformants  is  not  affected  by 
CA 
copy  number.  The  activitynthe  E.  coli  on  was  confirmed  by  transforming  the 
original  DNA  back  into  the  E.  coli  host  TGI.  (Table  5.3) 
The  transformation  efficiency  of  pIJ699  (ET12567)  into  M4018  was  slightly 
lower  than  the  control  pIJ699  (TK24)  [Table  5.1].  To  assess  if  the  restriction 
barrier  has  been  completely  removed,  a  colony  resulting  from  the  transformation 
of  pIJ699  (ET12567)  into  M4018,  was  picked  and  grown  up  in  50m1  of  YEME  to 
purify  the  DNA.  Ten  ng  of  this  DNA  was  retransformed  back  into  the  host 
M4018.  The  results  of  duplicate  transformation  experiments  revealed  an 
efficiency  of  5.75X104  trans  formants.  4g-1  DNA.  This  is  comparable  to  the 
transformation  efficiency  of  the  original  E.  coli  DNA  of  9X104  transformants.  µg-1 
DNA  (Table  5.1). 
MacNeil  et  al.,  (1988),  have  manipulated  the  E.  coli  host  strain  ET12567 
extensively  to  remove  all  it's  methylation  capacity.  This  was  required  to 
overcome  the  restriction  barrier  of  S.  avermetilis.  The  loss  of  methylation  appears 
to  carry  with  it  some  yet  further  undefined  mutations,  as  it  is  a  poor  growing 
strain  with  a  doubling  time  ca.  35  mins,  compared  to  the  average  E.  col  i  host 
doubling  time  of  20  mins  (Sambrook  et  al.,  1989). 
Two  E.  coli  strains,  GM31  and  CB51,  were  subsequently  obtained  to  test 
whether  the  S.  rimosus  host  strain  M4018  requires  completely  unmethylated 
DNA  before  being  accepted  into  the  cell.  GM31  is  a  dcm-  host  carrying  a 
mutation  in  the  gene  which  methylates  C5-cytosine,  the  internal  cytosine  residue 
is  non-methylated  in  either  of  the  following  two  sequences  CCAGG  and  CCTGG. 
CB51  (a  dam-  host)  is  also  methylation-deficient  as  no  methyl  group  is  added  to 
the  adenine  residue  in  the  5'  GATC  3'  sequence.  Both  strains  are  much  healthier 
than  the  ET12567  strain  and  exhibit  a  more  typical  growth  rate,  with  a  doubling 
time  of  ca.  20  rains.  pIJ699,  pXED3-13  and  pUC18  DNA  were  transformed  into 
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Plasmid  Transformarits.  µg-1  DNA  (X105) 
pXED3-13  (DS941)  0.95 
pXED3-13  (ET12567)  0.35 
pIJ699  (DS941)  2.1 
pIJ699  (ET12567)  1.6 
pIJ699  (S.  lividans)  5.0 
Table  5.2 
Transformation  efficiency  of  low-copy  number  plasmids  (pXED3-13)  and 
high-copy  number  plasmids  (pIJ699)  into  S.  lividans  strain  TK24.  The  DNA 
originated  from  two  different  E.  coli  hosts;  DS941  produces  DNA  which  is 
fully-methylated  and  ET12567  which  produces  DNA  which  methylation- 
deficient. 
131 Chapter  5 
Plasmid  Trans  formants.  µg-1  DNA  (X105) 
pXED3-13  (DS941)  10 
pXED3-13  (ET12567)  29 
pIJ699  (DS941)  1.2 
pIJ699  (ET12567) 
3.6 
pIBI24  (TG1) 
4.8 
Table  5.3 
Transformation  efficiency  of  low  copy-number  plasmids  (pXED3-13)  and 
high  copy-number  plasmids  (pIJ699)  in  E.  coli  strain  TG1.  The  DNA 
originated  from  two  different  E.  coli  hosts  DS941  which  produces  fully- 
methylated  DNA  and  ET12567  which  produces  DNA  that  is  unmethylated. 
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the  E.  coli  hosts  CB51  and  GM31.  Because  there  are  no  nutritional  requirements 
to  distinguish  the  two  strains,  the  DNA  was  digested  with  restriction  enzymes 
which  will  only  cleave  non-methylated  DNA.  The  restriction  enzyme  Mbol  will 
only  cut  DNA  which  is  not  methylated  in  the  5'  GATC  3'  sequence,  characteristic 
of  a  dam-  host.  EcoRII  restriction  enzyme  is  specific  for  DNA  in  which  the 
internal  cytosine  residue  of  the  dem  recognition  sites  are  non-methylated.  Figure 
5.2  illustrates  the  ability  of  the  EcoRII  and  MboI  restriction  enzymes  to  cut  the 
pUC18  DNA  isolated  from  the  CB51  and  GM31  hosts.  The  'GATC'  sequence  is 
commonly  found  in  pUC18,  MboI  cuts  this  DNA  15  times  (Sambrook  et  al.,  1989). 
pUC18  DNA  is  cut  by  the  enzyme  EcoRII  5  times.  By  comparison  with  the  uncut 
control  pUC18  DNA,  it  is  dear  that  pUC18  DNA  isolated  from  strain  GM31  is  cut 
by  EcoRII  but  not  MboI.  Similarly,  pUC18  DNA  isolated  from  strain  CB51  is 
digested  by  the  MboI  enzyme  but  remains  uncut  by  EcoRII. 
The  high  copy-number  plasmid  (pIJ699)  and  low  copy-number  plasmid 
(pXED3-13)  were  transformed  into  the  two  E.  coli  CB51,  E.  coli  GM31.  The  DNA 
was  isolated  by  the  Birnboim  Doly  protocol  and  25  ng  of  DNA  was  transformed 
into  S.  rimosus  M4018.  Two  hundred  µ1  of  the  transformation  mix  was  plated. 
Transformation  efficiencies  are  given  in  Table  5.4a,  along  with  the  transformation 
efficiency  of  the  control  plasmid  pIJ486  which  was  isolated  from  a  related  S. 
rimosus,  strain  R6.  This  was  kindly  provided  by  J.  Pigac.  The  ability  of  both  the 
high-  and  low-copy  number  plasmids  originating  from  the  dcm-  strain,  GM31,  to 
transform  M4018  suggests  that  the  methyl-dependent  restriction  occurs  at 
cytosine  residues.  Removal  of  the  methyl  groups  from  the  N6-methyladenines, 
acheived  by  isolating  DNA  from  the  dam-  strain,  had  no  affect  on  transformation 
efficiency. 
5.4.2  Electrotransformation 
Attempts  to  make  the  transfer  of  DNA  into  Streptomyces  more  efficient  and 
reliable  has  lead  to  the  development,  by  J.  Pigac,  of  a  transformation  protocol 
using  electroporation  technology.  The  cells  are  made  permeable  with  the  use  of 
electric  shocks.  The  rationale  of  the  technique  is  as  follows:  since  all  membranes 
are  charged  (negatively  on  the  outside,  positively  on  the  inside),  application  of  an 
electric  field,  by  displacing  these  charges,  leads  to  an  increase  in  the 
transmembrane  potential.  The  amplitude  of  the  potential  modulation  can  be 
monitored  by  assessing  the  intensity,  voltage,  and  duration  of  the  electric  field  as 
well  as  taking  into  account  the  diameter  of  the  cells.  Membranes  can  be 
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C¬1  (v.  C%  is  131, 
pUC18  DNA  isolated  from  the  dam-  host  CB51  and  dcm- host  GM31  verified 
with  two  restriction  enzymes  EcoRII  and  Mbol. 
a)  XHindIIl  marker 
b)  pUC18  in  CB51  uncut 
c)  pUC18  in  CB51  digested  with  EcoRII 
d)  pUC18  in  CB51  digested  with  Mbol 
e)  pUC18  in  GM31  uncut 
f)  pUC18  in  GM31  digested  with  EcoRII 
g)  pUC18  in  GM31  digested  with  Mbol 
h)  XHindIIl  marker 
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a) 
Host  DNA  Transform  ants.  µg-1  DNA  (X102) 
pIJ699  <1  E.  coli 
C  B51 
pXED3-13  <1 
E.  coli  pIJ699  470 
GM31 
pXED3-13  7 
S.  rimosus 
MV9  pIJ486  1570 
b) 
Host'  DNA  Transformants.  µg-1  DNA  (X102) 
p  IJ699  <1 
E.  coli 
CB51 
pXED3-13  <1 
pIJ699  2200 
E.  coli 
GM31 
pXED3-13  320 
S.  rimosus 
p  IJ486  10900 
MV9 
Table  5.4  Transformation  efficiencies  of  high-  and  low-  copy  number  DNA's 
from  dam  host  CB51  and  dcrri  host  GM31  by 
a)  transformation  of  protoplasts  and 
b)  transformation  of  electrocompetent  cells. 
135 Chapter  5 
reversibly  reorganised,  with  some  regions  becoming  thinner  and  pores  being 
formed.  The  diameter  of  the  pores  is  large  enough  to  allow  the  passive  transfer 
of  macromolecules  such  as  DNA.  Other  factors  which  lead  to  higher  efficiencies 
of  electrotransformation  are  the  composition  of  the  medium,  the  physiological 
state  and  concentration  of  the  cells  and  the  structure  of  the  cell  envelope.  Pre- 
treatment  with  an  enzyme  such  as  lysozyme,  can  also  increase  the  transformation 
efficiency  through  chemical  breakdown  of  the  cell  wall.  The  damage  created  in 
the  cytoplasmic  membrane  results  in  possible  death  of  the  cell.  A  delicate 
balance  between  minimal  cell  death  and  high  yields  of  transformants  is  achieved 
by  optimising  the  conditions  for  each  organism  (Doset  and  Guespin-Michel;  1993). 
J.  Pigac  optimised  the  conditions  for  S.  rimosus  R6,  as  previously  described  in 
Materials  and  Methods.  Transformants  grew  up  in  3  days  rather  than  7-10  days, 
as  seen  with  protoplast  transformations. 
Plasmids  pIJ699  and  pXED3-13  prepared  from  the  dcm-  E.  coli  host,  GM31, 
along  with  the  pIJ486  DNA  from  S.  rimosus  strain  MV9,  were  employed  to  test 
the  electroporation  technology.  Twenty-five  ng  of  DNA  from  all  three  samples 
were  mixed  with  50µl  of  electrocompetent  M4018  cells  and  electrotransformed 
under  the  conditions  described  previously.  Table  5.4b  shows  that  the  overall 
transformation  efficiency  was  approximately  1  order  of  magnitude  higher  for 
electrotransformed  cells  than  transformation  using  Aa.  plasts  (Table  5.4a).  This 
technique  has  the  double  advantage  of  10-fold  higher  efficiency  of 
transformation,  and  ability  to  pick  transformants  sooner,  in  25%  the  incubation 
time  of  protoplast  regeneration.  This  technique  was  used  routinely  in  further 
Streptomyces  transformations  described  in  Chapter  6. 
5.4.3  Conjugation 
The  ability  of  E.  coli  to  conjugate  with  Streptomyces  resulting  in  the 
unidirectional  DNA  transfer,  was  demonstrated  by  Mazodier  et  al.,  (1989).  The 
donor,  E.  coli  S17-1  with  the  integrated  RP4  tra  functions  was  used  to  mobilise 
the  pPM803  plasmid,  with  the  oriT,  into  S  lividans  TK24.  Exconjugates  were 
selected  using  neomycin  and  nalidixic  acid.  The  neomycin  resistance  gene  was 
carried  by  the  pPM803  plasmid  and  to  counterselect  the  E.  coli  donor  after 
transfer,  nalidixic  acid  was  used  because  many  of  the  Streptomyces  species  have  a 
natural  resistance.  The  1,200  exconjugates  generated  were  resistant  to  neomycin 
and  nalidixic  acid.  The  same  experiment  was  performed  in  this  laboratory,  with 
similar  results.  The  experiment  was  done  in  duplicate  and  the  presence  of  donor 
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Figure  5.3 
Restriction  digest  analysis  of  pPM803  DNA  isolated  from  E.  coil  S17-1  and  S. 
lividans  TK24. 
a)  kHindIIl  marker 
b)  pPM803/S17-1  digested  with  Pstl 
c)  pPM803/TK24  digested  with  Pstl 
d)  pPM803/S17-1  digested  with  Hin  dill 
e)  pPM803/TK24  digested  with  HindIII 
f)  pPM803/S17-1  digested  with  BclI 
g)  pPM803/TK24  digested  with  Bcll 
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plasmid  in  the  recipient  exconjugants  was  verified  by  DNA  analysis.  Restriction 
patterns  of  the  pPM803/S17-1  and  pPM803/TK24  were  identical  for  most 
enzymes.  ForBcl  I,  which  is  sensitive  to  dam  methylation,  pPM803/S1  -1  did  not 
cut,  whereas  pPM803/TK24  did  (figure  5.3).  This  proves  that  the  plasmid  had 
been  transferred  from  the  methylated  E.  coli  host  to  the  unmethylated  S.  lividans 
host. 
Attempts  to  transfer  DNA  from  E.  coli  to  S.  rimosus  by  conjugation 
initially  employed  many  of  the  procedures  of  Mazodier  et.  al.,  (1989).  The 
pPM803  plasmid  was  be  used  as  the  mobilising  plasmid  because  it  carries  the 
oriT  functions  and  is  functional  in  both  E.  coli  and  Streptomyces..  A  tetracycline 
resistance  marker  was  also  incorporated  into  the  system  to  counteract  the  small 
amount  of  tetracycline  which  could  be  produced  by  the  S.  rimosus  host.  This  was 
provided  by  the  SC101  plasmid  (Cohen  and  Chang  1973;  1977).  The  RP4 
functions  were  supplied  by  the  E.  coli  host  strain  S17-1.  As  a  control 
pPM803/S17-1  was  also  prepared  for  conjugational  transfer  into  TK24.  Spores  of 
the  Streptomyces  hosts  4018  and  TK24  were  first  induced  to  germinate  by  heat 
shock  (see  Materials  and  Methods,  section  2.2.3)  and  then  conjugated  with  the  E. 
coli  strain.  The  S17-1/TK24  plates  were  incubated  overnight  at  30°C,  the  S17- 
1/4018  plates  incubated  for  6  hours  at  30°C.  The  plates  were  washed  in  LB  and 
gently  scraped  to  remove  the  E.  coli  layer  with  the  Streptomyces  layer  still  attached 
to  the  plate.  Preliminary  experiments  showed  that  the  optimal  incubation  time 
before  removing  the  E.  coli  from  the  S.  rimosus  plates  was  in  the  range  of  6-8 
hours.  If  plates  were  left  to  incubate  overnight  (as  is  the  case  with  S.  lividans), 
flooding  the  plate  to  remove  the  E.  coli  resulted  in  the  entire  culture  of  S.  rimosus 
detaching  from  the  plate.  A  S.  rimosus  culture  incubated  for  less  time  was  still 
seen  attached  to  the  plates  after  the  removal  of  E.  coli..  Whereas  850  exconjugants 
per  plate  were  obtained  for  S.  lividans,  none  were  obtained  for  S.  rimosus. 
A  second  procedure  to  conjugate  from  E.  coli  to  Streptomyces  was 
attempted  which  involved  plating  the  donor  strain  with  mycelial  fragments  of 
the  recipient  strain  (as  described  in  Materials  and  Methods  section  2.2.9.2, 
Bierman  et  al.,  1992).  The  results  showed  that  exconjugants  were  obtained  from 
the  E.  coli/S.  lividans  matings  but  no  exconjugants  from  matings  between  E.  coli 
and  S.  rimosus.  A  control  plate  of  S.  rimosus  with  no  drug  added  showed  that  S. 
rimosus  was  able  to  grow  through  the  soft  nutrient  agar.  Therefore,  with  two 
separate  strategies  (spore  and  mycelial  recipients,  the  E.  coli  host  was  capable  of 
conjugating  with  S.  lividans  but  not  with  S.  rimosus.  This  may  however,  be 
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explained  bye  the  restrictive  nature  of  M4018  towards  hemimethylated  DNA.  In 
the  processAconjugal  transfer,  a  single  strand  of  DNA  is  transferred  from  donor 
to  recipient.  In  both  procedures  mentioned  above,  the  E.  coli  donor  carries 
modified  DNA  and  when  it  enters  the  S.  rimosus  host,  the  host  replicates  a  second 
unmethylated  strand.  The  resulting  hemimethylated  DNA  is  then  recognised  by 
the  host  and  subsequently  restricted  by  some  Streptomyces  hosts. 
A  third  conjugational  approach  taken  was  to  employ  a  donor  which 
produced  methylation-deficient  DNA  to  attempt  to  circumvent  the  restriction 
system  of  S.  rimosus.  The  E.  coli  host  S17-1  was  not  a  suitable  donor  because  it 
produced  methylated  DNA.  Therefore,  a  different  source  of  transfer  functions 
needed  to  be  supplied.  These  need  not  be  integrated  into  the  chromosome  of  the 
E.  coli  host  as  long  as  the  plasmid  carrying  the  tra  genes  did  not  also  carry  a 
Streptomyces  origin  of  replication.  A  number  of  E.  coli  strains  carrying  tra 
functions  were  kindly  supplied  by  D.  Sherratt,  Genetics  Department,  Glasgow 
University.  pDS620,  a  broad  host  range  plasmid  based  on  RP4,  seemed  most 
suitable.  However  resistance  markers  were  incompatible  with  the  pPM803 
plasmid  which  carried  the  oriT  functions.  pPM803  carries  only  the 
aminoglycoside  phoshotransferase  gene  conferring  resistance  to  neomycin.  The 
pDS620  plasmid  carries  the  kanamycin  resistance  marker,  which  also  confers 
resistance  to  neomycin,  and  therefore  the  selection  of  the  two  plasmids  in  the 
same  host  was  not  possible.  The  second  choice  was  a  IncP  plasmid  with  a 
resistance  marker  requiring  trimethoprim.  Trimethoprim  depresses  the  growth 
of  Thy+  cells,  in  the  presence  of  high  amount  of  thymine  or  thymidine. 
A  series  of  E.  coli  transformations  was  carried  out  to  produce  a  suitable 
donor.  The  fully  methylation  deficient  Ecoli  host  ET12567  (dam,  dcm-),  was  the 
only  methylation  deficient  host  available  at  the  time  of  the  initial  experiments. 
ET12567  was  therefore  the  basis  of  the  donor  strain.  The  tra  functions  were 
supplied  by  the  plasmid  DS649,  kindly  provided  to  us  by  D.  Sherratt.  DS649 
carries  the  broad  host  range  IncP  plasmid  encoding  the  tra  and  mob  functions. 
This  plasmid  also  carries  a  number  of  resistance  markers  to  facilitate  selection. 
DS649  was  transformed  into  ET12567  and  selected  by  trimethoprim  on  special 
medium,  isosensitest,  containing  a  high  concentration  of  thymine.  A 
tetracycline-resistance  marker  was  supplied  by  transforming  the  SC101  plasmid 
(Cohen  and  Chang;  1973,1977)  into  the  ET12567  host  which  also  carried  the 
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DS649  plasmid.  The  final  requirement  was  to  transform  the  pPM803  plasmid 
into  the  SC101  /DS649/ET12567  host.  The  resulting  E.  coli  donor,  was  an 
extremely  slow  growing  strain,  with  doubling  times  in  excess  of  35  minutes. 
Conjugation  experiments  were  set  up  in  parallel.  As  a  control,  the 
pPM803  plasmid  was  conjugated  to  S.  lividans  TK24  and  to  an  E.  coli  recipient 
strain,  DS801.  The  recently-constructed  p501  strain  was  mated  with  S.  rimosus 
4018,  S.  lividans  TK24  (using  mycelial  fragments  of  Streptomyces)  and  with  the  E. 
coli  recipient  strain  DS801  (See  Materials  and  Methods,  section  2.2.9,  for  E.  coli 
conjugation  procedure).  No  exconjugants  were  found  on  either  of  the 
Streptomyces  recipient  plates  employing  the  newly-constructed  donor  (Table  5.5). 
When  the  S17-1  donor  was  used  as  the  donor,  the  number  of  exconjugants  from 
DS801  was  greater  than  6X  higher  than  when  the  newly  constructed  strain  was 
the  donor.  Therefore,  if  the  E.  coli/E.  coli  conjugation,  with  the  newly 
constructed  strain  was  that  poor,  it  was  not  unexpected  that  the  Streptomyces 
conjugations  showed  no  result. 
A  second  E.  coli  host,  GM31,  was  used  for  the  conjugation  experiments. 
However,  this  host  was  no  more  efficient  as  a  donor,  than  ET12567  (Table  5.5). 
Although  the  reason  was  not  readily  apparent,  a  closer  look  at  the  compatibility 
of  the  tra  and  oriT  functions  suggested  that  this  may  be  the  problem.  All 
previous  studies  of  successful  conjugations  with  E.  coli  and  Streptomyces  has 
employed  the  S17-1  host  donor  with  the  integrated  RP4  oriT  functions.  This  was 
not  an  option  in  this  case  because  of  the  restrictive  properties  of  the  S.  rimosus 
host. 
A  third  approach  was  taken  to  try  to  employ  the  RP4  plasmid  containing 
the  oriT  in  the  strain  DS620  (D.  Sherratt).  For  this  approach,  a  second  resistance 
marker  had  to  be  engineered  into  the  pPM803  plasmid  so  it  could  be  selected 
independently  from  the  RP4  plasmid.  There  is  a  unique  KpnI  site  in  the  stability 
region  of  the  pIJ101  replicion  of  the  pPM803  plasmid.  The  gentamicin-resistance 
gene  was  removed  from  the  pGM160  plasmid  (Muth  et  al.,  1989)  and  cloned  into 
pGEM7.  The  resulting  clone,  pGEMgmr,  produced  a  1.7Kb  KpnI  cassette  which 
could  be  -,  sexi  into  the  unique  site  of  pPM803.  The  resulting  done  pSG803 
proved  to  be  structurally  unstable  and  therefore  this  approach  was  abandoned. 
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E.  coii  conjugations 
Donor  Host  Strain  Recipient  ConjugXtio 
j 
4ýiency 
1i.  c,  ton 
pPM803  S17  DS801  1.6X108  .4 
p501  ET12567  DS801  4.0X102  I`j  , 
p501  GM31  DS801  6.3X102  q.  3 
Streptomyces  conjugations 
Donor  Host  Strain  Recipient  Conjugation  ý  iency 
xconi. 
p501  ET12567  TK24  <1X102 
p501  GM31  TK24  <1X102 
p501  ET12567  M4018  <1X102 
p501  GM31  M4018  <1X102 
Table  5.5 
E.  coli  conjugations  (top  panel)  using  pPM803  and  p501  from  different  host 
strains  conjugated  to  the  recipient  strain  DS801. 
Streptomyces  conjugations  (bottom  panel)  using  the  same  donor  plasmid, 
p501  from  different  host  strains  conjugated  to  either  TK24  or  M4018. 
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5.5  Discussion 
The  advent  of  recombinant  DNA  technology  has  utilised  E.  co1i  hosts  as  the 
primary  tool  for  the  manipulation  of  DNA.  E.  coli  is  routinely  the  host  of  choice 
because  of  rapid  growth  rates  and  simple  DNA  isolation  techniques. 
Unfortunately  it  is  not  possible  to  transfer  DNA  isolated  in  E.  coli  into  most 
Streptomyces  species  because  of  the  restrictive  nature  of  the  recipients.  Methyl- 
specific  restriction  has  been  found  in  a  number  of  Streptomyces  species  (Table 
5.6). 
Three  other  bacteria,  E.  coli  (Raleigh  et  al.,  1989)  Acholeplasma  laidlawii 
(Sladek  et  al.,  1986)  and  Bacillus  thuringiensis  (Macaluso  et  al.,  1991)  are  known  to 
restrict  DNA  containing  5-methylcytosine  with  little  or  no  sequence  specificity. 
In  E.  coli,  two  distinct  genetic  loci  have  been  identified  which  encode  genes 
controlling  the  restriction  of  DNA  containing  5-methylcytosine,  mcrBC  and  mcrA. 
In  A.  laidlawii,  DNA  modified  with  any  of  five  5-methylcytosine-specific 
methylases  was  restricted,  but  no  sequence  specificity  was  found  (Sladek  et  al., 
1986).  Bacillus  thuringiensis  is  restrictive  to  DNA  containing  either  N6meA  or  5- 
meC  (Macaluso  et  al.,  1991).  This  is  very  similar  to  the  Streptomyces  spp.,  S. 
avermetilis  (MacNeil  et  al.,  1988). 
For  direct  introduction  of  shuttle  vectors  from  E.  coli  hosts  into 
Streptomyces,  the  DNA  must  be  isolated  from  a  non-methylating  host.  With  B. 
thuringiensis  poor  transformation  efficiencies  lead  to  the  investigation  into  the 
importance  of  DNA  modifications.  Results  confirmed  that  DNA  isolated  from  a 
dam-  dcm-  E.  coli  host  gave  a  500  to  1,000-fold  increase  in  transformation 
efficiency  over  fully  methylated  DNA.  The  source  of  the  plasmid  DNA  was 
especially  important  for  larger  plasmids  as  the  larger  plasmids  might  have  more 
sites  subject  to  modification  and  therefore  more  susceptible  to  restriction  by  B. 
thuringiensis.  In  S.  avermetilis,  plasmids  with  only  1-3  methylated  bases  per 
molecule  were  restricted  only  about  10-fold,  however  those  plasmids  with  more 
than  10  sites  were  restricted  greater  than  1000-fold  (MacNeil  et  al.,  1988).  When 
modified  DNA  was  introduced  into  S.  avermetilis  no  transformants  were 
obtained.  This  indicates  that  the  decrease  in  transformation  efficiency  is  greater 
than  106.  Similarly,  when  fully  modified  DNA  was  introduced  into  S.  rimosus 
4018  no  transformants  were  obtained  (Table  5.1).  This  indicates  a  drop  of 
transformation  efficiency  of  greater  than  105.  The  restriction  barrier  of  S.  rimosus 
was  circumvented  by  a  number  of  hosts.  DNA  isolated  from  a  relatively 
permissive  Streptomyces  host  like  S.  lividans  or  an  E.  coli  host  which  lacks  the  dem 
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Streptomyces  sp.  dam  (GmATC)  dem  (CCA/TGG) 
S.  avermitilis  ++++  +++ 
S.  bikiniensis 
S.  coelicolor  ++ 
S.  fervens 
S.  lividans  + 
S.  parvulus  +++ 
S.  rimosus  +++ 
Table  5.6 
Commonly  used  Streptomyces  species  and  their  methyl-specific  restrictive  nature. 
The  number  of  (+)  indicate  the  relative  restrictive  nature.  The  list  was  compiled 
from  data  taken  from  MacNeil  et  al.  (1988). 
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methylase  gene  gave  very  similar  efficiencies  of  transformation  to  that  of  DNA 
isolated  from  S.  rimosus.  The  E.  coli  hosts  capable  of  circumventing  the  restriction 
barrier  of  S.  rimosus  all  carried  a  mutation  in  the  dem  methylase  gene. 
E.  coli  has  two  methylase  systems  which  do  not  carry  an  accompanying 
restriction  endonuclease,  and  therefore  do  not  belong,  sensu  stricto,  to  the 
restriction-modification  processes,  these  are  the  DNA  adenine-methylation  (dam) 
and  the  DNA  cytosine-methylation  (dcm)  systems.  Mutations  in  these  two  genes 
have  allowed  the  study  of  the  role  of  these  enzymes  in  the  biology  of  E.  coli.  Dam 
methylation  has  been  shown  to  play  a  role  in  the  repair  of  DNA  mismatches 
(Modrich;  1989).  Dam  methylates  the  adenine  in  the  N6  position  of  the  sequence 
'GATC'.  This  methylation  occurs  shortly  after  the  DNA  strand  is  synthesised.  As 
a  result,  the  DNA  close  to  the  replication  fork  remains  hemi-methylated  for  a 
short  time.  This  allows  the  mismatch  repair  system  to  discriminate  between  the 
template  and  daughter  strand.  The  dam  methylation  proceeds  shortly  after  the 
mismatch  repair  system.  In  strains  with  a  mutation  in  the  dam  gene,  both  strands 
are  unmethylated  and  the  repair  system  can  not  distinguish  between  the  nascent 
and  daughter  strands.  The  repair  system  still  functions,  however  repair  occurs 
on  either  strand  and  as  a  result  dam  strains  have  an  increased  spontaneous 
mutation  rate  (Marinus  et  al.,  1975).  Other  functions  of  the  dam  gene  involve  the 
regulation  and  co-ordination  of  several  other  cellular  processes,  along  with 
providing  a  mechanism  for  coupling  gene  expression  to  the  cell  cycle. 
The  biological  functions  of  the  dem  gene  are  slightly  more  elusive. 
Originally,  the  only  phenotype  observed  in  dem  mutants  was  the  susceptibility 
of  IncN  plasmids  to  restriction  by  EcoRII  (Hattman;  1977).  There  is  evidence  that 
EcoRll  and  dem  methylases  may  have  been  common  ancestors  as  there  is  good 
sequence  similarity  (Lauster  et  al.,  1989)  and  they  are  functionally  very  similar. 
The  dem  gene  methylates  the  inner  cytosine  residue  of  the  sequence  CCA/TGG. 
5-methyl  cytosine  is  more  unstable  than  cytosine  and  the  deamination  results  in 
the  formation  of  thymine/guanine  mismatches.  If  not  repaired  correctly  before 
replication,  C-to-T  transitions  occur.  The  repair  system  which  recognises  and 
repairs  T:  G  mismatches  has  been  termed  very  short  patch  (vsp)  repair  (Lieb; 
1987).  The  dem  gene  was  originally  thought  to  be  involved  directly  along  with 
the  mutL  and  mutS  gene  products  (Lieb  et  al.,  1988).  Recent  studies  of  the  cloned 
dem  gene  and  surrounding  region  have  identified  that  the  gene  product  of  vsr  is 
responsible  for  the  Vsp  repair  and  not  the  overlapping  dem  gene  (Sohail  et  al., 
1990.  )  It  therefore  remains  unclear  what  the  function  of  the  dem  gene  is.  It  is 
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possible  that  recombination  events  between  the  IncN  plasmid  and  the 
chromosome  may  have  occurred  and  the  dem  gene  has  no  real  purpose  at  all. 
However,  there  is  evidence  that  a  dem  recognition  sequence  within  a  promoter 
region  may  be  under  the  regulation  of  dem  methylation,  as  in  the  case  of  the  lexA 
gene  (Miki  et  al.,  1981).  Ringquist  and  Smith  (1992)  also  showed  that  some  dem 
sites  remain  unmethylated  in  dcm+  strains  suggesting  that  these  sites  are 
protected  by  DNA  binding  molecules  or  changes  in  DNA  topology. 
DNA  prepared  from  the  E.  coli  host  GM31,  which  is  deficient  in  cytosine 
methylation,  is  able  to  overcome  the  restriction  barrier  of  S.  rimosus  M4018.  The 
status  of  the  methylation  at  the  dam  sites  has  no  influence  on  transformation 
efficiency  of  DNA  into  S.  rimosus.  This  was  outlined  by  the  similar 
transformation  efficiencies  of  both  the  ET12567  (dam  -,  dem  -)  strain  and  the  GM31 
(dcm  -)  strain  (Tables  5.1  and  5.4a).  The  evolutionary  differences  in  methylation 
deficient  DNA  requirements  for  various  Streptomyces  hosts  may  be  the  result  of 
their  natural  competitive  soil  envirnoment  and  that  the  expression  of  varied  and 
multiple  restriction  systems  might  give  an  advantage  in  survival  This  is 
exemplified  by  the  S.  fradiae  strain.  This  strain  contains  at  least  five  restriction 
systems  that  protect  it  from  bacteriophage  infections  (Matsushima  et  al.,  1987). 
The  total  number  of  restriction  systems  has  not  been  explored  with  S.  rimosus. 
This  could  easily  be  tested  by  transforming  DNA  into  S.  rimosus  which  had  been 
modified  in  vitro  with  various  methylases.  This  experiment  was  not  performed 
because  for  our  purposes  this  is  not  significant  as  the  dam-  strain  GM31  is  capable 
of  circumventing  the  restriction  of  S.  rimosus. 
Transformation  of  protoplasts  using  polyethyleneglycol  (PEG-mediated) 
protoplasting  has  been  the  established  way  of  introducing  DNA  into  the  some  of 
the  best-characterised  Streptomyces  strains  (Hopwood  et  al.,  1985).  Although  this 
method  of  transformation  is  generally  applicable,  it  is  necessary  to  establish  the 
optimal  conditions  of  growth,  of  formation  of  protoplasts  and  for  regeneration  of 
protoplasts.  The  transformation  of  the  fragile  protoplasts  is  tedious,  time- 
consuming  and  frequently  not  reproducible. 
Transformation  by  electroporation  has  been  rendered  possible  for  several 
Gram-negative  (i.  e.  E.  coli,  Dower  et  al.,  1988;  P  aeruginosa,  Diver  et  al.,  1990)  and 
Gram-positive  bacteria  (i.  e.  B.  lactofermtum  Bonnassie  et  al.,  1990;  Streptococcus, 
Powell  et  al.,  1988).  The  first  attempt  to  electroporate  S.  lividans  was  made  by 
MacNeil  (1987).  However  it  was  less  efficient  than  PEG-mediated 
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transformation.  The  conditions  for  the  S.  rimosus  strain  R6  has  been  optimised  by 
Pigac  and  Schrempf  (1994).  These  conditions  are  readily  applicable  to  S.  rimosus 
4018  except  that  a  greater  concentration  of  lysozyme  is  required  for  4018 
(100µg/ml  for  R6  vs.  400µg/ml  for  4018).  By  comparison  to  the  transformation 
efficiency  of  pIJ486  into  S.  rimosus  4018  in  Table  5.4  (a&b),  there  is  a  ten-fold 
increase  using  the  electrotransformation  procedure  over  transformation  of 
protoplasts.  The  consistent  drop  in  transformation  efficiency  of  low-copy 
number  plasmids  over  high-copy  number  plasmids  is  intriguing  as  this  is  not  the 
case  with  the  S.  rimosus  R6  strain  U.  Pigac;  pers.  comm.  ).  This  however,  may 
well  be  just  one  of  the  properties  which  differentiates  the  two  strains.  For  S. 
rimosus  this  new  technology  has  proved  to  be  considerably  more  rapid, 
reproducible  and  approximately  10  times  more  efficient  than  PEG-mediated 
transformation.  Although  conditions  for  all  of  the  commonly  used  Streptomyces 
strains  have  not  been  set,  it  is  a  good  advance  in  recombinant  technology. 
Conjugation  systems  have  been,  in  general,  used  less  than  other  methods 
of  gene  transfer  in  recombinant  DNA  studies.  However,  there  are  practical 
advantages  to  using  conjugation  systems,  (i.  e.  to  overcome  restriction  barriers  in 
gene  transfer  and  allow  for  genetic  manipulation  of  microbial  species  which  are 
considered  to  be  intractable  to  genetic  manipulation).  Until  recently,  it  had  been 
assumed  that  conjugal  transfer  was  restricted  to  closely-related  species. 
Conjugation  has  been  very  successful  in  promoting  diverse  gene  exchanges  (i.  e. 
E.  coli  to  Entercoccus,  Bacillus,  Listeria  Streptococcus,  and  Staphlococcus,  Trieu-Cuot 
et  al.,  1987).  An  important  factor  in  this  success  is  likely  to  be  the  replicative 
transfer  of  single-stranded  DNA  during  conjugation.  Single-stranded  DNA  is 
known  to  be  refractory  to  most  restriction  systems,  thus  the  transfer  of  single- 
stranded  DNA  during  bacterial  conjugation  may  escape  digestion  the  restriction 
systems  of  the  recipient.  The  conjugal  transfer  of  DNA  between  E.  coli  and  S. 
lividans  was  successful  for  a  number  of  reasons.  As  Streptomycetes  germinate 
they  extend  by  hyphal  growth.  The  newly-formed  cell  wall  may  be  more 
competent  to  take  up  DNA.  The  restriction  system  of  S.  lividans  is  a  relatively 
weak  one  and  can  accept  methylated  DNA  with  only  a  slight  decrease  in 
efficiency  of  transformation.  Successful  conjugation  may  also  be  attributed  to 
this  relatively  weak  restriction  system.  This  is  not  the  case  withS.  rimosus.  An 
initial  experiment  to  test  the  pPM803  plasmid  in  the  S17-1  E.  coli  host  (with  a 
tetracycline  resistance  marker  to  protect  against  the  production  of  both  OTC  and 
TC  by  the  M4018  strain)  did  not  result  in  any  exconjugants.  This  may  be 
explained  by  the  relatively  strong  restriction  system  of  S.  rimosus.  Initial  hopes 
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that  the  replicative  transfer  of  single-stranded  DNA  would  escape  restriction 
were  dashed.  C.  Smith  (1992),  demonstrated  that,  although  full},  methylated 
single-stranded  DNA  could  be  transformed  into  S.  coelicolor,  it  was  at  a  much 
reduced  effiency,  a  2X105  reduction  compared  with  a  double-stranded  S. 
coelicolor-derived  plasmid,  pIJ101.  Unmethylated  single-stranded  DNA,  on  the 
other  hand,  produced  a  transformation  efficiency  only  103  fold  lower  the  double- 
stranded  DNA  control,  pIJ101.  When  single-stranded  DNA  enters  the  cell  it  is 
replicated  into  double-stranded  hemi-methylated  DNA  and,  based  on  Smith's 
results,  is  then  subject  to  restriction. 
Plasmids  pPM803,  SC101  and  pDS649  (p501)  were  transformed  into 
ET12567  (dam-,  dcm-)  in  an  attempt  to  resolve  the  possible  hemimethylation 
problem.  The  single-stranded  DNA  to  be  transferred  would  be  unmethylated 
and  as  a  result,  the  double-stranded  DNA  produced  by  host  replication,  would 
not  be  susceptible  to  restriction  in  S.  rimosus.  This  strain  was  a  very  slow 
growing  strain,  with  doubling  time  of  ca.  35  mins.  This  combination  of  plasmids 
in  the  ET12567  E.  coli  host  has  proved  not  to  be  a  successful  combination  for 
conjugation  into  Streptomyces.  The  host  of  choice  has  to  be  the  highly  efficient 
S17-1  strain  with  the  integrated  RP4  plasmid.  Unfortunately  the  RP4  plasmid, 
available  to  the  lab,  carried  similar  antibiotic  markers  to  the  pPM803  plasmid 
which  made  selection  of  both  plasmids  in  the  same  host  inconvenient.  An 
attempt  to  insert  a  selectable  antibiotic  marker  in  a  unique  KpnI  site  in  the 
pPM803  plasmid  resulted  in  a  structurally  unstable  vector  (data  not  shown). 
Data  from  Mazodier  et  al.,  (1989)  and  Bierman  et  al.,  (1992)  on  different  protocols 
for  conjugal  transfer  between  E.  coli  and  Streptomyces  have  both  employed  the 
S17-1  host,  with  the  integrated  transfer  functions,  suggesting  it  was  an  important 
factor  in  the  process.  However  this  is  may  not  be  the  case  as  recent  publication 
by  Matsushima  et  al.,  (1994)  successfully  employed  a  RP4  (RK2)  plasmid, 
carrying  the  transfer  functions,  to  conjugate  DNA  from  E.  coli  to  Saccharopolyspora 
spinosa.  Buchanan-Wollaston  et  al.,  (1987),  showed  that  the  mob  and  oriT 
functions  of  the  broad-host  range  IncQ  plasmid  RSF1010  mediate  the  transfer  of 
plasmids  from  Agrobacterium  spp.  into  plant  cells.  The  broad-host  range  plasmid 
pRK2  (IncP)  was  unsuccessful  however,  in  similar  tests  of  transfer.  Trieu-Cuot  et 
al.,  (1991)  also  demonstrated  that  the  transfer  of  IncP  plasmids  and  some  shuttle 
vectors  were  acutely  sensitive  to  restriction  by  some  type  II  R-M  systems. 
Conversely,  effective  transmission  of  F-related  plasmids  is  relatively  resistant  to 
type  I  restriction  (Boyer;  1971).  To  determine  the  specific  broad-host  range 
plasmids  which  allow  the  transfer  of  DNA  to  S.  rimosus  may  be  a  question  of 
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trial  and  error  as  it  appears  that  not  all  broad-host  range  plasmids  are  compatible 
with  the  recipient's  restriction  systems.  The  use  of  heat  or  UV  irradiation  on  the 
recipient  S.  rimosus  may  destroy  the  restriction  system  and  may  then  promote 
conjugation.  Heat  was  used  successfully  to  increase  the  viability  of  conjugation 
of  corynebacteria  with  Ecoli  (Kreps  et  al.,  1990). 
Therefore,  at  this  time,  conjugation  does  not  appear  to  be  a  viable  option 
for  the  genetic  transfer  of  DNA  from  E.  coli  to  S.  rimosus  due  mainly  to  the 
restriction  barrier  of  the  Streptomyces  host.  The  improved  transformation 
effic4*e-n&týs  of  DNA  isolated  directly  from  an  E.  coli  host,  which  carries  a  mutation 
in  the  dem  gene,  are  a  result  of  overcoming  the  methyl-specific  restriction  barrier 
of  the  S.  rimosus  host.  This  was  further  advanced  with  electrotransformation,  a 
new  technique  in  the  Streptomyces  field.  This  will  prove  to  be  a  valuable  asset  in 
further  genetic  characterisation  of  the  S.  rimosus  chromosome. 
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Disruption  of  a  Putative  Ketoreductase  Gene  in  the  otcCluster 
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6.1  Introduction 
DNA  sequencing  of  the  otc  cluster  has  revealed  a  number  of  open  reading 
frames  (ORFs).  By  comparing  the  deduced  peptide  sequences  of  these  ORFs  with 
a  database  (e.  g.  Genbank),  functions  of  some  genes  can  be  assigned  based  on  a 
substantial  degree  of  similarity  with  other  gene  products  of  known  function. 
Whether  these  gene  products  are  catalytically  active  however,  has  not  been 
addressed  formally.  Therefore,  most  of  the  ORFs,  of  known  function,  in  the  otc 
cluster  have  been  assigned  in  this  way.  The  most  notable  exception  is  the  gene 
encoding  ATC  oxygenase,  which  through  enzyme  assays,  was  assigned  to  the 
otcC  gene  by  Binnie  et  al.,  (1989),  using  'reverse  genetics'.  They  first  purified  the 
ATC  oxygenase  protein  from  which  N-terminal  amino  acid  sequence  was 
obtained.  Oligonucleotide  probes  were  constructed  based  on  the  protein 
sequence  and  used  to  detect  the  corresponding  fragment  of  chromosomal  DNA 
from  S.  rimosus,  which  was  then  cloned.  Hence,  the  gene  function  assigned  is 
known  to  be  active,  as  it  has  been  transcribed  into  protein.  Another  way  to 
deduce  the  function  of  various  genes  in  the  otc  pathway,  using  a  molecular 
biological  approach,  is  through  gene  disruption  and  replacement.  A  schematic 
representation  of  gene  disruption  is  outlined  in  figure  6.1.  The  gene  to  be 
targeted  is  initially  disrupted  by  inserting  a  selectable  antibiotic  resistance 
marker  within  the  sequence  of  the  gene.  The  disrupted  gene  can  be  introduced 
into  a  wild  type  cell  through  one  (or  two)  'Campbell-type'  homologous 
recombination  events  (Chater  and  Bruton;  1983).  Replacement  of  the  wild-type 
sequence  with  the  disrupted  gene  and  selectable  marker  requires  two  crossover 
events.  A  single  crossover  event  results  in  the  incorporation  of  the  the  disrupted 
gene,  selectable  marker  and  shuttle  vector  sequence  into  the  streptomycete 
chromosome.  Results  of  both  single  and  double  crossover  events  (figure  6.6) 
disturb  all  downstream  transcription.  A  second  replacement  event  (a  double 
crossover),  is  required  to  introduce  a  copy  of  the  target  gene  carrying  an  in-frame 
mutation  so  that  all  downstream  transcription  is  restored.  At  this  point,  the 
build  up  of  metabolites  produced  by  the  mutant  strain  can  be  analysed 
chemically  and  the  role  of  the  target  gene  deduced. 
There  are  many  approaches  to  targeted  gene  disruption.  MacNeil  et  al., 
(1989)  constructed  a  non-replicating  suicide  vector  which  carries  the  origin  of 
replication  in  E.  coli  but  not  in  Streptomyces.  The  aim  is  to  force  the  plasmid  to 
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S.  rimosus 
gene  A  chromosome 
Disrupted  Gene  A 
gmr  , 
X 
gene  A* 
Y 
Mutant  A  gene 
with  an  'nframe' 
deletion 
I  gmrs  tsrS  S.  rimosus 
chromosome  with  a 
mutant  gene  A 
gene  A* 
Figure  6.1 
A  schematic  representation  of  the  strategy  for  integration  into  S.  rimosus 
chromosome  employing  the  gentamicin  resistance  (gmr)  gene. 
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integrate  into  the  streptomycete  chromosome  in  order  to  survive.  Homologous 
regions  flanking  the  disrupted  target  gene  are  first  cloned  out  of  the  duster  into 
the  plasmid.  It  is  the  homologous  flanks  of  wild-type  DNA  that  allow  the 
'Campbell-type'  recombination  event  to  occur.  Suicide  vectors  have  had  great 
success  with  numerous  Streptomyces  strains  (Khosla  et  al.,  1992;  Richardson  et  al., 
1990;  MacNeil  et  al.,  1989).  Variations  on  this  theme  include  the  use  of 
integration  vectors  in  the  single  stranded  form.  Hillemann  et  al.,  (1991)  found 
that  although  there  was  very  little  difference  in  transformation  frequency 
between  double-stranded  and  single-stranded  DNA,  when  a  plasmid  capable  of 
replicating  in  Streptomyces  was  used,  the  integrative  transformation  was  10-100 
times  more  efficient  when  the  vector  (carrying  no  Streptomyces  origin  of 
replication)  was  in  the  single-stranded  DNA  form.  It  has  been  observed  in 
various  bacteria,  that  integration  via  homologous  recombination  is  greatly 
facilitated  by  the  presence  of  single-stranded  DNA  (Lewin;  1994). 
A  second  commonly-used  approach  to  gene  disruption  is  by  introducing  a 
replicating  plasmid  into  the  host  chromosome.  This  plasmid  will  carry  the 
Streptomyces  origin  of  replication,  which,  when  introduced  into  the  host,  confers 
the  ability  to  replicate.  After  recombination  events  between  the  plasmid  and 
chromosome  occur,  the  plasmid  must  be  removed  from  the  cell  before  DNA 
analysis,  since  non-integrated  plasmids  contain  the  intact  mutant  gene.  Various 
methods  for  segregating  the  replicating  plasmid  from  the  cell  have  been  cited. 
Anzai  et  al.,  (1988)  cured  S.  hygroscopicus  cells  of  the  plasmid  pIJ702  by 
regeneration  of  protoplasts  in  the  absence  of  drug.  Weber  et  al.,  (1988)  employed 
the  plasmid  pIJ702  and  found  that,  although  it  was  maintained  stably  in  S. 
lividans  and  S.  coelicolor,  it  was  unstable  in  Sac.  erythraea,  being  maintained  poorly 
in  mycelia  and  excluded  almost  totally  from  the  spores.  A  third  example  of 
plasmid  displacement  employed  the  temperature-sensitive  replicating  plasmid 
pSG5  (Muth  et  al.,  1989).  The  replicon  is  inherited  stably  at  temperatures  below 
340C,  but  is  lost  at  incubation  temperatures  above  this.  Blanco  et  al.,  (1992)  were 
able  to  integrate  exogenous  DNA  into  the  chromosome  of  S.  halstedii  using  the 
temperature-sensitive  replicon. 
It  is dear  that  gene-disruption  experiments  have  been  carried  out  on  many 
Streptomyces  species  and  each  is  unique  to  a  specific  strain.  A  number  of 
strategies  have  been  considered  with  respect  to  S.  rimosus.  A  low  copy-number 
vector  was  not  feasible  because  of  the  inexplicable  drop  in  transformation 
efficiency  with  low-copy  number  vectors  compared  with  high-copy  number 
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vectors  (See  Chapter  5).  Two  genes  in  the  otcY  locus  were  disrupted  successfully 
in  the  S.  lividans  TK24  host  which  carried  the  entire  otc  cluster  (plasmid 
pGLW101).  However,  attempts  using  a  high-copy  number,  E.  coli  replicating 
vector  pIBI24,  as  a  suicide  integration  vector  in  S.  rimosus  were  unsuccessful 
mainly  because  the  recombination  efficiency  was  not  high  enough  to  produce 
any  transformants  (Thamchaipenet;  1994).  A  reasonable  frequency  of  double- 
crossover  recombinants  produced  in  the  S.  lividans  host  was  obtained,  all  of 
which  were  unable  to  produce  OTC.  Despite  the  convenience  and  ease  of 
integration  in  S.  lividans,  this  species  produces  other  antibiotics  such  as 
actinorhodin,  and  thus  must  express  similar  gene  products  to  those  disrupted  in 
the  otc  duster,  namely  the  keto-reductase  and  cydase  genes.  Interpretations  of 
these  integration  experiments  were  difficult  as  any  intermediates  and/or  shunt 
products  produced  from  these  disruptants  could  be  the  result  of  'crossfeeding' 
between  the  otc  and  actinorhodin  pathways.  Temperature-sensitive  plasmids 
were  also  not  appropriate  because  when  S.  rimosus  is  subjected  to  temperatures 
above  340C,  the  organism  does  not  produce  oxytetracycline  (Hunter  pers. 
comm.  ).  Therefore  the  data  from  disruptants  made  in  this  way  would  be  difficult 
to  interpret.  The  more  plausible  strategies  involve  the  use  of  replicating 
plasmids  and  subsequent  plasmid  loss  after  integration.  These  techniques  were 
looked  at  more  closely  and  are  the  subject  of  this  chapter. 
The  stability  of  the  Streptomyces  pIJ101-based  plasmids  was  investigated 
based  on  the  strategy  of  the  gene  disruption  experiments  carried  out  by  Weber  et 
al.,  (1988).  pIJ702,  in  particular,  appears  to  show  signs  of  instability  when 
inherited  in  Sac.  erythaea,  but  not  in  other  strains.  The  ability  of  pIJ702  and  two 
other  pIJ101-based  plasmids  to  be  maintained  stably  in  S.  rimosus  was  explored 
as  a  possible  basis  for  constructing  an  integration  vector  for  the  disruption  of 
OtcD-ORF3,  a  putative  'reductase'  gene,  in  the  otc  cluster.  The  sequence  and 
deduced  function  of  OtcD-ORF3  were  described  in  Chapter  3. 
pIJ101  is  the  parent  of  many  of  the  vectors  used  in  Streptomyces.  Its 
derivatives  range  in  copy  number  from  40-300  and  the  nucleotide  sequence  has 
been  determined.  Currently  more  is  known  about  the  biology  of  pIJ101  than  any 
other  Streptomyces  plasmid  (Kendall  et  al.,  1988).  Replication  of  pIJ101  is  thought 
to  occur  by  a  rolling-circle  mechanism  via  a  single-stranded  DNA  intermediate 
(Pigac  et  at.,  1988;  Gruss  et  at.,  1989).  The  essential  features  of  this  mode  of 
replication  are  (i)  an  origin  of  plus-strand  synthesis,  (ii)  a  replication  protein  (rep) 
which  interacts  with  the  plus  origin  to  generate  a  nick  which  allows 
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displacement  synthesis  of  the  plus  strand  to  occur,  and  (iii)  a  signal  for  efficient 
conversion  of  the  single-stranded  to  the  double-stranded  form  (Devine  et  al., 
1989).  The  sequence  of  the  active  site  of  the  Rep  protein  of  pIJ101  is  similar  to 
those  found  in  several  other  plasmid-encoded  Rep  proteins  which  bind  to  pC194- 
like  plus  origins  (Zaman  et  al.,  1993b). 
Deng  et  al.,  (1988)  identified  a  non-coding  region  of  pIJ101  DNA,  called  sti, 
which  causes  strong  incompatibility  when  present  in  its  natural  orientation  with 
respect  to  the  basic  replicon.  A  pair  of  plasmids  can  co-exist  in  the  same  host  if 
they  both  possess  sti  in  the  correct  orientation  (Sti+),  or  both  possess  sti  in  the 
reverse  orientation  (Stine')  or  both  lack  sti  (Sti-).  Sti+  and  Sti-  plasmids  cannot  co- 
exist  in  the  same  cell:  if  they  occur  together,  the  Sti+  plasmid  is  retained  while 
the  Sti-  plasmid  is  eventually  lost.  Sti-  plasmids  accumulate  more  ssDNA,  the 
presumed  intermediates  in  plasmid  replication,  than  Sti+  plasmids,  implicating 
sti  as  the  site  where  synthesis  of  the  second  strand  is  initiated.  The  primary  site 
for  second-strand  initiation  has  been  identified  as  a  0.53  kb  Spe1-SstII  fragment  in 
the  pIJ101  plasmid  (Zaman  et  al.,  1993).  It  is  contained  within  a  1.2  kb  Bcll-Bc1I 
region  of  the  pIJ101  plasmid  which  encodes  sti:  cop/korB.  Deng  et  al.,  (1988) 
suggested  that  Cop,  a  protein  which  is  encoded  by  a  gene  adjacent  to  sti  is  a 
trans-acting  negative  regulator  which  decreases  the  copy  number  of  Sti+  plasmids 
by  inhibiting  the  initiation  of  second-strand  synthesis  at  sti.  Mapping  studies 
indicate  that  cop  occupies  the  same  region  on  pIJ101  as  another  characterised 
gene  called  korB  (Kendall  et  al.,  1988).  KorB  represses  the  transcription  of  kilB,  a 
gene  necessary  for  normal  intra-mycelial  plasmid  transfer  (Kendall  et  al.,  1987; 
Stein  et  al.,  1989;  Stein  et  al.,  1990;  Zaman  et  al.,  1992). 
The  three  plasmids  in  this  study,  pIJ702,  pIJ486  and  pIJ680  (figure  6.2),  all 
contain  the  2.0  kb  BaII-SstII  region  of  pIJ101  found  to  be  essential  for  maintenance 
and  replication  in  Streptomyces  (Zaman  et  al.,  1993a).  However,  other  important 
regions  of  the  pIJ101  plasmid  are  missing  (figure  6.2).  These  include  the  region 
encoding  sti:  cop/korB.,  the  kilB  region  and  another  region  located  between  sti: 
cop/korB.  and  the  essential  region.  Kieser  et  al.,  (1982),  have  found  that  this  0.5  kb 
region  is  necessary  for  stable  inheritance.  Plasmids  with  deletions  in  this  region 
are  markedly  unstable  (ranging  from  13%-55%  loss  after  one  round  of  growth  on 
antibiotic-free  media).  A  FRAME  plot  (described  in  Chapter  3),  in  this  region 
does  not  indicate  a  defined  ORF,  although  there  are  a  number  of  direct  repeats 
and  two  very  strong  stem-loop  structures.  Although  not  strictly  defined,  it  is 
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structurally  very  similar  to  the  par  locus  in  the  E.  coli  plasmid  pSC101  (Nleacock 
et  al.,  1980;  Miller  et  al.,  1983). 
The  par  locus  in  the  plasmid  pSC101  has  been  identified  and  characterised 
genetically  and  physically.  It  does  not  encode  a  gene  product  or  specify  a 
function  responsible  for  incompatibility  but  appears  to  be  a  cis-acting  element 
that  probably  functions  as  the  site  that  interacts  with  other  cellular  components 
during  partitioning  of  plasmids.  The  precise  mechanisms  that  govern 
partitioning  of  plasmids  are  not  yet  well  understood.  In  Bacillus  subtilis,  the 
structure  of  the  par  locus  that  regulates  plasmid  partition  is  located  very  near  the 
site  for  second-strand  synthesis  and  has  been  shown  to  be  orientation-specific 
(Chang  et  al.,  1987).  Again,  it  is  not  encoded  by  a  protein  but  has  a  series  of 
inverted  repeats  and  two  sets  of  direct  repeats.  Direct  sequence  comparisons 
showed  no  significant  degrees  of  similarity  between  the  B.  subtilis  and  pIJ101 
sequences.  However  the  series  of  direct  and  indirect  repeats  along  with  the  loss 
of  plasmid  stability  when  the  region  is  disrupted  makes  a  strong  case  for  similar 
roles.  Further  work  by  Devine  et  at.,  (1989)  showed  that  the  accumulation  of 
single-stranded  DNA  does  not  equate  to  segregational  stability  in  Bacillus 
subtilis. 
Segregational  instability  of  plasmids  in  unicellular  bacteria  is  usually 
monitored  by  plating  samples  on  agar  to  reveal  the  proportion  of  colony-forming 
units  that  exhibit  a  plasmid-borne  phenotype  such  as  antibiotic  resistance.  A 
Streptomyces  colony  on  a  plate  is  not  derived  from  a  single  cell,  but  from  a  clump 
in  which  only  a  small  proportion  of  the  mycelial  filaments  need  to  have  a 
plasmid  for  a  colony  to  be  formed  on  selective  agar.  Therefore  a  simple  plating 
method  will  not  give  a  true  estimate  of  the  plasmid  loss.  S.  rimosus  grows  in 
liquid  as  a  very  dispersed  culture  and  therefore  decreases  the  size  of  the 
microscopic  clumps  of  mycelia  to  a  level  where  truer  estimates  of  plasmid  loss 
can  be  analysed.  A  better  method  devised  by  Wrigley-Jones  et  al.,  (1992),  to 
monitor  plasmid  stability  throughout  growth  is  to  measure  plasmid  copy 
number  since  segregational  stability  is  often  preceded  by  a  decrease  in  plasmid 
copy  number.  This  method  was  considered.  However  for  our  purposes,  the 
liquid  assay  proved  to  be  sufficient  to  deduce  the  percentage  of  cells  which 
retained  the  plasmid. 
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6.2  Objectives 
The  objective  of  the  work  described  in  this  chapter  was  to  disrupt  and 
replace  a  gene  in  the  otc  pathway  without  disturbing  any  downstream 
transcription. 
The  immediate  aims  of  the  experiments  discussed  in  this  chapter  were  as 
follows: 
i)  to  characterise  the  stability  of  three  Streptomyces  vectors 
ii)  to  develop  a  series  of  integration  and  replacement  constructs 
iii)  to  carry  out  gene  disruption  and  replacement  experiments  on  the  OtcD- 
ORF3,  a  putative  'reductase'  gene  from  S.  rimosus  4018 
6.3  Results 
6.3.1  Choice  of  Vector 
The  stability  of  three  Streptomyces  plasmids  was  tested  by  introducing  the 
plasmids  into  S.  rimosus  4018  by  PEG-mediated  transformation,  plating  the 
resulting  spores  on  non-selective  media  and  then  monitoring  the  loss  of  plasmid 
by  colony  counts  on  selective  versus  non-selective  media.  The  unique 
characteristics  of  the  three  plasmids  are  outlined  below.  All  three  are  non- 
conjugative  derivatives  of  the  natural  pIJ101  replicon,  and  as  such  are  high-copy 
number  vectors  (40-300  copies  per  cell  -  Kieser  et  al.,  1982).  Each  carries  the  tsr 
gene  (from  S.  azureus  ),  which  confers  resistance  to  thiostrepton  by  methylation 
of  the  rRNA  (Thompson  et  al.,  1982),  providing  a  selectable  marker  for 
propagation  in  Streptomyces. 
pIJ702 
A  5.8  kb  plasmid  (Figure  6.2a),  which  carries  2.0  kb  of  pIJ101  found  to  be 
essential  for  the  maintenance  and  replication  (rep)  in  S.  lividans 
. 
The  rep  region 
is  fused  with  the  thiostrepton  resistance  marker  (tsr)  and  the  mel  operon 
(consisting  of  the  two  genes  mel  and  ORF438  from  S.  antibioticus),  (Katz  et  al., 
1983). 
pIJ680 
A  5.3  kb  plasmid  (see  Figure  6.2b)  which,  similar  to  pIJ702,  carries  the  2.0 
kb  essential  region  for  maintenance  and  replication  in  Streptomyces  along  with  the 
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Restriction  maps  of  three  Streptomyces  based  plasmids  employed  for  stability 
testing.  References;  pIJ702  and  pIJ680  taken  from  Hopwood  et  al.  1985  and 
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fused  tsr  gene.  It  also  carries  the  neomycin  phosphotransferase  gene,  aph  I,  from 
S.  fradiae  (Thompson  et  al.,  1982).  The  removal  of  the  BamHI  site  from  the  pIJ101 
portion  of  the  plasmid  (T.  Eckhardt,  cited  in  Hopwood  et  al.,  1985),  allowed  for 
the  unique  BamHI  site  in  the  aph  gene  to  be  utilised  for  insertional  inactivation. 
pIJ486 
A  6.2  kb  plasmid  (see  Figure  6.2c),  again  carries  the  essential  region  for 
maintenance  and  replication  from  the  pIJ101  plasmid  which  is  fused  to  the  tsr 
gene.  This  plasmid  uses  the  aphlI  gene  of  Tn5  (resistance  to  kanamycin  or 
neomycin)  as  the  indicator  for  promoter  activity.  A  ribosome  binding  site  and  an 
in-frame  stop  codon  lie  between  the  BgIII  site  (underlined  in  figure  6.2c)  and  the 
start  codon  for  the  aphll  gene.  The  major  terminator  of  phage  fd  prevents  read- 
through  from  vector  promoters  into  the  aphll  gene.  p1J486  differs  from  pIJ424 
with  the  elimination  of  the  Barn  HI  site  from  the  pIJ101  region  of  the  plasmid  and 
the  insertion  of  a  polylinker  in  the  BglII  site. 
All  three  plasmids  (previously  isolated  from  S.  lividans  TK24)  were 
transferred  into  S.  rimosus  4018  and  recombinants  selected  by  resistance  to 
thiostrepton.  A  single  colony  was  picked  and  streaked  onto  a  Soya  mannitol 
agar  plate  supplemented  with  50µg.  mL-1  thiostrepton  to  ensure  a  true 
transformant  was  selected.  Spores  were  collected  after  three  -days  and  replated 
onto  a  Soya  mannitol  plate  lacking  thiostrepton.  Figure  6.3  gives  a  schematic 
representation  of  the  procedure  followed  for  a  single  round  of  selection.  This 
was  carried  out  over  several  cycles  for  all  three  vectors.  Spores  collected  from 
the  Soya  mannitol  plate  were  divided  into  four  aliquots.  Aliquot  A  was  replated 
onto  Soya  mannitol  plate  incubated  for  3  days  and  used  as  the  stock  for  the  next 
round.  500µl  of  Aliquot  B  was  used  to  inoculate  50  mL  of  TSB  media.  The  liquid 
culture  was  incubated  on  an  orbital  shaker  at  300C  for  48  hrs.  500µ1  was  then 
removed  and  plated  onto  a  non-selective  Soya  mannitol  plate.  After  3  days  at 
30°C,  spores  were  collected  and  a  series  of  serial  dilutions  made.  In  duplicate, 
10-5,10-6  and  10-7  dilution  cultures  were  plated  on  LB  with  and  without 
50µg.  mL-l  thiostrepton.  LB  media  was  preferred  because  non-sporulating 
colonies  could  be  seen  easily  after  a  2-day  incubation  at  30°C.  Aliquot  C  was 
used  to  make  a  similar  dilution  series  from  the  spores  harvested  directly  from  the 
Soya  plate,  as  opposed  to  aliquot  B  whose  spores  came  from  a  liquid  culture. 
Aliquot  D  was  stored  frozen  in  20%  glycerol  at  -20°C.  The  stability  of  the 
plasmids  in  both  liquid  and  solid  media  is  outlined  in  figure  6.4.  Figure  6.4(a) 
shows  the  results  for  an  agar  based  non-selection.  Figure  6.4b  shows  the  results 
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A  schematic  representation  of  a  single  cycle  in  both  liquid  and  solid  non- 
selection  of  3  plasmids,  pIJ702, pIJ486  and  pIJ680  in  S.  rimosus. 
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Figure  6.4 
Plasmid  loss  in  S.  rimosus  of  pIJ702  (0),  pIJ680  H  and  pIJ486  (o)  in  the  absence 
of  thiostrepton.  Plot  (a)  gives  the  results  of  agar  plate  selection,  plot  (b)  gives 
the  results  of  liquid  selection.  See  text  for  further  details.  The  plasmid- 
bearing  cells  were  initially  selected  on  thiostrepton. 
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of  a  liquid  non-selection.  Average  colony  counts  were  taken  for  duplicate  plates. 
To  determine  the  percentage  of  the  spores  retaining  the  plasmid,  the  average 
number  of  colonies  (taking  into  account  the  dilution  factor)  on  the  LB+  tsr  plates 
was  divided  by  the  average  number  of  colonies  on  the  LB  plates  and  expressed  as 
a  percentage.  The  plasmid  pIJ702  was  quite  stable  in  S.  rimosus  both  in  liquid 
and  solid  non-selection.  Although  there  is  a  decline  in  the  percentage  of  colonies 
retaining  the  plasmid,  with  both  pIJ680  and  pIJ486,  the  decline  is  significant  and 
more  rapid.  There  is  very  little  difference  between  both  pIJ680  and  pIJ486. 
pIJ486  was  selected  as  the  unstable  delivery  vector  for  subsequent  integration 
experiments  primarily  due  to  the  greater  choice  of  single  restriction  sites. 
6.3.2  Construction  of  Integration  Vectors 
To  deduce  the  function  of  various  genes  in  the  otc  duster,  gene  disruption 
experiments  were  set  up.  The  gene  to  be  disrupted,  the  OtcD-ORF3  gene,  is  a 
putative  reductase  (see  Chapter  3).  The  ORF  spans  the  KpnI26  site  and  this  was 
chosen  as  the  insertion  site  for  the  antibiotic-resistance  marker  (figure  6.5).  The 
antibiotic-resistance  gene  chosen  conferred  resistance  to  gentamicin.  There  are 
very  fewtantibiotics  that  inhibit  the  growth  of  S.  rimosus.  Initial  tests  on  the 
suitability  of  gentamicin  as  a  selectable  marker  were  carried  out  by  C.  Ives 
(Glasgow  University).  A  plasmid  carrying  both  the  tsr  and  gmr  genes  was 
introduced  into  S.  rimosus  and  selected  initially  with  gentamicin,  resulting  in 
confluent  growth.  These  colonies  were  patched  onto  selective  media  containing 
thiostrepton  and  after  three  days  at  300C  only  30%  of  the  colonies  were  found  to 
be  true  transformants  (C.  Ives;  pers.  comm.  ).  However,  a  plasmid  carrying  both 
gmr  and  tsr  genes,  for  which  the  tsr  gene  is  used  for  the  primary  selection,  can  be 
plated  subsequently  on  media  containing  gentamicin  and  be  found  to  be  truly 
resistant  to  gentamicin  as  well.  It  was  concluded  that  gentamicin  could  be  used 
only  as  a  secondary  marker. 
Gentamicin  is  an  aminoglycoside  which,  together  with  neomycin, 
kanamycin  and  hygromycin,  normally  causes  mistranslation  in  prokaryotes  and 
inhibits  protein  synthesis  (Holmes  et  al.,  1991).  Streptomyces  tenebrarius,  which 
produces  the  aminoglycoside,  contains  a  gene  that  encodes  an  S-adenosyl 
methionine-dependent  methylase  resistance  gene  that  modifies  the  16S  ribosomal 
RNA.  The  resistance  is  due  to  methylation  of  the  rRNA  at  a  single  site,  which  is 
characteristic  for  a  given  phenotype.  For  example,  the  gene  encoding  the  kgmB 
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Figure  6.5 
A  partial  restriction  map  of  the  otc  cluster  of  S.  rimosus  showing  the  position 
of  insertion  of  the  gentamicin  resistance  marker  into  the  reductase  gene. 
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(for  kanamycin-gentamicin  resistance  methylation)  methylates  residue  G-1405 
(Holmes  et  al.,  1991). 
The  first  step  in  the  construction  of  the  integration  vector  began  with  a 
three-way  ligation  into  the  shuttle  vector  pIBI24  to  produce  p503  (figure  6.6a).  A 
1.5  kb  BamHI-Sph  I  fragment  containing  the  gentamicin  gene  was  removed  from 
the  pLST14  plasmid  (Skeggs  et  al.,  1987).  The  promoter  was  included  in  this 
fragment.  The  second  fragment  from  pLUS801,  kindly  supplied  by  C.  Chen,  was 
digested  with  Barn  HI  and  Xbal.  This  plasmid  carries  a  series  of  restriction  sites 
that  cut  rarely  in  Streptomyces  (containing  a  high  percentage  of  A  and  T  bases). 
This  series  of  rare  restriction  sites  (rrs),  57  bp  in  length,  was  incorporated  into  the 
vector  so  that  upon  integration,  the  rare  sites  would  mark  the  otc  cluster,  at  the 
altered  Kpn126  site,  for  later  genomic  digestion  and  pulsed-field  gel 
electrophoresis  analysis  to  determine  the  location  of  the  cluster  within  the 
genome.  The  three-way  ligation  with  the  BamHI-Sph  I  fragment  from  pLST14, 
the  BamHI-XbaI  fragment  from  pLUS801  and  pIBI24  (Sphl-XbaI)  produced  the 
plasmid  p503  (see  Figure  6.6a).  By  utilising  the  restriction  sites  in  the  polylinker 
of  the  plasmid  pGEM7,  a  XbaI  cassette  containing  the  gentamicin-rare  restriction 
site  (gmr-rrs)  insert,  was  produced.  The  resulting  plasmid  was  labelled  p504 
(Figure  6.6a). 
A  3.4  kb  fragment  of  the  otc  duster  from  SstI24-SphI27  (see  figure  3.2)  was 
inserted  onto  the  shuttle  vector,  pIBI24  to  produce  the  plasmid,  pSRG6.  This 
plasmid  contains  the  putative  reductase  gene  that  was  chosen  for  disruption. 
The  plasmid  was  linearised  by  digestion  at  the  KpnI26  site  and  the  overlapping 
ends  filled  in  with  T4  DNA  polymerase.  Xbal  linkers  were  ligated  to  the  blunt- 
ended  fragment  to  produce  the  plasmid  pSRG6X.  The  gmr-rrs  XbaI  cassette  from 
plasmid  p504  was  then  ligated  to  the  XbaI  site  of  pSRG6X  to  produce  the  plasmid 
p505.  The  orientation  of  the  gentamicin  gene  is  opposite  to  that  of  the  otc  genes  to 
avoid  a  possible  lethality  caused  by  overexpression  of  any  downstream  otc  genes. 
p505  now  contained  the  gmr-rrs  resistance  marker  flanked  by  2.0  kb  to  the  left 
and  1.4  kb  to  the  right  of  the  KpnI26  of  the  otc  cluster  in  a  pIBI24  shuttle  vector 
(Figure  6.6b). 
The  final  component  in  the  construction  of  the  integration  vector  was  the 
unstable  delivery  vector  containing  the  Streptomyces  origin  of  replication.  The 
plasmid  p505  contains  a  unique  Sstl  site,  which  was  cleaved  to  linearise  the 
Plasrnid.  The  linear  fragment  was  then  ligated  to  pIJ486  restricted  at  the  unique 
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Figure  6.6a 
Construction 
of  p504,  a  Xba  I  cassette  containing  a  gentamicin  resistance  gene. 
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Construction  of  p505,  a  pIBI24  based  vector.  A  gentamicin  resistance  marker  has  been 
inserted  into  the  otc  duster  of  S.  rimosus  at  a  newly  created  Xba  I  site. 
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Construction  of  p507,  the  disruption  vector  for  integration  into  the 
S.  rimosus  otccluster. 
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SstI  site.  To  facilitate  cloning,  the  plasmid  carrying  the  E.  coli  origin  of  replication 
was  treated  with  calf  intestinal  phosphatase,  so  that  the  vector  could  not  self- 
ligate.  The  resulting  bifunctional  plasmid  was  named  p506  (figure  6.6c).  By 
producing  DNA  which  comes  from  the  E.  coli  host  GM31  (see  Chapter  5),  this 
plasmid  could  be  transformed  directly  into  protoplasts  of  S.  rimosus  4018. 
However,  until  this  stage,  the  integrity  of  the  gentamicin  marker  had  not  been 
tested.  Although  the  promoter  for  the  gentamicin  marker  was  included  in  the 
cloned  fragment,  it  did  not  confer  resistance  to  gentamicin  in  the  E.  coli  host. 
This  was  not  unusual  as  the  promoter  sequences  found  in  Actinomyces  differ 
greatly  from  each  other  and  from  the  prokaryotic  consensus,  which  is  based 
mainly  on  E.  coli  and  B.  subtilis  promoter  sequences  (Holmes  et  al.,  1991).  The 
variety  in  sequences  of  streptomycete  promoters  may  reflect  their  complex 
temporal  differentiation,  and  may  imply  recognition  by  different  sigma  factors 
which  have  no  counterpart  in  E.  coli.  Therefore,  streptomycete  genes  may  not  be 
expressed  in  the  E.  coli  even  from  their  own  promoters.  To  ensure  that  the  cloned 
gentamicin  gene  was  functional  and  at  the  same  time  to  remove  the  E.  coli  pIBI24 
vector  sequence,  an  additional  cloning  step  was  undertaken.  The  E.  coli  origin  of 
replication  was  removed  in  part  to  ease  the  final  interpretation  of  data  after 
Southern  analysis  and  to  reduce  the  size  of  the  final  construct.  By  carrying  out  a 
partial  Hindill  digestion,  in  the  presence  of  increasing  concentrations  of  ethidium 
bromide  (Thamchaipenet;  1994),  a  linear  11  kb  fragment  was  purified  and  the 
construct  religated.  The  ligation  mix  was  transferred  into  protoplasts  of  S. 
lividans  TK24.  The  resulting  transformants  were  selected  by  resistance  to 
thiostrepton.  Subsequent  plating  onto  gentamicin-containing  media  confirmed 
the  integrity  of  the  gentamicin  gene.  This  final  construct,  p507  (figure  6.6c),  was 
verified  by  restriction  analysis. 
6.3.3  Analysis  of  Putative  Integrants 
Plasmid  p507  was  transformed  into  S.  rimosus  4018  and  the  resulting 
transformants  were  selected  on  thiostrepton-containing  plates.  The 
transformation  efficiency  was  4.0X105  transformants.  µg-1  DNA.  Ten  colonies 
were  selected  and  spore  suspensions  made.  From  the  spore  suspensions,  30m1  of 
liquid  TSB  media  was  inoculated.  No  antibiotic  was  added  to  the  media, 
therefore  relaxing  the  selective  pressure  on  the  strain  to  retain  the  plasmid.  After 
3  days,  the  culture  was  streaked  for  single  colonies  onto  a  Soya  mannitol  plate 
containing  no  antibiotic  A1  mL  aliquot  was  also  stored  in  20%  glycerol  at  -20°C. 
The  appearance  of  the  individual  colonies  appeared  to  indicate  that  some  sort  of 
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recombination  event  was  taking  place.  A  control  plasmid  with  no  homologous  S. 
rimosus  chromosomal  DNA  gave  recombinants  with  a  uniform  brown  pigment 
indicative  of  an  otc-  producing  strain.  The  colonies  on  the  experimental  plates 
were  of  mixed  pigmentation,  with  various  shades  of  brown  and  a  number  were 
completely  white  in  colour.  Fifty  colonies  from  each  of  the  10  plates  were 
patched  simultaneously  onto  Soya  mannitol,  Soya  mannitol  plus  50µg.  mL-1 
thiostrepton,  and  Soya  mannitol  plus  200µg.  mL-1  gentarnicin.  An  attempt  to 
replica  plate  the  colonies  proved  to  be  unsuccessful  and  therefore  individual 
patching  of  colonies  was  required.  The  Soya  mannitol  plate  was  used  as  a  master 
plate  for  further  plating  of  individual  colonies.  The  control  strain  4018  and  a 
recombinant  containing  plasmid  pIJ486  were  also  plated  onto  the  Soya  mannitol 
plates.  Putative  positives  were  streaked  onto  a  higher  concentration  of 
gentamicin  (500µg.  mL-1),  as  there  was  a  slight  growth  by  recombinants 
containing  the  control  pIJ486.  Of  the  500  colonies  originally  picked,  106  were 
gentamicin-resistant  and  thiostrepton-sensitive,  indicative  of  the  double 
crossover  event  (as  illustrated  in  figure  6.7).  Ten  colonies,  producing  various 
shades  of  brown  pigment,  were  selected  for  further  analysis.  Chromosomal 
DNA  was  purified  and  digested  with  Sstl.  A  single  SstI  site  in  the  integration 
vector  facilitates  the  interpretation  of  hybridisation  results.  Wild-type  genomic 
DNA  cut  with  Sstl  gives  rise  to  a  5.4  kb  fragment  encompassing  the  region 
surrounding  the  putative  reductase  gene  (see  figure  6.7).  A  single  cross-over  will 
produce  two  Sstl  fragments,  13.3  kb  and  5.4  kb.  A  double  cross-over  event  will 
produce  a  single  SstI  fragment  of  7.4  kb.  A  Southern  blot  was  hybridised  with 
the  random-primed,  DIG  labelled,  800  bp  MIuI-Sall  fragment  containing  part  of 
the  wild-type  reductase  gene.  The  positive  control  used  was  the  S.  rimosus  strain 
G7  which  also  produces  OTC.  The  chromosomal  DNA  was  digested  with  SstI 
and  blotted.  When  probed,  a  number  of  clones  contained  the  expected  7.4  kb 
fragment,  indicative  of  a  double  crossover  event.  However,  most  of  these  also 
appeared  to  have  an  amplified  number  of  the  copies  of  the  gmr::  reductase  gene 
(See  figure  6.8)  There  was  one  colony  which  had  only  a  single  copy,  similar  to 
the  G7  strain.  This  was  colony  16,  and  was  labelled  Int16,  (figure  6.8,  lane  g). 
The  integrity  of  the  Int16  DNA  was  checked  by  probing  with  both  the  1.6  kbgmr 
and  1.1  kbtsr  genes.  As  shown  in  figure  6.8,  the  gmr  gene  was  present,  by 
interpretion  of  the  band  size,  and  in  figure  6.9  (lane  b),  the  tsr  gene  was  not.  In 
figure  6.9,  upper  band  observed  in  the  pIJ486  control  lane  (f)  represents 
supercoiled  undigested  plasmid  DNA.  The  Int16  colony  was  pale  in  colour  and 
did  not  produce  OTC  when  checked  in  plate  assays  but  was  resistant  to  OTC 
when  plated  on  media  containing  50µg.  mL-1  OTC. 
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Figure  6.7 
A  schematic  diagram  of  the  possible  outcomes  of  homologous  recombination 
events  with  p507  and  the  S.  rimosus  chromosome.  A  double  cross-over  event  (a) 
results  in  a  7.4  kb  fragment  when  digested  with  SstI.  A  single  cross-over  event 
(b)  results  in  two  fragments,  13.3kb  and  5.4kb,  when  digested  with  Sstl. 
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Figure  6.8 
DNA  from  putative  recombinants  with  gmr  integrated  in  the  chromosome 
were  digested  with  Sstl  and  probed  with  an  800  bp  MluI-Sall  otc  fragment 
from  pSRGI  (lanes  b-h).  The  control  lane  (i)  contains  DNA  from  wild-type  S. 
rimosus,  digested  with  SstI  showing  hybridisation  to  a  5.4  kb  fragment. 
XHindIII  markers  are  marked  in  Kb  in  lanes  a&j.  The  ethidium  bromide  gel 
(not  shown)  showed  equal  loading  in  all  tracks. 
15  -(  ,;,  ."  I0hz  1,. 
170 
I 
abcdefahl Chapter  6 
23.1- 
9.4- 
6.5- 
4.3- 
2.3-  "  2.0- 
!' 
0.5- 
Figure  6.9 
DNA  from  putative  recombinants  with  gmr  integrated  in  the  chromosome 
probed  with  1.1  kb  BcII  tsr  gene,  (lanes  b-e).  The  1.1  kb  BcII  fragment  of  the 
control  plasmid,  pIJ486  (lane  f)  is  the  tsr  probe.  The  flanking  lanes 
contain  X  HindIII  markers  (kb).  Int16  (lane  b)  corresponds  to  lane  (g)  in  figure 
6.8.  Lanes  c,  d  and  e  represent  the  same  samples  as  lanes  b,  c  and  d 
repectively,  in  figure  6.8. 
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Strain  Int16  contains  a  gentamicin  gene  that  disrupts  the  putative 
reductase  gene  and  any  genes  downstream  which  run  off  the  same  transcript. 
Preliminary  sequence  analysis  shows  that  the  open  reading  frames  of  the  OtcD- 
ORF4  and  OtcD-ORF5  also  run  in  the  same  direction  (see  Chapter  3).  It  was 
assumed  at  this  point  that  the  polarity  effects  might  prevent  or  reduce  expression 
of  the  two  downstream  genes.  The  OtcD-ORF4  gene  product  is  thought  to  be 
involved  early  in  the  pathway  and  the  only  pale  mutants  known  so  far  (Butler  et 
al.,  1989)  are  those  of  genes  early  in  the  pathway.  The  pale  colour  observed  for 
the  Int16  strain  maybe  the  result  of  lost  downstream  transcription  at  OtcD-ORF4, 
rather  then  the  disrupted  gene,  OtcD-ORF3.  To  facilitate  experimental 
interpretation,  a  second  strategy  was  set  up  to  replace  the  gentamicin  marker 
with  a  mutant  form  of  the  reductase  gene,  taking  care  not  to  disturb  the 
transcription  of  the  downstream  genes. 
6.3.4  Construction  of  the  Mutant  Reductase  Gene 
By  careful  analysis  of  the  reductase  gene  and  the  homologous  sequences 
of  other  reductase  genes  it  became  clear  that  a  highly-conserved  region  was  a 
good  target  for  mutagenesis.  An  in-frame  deletion  was  favoured  over  any  point 
mutations  or  insertions  because  there  is  less  risk  of  restoring  the  wild-type  gene. 
A  schematic  diagram  of  the  cloning  strategy  to  produce  the  mutant  reductase  is 
shown  in  figure  6.10.  A  five  amino  acid  sequence  was  to  be  deleted  from  the 
highly  conserved  sequence  of  GXXXGXGXAXA.  (Those  in  bold  were  removed). 
PCR  was  the  technique  employed  to  produce  the  mutant  gene.  From  sequencing 
analysis,  single-stranded  templates  were  available  in  both  orientations  (See 
figure  3.1).  This  allowed  the  use  of  the  universal  primer,  which  recognises  and 
binds  to  vector  sequence,  as  one  of  the  primers  needed  to  generate  the  PCR 
product.  In 
_ 
fact  two  fragments  would  be  generated,  one  to  the  left  of  the 
missing  bases  and  one  to  the  right.  The  two  oligos  designed  to  'loop-out'  the 
conserved  region  also  incorporated  a  new  BamHI  site.  This  allowed  the  mutant 
gene  to  be  located  by  simple  restriction  analysis.  After  the  PCR  was  complete,  a 
second  series  of  constructions  was  made  to  produce  a  vector  that  could  replace 
the  gentamicin  gene  in  Int16  by  two  'Campbell-type'  recombination  events.  As 
shown  in  figure  6.10,  the  constructions  ensured  that  the  only  DNA  generated  by 
PCR  in  the  final  construct  was  that  which  was  contained  within  the  reductase 
gene. 
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Figure  6.10 
The  mutation  strategy  using  PCR  to  create  an  'in-frame'  deletion  of  the 
reductase  gene  in  the  otc  cluster.  Thin  lines  indicate  vector  sequence,  thick 
lines  indicate  chromosomal  sequence.  The  boxed  region  shows  the  location  of 
the  reductase  gene.  PCRP1  and  PCRP2  are  the  mutagenic  oligos  which  create 
a  BamHI  site.  Universal  denotes  the  universal  primer. 
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Figure  6.11a 
Construction  of  p509  from  two  PCR  generated  fragments,  mrA  and  mrB.  'otc'  denotes 
wild-type  otc  DNA,  'cmr'  denotes  PCR-generated  otc  DNA. 
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Figure  6.11b 
Construction  of  p511,  which  contains  a  mutated  'reductase'  gene  from  the  otc  cluster 
of  S.  rimosus. 
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Construction  of  p512,  which  carries  the  mutant  'reductase'  gene  of  the  otc  cluster 
in  S.  rimosus. 
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Plasmid  pmrA  contains  the  PCR  product  generated  from  left  of  the 
missing  amino  acids  using  the  PCRP1  primer  and  the  universal  primer.  It  was 
cloned  into  the  BamHI-Xbal  sites  of  the  vector,  pIBI24.  Clone  pmrB  contains  the 
PCR  product  generated  from  right  of  the  deleted  amino  acids  using  the  PCRP2 
primer  and  universal  primer.  It  was  cloned  into  the  BamHI-Sphl  sites  of  pIBI24. 
Because  both  fragments  were  originally  cloned  in  the  same  direction  in  the 
pIBI24  vector,  a  three  way  ligation  was  set  up  to  produce  a  contiguous  fragment 
of  otc  DNA  from  Kpn126  to  Sph127  with  the  newly  created  BamHI  site  in  the 
middle.  This  was  cloned  into  pIBI24  to  create  pCMR  (figure  6.11a).  The  plasmid 
pCMR  now  contained  the  mutant  reductase  gene.  However  it  was  necessary  to 
replace  all  of  the  surrounding  otc  DNA  with  wild-type  sequence.  This  was 
accomplished  in  two  cloning  steps.  The  first  required  a  partial  digestion  of 
pSRG7  with  Mlul  followed  by  complete  digestion  with  Sphl.  This  838  bp 
fragment  was  then  ligated  to  the  large  Mlul-Sphl  fragment  created  from  pCMR. 
The  resulting  plasmid,  p509,  (figure  6.11a),  now  contained  wild-type  otc  DNA  to 
the  right  of  the  MIuI  site,  very  dose  to  the  newly-created  BamHI  site.  The  second 
cloning  step  added  wild-type  otc  DNA  (SstI24  to  KpnI26)  to  the  left  of  the 
reductase  gene  from  plasmid  pSRG1  to  produce  the  plasmid  p510  (figure  6.11b). 
The  amount  of  DNA  which  flanks  the  right-hand  side  of  the  mutant 
reductase  in  plasmid  p510  is  only  500  bp.  To  increase  the  probability  of 
homologous  recombination-  an  additional  2  kb  fragment  of  otc  DNA  was  ligated 
to  the  plasmid  to  produce  the  clone  p511.  To  facilitate  cloning,  a  different  shuttle 
vector  was  employed,  pGEM7Zf.  The  final  cloning  requirement  was  to  include 
the  vector,  pIJ486  in  the  construct.  This  was  accomplished  by  opening  up  the 
p511  plasmid  with  Xbal,  figure  6.11b,  and  inserting  XbaI-digested  pIJ486.  p511 
was  treated  with  calf  intestinal  phosphatase  to  avoid  self-religation.  Selection 
was  carried  out  in  the  E.  coli  host  GM31  so  that  the  resulting  recombinant 
plasmid,  p512,  (figure  6.11)  could  be  transformed  directly  into  S.  rimosus  Int16. 
The  transformation  was  done  using  electrocompetent  Int16  cells  (Chapter  2.2.8), 
with  selection  on  TSB  media  containing  50µg.  mL-1  thiostrepton. 
6.3.5  Analysis  of  Intergrants  with  Mutant  Reductase 
A  second  series  of  transformants  was  analysed.  Ten  transformants  were 
picked  from  the  transformation  plate.  For  simplicity,  these  were  labelled  mr  1- 
10.  TSB  liquid  media  containing  no  antibiotic  was  used  to  segregate  the  unstable 
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delivery  vector  from  the  cells,  similar  to  the  procedure  outlined  above,  section 
6.3.3,  for  the  p507  plasmid.  Single  colonies  were  patched  onto  selective  and  non- 
selective  media  as  above  (Section  6.3.3).  Only  those  colonies  which  were 
thiostrepton-sensitive  (tsrs)  and  gentamicin-sensitive  (gmrs),  were  analysed 
further.  Of  the  500  colonies  tested,  61  were  both  tsrs  and  gmrs.  Ten  of  these 
colonies  were  grown  in  liquid  culture,  chromosomal  DNA  was  purified  and 
digested  with  BamHI  and  SstI.  Positive  controls  of  wild  type  G7  and  Int16  DNA's 
were  also  included.  BamHI,  which  has  the  recognition  sequence  GGATCC,  does 
not  cut  Streptomyces  DNA  frequently.  A  SstI  digest  alone  would  not  distinguish 
between  the  mutant  reductase  and  the  wild  type.  With  the  engineered  BamHI 
site  in  the  mutant  reductase,  the  BamHI  and  Sstl  double  digestion  would  divide 
the  5.4  kb  SstI  fragment  into  two  fragments  of  2.5  and  2.9  kb.  It  is  possible  for  a 
colony  to  be  gmrs  and  tsrs  without  mutating  the  reductase  gene  due  to  the 
distance  required  between  the  crossover  points,  as  shown  in  figure  6.12.  The 
gentamicin  marker  was  inserted  at  the  KpnI26  site  and  the  deleted  portion  of  the 
reductase  gene  is  located  456  bp  distal.  The  digested  DNA  was  run  on  a  0.8% 
agarose  gel  and  blotted  onto  nylon  membrane.  The  probe  used  to  identify  the 
putative  reductase  mutants  was  a  800  bp  fragment  stretching  from  the  Sall  site 
left  of  the  Kpn126  to  the  MluI  site  to  the  right  of  Kpn126.  As  shown  in  Figure  6.13, 
no  signal  was  observed  in  any  of  the  clones.  The  G7  sample  contained  the 
expected  5.4  kb  signal,  lane  m.  Int16  contained  the  expected  7.4  kb  fragment, 
lane  1.  It  appeared  as  if  all  the  mr  clones  lacked  the  otc  DNA  (lanes  b-k).  The 
colonies  were  plated  onto  media  containing  50  µg.  mL-1  OTC  and  were  found  to 
be  sensitive.  The  attempted  replacement  event  induced  the  cells  to  delete  the 
entire  duster.  At  this  stage,  a  closer  look  at  the  Int16  done  was  taken.  DNA's 
from  Int16  and  Int17,  a  done  which  showed  an  amplified  signal,  (see  figure  6.8), 
were  digested  with  Bam  HI  and  SstI  and  run  along  side  a  sample  of  wild-type 
DNA  digested  with  the  same  enzymes.  The  blot  was  probed  initially  with  otrA 
and  subsequently  with  otrB  (figure  6.14).  It  was  evident  that  otrA  (lane  a)  gave  a 
signal  but  otrB  (lane  b)  did  not.  The  signal  of  the  Int17  was  also  amplified  in 
comparison  with  Int16  and  wild  type  DNA  (lane  c  in  both  blots).  From  these 
results,  it  is  clear  that  Int16  clone  did  indeed  undergo  an  integration  event. 
However,  a  portion  of  the  cluster  was  lost  as  well.  In  retrospect,  the  loss  of  otrB 
and  at  least  a  portion  of  the  otcY  locus,  might  explain  the  pale  colour  of  the  Int16 
colony  as  otcY  genes,  close  to  otrB,  are  involved  in  polyketide  biosynthesis.  The 
second  event  augmented  the  first  deletion  event  to  remove  the  entire  cluster. 
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Putative  recombinants  likely  to  contain  an  integrated  mutant  reductase  gene 
(lanes  b-K),  digested  with  Sstl-BamHI  and  probed  with  a  MIuI-Sall  fragment 
from  pSRG1.  Int  16  (lane  1)  and  wild-type  S.  rimosus  (lane  m)  showed  the 
expected  hybridisation  bands.  The  ethidium  bromide  gel  (not  shown) 
showed  equal  loading  in  all  tracks.  a  ,  c\Ui 
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Int16  (lane  a)and  Int17  (lane  b)  chromosomal  DNA  was  digested  with  BainHI 
and  Sstl  and  probed  with  a)  otrA  and  b)  otr&  The  positive  control  DNA  used 
was  S.  rimosus  G7,  lane  c,  a  Her  i  &,,  e-  d 
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With  the  advent  of  electrotransformation  and  the  consequent  increase  in 
the  transformation  efficiency  of  S.  rimosus  M4018,  integration  using  a  suicide 
vector  system  was  attempted.  This  would  eliminate  any  deleterious  effects  the 
unstable  Streptomyces  replicon  might  have  had  on  the  integration  events. 
Preliminary  tests  were  carried  out  using  different  selective  media  to  monitor  the 
growth  of  electrotransformants.  Previous  work  (C.  Ives;  pers.  comm.  ),  showed 
that  gentamicin  could  not  be  used  as  the  primary  selectable  marker  for 
transformation  of  protoplasts,  see  Section  3.3.2.  The  plasmid,  p507,  which  carries 
both  the  tsr  and  gmr  antibiotic  resistance  markers  was  transformed  into 
electrocompetent  S.  rimosus  M4018  cells.  Following  electrotransformation,  the 
cells  were  plated  onto  either  Soya  mannitol  or  Tryptic  Soya  broth  (TSB)  media 
containing  varying  concentrations  of  gentamicin.  The  concentrations  ranged 
from  200µg.  mL-1  to  600µg.  mL-1.  The  positive  control  plate  contained  50µg.  mL-1 
thiostrepton.  The  plates  were  incubated  at  300C  for  three  days.  In  the  case  of 
Soya  mannitol,  there  was  confluent  growth  at  all  concentrations  of  gentamicin. 
However,  the  TSB  plates  contained  individual  colonies,  some  of  which 
sporulated  after  3  days  and  some  that  did  not.  The  transformation  efficiency 
calculated  from  the  control  plates  containing  thiostrepton  was  9.0X105.  The 
sporulating  and  non-sporulating  colonies  on  the  gentamicin-containing  TSB 
plates  were  picked  onto  a  separate  Soya  mannitol  plate  containing  50µg.  mL-1 
thiostrepton.  After  three  days  at  30°C,  all  of  the  sporulating  colonies  grew  and 
all  of  the  non-sporulating  colonies  did  not.  This  provided  a  good  visual  screen 
for  the  true  transformants.  This  was  an  encouraging  result,  and  50ng  of  the 
plasmid  p505  isolated  from  the  GM31  E.  coli  host,  was  transformed  into  S. 
rimosus  M4018  by  electroporation,  and  plated  onto  TSB  plates  containing 
400µg.  mL-l  gentamicin.  Plasmid  p505  (see  figure  6.6)  carries  only  an  E.  coli 
origin  of  replication,  and  therefore  integration  is  required  for  survival.  The  entire 
one  mL  was  plated  and  after  3  days,  there  were  23  sporulating  colonies.  Twelve 
of  these  colonies  were  grown  up  in  TSB  for  analysis.  Gentamicin  was  added  to 
the  media  to  maintain  the  selective  pressure  on  the  gmr  gene  should  a  single 
cross-over  event  have  occurred.  The  chromosomal  DNA  preps  were  digested 
with  SstI,  blotted  and  probed  with  the  1.6  kb  gmr  gene.  The  resulting  blot 
showed  that  all  of  the  clones  carried  the  integrated  gmr  gene,  but  again  the  DNA 
was  amplified  (blot  not  shown).  The  number  of  copies  of  the  amplified  region 
was  well  in  excess  of  500.  No  further  analysis  was  undertaken  with  these  clones. 
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6.4  Discussion 
Gene  disruption  and  replacement  is  a  valuable  tool  in  determining  the 
function  of  specific  genes.  The  primary  approach  takes  here  employed  an 
unstable  Streptomyces  replicon  as  the  delivery  vehicle.  All  three  plasmids 
considered,  pIJ702,  pIJ680  and  pIJ486,  are  based  on  the  pIJ101  replicon. 
pIJ702  is  maintained  quite  stably  in  some  Streptomyces  hosts  such  as  S. 
lividans,  S.  coelicolor  (Katz  et  al.,  1983)  as  well  as  S.  rimosus  (this  work),  and  poorly 
maintained  in  others  (Sac.  erythraea,  Weber  et  al.,  1988).  The  variability  between 
strains  also  extends  to  variability  of  different  plasmids  within  a  given  host.  For 
example,  pIJ680  and  pIJ486  are  unstable  in  S.  rimosus  although  there  is  very  little 
difference  in  plasmid  size  or  content  when  compared  to  the  more  stable  pIJ702. 
Many  naturally-occurring  plasmids,  irrespective  of  their  copy  number,  are 
maintained  stably  in  a  growing  bacterial  population.  Chimeric  plasmids 
generated  by  in  vitro  recombination  methods,  however,  are  frequently  deficient 
in  partition  because  they  usually  consist  of  only  the  replication  origin,  the 
associated  replication  functions,  and  one  or  two  additional  selectable  markers 
such  as  antibiotic-resistance  genes.  This  is  the  case  with  all  three  plasmids,  and 
until  the  mechanisms  that  govern  partitioning  are  fully  understood  there  is 
bound  to  be  plasmid  variability  within  a  given  Streptomyces  host. 
Using  resistance  to  the  antibiotic  marker  gentamicin  as  a  screen  to  identify 
integration  into  the  S.  rimosus  "reductase"  gene  via  the  unstable  delivery  vector, 
pIJ486,  has  lead  to  chromosomal  amplifications  and  deletions.  The  strategy 
employing  the  unstable  vector  was  sound  as  the  gentamicin  gene  was 
incorporated  into  the  gene  which  was  targeted  (see  figure  6.5).  Unfortunately, 
the  organism  elicited  its  own  repair  mechanisms  to  counteract  the  integration 
event.  The  genetic  instability  of  Streptomyces  is  well  documented  (Leblond  et  al., 
1991;  Birch  et  al.,  1990;  Dyson  et  al.,  1987;  Betzler  et  al.,  1987)  with  many  strains 
exhibiting  extraordinarily  high  ;  4ýýýg«}rates  in  certain  genes.  Unstable 
phenotypes  are  lost  spontaneously  at  frequencies  as  high  as  0.1  %  of  plated  spores 
(Birch  et  al.,  1990).  Also  associated  with  this  genetic  instability,  which  often 
correlates  with  deletion  of  unstable  genes,  is  the  formation  of  very  high-copy 
number  tandemly-amplified  DNA  sequences  (ADS)  that  takes  place  in  the 
absence  of  any  obvious  selective  pressure.  A  range  of  different  sequences  can  be 
amplified,  and  to  varying  extents  (5  to  10%  of  the  total  DNA),  in  different 
mutants  derived  from  the  same  progenitor  (Hornemann  et  al.,  1986).  The 
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deletions  can  extend  to  in  excess  of  800  kb  (Birch  et  al.,  1987)  and  the  physically- 
amplified  arrays  can  extend  to  3,000  kb  (Häusler  et  al.,  1989)  constituting  18-45% 
of  the  chromosome,  respectively  (Birch  et  al.,  1990). 
Amplifications  can  be  classified  into  two  main  types.  Type  I 
amplifications  are  non-reproducible  and,  when  characterised,  have  been  shown 
to  originate  from  overlapping  regions  of  the  chromosome.  The  majority  of 
amplifiable  units  of  DNA  (AUDs)  in  S.  glaucescens  have  been  mapped  to  a  single 
chromosomal  locus  of  100  kb  (Häusler  et  al.,  1989).  There  is  no  consensus  core 
sequence  involved  and  the  AUDs  are  present  only  in  a  single  copy  in  the 
progenitor  chromosome,  flanked  by  short  imperfect  direct  repeats  (Häusler  et  al., 
1989).  Type  II  amplifications,  in  contrast  to  type  I  amplifications,  are  the  result  of 
events  which  are  reproducible,  and  the  AUDs  are  either  flanked  by  extensive  (1.0 
to  2.2  kb)  direct  repeats  (Fishman  et  al.,  1985)  or  are  already  present  in  the 
chromosome  in  duplicate  (Altenbuchner  et  al.,  1985).  In  S.  fradiae,  the  flanking 
repeat  structure  is  present  in  three  copies  in  the  chromosome,  and  in  S.  lividans, 
the  repeat  structure  consists  of  three  copies  of  a  1.0  kb  repeat  with  two  copies  of  a 
4.7  kb  sequence  sandwiched  between  them.  At  first  glance  one  may  see  these 
repeats  as  insertion  sequences.  However,  the  restriction  patterns  of  the  different 
repeats  in  S.  lividans  clearly  show  divergence  (Altenbuchner  et  al.,  1985).  This 
suggests  that  the  direct  repeat  itself  and  not  any  other  properties  which  it  may 
possess,  is  the  critical  factor.  This  was  confirmed  when  Altenbuchner  et  al., 
(1985)  found  that  S.  lividans,  with  only  two  copies  of  the  1.0  kb  repeat  flanking 
the  4.7  kb  sequence,  was  amplified  at  a  much  lower  frequency  than  the  larger 
duplicated  repeat. 
Amplifications  have  been  closely  linked  to  large  chromosomal  deletion 
events.  The  integration  of  the  gmr  gene  into  the  otc  duster  of  S.  rimosus  has  lead 
to  the  amplification  and  subsequent  deletion  of  approximately  one  half  of  the 
duster.  The  chromosomal  DNA  of  Int16  appears  to  be  in  single-copy  form.  It 
appears  that  during  the  liquid  non-selection  stage  it  may  have  been  in  a  higher 
copy  number  and  when  allowed  to  sporulate  on  the  Soya  mannitol  plate,  the 
organism  attempted  to  stabilise  the  chromosome  by  deletion  of  the  amplified 
sequence,  in  this  case,  the  otrB  end  of  the  duster.  Several  instability  systems  in 
Streptomyces  spp.  display  a  characteristic  stepwise  loss  of  markers  (Dyson  et  al., 
1987),  in  which  primary  high-frequency  mutant  types  give  rise  to  secondary 
mutant  types  at  even  higher  frequencies.  This  pattern  of  appearance  of  mutants 
is  highly  suggestive  of  a  two-step  mechanism  whereby  a  primary  deletion 
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facilitates  further  secondary  events.  This  theory  was  supported  in  this  work 
when,  with  the  second  integration  event,  the  S.  rimosus  organism  created  further 
deletions  to  remove  the  entire  cluster.  This  was  verified  by  the  loss  of  otc 
resistance  on  a  Soya  mannitol  plate  containing  50µg.  mL-1  OTC.  This  step-wise 
loss  of  markers  has  been  also  demonstrated  in  S.  glaucescens  (Hintermann  et  al., 
1984)  with  the  sequential  loss  of  the  unstable  genes  coding  for 
phosphotransferase  (strS)  and  subsequently  tyrosinase  (melC)  proteins.  In  S. 
glaucescens  ,  the  loss  of  800  kb  of  genetic  material  certainly  impairs  the  viability  of 
the  cells.  However,  they  are  still  able  to  grow  on  minimal  media,  indicating  that 
they  have  lost  no  essential  genes.  This  is  also  the  case  with  S.  rimosus,  indicating 
that  the  deleted  region  apparently  contains  relatively  dispensable  DNA  which 
may  be  rich  in  genes  encoding  the  biosynthesis  of  secondary  metabolites.  This 
work  is  further  corroborated  by  that  of  Gravius  et  al.,  (1993),  who  during 
screening  programs  to  improve  oxytetracycline  production  in  S.  rimosus  R6, 
showed  that  some  high-yielding  isolates  showed  high  levels  of  genetic  instability 
manifested  by  the  production  of  morphological  variants.  Five  phenotypic  traits 
were  affected:  sporulation,  pigmentation,  colony  morphology,  oxytetracycline 
production  and  oxytetracycline  resistance.  The  variants  were  classified  into  three 
classes  based  on  oxytetracydine  resistance.  Class  I  variants  (99%)  had  parental 
levels  of  OTC  resistance.  They  showed  a  variety  of  phenotypes  affecting  colony 
morphology,  pigmentation,  degrees  of  sporulation  and  otc  production.  These 
variants  were  very  unstable  and  gave  rise  to  further  variants  and  some 
reversions  to  the  parental  phenotypes.  There  were  no  DNA  rearrangements 
detected  in  the  primary  Class  I  variants.  Class  II  variants  were  sensitive  to  OTC, 
but  showed  uniform  phenotypic  properties.  Hybridisation  analysis  showed  the 
deletion  of  the  otrB  resistance  gene  and  indeed  all  of  the  duster.  Restriction 
analysis  of  these  Class  II  variants  using  pulsed-field  gel  electrophoresis 
confirmed  a  deletion  of  455  kb,  all  with  identical  restriction  patterns  suggesting 
that  there  are  specific  deletion  end-points.  Class  III  variants  were  the  rarest 
observed  (0.1%),  exhibited  uniform  phenotypes  and  showed  a  30-40% 
overproduction  of  OTC  and  a  corresponding  increased  level  of  OTC  resistance. 
There  were  extensive,  reproducible,  large-scale  DNA  rearrangements  of  about 
200  kb,  including  the  otrB  gene. 
It  is  presumed  that  the  second  replacement  event  created  a  series  of  Class 
II  variants  which  have  lost  a  total  of  455  kb  of  DNA,  including  the  otc  cluster  and 
flanking  sequence.  Pulsed-field  gel  electrophoresis  would  have  to  be  undertaken 
to  confirm  that  these  variants  contain  the  same  deletion  end-point  as  those  cited 
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in  Gravius  et  al.,  1993..  It  can  also  be  presumed  that  within  this  455  kb  there  are 
non-essential  genes  due  to  the  uniform  phenotypes  observed. 
The  physical  map  of  S.  rimosus  is  currently  being  constructed  by  J.  Cullum 
(pers.  comm.  )  with  the  use  of  pulsed-field  gel  electrophoresis.  Because  of  the 
high  G+C  content  of  the  Streptomyces  DNA  (70  to  74%),  restriction  enzymes  with 
recognition  sites  containing  only  A  and  T  nucleotides,  such  as  AseI  (ATTAAT) 
and  Dra  I  (TTTAAA),  will  generate  relatively  few  fragments.  Asel  and  Dra  I 
linking  cosmids  (i.  e.  recombinant  cosmids  including  either  Asel  or  Dral  sites) 
were  isolated  from  a  gene  bank  and  used  as  hybridisation  probes  against 
Southern  transfers  of  the  pulsed-field  gel  electrophoresis  restriction  patterns. 
The  precise  mapping  with  both  single  and  double  digests  supports  the 
interpretation  that  the  chromosome  is  a  linear  structure.  A  preliminary  map  is 
shown  in  figure  6.15. 
Bacterial  linear  plasmids  were  first  described  in  Streptomyces  rochei 
(Hayakawa  et  al.,  1979)  and  have  now  been  detected  in  at  least  10  other 
Streptomyces  spp.  (Hinnebusch  et  al.,  1993).  The  linear  plasmid  DNA  has  a 
terminal  protein  attached  covalently  to  the  5'  end  of  each  DNA  strand,  as  well  as 
inverted  terminal  repeats,  dubbed  'invertrons'  (Sakaguchi;  1990).  Streptomyces 
linear  plasmids  as  well  as  other  invertrons  probably  replicate  by  a  protein- 
primed  DNA  replication  mechanism  that  has  been  well  characterised  for  B. 
subtilis  phage  X29  and  Adenovirus  (Salas,  1991).  The  telomere  is  the  origin  of 
replication  and  is  recognised  by  specific  initiation  proteins  that  promote 
unwinding.  The  5'-terminal  protein  (TP)  serves  as  the  primer  for  a  specific  DNA 
polymerase.  In  the  priming  reaction,  a  free  TP  first  complexes  with  DNA 
polymerase  at  the  origins  of  the  telomere.  The  DNA  polymerase  then  catalyses 
the  formation  of  a  covalent  bond  between  the  free  TP  and  a  dNTP.  This  TP- 
linked  dNTP  becomes  the  5'  terminal  nucleotide  of  the  nascent  strand,  which  can 
then  grow  to  the  end  of  its  template. 
Linear  chromosomes  have  been  found  recently  in  a  number  of 
Streptomyces  spp  including  S.  coelicolor  and  S.  lividans  (Chen;  1993).  This  linear 
structure  is  similar  to  the  linear  plasmids  with  two  identical  free  ends  each 
carrying  a  covalently  bound  protein  and  a  25  kb  inverted  repeat.  The  linear 
chromosome  contains,  in  the  middle  of  it,  a  functional  oriC  (Zakrzewska- 
Czerwinska  et  al.,  1992)  and  has  been  shown  to  replicate  by  this  mechanism 
following  forced  circularisation  (Lin  et  al.,  1993)  and  therefore  is  able  to  exist,  in  a 
186 Chapter  6 
IRP-) 
/ 
/ 
/ 
/ 
ýM1i  ý' 
r 
I- 
Figure  6.15 
A  schematic  representation  of  the  linear  chromosome  of  S.  rimosus  R6.  The 
construction  of  the  physical  map  employed  restriction  digests  of  Asel  and  Dral 
and  pulse-field  electrophoresis  (Hranueli  et  al.,  unpublished). 
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viable  cell,  as  linear  or  a  circular  molecule.  Physical  mapping  of  the  S.  lividans  66 
chromosome  located  both  of  the  telomeres  in  the  'unstable  region'  where  large 
deletions  (up  to  2  Mb)  and  extensive  amplifications  frequently  occur  (Redenbach 
et  al.,  1993).  Lin  et  al.,  (1993)  speculated  that  large  deletions  may  remove  the 
DNA  together  with  the  terminal  proteins  from  both  telomeres,  thereby  forcing 
the  organism  to  fuse  the  linear  chromosomal  DNA  into  a  circle  and  this  was 
confirmed  by  hybridisation  analysis.  To  carry  this  further,  the  location  of  the  otc 
duster  has  been  provisionally  mapped  very  close  to  one  end  of  the  chromosome 
(see  figure  6.15;  D.  Hranueli;  pers.  comm.  ).  A  more  definite  location  might  have 
been  assigned  employing  the  Int16  clone.  It  carries,  within  the  gmr  cassette,  a 
series  of  AT-rich  restriction  sites.  However  with  the  loss  of  the  otrB  end  of  the 
duster,  comparative  restriction  mapping  is  not  possible.  The  orientation  of  the 
cluster  can  however  be  assigned,  with  the  otrB  gene  closest  to  the  telomere. 
Further  investigation  is  needed  to  confirm  whether  the  genome  of  Int16  clone  is 
linear  and  the  replacement  clones,  which  are  sensitive  to  OTC,  are  circular.  The 
organism,  in  its  struggle  to  survive  may  have  deleted  the  dispensable  DNA  along 
with  the  terminal  proteins  and  re-circularised  to  form  a  stable  chromosome  with 
the  minimal  DNA  requirements  for  survival. 
The  location  and  orientation  of  the  otc  cluster  is  a  stroke  of  misfortune.  It 
appears  that  the  cluster  is  located  between  two  large  repeat  sequences  that  has 
attached  itself  to  the  end  of  the  genome,  not  unlike  a  transposon  U.  Cullum;  pers. 
comm.  ).  The  consistent  genetic  instability  makes  it  very  difficult  to  integrate  into 
the  duster  without  subsequent  loss  of  some  of  the  genes.  Of  over  1500  colonies 
patched,  and  more  than  50  chromosomal  DNA  preparations,  only  Int16  appeared 
not  to  be  amplified.  If  the  orientation  of  the  duster  had  been  reversed  and  the 
otrA  gene  closest  to  the  telomere,  the  antibiotic  minocycline  could  have  been 
added  to  the  growing  cultures  to  prevent  the  loss  of  the  duster.  Minocycline  acts 
on  the  ribosomes.  The  otrA  resistance  gene  mediates  resistance  via  non-covalent 
ribosomal  modification  (Doyle  et  al.,  1991).  The  otrB  resistance  gene,  on  the  other 
hand,  acts  as  an  exporter  of  OTC  (McGregor;  pers.  comm.  ).  Therefore, 
minocyline  could  have  been  incorporated  into  the  media  to  add  selective 
pressure  to  retain  the  otrA  resistance  gene,  had  the  otrA  gene  been  closest  to  the 
telomere.  The  organism  would  have  been  forced  into  retaining  the  entire  cluster, 
but  as  it  is,  the  addition  of  minocycline  would  have  no  affect  on  retaining  the  otrB 
end  of  the  duster. 
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It  appears  that  integration  into  the  S.  rimosus  chromosome  to  study  the 
specific  functions  of  genes  in  the  otc  duster  is  not  a  viable  option.  The  duster  has 
been  cloned  into  the  SCP2*  plasmid,  GLW101  (IS  Hunter;  pers.  comm.  ).  When 
transformed  into  S.  lividans  integration  using  suicide  vectors  is  possible 
(Thamchaipenet;  1994).  This  is  not  an  ideal  environment  to  test  possible  shunt 
metabolites  because  metabolites  produced  could  be  either  the  result  of  disruption 
of  the  otc  duster  or  a  reponse  of  S.  lividans  to  the  presence  of  a  disrupted  cluster. 
The  next  best  situation  would  be  to  relocate  the  cluster  within  the  S.  rimosus 
genome  using  either  transposons,  or  phage  attachment  sites.  The  attachment 
sites  for  RP2  and  RP3  phage  have  been  located  on  the  genome  and  they  are  much 
closer  to  the  centre  of  the  chromosome  U.  Cullum;  pers.  comm.  )[figure  6.15]. 
Vectors  with  compatible  phage  attachment  sites,  which  enable  the  plasmid 
carrying  them  to  integrate  into  the  chromosome,  could  be  employed.  Another 
possibility  is  to  transform  the  plasmid  containing  the  entire  otc  cluster  into  an 
OTC-sensitive  mutant.  This  has  been  attempted  but  has  been  unsuccessful  so  far. 
The  plasmid  containing  the  cluster  is  very  large  and  therefore  difficult  both  to 
isolate  and  to  transform.  If  this  approach  does  prove  to  be  successful,  suicide 
plasmids  could  then  be  used  to  disrupt  the  cluster  in  the  plasmid.  The  resulting 
shunt  metabolites  could  then  be  analysed  and  identified  chemically  and  gene 
functions  assigned. 
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Concluding  Remarks 
The  primary  objective  of  the  work  described  in  this  thesis  was  to 
determine  the  functions  of  genes  encoded  by  part  of  the  otc  cluster  from  S. 
rimosus.  A  strategy  for  the  integration  and  disruption  of  various  gene  products 
was  also  investigated.  A  3.0  kb  KpnI-MluI  region  of  the  cluster  was  sequenced 
and  its  transcription  analysed.  The  deduced  function  of  one  of  the  ORFs,  OtcD- 
ORF3  (a  putative  reductase),  was  determined  by  similarity  to  other  polyketide 
oxidoreductases.  However,  the  precise  function  within  the  pathway  was  only 
speculative.  Gene  disruption  and  replacement  experiments  were  therefore 
undertaken  to  help  deduce  its  function.  These  experiments  were  facilitated  by 
development  of  a  strategy  for  the  introduction  of  DNA  into  S.  rimosus. 
Much  of  the  otc  duster  has  been  sequenced  (figure  7.1).  The  functions  of 
the  ORFs  have  been  deduced  by  sequence  similarity  with  other  gene  products  in 
the  databases.  A  3.0  kb  region  between  the  otcX  and  otcD  loci  was  sequenced  in 
this  work.  The  overall  G+C  composition  was  72.8%  and  three  open  reading 
frames  were  uncovered.  FRAME  (Bibb;  1984)  and  CODONPERENCE  (Devereux 
et  al.,  1984)  programs  revealed  that  all  three  ORFs  were  transcribed  in  the  same 
direction.  The  first  ORF,  labelled  OtcD-ORF3,  encodes  a  protein  252  amino  acids 
in  length  with  a  predicted  molecular  weight  of  25,274  D.  The  OtcD-ORF3  gene 
product  has  an  average  21.8%  amino  acid  sequence  identity  and  43.6%  amino 
acid  sequence  similarity  with  FAS-type  ketoreductases,  such  as,  NodG  (nod  G) 
from  Rhizobium  meliloti  (Fisher  et  al.,  1987)  and  E.  coli  FabG((3-ketoacyl  acyl  carrier 
protein  reductase)  (Cronon  et  al.,  1992).  A  much  greater  similarity  to  type  II  PKS 
ketoreductases  was  seen,  including  OtcY-ORF1  (Thamchaipenet;  1994),  DauB  (Ye 
et  al.,  1994),  ActIII  (Hallam  et  al.,  1988),  Gra-ORF5  and  Gra-ORF6  (Sherman  et  al., 
1989)  as  shown  in  figure  3.5.  The  function  of  the  ActIII  gene  product  has  been 
determined  genetically,  (Bartel  et  al.,  1990),  and  shown  to  reduce  a  keto  group  at 
position  C-9  from  the  carboxy  terminus  of  the  actinorhodin  molecule.  The 
sequence  similarity  suggests  that  the  function  of  OtcY-ORF1  is  similar  to  that  of 
actill,  performing  the  reduction  at  position  C-9  in  the  OTC  molecule.  In  these 
amino  acid  sequences  there  is  a  consensus  NADP(H)  binding  motif,  Gly-X-Gly- 
X-X-Ala  (where  X  is  any  amino  acid)  (Scrutton  et  al.,  1990).  This  was  proposed  as 
a  consensus  NADP(H)  binding  motif  in  putative  ketoreductases  (Hopwood  and 
Sherman;  1990).  However,  this  motif  is  not  conserved  at  the  same  position  in 
other  reductases.  It  was  proposed  that  another  conserved  motif,  Gly-3(X)-Gly-X- 
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Gly-3(X)-Ala-6(X)-Gly,  which  was  conserved  near  the  N-terminus  of  the  putative 
protein  was  likely  to  be  an  NADPH  binding  motif  (Thamchaipenet;  1994).  This 
consensus  sequence  has  been  found  in  all  the  aligned  sequences  (figure  3.6).  In 
the  biosynthesis  of  OTC,  three  oxidoreductase  steps  are  required.  One,  already 
mentioned  above,  at  position  C-9,  one  in  the  series  of  steps  which  ultimately 
convert  4-keto-ATC  to  ATC  and  one  at  the  last  step  of  the  pathway,  OTC 
dehydrogenase.  The  OtcD-ORF3  gene  product  has  tentatively  been  assigned  to 
the  reduction  step  at  position  C'-,  see  figure  1.10,  theS  s  %nvotv,  a  ,n  -we  C 
RTC-  however,  gene  disruption  experiments  would  help  to  confirm 
this  function. 
The  second  ORF,  OtcD-ORF4  encodes  a  protein  of  258  amino  acids  with  a 
predicted  molecular  weight  of  28,571  D.  It  shows  good  end-to-end  similarity, 
(79.7%),  with  ORF1  in  the  lkmB  region  of  the  gene  cluster  for  biosynthesis  of 
daunorubicin  from  S.  griseus  (Krügel  et  al.,  1993).  Mutations  in  this  region  of  the 
S.  griseus  cluster  were  confirmed  by  complementation  analysis  of  a  gene  product 
found  early  in  the  biosynthetic  pathway.  However  no  matches  with  genes  of 
known  function  were  found  in  database  searches  and  therefore  the  function  of 
the  gene  product  could  not  be  deduced.  The  final  ORF,  OtcD-ORF5,  encodes  a 
protein  of  353  amino  acids  with  a  predicted  molecular  weight  of  38,113  D.  The 
composition  of  amino  acids.  that  make  up  this  gene  product  is  unique.  It  is  a  very 
hydrophobic  molecule  and  carries  a  series  of  repeat  sequences,  with  a  consensus 
of  LRGAD,  close  to  the  C-terminus.  The  significance  of  this  region  is  not  readily 
apparent  but  the  evenly-spaced  leucine  residues  and  a  secondary  structure  of  a 
helix-turn-helix  in  the  protein  suggests  that  it  may  be  involved  in  bending  of 
DNA  or  binding  of  protein  to  DNA  (Csank  et.  al.,  1992).  Further  searches  of  the 
databases  revealed  a  strong  similarity  to  a  B.  subtilis  gene  product  of  unknown 
function.  The  region  of  similarity  was  confined  solely  to  this  LRGAD  consensus 
region,  adding  credibility  to  the  premise  that  the  motif  is  important. 
Hybridisation  studies  using  OtcD-ORF5  as  a  probe  to  DNA  of  S.  peucetius  and  S. 
galilaeus  produced  positive  results.  The  antibiotic  dusters  of  both  strains  are 
currently  being  studied  and  as  a  result  of  the  hybridisation  results  with  OtcD- 
ORF5,  comparative  studies  should  reveal  ORFs  with  substantial  similarity. 
Preliminary  transcriptional  analysis  of  the  recently-sequenced  region 
between  the  Kpnl23  to  PvuII26a  (figure  6.1)  was  undertaken  with  the  premise  that 
all  three  ORFs  were  part  of  the  same  polycistronic  message  originating  from 
OtcY2-ORF1  (Thamchaipenet;  1994).  Previous  work  by  Thamchaipenet  (1994) 
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showed  that  OtcY2-ORF1,  OtcD-ORF1  and  OtcD-ORF2  were  all  contained  on  the 
same  message  reading  in  the  same  direction  and  upstream  of  the  three  ORFs 
sequenced  here.  The  3.0  kb  region  was  divided  into  three  sections  and  mapped 
using  low-resolution  S1  protection  assays.  OtcD-ORF3  and  OtcD-ORF4  -,,,,  ere 
found  to  be  transcribed  in  the  same  direction  as  the  above  mentioned  ORFs  and 
are  transcribed  from  the  same  6.2  knt  polycistronic  message.  A  very  stable 
stemloop  structure  was  found  immediately  downstream  of  the  OtcD-ORF4  gene 
product  and  high  resolution  mapping  confirmed  that  a  mRNA  does  end  in  this 
region.  In  vivo  assays  are  warranted  to  confirm  that  the  terminator  is  active.  This 
can  easily  be  done  using  promoter  probe-type  constructs.  The  potential 
terminator  is  placed  between  a  promoter  and  reporter  gene  and  the  level  of 
termination  is  measured  by  the  relative  decrease  in  gene  expression  (Ingham  et 
al.,  1994).  The  third  ORF,  OtcD-ORF5  did  not  produce  a  transcript  under  the 
conditions  during  which  the  RNA  was  isolated,  40  hours  after  inoculation.  The 
OtcD-ORF5  region  has  proved  to  be  very  interesting.  Sequence  analysis  shows  a 
potential  promoter  region  upstream  with  good  agreement  to  the  consenus 
sequences  of  the  -10  and  -35  regions  of  Streptomyces.  There  is  no  sequence 
similarity  with  any  other  Streptomyces  gene  products  in  the  database.  However,  a 
potential  variation  on  a  leucine  zipper  motif  cannot  be  ruled  out.  Leucine 
zippers  have  been  associated  with  regulatory-type  functions  of  proteins.  An 
activator  has  not  been  located  within  the  otc  duster  to  date,  and  following  the 
general  layout  of  other  streptomyces  antibiotic  clusters,  such  as  actII  of  the 
actinorhodin  duster  (Fernandez-Moreno  et  al.,  1991),  one  would  expect  to  find 
one.  A  repressor  that  shows  good  similarity  to  multidrug  resistance  repressors  in 
E.  coli,  has  been  located  next  to  the  OtrB  resistance  gene  and  the  cluster  could 
therefore  be  negatively-regulated.  Most  clusters  contain  more  than  one 
regulatory  mechanism  so  it  possible  that  there  will  be  an  activator  as  well. 
Further  time-point  analysis  of  the  RNA  will  be  required  to  determine  if  this  gene 
is  transcribed  and  then  potential  knock-out  experiments  can  be  performed  to 
help  determine  its  function. 
Recombinant  DNA  technology  has  used  E.  coli  as  the  primary  host  of 
manipulation  of  DNA.  The  reasons  for  the  use  of  E.  coli  as  the  primary  host  arise 
from  its  rapid  growth  rate  and  simple  techniques  for  isolation  of  DNA. 
Streptomyces  molecular  biology  cannot  benefit  directly  from  these  advances 
because  of  the  restrictive  nature  of  the  hosts.  Most  E.  coli  strains  tend  to 
methylate  adenine  at  the  N6  position  in  the  sequence  5'  GATC  3'  and  cytosine  at 
the  C5  or  N4  position  in  the  sequence  CCA/TGG  (Sambrook  et  al.,  1989).  A 
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number  of  Streptomyces  strains  encode  a  restriction  system  which  will  digest 
DNA  containing  either  5-methylcytosine  or  N6-methyladenine.  Mac.  eil  et  al., 
(1988),  investigated  the  restriction  systems  of  a  number  of  Streptomyces  strains, 
with  particular  emphasis  on  S.  avermetilis.  Of  the  nine  Streptomyces  spp.  tested, 
seven  strains  had  methyl-dependent  restriction  systems,  including  S.  coelicolor 
and  S.  lividans.  Only  S.  avermetilis  restricted  DNA  modified  at  either  N6meA  or 
5meC.  The  other  methyl-dependent  strains  restricted  DNA  methylated  only  at 
one  site.  S.  lividans,  although  restrictive  to  DNA  methylated  at  N6meA,  has  a 
very  weak  restriction  barrier  and  can  accept  DNA  derived  from  E.  coli  with  little 
affect  on  transformation  efficiencies  and  therefore  has  become  a  popular 
Streptomyces  host.  Three  E.  coli  hosts  were  used  to  investigate  the  S.  rimosus 
restriction  system;  ET12567,  which  produces  unmethylated  DNA,  CB51,  which 
produces  DNA  unmethylated  at  N6-methyladenine  sites  and  GM31,  which 
produces  unmethylated  DNA  at  5-methylcytosine  sites.  The  efficiencies  of 
transformation  of  S.  rimosus  with  the  DNA  isolated  from  these  three  E.  coli  hosts 
were  compared  with  DNA  isolated  from  a  Streptomyces  host,  S.  lividans.  DNA 
iolated  from  both  ET12567  and  GM31  showed  comparable  levels  of 
transformants  per  µg  DNA  as  DNA  isolated  from  Streptomyces 
. 
This,  along  with 
the  low  transformation  efficiencies  of  DNA  isolated  from  CB51,  indicated  that  S. 
rimosus  contains  a  methylcytosine-specific  restriction  system.  High-  and  low- 
copy  number  plasmids  tested  revealed  a  consistent  103  drop  in  efficiency  for  the 
low-copy  number  plasmids.  This  is  not  observed  with  S.  lividans  or  another  S. 
rimosus  strain  R6  U.  Pigac;  pers.  comm.  ).  No  explanation  is  readily  available  but 
this  precludes  the  use  of  low-copy  number  plasmids  in  any  integration  strategies. 
An  increased  efficiency  in  the  transfer  of  DNA  into  the  host  S.  rimosus,  was 
desirable  before  any  attempts  at  chromosomal  integration  could  be  made.  Two 
different  strategies  were  employed.  The  first  involved  conjugal  transfer.  A  series 
of  constructs  were  made  which  contained  all  the  requirements  for  successful 
conjugation.  The  tra  locus  which  encodes  the  cell  surface  components  as  well  as 
mobilisation  proteins  (mob  gene  products),  promotes  DNA  transfer  by  interaction 
with  a  cis-acting  sequence  known  as  the  origin  of  transfer  (oriT)  (Willetts  et  al., 
1984).  Conjugation  has  been  very  successful  in  promoting  gene  exchanges 
between  distantly-related  species  (i.  e.  E.  coli  to  Entercoccus,  Bacillus,  Listeria 
Streptococcus,  and  Staphlococcus,  Trieu-Cuot  et  al.,  1987).  Of  particular  interest 
was  the  demonstration  of  conjugation  between  E.  coli  and  Streptomyces  (Mazodier 
et  al.,  1989;  Bierman  et  al.,  1992).  An  important  factor  in  this  success  is  likely  to  be 
the  transfer  of  single-stranded  DNA  during  conjugation.  Single-stranded  DNA  is 
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known  to  be  refractory  to  most  restriction  systems  (Hillemann  et  al.,  1991),  thus 
the  transfer  of  single-stranded  DNA  during  bacterial  conjugation  may  escape 
digestion  by  restriction  systems  of  recipients.  Successful  conjugal  transfer  from 
E.  coli  to  a  relatively  weakly-restricting  Streptomyces  host  has  been  demonstrated 
with  S.  lividans.  The  more  restricting  nature  of  S.  rimosus,  which  actively 
degrades  hemi-methylated  DNA,  proved  that  conjugation  was  not  a  viable 
option.  The  second  strategy  involved  improving  the  existing  transformation 
procedure.  The  advent  of  the  electrotransformation  technology  has  provided  a 
good  option  for  increased  efficiencies  of  transformation.  The  protocol  was 
developed  by  J.  Pigac  and  H.  Schrempf  (1995),  and  provided  a  much  more 
efficient  method  of  obtaining  transformants.  The  increased  transformation 
efficiency  in  itself  was  not  the  most  important  advance,  but  the  shortened 
incubation  times  for  regeneration  of  transformed  cells  has  improved 
recombinogenic  methods. 
Many  methods  for  gene  disruption  have  been  employed  for  the  numerous 
Streptomyces  spp.  It  appears  that  each  has  variations  to  accomodate  the  specific 
organism  in  question.  The  same  proved  to  be  true  with  S.  rimosus.  A  series  of 
constructs  was  made  to  introduce  a  1.7  kb  gentamicin-resistance  marker  into  the 
KpnI26  site  of  the  otc  cluster.  This  disrupted  the  OtcD-ORF3  gene  product,  a 
putative  reductase  gene.  The  construct  was  introduced  on  an  unstable  replicon, 
pIJ486.  Preliminary  evidence  indicated  that  the  plasmid  pIJ486  could  be  lost 
through  a  single  round  of  liquid  non-selection  at  89%.  The  resulting  integrants 
were  analysed  by  hybridisation  and  found  in  many  cases  to  contain  amplified 
copies  of  the  otc  cluster.  Further  analysis  revealed  that  the  amplifications  were 
also  accompanied  by  deletions  of  one  end  of  the  cluster.  OtrB  used  as  a  probe 
did  not  produce  a  signal  whereas  otrA  used  as  a  probe  did.  The  integration  event 
did  take  place  as  the  gmr  gene  was  found  in  the  S.  rimosus  chromosome. 
However,  the  loss  of  a  section  of  the  duster  was  also  found.  The  otc  cluster  has 
recently  been  located  on  the  linear  chromosome  of  S.  rimosus.  It  is  located  dose 
to  one  end  and  is  situated  between  large  direct  repeats.  Amplified  sequences 
have  been  observed  in  other  Streptomyces  strains  including  S.  lividans.  These 
unstable  amplified  sequences  are  frequently  accompanied  by  large  deletions. 
The  deletions  do  not  disrupt  the  viability  of  the  cell  and  are  therefore  thought  to 
encompass  predominately  genes  for  secondary  metabolism.  This  is  in  good 
agreement  with  the  observations  made  for  the  chromosomeS.  rimosus.  The 
integration  strategy  in  itself  is  viable.  However  the  otc  cluster  must  be  relocated 
in  the  chromosome  before  specific  gene  disruptants  can  be  obtained.  The  34  kb 
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otc  cluster  has  been  cloned  into  the  SCP2*  plasmid  and  this  could  be  introduced 
into  a  OTC-  S.  rimosus  strain.  Attempts  have  been  made  to  isolate  and  transform 
this  plasmid,  but  its  size  has  proved  to  be  very  cumbersome.  A  second  option  is 
to  introduce  the  duster  into  the  chromosome  on  a  plasmid  containing  phage 
attachment  sites.  Two  phage  attachment  sites  have  been  located  towards  the 
middle  of  the  S.  rimosus  chromosome  and  this  may  increase  the  chances  of 
integrated  single  copies. 
The  resulting  disruptions  will  then  be  replaced  with  a  copy  of  the  gene 
product  containing  a  specific  'in-frame'  mutation  which  renders  the  product  non- 
functional  and  at  the  same  time  does  not  disturb  transcription  of  any 
downstream  genes.  The  shunt  metabolites  produced  can  then  be  chemically 
analysed  to  establish  definitive  gene  functions. 
The  number  of  natural  antibiotics  used  in  human  therapy  has  decreased 
steadily  as  the  number  of  resistant  bacteria  has  grown.  Antibiotics  are  a 
fundamental  tool  in  the  fight  against  disease  and  new  strategies  in  this  battle  are 
needed.  One  approach  is  to  produce  hybrid  antibiotics.  A  number  of  antibiotic 
clusters  have  already  been  elucidated  and  as  this  number  grows  and  gene 
functions  defined,  a  concerted  effort  can  be  made  to  'mix  and  match'  gene 
functions  of  a  number  of  related  antibiotics  to  produce  a  whole  new  range  of 
genetically-engineered  products.  The  work  presented  here  is  another  step 
towards  this  goal,  using  otc  as  the  model  biosynthetic  pathway,  to  help  in  the 
battle  against  bacterial  infection. 
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